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Abstract 
Each year approximately 90,000 new cases of cancer are diagnosed in people 
of working age in the United Kingdom (UK) (Morrell & Pryce, 2005).  The 
potential impact of cancer and its treatment on working life is substantial, with 
approximately 40% of all cancer patients taking time off work during treatment 
and recovery (Short, Vasey & Tunceli, 2005).  However, little information is 
available on employment outcomes for those managing colorectal cancer.  
Colorectal cancer is a commonly diagnosed cancer with approximately 36,000 
people diagnosed each year in the UK.  Although research demonstrates 
promising return to work outcomes for this group, not enough is known about 
the factors (variables) impacting their return to work intentions, work ability and 
employment outcomes.  The aims of this research were to: examine the return 
to work intentions, work ability and employment outcomes of colorectal cancer 
patients over six months; explore the role of self-efficacy and psychosocial well-
being, and explore the role of health professionals in providing work-related 
support and information to patients.  Findings from these studies may help to 
better inform future interventions to support this cancer group.  
Fifty participants newly diagnosed with colorectal cancer were recruited from 
three Acute NHS Trusts (n = 27) across the Midlands and a support group       
(n = 23) affiliated to a National Cancer Charity.  Participants completed 
questionnaires at three time points: baseline (post surgery or pre-treatment); 
follow-up time 1 (3 months), and follow-up time 2 (6 months).  As well as illness 
and demographic characteristics, the questionnaires measured job self-efficacy, 
work ability, cancer self-efficacy, quality of life, fatigue and depression.  A sub-
sample of participants (n  = 10) completed a monthly diary over six months. 
This captured temporal fluctuations and patterns in cancer management, return 
to work intentions and work ability and the factors impacting upon these (self-
efficacy and social support).  Finally, 18 health professionals participated in 
semi-structured interviews that explored the nature and type of work-related 
advice currently provided to colorectal cancer patients.  Data were analysed 
using both quantitative (ANOVAs and regression) and qualitative techniques 
(thematic analysis).   
  i 
The questionnaire study identified varying levels in self-assessed work ability 
and psychosocial well-being.  Most importantly, positive changes in perceptions 
of cancer self-efficacy F (1.02, 61.12) = 14.70, p = 0.0005, and job self-efficacy 
F (2, 94) = 10.85, p = 0.0005 were detected over time; however, interactions 
between treatment type and time did not emerge (p > 0.05).  Factors related to 
perceived work ability outcomes cross-sectionally included type of occupation  
(β = 0.31, t = 2.65, p = 0.0005) and quality of life (β = 0.42, t = 2.57, p = 0.01) at 
baseline, treatment type (β = -0.19, t = -1.94, p = 0.05) at follow-up time 1 and 
job self-efficacy at follow-up time 1 (β = 0.57, t = 4.40, p = 0.0005) and time 2  
(β = 0.50, t = 2.92, p = 0.006).  In contrast, factors related to employment status 
(i.e. working, not working) were job self-efficacy (OR = 2.20, 95% CI:            
1.17 – 4.13) at baseline and occupation (OR = 0.03, 95% CI: 0.00 – 0.86), and 
perceived work ability (OR = 3.05, 95% CI: 1.00 – 12.80) at follow-up time 2.  
Along with self-assessed work ability at baseline (β = 0.67, t = 3.99,                     
p = 0.0005), receiving chemotherapy alone or a combination of treatments (i.e. 
other than surgery alone) (β = -0.24, t = -1.99, p = 0.05) were the strongest 
predictors of follow-up work ability (independent of age and occupation).  
Finally, treatment type (OR = 9.91, 95% CI: 1.57 – 62.50) was also identified as 
the strongest predictor of employment status approximately six months after 
diagnosis. 
Findings from the diary study suggest that self-efficacy beliefs were important in 
understanding employment outcomes and return to work intentions.  The role of 
such beliefs was multi-faceted and results infer that several factors seemed to 
impact return to work intentions and self-efficacy temporally.  Treatment, 
symptoms and decrements in perceived work ability were identified as the most 
prominent factors that served as barriers preventing resumption of work.  
Moreover, there was a degree of disparity between return to work intent and 
work ability.  Additionally, the diary study identified variation in work-related 
advice and guidance provided to colorectal patients.  Subsequently, some 
participants may have been under the impression that they were unable to 
work, especially during treatment.    
  ii 
Results from the interview study found that health professionals attempted to 
provide guidance to working-aged patients.  However, the nature of such 
guidance varied due to experience, knowledge and time constraints.    
Furthermore, participants highlighted a lack of knowledge and an insufficient 
evidence base were barriers to providing more appropriate guidance.  The 
majority of participants stated that this was an aspect of patient care that falls 
short and to address the issue a concerted multi-disciplinary effort was required.   
In short, the findings indicate that the factors related to work ability, return to 
work intentions and employment outcomes of colorectal cancer patients varied 
over time, whereby certain variables took precedence over others at particular 
time points.  Furthermore, the results suggest that self-efficacy beliefs are 
important; however, it is crucial to point out that self-efficacy is unlikely to 
operate as a stand-alone factor.  Indeed, it is argued that it may be a construct 
that is considered in future research endeavours alongside pre-existing findings, 
which would inevitably help towards gaining a more comprehensive account of 
the factors related to the work outcomes of individuals affected by cancer.   
Key words: Cancer, colorectal, self-efficacy, work ability, employment 
outcomes, return to work intentions, psychosocial well-being. 
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Chapter 1 
 
1. Colorectal Cancer, its Treatment and Psycho-Oncology 
1.1. Introduction 
The aim of the following chapter is to provide some background regarding 
cancer and the associated treatment(s); this is necessary to understand how 
these factors may impact an individual’s work ability and return to work 
outcomes.  Firstly, the chapter will present a brief overview about cancer and 
the key statistics associated with the disease, particular attention will be paid to 
commonly diagnosed cancers.  Secondly, the chapter will move on to consider 
colorectal cancer in more detail as this cancer type will form the focus of this 
thesis.  In particular, how it is diagnosed, staged and treated will be discussed.  
Thirdly, the physical effects of treatment and psychosocial impacts of cancer will 
be considered as these have been shown to be important in understanding 
illness management and employment outcomes.  At present, little is known 
about how such factors may impact those affected by colorectal cancer.  Finally, 
the possible role of self-efficacy (perceived self-beliefs in ability to perform a 
task or behaviour) as a psychosocial factor, that has not previously been 
considered, especially in relation to understanding work outcomes of cancer 
patients, will be discussed.   
1.2. Overview of Cancer 
Statistics indicate that approximately a quarter of a million persons are 
diagnosed with cancer each year in the UK; this approximates to 1 in 3 people 
(Cancer Research UK, 2006a).  In order to understand how cancer affects 
people, it is important to begin by providing a brief overview about the nature of 
cancer and to present some of the important statistics associated with the 
disease.  In doing so, prognosis, treatment effects and impacts on quality of life 
outcomes, including quality of working life, can then be understood. 
  1 
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1.3. What is Cancer? 
Cancer is a group of diseases affecting the cells of the body.  It arises when the 
processes governing cell growth and division in the human body become out of 
control (Cancer Backup, 2007).  Normally, as cells grow old and die, new cells 
are formed to replace them; however, in some cases the cells continue to divide 
which leads to the formation of a lump that is known as a tumour.  Tumours can 
be benign or malignant where the latter are cancerous; malignant tumours 
comprise of cells that have the ability to spread to different areas and, if left 
untreated, these cells can spread to the surrounding tissues and organs via the 
bloodstream and lymphatic system (Cancer Backup, 2007).  If these cells reach 
a new area they can continue to divide leading to another tumour: this new 
tumour is known as a secondary cancer or metastasis (Cancer Backup, 2007).  
As the human body is made up of many types of cells, it is not surprising that 
there are over 200 different types of cancer each with their own type of 
diagnosis, treatment and prognosis (Cancer Backup, 2007).   
1.4. Commonly Occurring Cancers: The Key Statistics 
Statistics from the UK show breast, lung, bowel (colorectal) and prostate 
cancers account for more than 50% of all new cases (Table  1.1) (Cancer 
Research UK, 2006a).  Commonly diagnosed cancers in men are prostate 
(23%), lung (16%), colorectal (14%) and bladder cancer (5%) (Cancer Backup, 
2007); for women, breast (31%), colorectal (11%), lung (11%) and ovarian 
cancers (5%) are the most common (Cancer Backup, 2007).  Age is a risk 
factor for most cancers with 64% of cases observed in those aged 65 years and 
above (Cancer Research UK, 2006a).  However, 1 in 10 cancers are diagnosed 
in those aged between 25 and 50 years (Cancer Research UK, 2008), with 
women aged between 30 and 50 years at more risk of developing cancer than 
their male counterparts.  Colorectal cancer incidence is highly associated with 
increasing age (Cancer Research, 2006c; 2006d).  Bowel Cancer UK (2006) 
report that 90% of people diagnosed with colorectal cancer are aged over 55 
years (average age of 70 years), although, colorectal cancer diagnoses are also 
on the increase in younger persons (Bowel Cancer UK, 2006).   
 
 
 
Chapter 1                     Colorectal Cancer, its Treatment & Psycho-Oncology 
 
  3 
Table  1.1: Incidence of five most common cancers in UK, 2004 (Cancer Research UK, 2006a). 
Cancer Type Male Female % of total cancer population 
Breast 
 
324 
 
44335 
 
15.69 
Lung 
 
22495 
 
15818 
 
13.46 
 
Colorectal 
 
19657 
 
16452 
 
12.69 
 
Prostate 
 
34986 
 
0 
 
12.29 
 
Bladder 
 
7168 
 
2925 
 
3.55 
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Despite the increasing prevalence and incidence of cancer, the outlook for 
those diagnosed with cancer appears to be promising.  Due to improvements in 
detection and treatment cancer survival rates have increased dramatically in the 
last ten years (Cancer Research UK, 2006a).  In particular, for men, the highest 
five-year survival rates are associated with testicular cancer whereas for women 
it is malignant melanoma (Figure  1.1) (Cancer Research UK, 2007).  When 
considering commonly diagnosed cancers, the estimated relative five-year 
survival rate for breast cancer is approximately 80% (Cancer Research UK, 
2005a; 2006e; 2007).  For colorectal cancer, the five-year relative survival rate 
has doubled between the 1970s and 1990s (approximately 23% to 50%); 
however, if diagnosed early these rates are reported to be as high as 83% 
(Cancer Research UK, 2006e).  In contrast, the survival rates for lung cancer 
are low, with only 25% likely to survive one year after diagnosis (Cancer 
Research, UK 2007).     
The prior discussion sought to provide an insight into cancer in a general sense.  
However, the focus of this thesis is on colorectal cancer.  At present, little 
information is available on those managing colorectal cancer, particularly in 
relation to their work outcomes.  Each year approximately 36,000 people are 
diagnosed with colorectal cancer in the UK (Bowel Cancer UK, 2006); this is the 
second most commonly diagnosed cancer in women and the third most 
commonly diagnosed in men (Cancer Backup, 2007).  Due to improvements in 
bowel cancer screening, detection, treatment and, therefore, survival, research 
in this area is important for the following reasons.  Firstly, although colorectal 
cancer is diagnosed with increasing age (90% diagnosed are over 55 years, 
Bowel Cancer UK, 2006) a proportion of these will be working and due to falling 
birth rates and people living longer, Government and policymakers are 
encouraging people to work for longer (Centre for Research in the Older 
Workforce, 2004).  Secondly, as well as undergoing chemotherapy or 
radiotherapy treatment, surgical treatment may result in life changes (e.g. stoma 
appliance) which, in turn, may impact colorectal cancer patients’ ability to 
resume everyday activities such as continuing with or returning to work.  
Currently, there is very little information for employers and patients on this 
aspect.  Finally, few studies have considered the key psychosocial factors that 
  4 
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may impact upon work ability for colorectal cancer (e.g. self-efficacy, social 
support and treatment). 
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Figure  1.1: Five year age standardised relative survival (%), adults diagnosed 1996-1999, 
England and Wales by sex and site (Cancer Research UK, 2007). 
The following discussion will describe this type of cancer, the apparent risk 
factors and causes, diagnosis (staging) and treatment in more detail.  It is 
necessary to provide this background prior to moving on to the next chapter 
which will aim to discuss how cancer has been reported to impact ability to work 
and return to work outcomes. 
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1.5. Colorectal Cancer 
Colorectal cancer (cancer of the large bowel) refers to growths, lumps or 
tumours that arise in the colon and rectum which make up the large bowel.  T
bowel wall consists of numerous layers; these cancers start to develop in th
innermost layer (bowel lining).  If left untreated or undiagnosed the cancer can 
spread through the layers and eventually pass through the bowel wall (Cance
Research UK, 2002).  According to Cancer Research UK (2002), bowel cancer
can take between 5 and 10 years to develop, beginning predominantly as 
polyps / adenomas (bowel wall growths).  Statistics indicate that two-thirds of 
colorectal cancers are diagnosed in the colon and one-third in the rectum 
(Cancer Backup, 2007a).  To understand colorectal cancer, it is appropriate to 
outline the parts of the body involved and how they function normally.  The 
bowel (see 
he 
e 
r 
 
Figure  1.2), is part of the digestive system and is often referred to as 
the gastrointestinal tract (GI tract).  It is split into the small bowel (small 
 rectum; this is where 
 the 
 
to 
dy can utilise (Cancer Research UK, 2002; 
Cancer Backup, 2007a).  This process begins once food has passed down the 
esophagus to the stomach.  The small bowel then absorbs the essential 
nutrients from the food.  The digested food is then passed through the large 
bowel where the colon absorbs water from the food and the rectum stores 
waste matter until it is ready to be passed from the body (Cancer Research UK, 
2002; Cancer Backup, 2007).  The large bowel consists of five sections (see 
Figure  1.2).  Cancer can arise in any of these areas: 1) the ascending colon – 
starts at the appendix at the bottom of the small bowel and runs up the right-
hand side of the abdomen; 2) the transverse colon – goes across the body;     
3) the descending colon – goes down the abdomen to the sigmoid colon; 4) the 
sigmoid colon – this joins the descending colon to the rectum, and 5) the rectum 
intestine) and the large bowel, comprising of the colon and
the majority of bowel cancers are diagnosed; cancer of the small bowel, on
other hand, is rare (Cancer Research UK, 2002).  The large bowel (colon) is 5 
feet long and surrounds the small bowel which is approximately 20 feet long:
the small bowel is narrower than the large bowel, hence the name.  The 
digestive system processes food that has been consumed, converting it in
energy and nutrients that the bo
o
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– this is the  through 
e anus.   
 of 
age: 90% of those diagnosed are aged over 55 years (Bowel Cancer UK, 
007).  Prior history of colorectal cancer also leads to an increased risk 
(Cancer Research UK, 2002).  
 back passage where waste matter is held until it is passed
th
1.5.1. Risk Factors and Causes of Colorectal Cancer 
The causes of colorectal cancer are still largely unknown (Cancer Backup 
2007a), although it has been reported that certain individuals are more at risk
developing colorectal cancer than others.  The most prominent risk factor is 
2
 
 
Figure  1.2: Diagram of the large bowel (Cancer Backup, 2007a). 
 
An additional risk factor is family history: it is estimated that between 5% and 
10% of those diagnosed with bowel cancer (in the UK) have a family histor
the illness (Bowel Cancer UK, 2007).  However, this risk is contingent upon 
certain cond
y of 
itions: if bowel cancer is diagnosed in a first degree relative under 
the age of 45 years, or is diagnosed in several members of the same family 
 (Cancer Backup, 2007; Cancer Research UK, 2002; Bowel Cancer UK, 2007).
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There are two inherited genetic conditions that increase colorectal ca
risk: Familial Adenomatous Polyposis (FAP) and Hereditary Non-Polyposis
Colon Cancer (HNPCC) (Cancer Backup, 2007; Cancer Research UK, 2002
Bowel Cancer UK, 2007).  FAP causes benign tumours known as polyps in the 
large bowel.  Over time these polyps can become cancerous particularly by the
age of 40 to 50 years (Cancer Research UK, 2002).  FAP can arise in those 
without a family history of the condition.  HNPC
ncer 
 
; 
 
C is another rare inherited 
genetic condition where the healthy form of this gene aids DNA repair.  
of developing 
 
estingly, 
rch 
There is some evidence to suggest that individuals affected by inflammatory 
hn’s disease which cause 
diet 
 
sk of developing the disease (Cancer 
Research UK, 2002; Cancer Backup, 2007a).  
, 
staged and treated.  This is because the stage of a colorectal cancer is likely to 
Therefore, possessing the faulty gene leads to an increased risk 
various cancers with the highest risk being associated with developing bowel 
cancer (Cancer Research UK. 2002).  Both FAP and HNPCC account for 1 in 
20 bowel cancers (Cancer Research UK, 2002; Cancer Backup, 2007a).  Non-
inherited risk factors such as benign polyps and / or adenomas (growths in the
bowel) can also lead to bowel cancer.  In fact, it has been suggested that most 
bowel cancers develop from these (Cancer Research UK, 2002).  Inter
1 in 4 has one or more adenomas by the age of 50 years but only a small 
number will develop into cancer over a long period of time (Cancer Resea
UK, 2002). 
bowel diseases such as ulcerative colitis or Cro
inflammation of the large bowel have an increased risk of developing colorectal 
cancer (Cancer Backup, 2007a).  Additionally, it has been suggested that a 
high in animal fat and proteins and low in fibre may increase the risk of 
developing colorectal cancer (Cancer Backup, 2007a; Chao et al., 2005).  
However, there is research to counteract this argument (Park et al., 2005).  
Likewise, those participating in behaviours such as smoking (American Cancer
Society, 2000), consuming large amounts of alcohol (Su & Arab, 2004) and a 
sedentary lifestyle may be at a higher ri
1.5.2. Colorectal Cancer Diagnosis, Staging and Treatment 
For this thesis, it is important to understand how colorectal cancer is diagnosed
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determine a patient’s treatment pathway which in turn may have implica
prognosis and subsequently impact upon return to work intentions, work abi
and employment outcomes.  More specifically, staging will determine the exten
of the cancer (local / spread / nodal involvement) and the subsequent 
treatment(s) that will be administered to the patient.  Hence, this will allow one 
to gain an insight into the extent to which these factors may impact upo
individuals’ ability to work, their return to work intentions and other employme
outcomes.         
Diagnosis and Staging of Colorectal Cancer 
Colorectal cancer can take many years to develop.  However, the earlier it is
diagnosed the greater the likelihood it can be cured.  The symptoms of 
colorectal cancer are similar to those associated with more common bowel 
conditions (e.g. Irritable Bowel Syndrome, Inflammatory Bowel Disease).  The
may include: abnormal bow
tions on 
lity 
t 
n 
nt 
 
se 
el habit, blood in stools, weight loss, abdominal 
pain, fatigue, anaemia, vomiting, constipation and a feeling of bloatedness 
l 
netic 
se 
t by the radiologist and fed back to colorectal 
consultants to decide how the patient will be treated), and 7) Computerised 
hy – which involves inserting a colonoscope into 
Additional tests are often used 
(Cancer Backup, 2007a).  A number of tests can be used to diagnose colorectal 
cancer including:  
1) Proctoscopy – involves inserting a small tube (proctoscope) into the back 
passage to examine the inside lining of the rectum; 2) Sigmoidoscopy – 
involves using a camera and light to examine the rectum and colon; 3) Faeca
Occult Blood Test – investigates the presence of blood in the stools; 4) 
Colonoscopy – this lighted probe is inserted into the rectum and allows the 
whole colon to be looked at.  The test involves taking images and biopsies of 
the cells (Cancer Backup, 2007a); 5) Barium enema – this is an x-ray of the 
large bowel; 6) Magnetic Resonance Imaging (MRI) scan -  this uses mag
and radio waves to build up images of all the tissues in the body.  It is 
particularly useful in providing an initial indication of the stage of the disea
(this staging is carried ou
tomography (CT) colonograp
the bowel where a computer uses CT images to examine the area (Cancer 
Backup, 2007a; Cancer Research UK, 2008).  
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once cancer has been identified to find out the precise size and location, the
include: b
se 
lood tests; chest x-rays; abdominal ultrasound scan, and CT scans 
(Cancer Backup, 2007a). 
The staging of a cancer indicates the size of the tumour, whether it has spread, 
ne the prognosis and survival rate (Cancer Research UK, 2002; Cancer 
Backup, 2007a).  This is relevant to the present study as the type and number 
act the resumption of normal 
activities including ability to work.  Studies have found that the more treatment 
worse the impact on work ability and return to work 
 Boer 
 
The Dukes Staging System 
 liver 
the type (and order) of treatment an individual will undergo and helps to 
determi
of treatments an individual undergoes is likely to have far reaching implications 
for example, on prognosis which in turn will imp
an individual undergoes the 
outcomes (Bradley, Neumark, Luo, & Schenk, 2007; Amir et al., 2007; de
et al., 2008).  There are two staging systems used to identify the stage of a
cancer: The Dukes staging system and the TNM staging system.  These 
staging systems are often used interchangeably and consultants often refer to 
one or both systems when discussing the stage of a tumour.  These are 
described briefly below: 
This staging system was introduced by Dr. Cuthbert E. Dukes (1932), which 
stages colorectal cancer in the following way: 
Dukes A – The cancer is only affecting the innermost lining of the colon or 
rectum. 
Dukes B – The cancer has spread to the muscle layer of the colon or rectum. 
Dukes C – The cancer has spread to at least one of the lymph nodes near the 
bowel. 
Dukes D – The cancer has spread to another part of the body such as the
or the lungs (metastases / secondary cancer). 
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The TNM Staging System  
The TNM staging system (Tumour, Node, Metastases) is becoming the 
commonly adopted method for staging a cancer (Wittekind & Sobin, 2002; 
search UK, 2002).  The staging system 
ph 
 the tumour the 
poorer the prognosis is.  Table 1.2 shows approximate five-year relative survival 
 
The table shows the majority (35%) of colorectal cancers are diagnosed at 
Dukes’ stage B; whereas only 11% are diagnosed at the earliest possible stage 
( hen conside t o s 
with Dukes’ A or B colorectal cancers are more likely to recover, have a better 
prognosis and be able to resume near normal daily activities such as returning 
to work than individuals affected by Dukes’ C or D cancer.  Furthermore, the 
perceived work ability of those with earlier stage disea is likely to be better 
and more comparable with pre-cancer levels than those with later staged 
ber of treatment types individuals will 
undergo is another important factor that is likely to impact perceived work ability 
The treatment of colorectal cancer is selected according to the stage and 
ave 
lter 
n 
Cancer Backup, 2007a; Cancer Re
identifies the size of the tumour (T), the presence of cancer cells in the lym
nodes (N) and whether the cancer has spread to another part of the body (M).  
Please refer to Appendix 1 where more detailed information regarding this 
staging system is provided.  
Staging will determine whether the affected individual is treated with curative 
intent or with a palliative approach.  Thus, the more advanced
rates associated with the Dukes’ staging system (Cancer Research UK, 2006e). 
Dukes’ A).  W ring this within the contex f this study, individual
se 
disease.  Treatment, particularly the num
and work outcomes in the current study. 
Treatment of Colorectal Cancer 
location of the cancer in the bowel (Cancer Backup, 2007a).  Colon and rectal 
cancers are often treated using different methods.  Different treatments h
been reported to have varying affects on quality of life (Gruber et al., 2003; 
Kennedy, Haslam, Munir & Pryce, 2007), return to work outcomes (Buckwa
et al., 2007; Balak et al., 2008) and work ability (Taskila, Martikainen, Hietane
& Lindbohm, 2007; de Boer et al., 2008; Drolet et al., 2005). 
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Table  1.2: Approximate frequency and five-year relative survival (%) according to Dukes’ 
Stage (Cancer Research UK, 2006e). 
Dukes’ Stage Approximate frequency at 
diagnosis (%)
Approximate five-year 
survival (%)
A 11 83
B 35 64
C 26 38
D 29 3
 
Specifically, more profound adverse affects are reported in those undergoing 
more than one treatment modality (Bradley, Oberst & Schenk, 2006).  Table 1.3 
summarises the different treatments usually given to colorectal patients. 
The treatment pathway varies according to colon and rectal cancers, thus, each 
will be considered separately.  For colon cancers, surgery is commonly 
undertaken to remove the part of the bowel (colon) containing the cancer.  The 
type of surgery is dependent upon the location of the cancer.  Procedures 
include total-colectomy (removal of colon), hemi-colectomy (half of the colon 
removed), sigmoid-colectomy (sigmoid colon removed), or a transverse 
colectomy (transverse colon removed).  These procedures also remove nearby 
lymph nodes which are checked to see if the cancer has spread (Cancer 
Backup, 2007a).  Patients are often advised to rest for at least six weeks after 
surgery (advised not to drive for this amount of time).  However, this varies 
based upon the patient’s characteristics, including the nature of his / her 
employment.  Furthermore, subsequent treatments may also impact an 
individual’s work outcomes.  For those whose cancer is in the early stages 
(Dukes’ A), surgery alone is usually sufficient; for those with more advanced 
stage bowel cancer (Dukes’ B or C) chemotherapy is often given to reduce the 
risk of recurrence, particularly if the cancer has spread to nearby lymph nodes 
(Cancer Backup, 2007a).   
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 Surgery Chemotherapy Radiotherapy Monoclonal Antibodies
 
Early Stage Colon Cancer
 
Surgery can often remove 
the cancer.  Those whose 
cancer is confined to the 
inner lining of the bowel 
rarely need other treatment.
 
Chemotherapy is often given 
to those whose cancer may 
have grown into the muscle 
layer, to prevent recurrence.  
This is given after surgery.  
Chemotherapy is often given 
to those with lymph node 
involvement (after surgery). 
 
  
Often given with 
chemotherapy to destroy the 
cancer cells. 
 
Rectal Cancer
 
Surgery is used to remove 
the cancer. 
 
Chemotherapy can be 
combined with radiotherapy 
(chemoradiotherapy), and 
administered prior to surgery 
to shrink the cancer. 
 
 
Radiotherapy can be given 
prior to surgery. 
 
 
Advanced Colon Cancer 
- Cure not usually possible.  
Therefore, treatments are 
given to control the cancer 
and alleviate symptoms. 
 
 
Surgery can remove some of 
the cancer cells, or 
secondary cancers. 
 
Chemotherapy is commonly 
given to control the disease 
for a length of time.  It can 
also reduce symptoms. 
  
  
Can be used to control the 
advanced disease. 
 
Advanced Rectal Cancer 
- Cure not usually possible.  
Therefore, treatments are 
given to control the cancer 
and alleviate symptoms. 
 
 
Surgery can remove some of 
the cancer cells, or 
secondary cancers. 
Radiotherapy is commonly 
used to shrink the tumour, 
which is causing discomfort 
(palliative radiotherapy). 
 
Table  1.3: Treatment according to type of colorectal cancer. 
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For those with rectal cancer, surgery is conducted to remove the tumour (where 
possible).  Those with rectal cancers are more likely to be left with a colostomy 
because of less healthy bowel remaining (Cancer Backup, 2007a).  Rectal 
surgical procedures include: anterior resection (upper rectal tumours) or 
abdominal-perineal resection (lower rectal tumours).  Radiotherapy is often 
given prior to, or following, surgery.  Prior to surgery, five sessions over a week 
can help to shrink the tumour, allowing it to be removed more easily during 
surgery.  Like chemotherapy, radiotherapy is also given to try and prevent the 
cancer from recurring (Cancer Backup, 2007a).  A larger tumour usually 
requires a longer course of radiotherapy treatment and is often combined with 
chemotherapy (chemoradiotherapy) (Cancer Backup, 2007a).  Radiotherapy 
after surgery is administered if cancer cells are still present, or if the cancer has 
passed into the bowel wall or nearby lymph nodes (Cancer Backup, 2007a).   
For those whose colorectal cancer has surpassed to an advanced stage and 
spread to other areas, for example, the liver or lungs (metastatic disease), cure 
is not usually attainable (Cancer Backup, 2007a; Cancer Research UK, 2007).  
Therefore, palliative treatment is provided in an attempt to control the cancer for 
as long as possible and treatment is given to alleviate symptoms experienced 
by the patient.  
Consequently, for patients undergoing more than one treatment modality, it is 
likely that the impact on an individual’s normal routine (including work decisions) 
may be more profound than those undergoing surgery alone.  For example, 
those undergoing chemotherapy and / or radiotherapy may experience 
treatment side effects such as fatigue, nausea, diarrhoea and reduced 
resistance to infection.  Therefore, the implications of treatment can be far 
reaching for an individual; for instance, an individual’s work environment may 
prevent them from returning or continuing with work due to the risk of infection 
(Cancer Research UK, 2008a).  Being left with a colostomy (if bowel cannot be 
rejoined upper part is brought out onto the abdominal wall) or ileostomy (end of 
small bowel is brought onto of the abdominal wall) after surgery may also have 
implications for work outcomes, particularly for those formerly in physically 
demanding or manual work who may experience problems such as bag 
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leakages (Cancer Research UK, 2008b).  Although the treatment types 
colorectal patients undergo are similar to other cancer types, the effects are 
somewhat different; these include altered bowel habits which can take time to 
return to normal after surgery.  At present, the impact of colorectal cancer and 
the associated treatment effects and outcomes (e.g. colostomy / ileostomy) 
upon work ability and work outcomes have not been considered.  The following 
section will move on to consider some of the physical effects and psychosocial 
impacts experienced by persons affected by cancer and its associated 
treatments.  
1.6. Physical Effects and Psychosocial Impacts of Cancer 
Numerous studies have examined the physical effects and psychosocial 
impacts of cancer on quality of life outcomes.  Evidence suggests many cancer 
patients experience nausea, pain, fatigue, depression, poor quality of life, low 
self-esteem and stigma as a result of their cancer diagnosis, treatment and 
recovery (Spelten et al., 2003; Short, Vasey & Tunceli, 2005; Pasquini et al., 
2006).  It is important to understand the extent and nature of these effects as 
they are likely to have implications on work ability and return to work intentions.  
For example, those experiencing symptoms of fatigue may perceive that their 
work ability is poor, which in turn prevents them from being able to return to 
work, or it may take them longer to return to work compared with someone not 
experiencing such symptoms (Spelten et al., 2003).  Evidence suggests that the 
more side effects or symptoms experienced can exacerbate detrimental effects 
on work ability and work outcomes (Spelten, Sprangers & Verbeek, 2002).  The 
most commonly occurring physical side effects and psychosocial impacts are 
discussed in more detail below.  
1.6.1. Physical Effects 
This section will consider the most common physical side effects associated 
with different types of cancer treatment.  Where possible, those side effects 
reported specifically in colorectal cancer patients will be discussed.  It is likely 
that physical effects vary from person to person (Cancer Research UK, 2008a).  
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One individual may experience more physical effects whilst undergoing 
treatment than someone else, or to a higher degree. 
Surgery 
For colorectal cancer patients, surgery can lead to post-operative pain which 
can be treated with pain killers if necessary (Cancer Research UK, 2008c).  In 
addition, patients may experience problems with eating and drinking post-
operatively as it takes time for the bowel to resume its normal function (Cancer 
Research UK, 2008c).  Certain foods may affect the lining of the bowel and 
colostomy function, perhaps indefinitely.  For example, foods high in fibre can 
lead to loose stools, including diarrhoea (Cancer Backup, 2007a).  However, no 
set guidance is provided on this as people react differently to certain foods 
(Cancer Backup, 2007a).  For those with an ileostomy or colostomy, there is the 
added need to get used to their stoma appliance; this is because it can take 
several weeks for patients to learn how to fit the bags and many also 
experience problems with bag leakages (Cancer Backup, 2007a).  
Subsequently, one could argue that such problems could prevent patients 
resuming everyday activities.  For example, some individuals may be unsure or 
lack confidence in their ability to manage symptoms such as diarrhoea or 
changing a colostomy bag whilst at work.   
Chemotherapy 
Whilst chemotherapy treatment seeks to destroy damaged cells, it can also lead 
to normal cell damage which in turn can result in a number of unpleasant side 
effects (Cancer Research UK, 2008d; Cancer Backup, 2007a).  Hair (loss / 
thinning), skin and nails are often affected during chemotherapy.  Fatigue is 
also common in those undergoing chemotherapy (Spelten et al., 2003).  
Evidence suggests fatigue can worsen as treatment progresses and persist 
after treatment has ceased.  Studies have shown fatigue to impact return to 
work in those diagnosed with cancer (Spelten et al., 2003).  Cancer-related 
fatigue as a psychosocial impact of cancer is discussed in more detail further on 
(p. 18).  Physical effects relating to the digestive system such as nausea and 
diarrhoea are also reported (Cancer Research UK, 2008d).  This can add to the 
existing bowel problems colorectal patients experience due to their diagnosis 
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and surgery (Cancer Backup, 2007a).  An increased risk of infection, tiredness 
and breathlessness is also linked to the diminished ability of bone marrow to 
produce blood cells.  Furthermore, damage to the nerves can produce tingling 
in the hands and feet and this can take some time to improve (Cancer Backup, 
2007a).  Chemotherapy-related side-effects such as fatigue, nausea, reduced 
mental capacity (e.g. lack of concentration) have been shown to impact 
everyday life, including work ability (e.g. de Boer et al., 2008). 
Radiotherapy 
Radiotherapy treatment aims to destroy cancer cells in the affected area 
(Cancer Research UK, 2008e).  Like chemotherapy, normal cell damage can 
also occur (Cancer Research UK, 2008e).  Tiredness and fatigue can arise and 
persist for a number of months after treatment because the body continues to 
repair damage to healthy cells.  Radiotherapy is often administered to those 
diagnosed with rectal cancers, hence, leading to stomach and pelvic area 
physical effects, such as diarrhoea, spasms in bowel muscles, sickness and 
vomiting (Cancer Research UK, 2008f).  Moreover, radiotherapy to the large 
bowel can lead to tenesmus, which is a need to go to the toilet often (Cancer 
Research UK, 2008f).  Bladder irritation, including a burning feeling when 
passing urine, a need to pass urine often, pain and incontinence can all arise 
after radiation to the stomach and / or pelvic area in rectal patients (Cancer 
Research UK, 2008g).  Unlike chemotherapy, hair is only lost at the radiated 
area (Cancer Research UK, 2008e). 
1.6.2. Psychosocial Impacts 
A cancer diagnosis can lead to feelings of distress, anxiety, fear and anger 
(Weisman, 1976; Brothers & Anderson, 2008); some of these symptoms may 
exacerbate over time (during and after treatment) leading to symptoms of 
fatigue (Bower et al., 2000; 2006), depression (den Oudsten et al., 2009) and 
altered quality of life (Arndt et al., 2006).  These psychosocial impacts are 
commonly exhibited in cancer patients, particularly whilst undergoing treatment.  
The following discussion will therefore focus on these psychosocial factors in 
more detail.   
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Fatigue 
According to Lawrence et al. (2004), fatigue is the most distressing side effect 
of cancer treatment and the impact of fatigue has been studied extensively in 
cancer patients.  According to Curt et al. (2000), fatigue is one of the most 
common and problematic symptoms experienced by cancer patients.  
Researchers suggest cancer-related fatigue is different to normal fatigue, in that 
it is more severe, lasts longer and is not relieved by sleep (Poulson, 2001; 
Jean-Pierre et al., 2007).  Research by Cella et al. (2002) emphasises this point 
as their study found fatigue to be worse in cancer patients compared with the 
general US population.  Subsequently, Mock (2001, p. 1700) describes cancer-
related fatigue as, “an unusual, persistent, subjective sense of tiredness related 
to cancer or cancer treatment that interferes with usual functioning.”  Both 
physiological and psychological factors are considered to contribute to the onset 
and maintenance of cancer-related fatigue (Kangas et al., 2008); consequently, 
cancer-related fatigue was accepted as a diagnosis in the International 
Classification of Diseases 10th Revision Clinical Modification (Portenoy & Itri, 
1999).  However, definitions of cancer-related fatigue, operationalising 
diagnosis and assessment are not universally accepted (Kangas et al., 2008) 
rendering it difficult to compare findings across studies. 
The prevalence of fatigue during cancer treatment ranges from 25% to 99% in 
the literature.  Estimates of fatigue experienced in those undergoing either 
radiotherapy, chemotherapy, hormone therapy and biological therapy commonly 
fall between 30% and 60% (Lawrence et al., 2004).  Some continue to 
experience fatigue after treatment, for instance, Bower et al. (2000; 2006), 
reports a third of breast cancer survivors experienced symptoms at 1 to 5 years 
and 5 to 10 years post diagnosis.  Furthermore, 21% reported fatigue symptoms 
at both assessments (Bower et al., 2006); these estimates are supported in the 
literature (Cella, Davis, Breitbart & Curt, 2001).  The subsequent impact of 
fatigue on everyday life is also well documented (Curt et al., 2000).  Curt et al. 
(2000) found that 50% of cancer patients reported that fatigue impacted on 
physical and social well-being, social activity and ability to work. 
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Depression 
Depression is also frequently observed in cancer patients (Sharpley & Christie, 
2007) and can interfere with an individual’s ability to sleep, eat and work 
(Cancer Research UK, 2009).  However, unlike fatigue, it is argued to be the 
least acknowledged (and diagnosed) psychosocial impact of cancer and cancer 
treatments (Cancer Research UK, 2009a).  This is surprising as estimates of its 
prevalence are of concern with as many as 1 in 2 experiencing depressive 
symptoms (Cancer Research UK, 2009a).  However, prevalence rates of 
depression vary immensely in the literature, where estimates predominantly fall 
between 10% and 25% (Massie, 2004; Sellick & Crooks, 1999).     
The prevalence of depression varies according to cancer type and treatment 
type.  The cancer types highly associated with depression include 
oropharyngeal (Davies, Davies & Delpo, 1986; Cavusoglu, 2001), pancreatic 
(Fras, Litin & Pearson, 1967; Joffe et al., 1986), breast (Sneeuw et al., 1993; 
Sachs et al., 1995), and lung (Buccheri, 1998; Montazeri et al., 1998).    
Cancers with a less high prevalence of depression include colon (Fras et al., 
1967; Koenig, Levin & Brennan, 1967), gynaecological (Golden et al., 1991) 
and lymphoma (Devlen, Maguire, Phillips & Crowther, 1987).  Few studies have 
considered mood disturbance in patients with colorectal cancer (Ramsey et al., 
2002).  Although lower prevalence levels of depression have been reported in 
those with colon cancer (Fras et al., 1967; Koenig et al., 1967), more recently, 
Ramsey et al. (2002) report that colorectal cancer patients still exhibit 
prevalence levels of depression that exceed those seen in the general 
population.   
Regarding treatment, Schagen et al. (1999) found higher levels of depression in 
women undergoing chemotherapy for breast cancer compared with those who 
did not receive this treatment.  A recent study by Fann et al. (2009) found 
depressive symptoms were more severe during treatment when compared to 
prior treatment scores in a mixed cancer sample (N = 342).  These studies 
suggest that depression has a strong impact on cancer patients and their quality 
of life.  Subsequently, studies have found depression also affects return to work 
and work ability outcomes which will be discussed later (Cancer Research UK, 
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2009).  However, more detailed information is needed on how such symptoms 
may impact those diagnosed with colorectal cancer. 
Quality of Life 
A number of studies report that cancer and its treatment can lead to poorer 
levels of quality of life in patients (Arndt et al., 2004; 2006; Tsunoda et al., 
2007).  Quality of life is defined as, “a multidimensional concept encompassing 
behavioural competence and health, perceived quality of existence, and 
psychological well-being" (Robb et al., 2007, p. 85).  Quality of life can refer to 
specific domains of life (social function, physical function, emotional well-being) 
or to an overall evaluation of life (de Haes & van Knippenberg, 1985) and has 
become an important outcome measure for cancer patients (Arndt et al., 2004).   
Studies suggest that quality of life in cancer patients is significantly lower than 
levels seen in the general population (Arndt et al., 2004; 2005; Karadjova, 
Shishkov & Petrov, 2007; Robb et al., 2007; Ding, Zhu & Zhang, 2007).  These 
studies have investigated the quality of life of cancer patients with at least a 
year of survivorship after diagnosis or surgery (Karadjova et al., 2007; Robb et 
al., 2007; Arndt et al., 2004; 2005).   Compared with the general population, 
colorectal cancer patients showed similar quality of life scores in global and 
physical functioning, but significantly lower emotional and social functioning 
quality of life (Karadjova et al., 2007).  Similar results have been found in 
ovarian cancer patients (Ding et al., 2007) and breast cancer patients (Arndt et 
al., 2004; 2005; Robb et al., 2007).  According to Arndt et al. (2005), such 
negative impacts on quality of life can persist for three years after diagnosis.   
Treatment type may be an important factor impacting upon quality of life 
outcomes; for example, Tsunoda et al. (2007) investigated quality of life 
patterns in five domains in colorectal cancer patients each month for a year 
after surgery.  The study found quality of life in five domains (physical function, 
role function, fatigue, pain, and dyspnoea) was significantly lower at one month 
post surgery when compared with pre-operative scores (Tsunoda et al., 2007).  
Subsequent assessments found that scores for these domains returned to pre-
operative values within three months of the operation.  Overall, seven of the 
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quality of life scale scores improved within this time (global quality of life, 
emotional function, social function, insomnia, appetite loss, diarrhoea and 
financial difficulties).  Furthermore, when compared with a non-chemotherapy 
group, those undergoing adjuvant chemotherapy showed worse scores (over 12 
month period) on a number of quality of life domains (e.g. role function, physical 
function, cognitive function, emotional function, fatigue and appetite loss) 
(Tsunoda et al., 2007).    
Differences in quality of life are also apparent according to the age of the cancer 
patient / survivor (Karadjova et al., 2007; Arndt et al., 2004; 2005, Robb et al., 
2007).  Karadjova and colleagues (2007) observed more deficits in younger 
colorectal patients (<60 years) compared with older ones (Karadjova et al., 
2007; Arndt et al., 2004; 2005).  Other researchers argue that older patients 
report worse global quality of life and physical functioning, but have higher 
levels of emotional functioning than younger patients (Vinokur, Threatt, Caplan 
& Zimmerman, 1989; Stone, Richards, A’Hern & Hardy, 2000; Tomich & 
Helgeson, 2002).  However, such studies are criticised for comprising of 
selective samples and individuals with wide survival times (Arndt et al., 2004).  
Furthermore, it is difficult to compare findings across studies due to the different 
measures utilised.   
Overall, it is evident that cancer and the associated treatment(s) produce a 
number of physical effects and psychosocial impacts that may continue after the 
completion of treatment.  It is clear that such problems may lead to an inability 
to function in a manner similar to pre-diagnosis.  Problems with diet, digestion 
(abnormal bowel habits / colostomy), nausea, fatigue and depression could 
interfere with performing everyday activities including resuming work and work 
ability.   
1.7. The Role of Social Support, Self-Efficacy and Health Professionals  
Evidence suggests that psychosocial factors such as fatigue and depression 
can impact individuals’ quality of life and work outcomes (Spelten et al., 2002; 
Taskila & Lindbohm, 2007).  However, few studies have considered the role of 
factors such as social support, self-efficacy and health professionals’ advice 
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and guidance.  Some studies have investigated how self-efficacy and social 
support are important factors in patients’ management of their cancer diagnosis 
and treatment, however, the impact of these two factors on work ability and 
return to work intentions have scarcely been considered.  Further to this, there 
is a need to understand the role health professionals play in providing 
information about the management of cancer and work.  The nature of the 
patient and health professional relationship during cancer diagnosis and 
treatment is important.  In terms of cancer management, health professionals 
provide information to cancer patients on diagnosis, treatment and prognosis.  
However, little is known about the extent to which health professionals provide 
work-related advice and guidance.  Please refer to Chapter 2 (pp. 67-68) which 
discusses the potential importance of this factor in more detail.  Studying these 
factors will enable a more comprehensive understanding of how such factors 
may impact colorectal cancer patients’ (cancer patients in general) return to 
work intentions, work ability and employment outcomes.  The next section will 
consider the potential importance of social support and self-efficacy in turn. 
Social Support 
Those diagnosed with cancer are reported to experience feelings of 
vulnerability, loss of control and uncertainty about their future (Helgeson & 
Cohen, 1996; Sammarco, 2001).  Understanding how people adapt to a cancer 
diagnosis is important as it will help to identify the factors that lead to more 
positive adjustment (Coughlin, 2008).  The presence and utilisation of social 
support could be one of the factors that facilitate better adjustment (Carver, 
2005; Rowland & Baker, 2005).  It has been argued that the level of social 
support an individual receives is likely to influence his / her ability to seek and 
process cancer-related information, regulate emotions and decision making 
(Arora et al., 2007).  The role of social support has been studied in the cancer 
population immensely (Michael et al., 2002; Sapp et al., 2003).  After a 
diagnosis individuals often seek out social support from various sources such 
as family, friends and caregivers.  Moreover, individuals may turn to additional 
sources of support, for example, support groups and cancer information 
charities (e.g. Cancer Backup UK).   
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Research on the role of social support has led to mixed findings.  The beneficial 
value of social support is well documented and reported to improve patients’ 
psychological adjustment to cancer, well-being and survival (Sapp et al., 2003; 
Michael et al., 2002; Jackson et al., 2007).  Studies on breast cancer found 
social support was associated with better survival outcomes (Funch & Marshall, 
1983; Maunsell, Brisson & Deschenes, 1995).  In a randomised control trial, 
Cassileth et al. (1985) found those that received the psychosocial intervention 
showed significant increments in survival compared with the control group; 
however, this finding was not observed in those with more advanced stage 
disease (Cassileth et al., 1985).  In 307 (all female) colorectal cancer survivors, 
Sapp et al. (2003) found a positive association between social network scores 
and mental health outcomes, however, this association was not observed in 
physical health outcomes.  Alternatively, in a study that comprised of 699 
women diagnosed with breast cancer (on average four years post diagnosis), 
Michael et al. (2002) found that the presence of social support enhanced 
physical functioning and that social integration improved health-related quality 
of life.  The study also found socially isolated women reported more problems, 
hence, were more negatively affected by the cancer.  However, a limitation of 
this study and many other studies (including cancer and employment literature) 
is that samples comprise of participants diagnosed at various time points.  It is 
likely that the role and nature of social support alters over time, whereby, at 
diagnosis the role of health professionals (e.g. nurse specialists) may be more 
important than support from family, friends and employers.  Alternatively, social 
support from employers would be more important when an individual is 
considering a return to work. 
Much of the research discussed suggests that social support could improve 
patients’ health outcomes and overall quality of life (Coughlin, 2008; Michael et 
al., 2002; Jackson et al., 2007).  As social support is something that is 
modifiable, the promise for interventions incorporating this appears to be 
encouraging.  In addition to considering social support from family / friends, the 
current research aims to examine the role of social support in the workplace 
and how this may impact subsequent employment outcomes. 
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The Role of Self-Efficacy 
Self-efficacy is the perceived confidence an individual has in their ability to 
perform a task or behaviour (Marks, Allegrante & Lorig, 2005); self-efficacy has 
been studied immensely in relation to various health behaviours in applied 
settings.  However, little is known about how self-efficacy may impact the illness 
management and work outcomes, particularly the perceived work ability of 
colorectal cancer patients.  Research suggests that being employed can have 
positive psychosocial impacts such as improving self-esteem and quality of life 
(Barofsky, 1989).  From such findings it could be argued that cancer patients’ 
self-efficacy beliefs may influence the psychosocial impact of cancer.  The 
proceeding discussion will consider the application of self-efficacy to health 
behaviours and cancer.  Firstly, self-efficacy theory will be outlined and the 
development of these beliefs will be discussed.  Secondly, the application of the 
theory will be considered in relation to chronic disease self-management.  This 
will indicate the usefulness of the theory in various applied settings.  Finally, the 
discussion will focus on how self-efficacy has been studied in relation to cancer. 
1.7.1. Self-Efficacy: Theoretical Background  
The self-efficacy construct was incorporated as a feature of the Social Cognitive 
Theory (Bandura, 1977; 1986).  According to Bandura (1977), existing learning 
theories including his own (social learning theory) were missing a key feature: 
self-efficacy (self-beliefs).  The social cognitive theory takes the view that 
cognitive, vicarious, self-regulatory and self-reflective processes are crucial in 
human adaptation and change (Bandura, 1986).  Human functioning is 
therefore governed by behavioural, cognitive and other personal factors and 
environmental factors which form a triadic model (Bandura, 1986; Pajares, 
2002).   
Self-efficacy beliefs are argued to be the most central types of thoughts 
influencing an individual’s actions (Bandura, 1986).  Self-efficacy is, “concerned 
with how people judge their capabilities and how their self-percepts of efficacy 
affect their motivation and behaviour” (Bandura, 1986, p. 391).  According to 
Bandura (1997), these perceived beliefs play a major role in how individuals 
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think, feel, motivate themselves and act in a variety of situations.  Individuals 
differ in terms of the beliefs they hold.  Some individuals will believe that they 
are capable of executing the necessary actions to attain a particular goal; others 
may believe that they are less capable and as a result may choose to avoid a 
situation altogether.   
The usefulness of self-efficacy has been demonstrated empirically, whereby, 
self-efficacy beliefs were found to contribute significantly to human motivation 
and attainment (Bandura, 1992).  Such findings lend support to Bandura’s 
suggestion that self-efficacy beliefs impact individuals’ lives in a global sense.  
Pajares (2002) encapsulates this argument effectively in that efficacy beliefs 
influence “whether they think productively, self-debilitatingly, pessimistically or 
optimistically; how well they motivate themselves and persevere in the face of 
adversities; their vulnerability to stress and depression and the life choices they 
make” (Pajares, 2002, p. 4).   
1.7.2. The Development of Self-Efficacy Beliefs 
According to Bandura (1997), self-efficacy beliefs can be shaped by four 
sources of influence.  Firstly, there are mastery experiences, whereby, previous 
endeavours are most influential (Pajares, 2002).  Not surprisingly, prior 
successes would enhance an individual’s sense of self-efficacy and failures 
would weaken it (Bandura, 1997).  Therefore, self-efficacy beliefs are dynamic 
as they continue to adapt as various cognitive, behavioural and self-regulatory 
tools are attained over the life-course (Bandura, 1997).  Secondly, vicarious 
experiences of observing others influence the creation and strengthening of 
efficacy beliefs.  However, these exert a weaker influence upon self-efficacy 
beliefs than mastery experiences (Pajares, 2002).  Thirdly, the social 
persuasion an individual receives from others regarding their capability (can be 
positive or negative) can impact the development of self-efficacy beliefs (Litt, 
1988; Pajares, 2002).  Finally, individuals also utilise their physiological and 
emotional states (anxiety, stress, arousal and mood) when judging their 
capabilities (Bandura, 1997).  Positive mood has been found to enhance 
perceived self-efficacy (Ewart, 1992); whilst a negative mood weakens it 
(Kavanagh & Bower, 1985).  Consequently, efficacy beliefs could be changed 
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by reducing stress and negative emotions and correcting the misperceptions 
individuals have about emotional and physical reactions (Bandura, 1997).  It is 
these sources of efficacy information that are used to evaluate self-efficacy 
beliefs (Bandura, 1986).   
1.7.3. Self-Efficacy in Health Behaviours 
The concept of self-efficacy has been incorporated into many models of 
behaviour (Bandura, 1977).  For instance, many public health campaigns are 
rolled out to promote the adoption of healthy practices (Bandura, 2004); these 
health communications have been argued to alter health behaviours via four 
mechanisms (Meyerowitz & Chaiken, 1987).  The mechanism most relevant to 
the present discussion is that altering one’s perceived self-efficacy beliefs can 
lead to the adoption of healthful practices.  In other words, beliefs in their own 
efficacy to alter habits are enhanced (Bandura, 2004).  Thus, according to 
Bandura (2004), the most useful approach to adopt is to “change the emphasis 
from trying to scare people into health to enabling them with the self-
management skills and self-beliefs needed to take charge of their health habits” 
(p. 148).  Consequently, this is the commonly adopted approach.  The pivotal 
role of self-efficacy will now be discussed in relation to chronic disease self-
management and cancer. 
Chronic Disease Self-Management 
The importance of self-efficacy has been studied in relation to chronic disease 
management (Clark & Dodge, 1999; Bodenheimer, Lorig, Holman & Grumbach, 
2002; Grace et al., 2006; Lorig, Ritter & Jacquez, 2007).  Many individuals 
affected by a chronic condition such as diabetes are responsible for its day-to-
day management; this comprises of medical management (medication, 
adhering to a diet and so on), maintaining, changing and creating behaviours to 
coincide with the ever-changing condition and by dealing with the psychosocial 
factors associated with having an illness (Lorig & Holman, 2003).  Self-efficacy 
is argued to have an important mediating role in self-management activities, 
adopting and maintaining health behaviour changes and health outcomes 
(Strecher et al., 1986; Bodenheimer et al., 2002; Marks et al., 2005).  Reasons 
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for the effectiveness of self-efficacy based interventions are that these beliefs 
are modifiable and can impact health status, motivation levels and adherence to 
prescribed regimens.  As a result, intervention approaches focusing on self-
efficacy hold much promise for improving chronic disease outcomes (Marks et 
al., 2005).   
Studies have shown that self-management programmes utilising self-efficacy 
enhancing strategies produce more positive outcomes than standard 
interventions (Lorig et al., 1985; Barlow, Williams & Wright, 1999).  In a self-
management program for women with heart disease Clark and Dodge (1999) 
found self-efficacy significantly predicted disease management behaviours 
(medication adherence, exercise, managing stress, following a diet) at 4 and 12 
months after baseline.  Other researchers lend support to the argument that 
changes in self-efficacy lead to changes in health status (Lorig & Holman, 
2003).  Moreover, enhancing self-efficacy which leads to better disease self-
management has been shown to influence quality of life outcomes favourably 
(Han, Lee, Lee & Park 2003).  Alternatively, health outcomes worsened in those 
with lower self-efficacy beliefs due to poor self-management (Han et al., 2003).  
It is possible that self-efficacy plays a vital role in a number of health 
behaviours.   
1.7.4. Cancer and Self-Efficacy 
Due to improvements in detection and effective treatments, cancer is 
increasingly being viewed as a chronic illness (Beckham et al., 1997).  
Researchers are now beginning to consider the various roles self-efficacy has in 
cancer populations (Beckham et al., 1997; Manne et al., 2006).  For instance, it 
has been examined in relation to participation in screening behaviour 
(Carpenter & Colwell, 1995; Tolma, Reininger, Evans & Ureda, 2006).  Tolma 
and colleagues (2006) found self-efficacy to be a strong predictor of intention to 
obtain an initial screening mammogram.  Carpenter and Colwell (1995) add to 
this finding suggesting that increased knowledge is associated with increased 
self-efficacy for cancer screening.  Knowledge appears to be important when 
considering self-efficacy in cancer patients (LaCoursiere, Knobf & McCorkle, 
2005); this study found that knowledge gained from accessing information 
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online enhanced self-efficacy: this could empower individuals to participate in 
their own care, resulting in adjustment to the condition (LaCoursiere et al., 
2005).   
Further application of the theory has been demonstrated by Cunningham, 
Lockwood and Cunningham (1991); the study found strong positive correlations 
between self-efficacy and quality of life and self-efficacy and mood in cancer 
patients (Cunningham et al., 1991).  Furthermore, a brief coping skills 
intervention led to improvements in all three.  These findings tie in appropriately 
with earlier discussions regarding the usefulness of self-efficacy in self-
management interventions.  In breast cancer patients undergoing 
chemotherapy, interventions enhancing self-efficacy led to increases in quality 
of life and decreased symptom distress (Lev et al., 2001).  These results 
indicate that it may be most beneficial (for patients) to employ self-efficacy 
enhancing strategies as early as possible (diagnosis / treatment stage): this 
could have far-reaching implications for self-management and adjustment. 
Domain-specific self-efficacy has also been investigated in cancer patients.  De 
Boer et al. (1998) studied the role of physical self-efficacy in head and neck 
carcinoma patients.  Patients perceiving themselves as more physically 
efficacious were more likely to survive and less likely to have disease 
recurrence (de Boer et al., 1998).  It is suggested that those with more positive 
physical self-efficacy beliefs would be in a better position (in terms of fitness) to 
cope with illness stresses (Thornton, Rychman, Robbins & Donolli, 1987).  
Evidence for this can be seen within the context of treatment whereby it could 
be expected that high physical self-efficacy patients handle treatment side-
effects better (Morrow, 1992).  Additional research has reported highly 
physically efficacious patients experienced fewer concerns regarding treatment 
and consequences of cancer (de Boer et al., 1995).  Jerusalem and Schwarzer 
(1992) corroborate these findings demonstrating that persons with high physical 
self-efficacy were less likely to exhibit fear, worry and anxiety when faced with 
difficult situations.  Consequently, possessing the necessary beliefs to cope with 
such situations could lead to increased chances of survival.  
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Future research needs to examine the role of self-efficacy in other aspects of 
illness management among cancer patients such as resuming everyday 
activities including returning or maintaining work after a cancer diagnosis. 
1.7.5. Self-Efficacy and Cancer Psychosocial Adjustment 
Cancer patients need to adjust to the impact and potential consequences of 
their disease; consequently, researchers need to consider how such a 
diagnosis could affect patients emotionally and socially (i.e. psychosocial 
adjustment) (Irvine et al., 1991).  A number of studies have examined the role of 
self-efficacy in the adjustment to cancer.  Self-efficacy theory assumes that the 
greater confidence people have in their ability to execute specific actions, the 
greater the probability of attaining their goals (Bandura, 1977; 1997).  The 
literature suggests higher coping self-efficacy is associated with better 
adjustment and more positive quality of life outcomes in cancer patients 
(Beckham et al., 1997; Lev, Paul & Owen, 1999; Lev et al., 2001).  However, 
the precise role of self-efficacy in adjustment to cancer is somewhat unclear 
(Lev et al., 2001; Rancor et al., 2002; Schulz & Mohamed, 2003; Kreitler, Peleg 
& Ehrenfeld, 2007).  In breast cancer patients, studies have found a positive 
relationship between self-efficacy and psychosocial adjustment (e.g. experience 
fewer symptoms whilst having chemotherapy) (Arora et al., 2002; Lev et al., 
2001).  In evaluation, these studies comprised of a small sample and were 
cross sectional (Lam & Fielding, 2007).  Schulz and Mohamed (2003) found 
relationships between self-efficacy, social support and benefit finding.  
Research refuting the role of self-efficacy in adjustment suggested that self-
efficacy was not a pre-disease predictor of adjustment to cancer (Rancor et al., 
2002).  Thus, findings regarding the role of self-efficacy are inconsistent.  It 
could be argued that methodological factors such as the use of different 
measures may account for these differences. 
In response, Kreitler et al. (2007) sought to delineate some of the existing 
ambiguities; they utilised structural equation modelling to examine the effects of 
different stressors (perceived stress and self-efficacy) on quality of life 
outcomes.  Results indicated that self-efficacy impacted upon perceived stress 
which in turn impacted upon quality of life.  However, self-efficacy was also 
  29 
Chapter 1                     Colorectal Cancer, its Treatment & Psycho-Oncology 
 
found to have a direct effect on quality of life (the higher self-efficacy = more 
positive quality of life).  Therefore, such findings suggest that to aid adjustment, 
self-efficacy needs to be engaged (along with other mechanisms e.g. social 
support) (Kreitler et al., 2007).  Inevitably, this would lead to a decrease in 
perceived stress and better adjustment.  The important point to keep in mind is 
that self-efficacy is unlikely to operate alone when influencing various health 
behaviours.   
In sum, self-efficacy theory has been applied successfully to a variety of areas.  
The theory offers an insight into why some people more than others may be 
more successful in performing certain behaviours.  Appropriate interventions 
have been designed and successfully delivered to those possessing lower 
perceived self-efficacy beliefs.  Thus, the principles of the theory seem to drive 
individuals’ lives in many ways.  With regard to self-efficacy and cancer, 
research is still required in the area.  Understanding the complex effects self-
efficacy has upon processes of adjustment and so on are still in their infancy.  
Research now needs to unpick how perceived self-efficacy impacts upon wider 
aspects of an individual’s life, for example, employment decisions and return to 
work intentions in cancer patients.  Considering both illness and work self-
efficacy in this population would provide a richer insight into the adjustment and 
management of cancer over time. 
1.8. Summary 
To conclude this chapter, it is evident that a cancer diagnosis can lead to a 
number of physical effects and psychosocial impacts.  The literature has 
provided a plethora of results indicating that treatment effects such as nausea 
and psychosocial impacts like depression and fatigue are likely to influence 
quality of life outcomes including the quality of working life.  However, the role of 
social support and self-efficacy is somewhat unclear, particularly in relation to 
work outcomes.  The literature discussed suggests that these factors are likely 
to be important when attempting to understand colorectal cancer patients’ 
disease management, work ability and employment outcomes.  Further to this, 
some existing research is limited as samples comprise of various cancer types 
where much time has elapsed since individuals’ diagnosis. 
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Chapter 2 
2.  Cancer and Employment: Literature Review 
2.1. Introduction 
This chapter will discuss the existing literature relating to how cancer can 
impact upon employment outcomes, particularly in relation to work ability and 
return to work.  Many cancer survivors are likely to have been employed at the 
time of diagnosis; therefore, for some of this group, returning to work is of more 
significance to some patients than others.  A proportion may return to work due 
to financial loss (Barofsky, 1989), whereas others may feel that work benefits 
them psychologically (improved self-esteem) (Hakkaart-van Roijen, 1998).  This 
chapter will consider research that has concerned itself with investigating 
absence from work, particularly in relation to diagnosis and treatment.  There 
will then be some discussion considering the return to work amongst cancer 
patients: this will focus on cancer type, treatment and person-related factors.  
Finally, established research into the work ability of cancer patients re-entering 
the workplace will be discussed and evaluated.  
2.2. Work Absence: The Impact of Diagnosis and Treatment 
The impact of diagnosis and treatment on ability to work (sickness absence) is 
well documented in the literature (Morrell & Pryce, 2005; Bradley et al., 2005; 
Bradley, Oberst & Schenk, 2006; Pryce, Munir & Haslam, 2007; Amir et al., 
2007).  Studies suggest that approximately 40% of all cancer patients take time 
off work during treatment and recovery (Short et al., 2005).  More recently, 
Pryce et al. (2007) established 70% of 328 respondents did not work during 
treatment.  Evidence suggests that the detrimental impact of cancer on work 
absence can continue for a number of years after diagnosis (Taskila-Abrandt et 
al., 2004) and may vary according to cancer site.  For example, when 
considering those diagnosed with breast cancer, it is estimated that between 
62% and 84% will take time off work during treatment (Maunsell et al., 1999; 
Short et al., 2005).  Little information is available on colorectal cancer; however, 
Choi et al. (2007) studied job loss and reemployment in a sample of stomach, 
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liver and colorectal cancer patients from Korea (over a 24 month period).  For 
colorectal patients, 46% stopped working compared to 48% with stomach and 
63% with liver cancer whilst undergoing treatment.  However, this study 
comprised of male cancer patients only; it is, therefore, unlikely to represent the 
general population of cancer survivors (Choi et al., 2007).  In a sample of 
prostate cancer patients, treatment was associated with sickness absence up to 
six months post-diagnosis (Bradley et al., 2005).  At 12 months, 30% of these 
individuals reported a work limitation associated with their cancer and treatment 
(Bradley et al., 2005b).  In a later study, Bradley et al. (2006) recruited patients 
six months post-diagnosis and found an association between cancer treatment 
and absence.  For breast cancer patients, those treated surgically missed an 
average 26.5 days from work; this rose to 68.5 days for those undergoing 
surgery, chemotherapy and radiotherapy.  For men diagnosed with prostate 
cancer, the study found an average absence of 33 days in those that underwent 
surgery alone; for those that underwent surgery, together with chemotherapy or 
radiotherapy, this rose to 40 days and finally, the lowest rate of absence was 
observed in those who underwent radiotherapy alone (9.5 days) (Bradley et al., 
2006).   
For treatment, the impact on sickness absence is likely to be greater in those 
undergoing more than one treatment modality (Bradley et al., 2006).  Amir et al. 
(2007) conducted a study in the UK and also found significant differences in 
duration of sick leave according to treatment modality: 83% of those receiving 
surgery returned to work in less than six months following diagnosis whereas 
only 47% of those who received a combination of surgery and radiotherapy, 
chemotherapy or hormone therapy returned to work less than six months post-
diagnosis.  Further to this, Amir et al. (2007) reported from their sample that 
females were more likely to take 6 -12 months sick leave compared with males 
(33% of women as opposed to 18% of men).  Males were more likely to take 
sick leave lasting at least a year (18% of men as opposed to 10% of women).  
However, a limitation of this study is that gender was unevenly distributed and 
almost half of the sample (48%) comprised of respondents with breast cancer 
(Amir et al., 2007). 
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Therefore, despite a lack of information related to absence following a colorectal 
cancer diagnosis, existing findings suggest that it is likely that those undergoing 
more than one type of treatment may take more time off than an individual 
receiving just one form of treatment.  However, differences in employment 
outcomes according to cancer type make it difficult to envisage the precise 
impact a colorectal cancer diagnosis may have upon these outcomes.  
Moreover, differences in the nature of symptoms (e.g. altered bowel habits after 
surgery) and side effects according to cancer type and treatment type make it 
difficult to apply existing findings to colorectal cancer patients. 
2.3. Return to Work Following Cancer 
Improvements in cancer detection and treatment have led to improvements in 
cancer recovery, resulting in resumption of everyday activities including work. 
Returning to work is often deemed to be a marker of recovery and a regaining 
of a sense of normalcy for patients (Spelten et al., 2002; Kennedy et al., 2007).  
However, others may return to work due to a potential loss or change to their 
health insurance (Choi et al., 2007).  Within the cancer literature, return to work 
and work continuance statistics vary immensely as many studies have utilised 
different methods, designs and differing cancer populations (Spelten et al., 
2002; Bushunow, Sun, Raubertas & Rosenthal, 1995; Maunsell et al., 1999).  
Evidence suggests that a number of those diagnosed with cancer continue to 
work during treatment; for example, a cross-sectional retrospective study of 328 
cancer patients and survivors revealed that 30% continued to work throughout 
treatment and even more returned to work upon completion of treatment (Pryce 
et al., 2007). 
Table 2.1 summarises return to work rates reported in the literature.  Studies 
comprising of cancer patients and survivors indicate that return to work rates 
range between 27% (Bergman & Sorenson, 1987) and more recently to 94% 
(Balak et al., 2008).  The prior rate is based on a lung cancer sample, which is 
associated with a poor prognosis; thus, returning to work would be less likely in 
this group (Cancer Research UK, 2007).  In a review of 14 studies comprising 
different cancer types, Spelten et al. (2002) reported that the mean rate of 
return to work was 62% (range 30% - 93%); this review was the important  
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Table  2.1: Summary of return to work / work continuance studies.  
Author (year) Design Cancer Type (N, n)  Return to
Work Rate 
(%) 
Point of Return to Work Factors associated with Return 
to Work 
Balak et al. (2008) Longitudinal  Breast cancer (N = 72) 94%  65% continued or returned to 
work within a year.  94% 
continued or returned to work 
within 2 years of diagnosis. 
 
Treatment (chemotherapy or 
multimodal treatment). 
Bergman & Sorenson 
(1987) 
 
Cross-sectional  Lung cancer (N = 44) 27%  14 - 83 weeks.  Advanced disease and ‘heavy’ job 
type. 
Bouknight et al. 
(2006) 
Longitudinal  Breast cancer (N = 416) 81% 82% returned to work at 12 
months (26 of these stopped 
working at 18 months).  81% 
returned to work at 18 months. 
Income, advanced disease, manual 
labour, heavy lifting, employer 
discrimination, older age, black race, 
less educated and fair/poor health at 
diagnosis. 
 
Buchmann et al. 
(2003) 
Cross-sectional Leukaemia and lymphoma 
(N = 163) 
70% 70% returned to work within two 
years of transplantation. 
Pain, anxiety, sleep disorder, 
depression, impaired social function, 
partnership and family life. 
 
Buckwalter et al. 
(2007) 
Longitudinal Head and neck cancer  
(n = 666; employed prior to 
treatment n = 239)  
 
40%  40% returned to work within first 
year. 
Advanced disease, multimodal 
treatment, older age, fatigue and pain. 
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Author (year) Design Cancer Type (N, n) Return to 
Work Rate 
(%) 
Point of Return to Work Factors associated with Return 
to Work 
Bushunow et al. 
(1995) 
Longitudinal 
retrospective  
Breast cancer (N = 145; 
two groups chemotherapy 
n = 76 and not receiving 
chemotherapy n = 69) 
93%  92% of those receiving 
chemotherapy returned to work 
within 12 months.  94% of those 
not receiving chemotherapy 
returned to work within 12 months 
  
de Boer et al. (2008) Longitudinal Various (N = 195) 64%  24 % continued to work or 
returned to work at six months,  
50% continued to work or 
returned to work at 12 months 
and 64% continued to work or 
returned to work at 18 months. 
 
Work ability, physical work ability, 
mental work ability and treatment. 
de Lima et al. (1997) Cross-sectional  
  
  
Acute Myeloid Leukaemia
(AML) (N = 215) 
 
74% <50 years  
35% >50 years 
 
Age. 
Edman et al. (2001) Cross-sectional  Chronic leukaemia, acute 
leukaemia and lymphoma  
(N = 25) 
 
85%  
Estey et al. (1997) Cross-sectional Acute Myeloid Leukaemia 
(AML) (n = 215; working  
n = 155) 
 
66%  
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Author (year) Design Cancer Type (N, n) Return to 
Work Rate 
(%) 
Point of Return to Work Factors associated with Return 
to Work 
Gruber et al. (2003) Cross-sectional  Leukaemia (N = 163) 60%  
 
Pain, anxiety, sleep disorders, 
depression, impaired social 
functioning, partnership and family life 
 
Hinman (2001) Cross-sectional Breast cancer (N = 31) 80%  
 
Physical impairments. 
Jacoulet et al. (1997) Longitudinal Small cell lung cancer (N = 
155; working n = 77) 
40%  40% continued with or returned to 
work within 24 months. 
 
Johnsson et al. 
(2007) 
Prospective  Breast cancer (N = 270) 86%  79% continued or returned to 
work within 12 months, 24 months 
84% continued or returned to 
work and at 36 months 86% 
continued or returned to work. 
 
Adjuvant endocrine therapy and 
chemotherapy / nodal status. 
Kennedy et al. (2007) Qualitative  
  
Breast cancer, non-
Hodgkin's Lymphoma, 
uterus cancer, larynx  
(N = 29) 
 
93%  
Lee et al. (2008) Cross-sectional 
and retrospective 
Stomach cancer (n = 408); 
plus disease free control 
group  
(n = 994) 
54%  
 
Fatigue and treatment. 
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Author (year) Design Cancer Type (N, n) Return to 
Work Rate 
(%) 
Point of Return to Work Factors associated with Return 
to Work 
Main et al (2005) Qualitative Various (N = 28) 86%  
 
Pain, nausea, fatigue impacted ability 
to work, thus work decisions. 
Pryce et al. (2007) Cross-sectional  Various (N = 328) 30% continued 
to work through 
treatment; 
42.3% returned 
to work after 
treatment 
  
Pain, stress, physical changes, 
employer return to work meeting, 
doctor’s advice, work flexibly. 
Satariano & 
DeLorenze (1996) 
Qualitative Breast cancer (N = 296)  
 
Upper body strength, jobs requiring 
physical activity, transport and 
ethnicity. 
 
Spelten et al. (2002) Review Various (N = 1904) 30 to 93% 
(mean 62%)  
 
Age, work factors, disease and 
treatment and person-factors. 
Spelten et al. (2003) Longitudinal  Various (n = 235) 64% 24% returned to work at 6 
months, 50% returned to work at 
12 months and 64% returned to 
work at 18 months. 
 
 
Age and physical workload. 
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Author (year) Design Cancer Type (N, n) Return to 
Work Rate 
(%) 
Point of Return to Work Factors associated with Return 
to Work 
Steiner et al. (2008) Cross-sectional  Various (N = 100) 92% 
   
Sultan et al. (2006) Longitudinal Prostate cancer (N = 537) 50%  50% returned to work within 14, 
21 and 30 days within being 
discharged. 
 
Age, disease, occupation and marital 
status. 
Suzuki-Tsunoda et al. 
(2002) 
  
Adult acute leukaemia (N = 
42) 
48% 
  
  
 
 
Syrjala et al. (2004) Longitudinal Leukaemia and lymphoma 
(n = 315) 
84% survivors 
without 
recurrence 
 
84% returned to work within 5 
years. 
 
Taskila-Abrandt et al. 
(2004) 
Cross-sectional  Various (N = 12,542) 64% 64% returned to work within 2-3 
years post diagnosis. 
Taskila-Abrandt et al. 
(2005) 
Cross-sectional Various (n = 46,312) (and 
control group) 
 
50%  
 
Cancer type and age. 
Taskila & Lindbohm 
(2007) 
Review  Various (12 studies) 41 - 84% 
 
Age, cancer type, lower education, 
manual work and perceived 
discrimination. 
 
Yokoyama et al. 
(1985) 
 
Cross-sectional Rectal cancer (N = 34) 47%  
 
Surgery type. 
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Author (year) Design Cancer Type (N, n) Return to 
Work Rate 
(%) 
Point of Return to Work Factors associated with Return 
to Work 
Van der Wouden et 
al. (1992) 
 
Cross-sectional 
  
Various (N = 849) 44% 
Weis et al. (1992) Cross-sectional  Various (N = 380) 33% 
 
Age, tumour stage, prognosis and 
former work status. 
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milestone in the area of cancer and work research and identified areas for 
future researchers.  Consequently, a more recent review of 12 cancer and work 
ability studies between 2002 and 2007, reports return to work rates ranging 
between 41% and 84% (Taskila & Lindbohm, 2007).  A substantial amount of 
return to work literature focuses on breast cancer patients; return to work rates 
range between 80% and 94% in these studies (Bushunow et al., 1995; Hinman, 
2001; Drolet et al., 2005; Bouknight, Bradley & Luo, 2006; Johnsson et al., 
2007; Balak et al., 2008).  Even though breast cancer is the most commonly 
diagnosed cancer in women and these results are useful, they are not 
representative of cancer sufferers in general. 
The literature also provides some information relating to the time taken to return 
to work, which is also summarised in Table 2.1.  In a recent prospective study 
(N = 195), de Boer and colleagues (2008) found 24% continued or returned to 
work within 6 months of diagnosis; at 12 and 18 months this rose to 50% and 
64% respectively.  Such results are perhaps unsurprising as it is likely that 
treatment patterns soon after diagnosis make it difficult to continue with work.  
Furthermore, as more time has elapsed since diagnosis and treatment, the 
likelihood of returning to work increases.  The most favourable return to work 
outcomes have been found in studies comprising of breast cancer patients 
(Balak et al., 2008; Bouknight et al., 2006; Johnsson et al., 2007).  However, 
this may be a reflection of the variety of studies that have sought to investigate 
this group as opposed to other cancer types.  In short, from such return to work 
rates reported in the literature, it is feasible to suggest that return to work is an 
attainable outcome for the majority of cancer patients.  Moreover, differences in 
return to work are likely to be associated with a number of factors including 
treatment type, age and job type. 
2.3.1. Factors Related to Return to Work 
A number of factors correlated with return to work have been identified, 
including: cancer type (Spelten et al., 2002; Taskila-Abrandt et al., 2004; Shultz, 
Beck, Stava & Sellin, 2002; Short et al., 2005; Taskila-Abrandt et al., 2005); 
fatigue (Spelten et al., 2002; Spelten et al., 2003); depression, poor social 
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support (Berry, 1993); treatment factors (Spelten et al., 2002); person-related 
factors such as age and education (Lima et al., 1997; Maunsell et al., 1999), 
and work-factors such as job type (Maunsell et al., 1999; Spelten et al., 2002; 
Main et al., 2005; Ehrmann-Feldman et al., 1987).  However, according to 
some, the existing literature has not offered enough insight into how the 
identified problems could be rectified (Steiner et al., 2004). 
For example, when considering cancer type, return to work rates are high in 
testicular cancer patients and low in head and neck cancer patients (Spelten et 
al., 2002; Taskila-Abrandt et al., 2004).  Higher return to work rates in testicular 
patients could be attributed to diagnosis occurring at a younger age when 
compared with other cancer types (e.g. prostate cancer); furthermore, due to 
successful treatments, survival rates associated with this group are also high 
(Taskila-Abrandt et al., 2004). 
Differences in return to work rates have also been reported according to age 
(person-related factor) (Lima et al., 1997).  Lima et al. (1997) found for those 
aged 50 years or less return to work was 74%; however, for those over the age 
of 50 years return to work was 30 per cent.  In spite of this, recent economic 
trends suggest that increased life expectancy has inevitably altered the 
demographic make-up of the work-force: hence, there are many more ageing 
workers than previously (Riche, 2001 as cited in Sanchez & Richardson, 2006).  
In response to this, Governments are striving to keep people working for longer 
(Munir, Khan, et al., 2009).  Subsequently, it can be argued that many people 
may not retire at the statutory age of 65 years for men and 60 years for women 
as was common in previous generations (Sanchez & Richardson, 2006; Amir et 
al., 2007).  Furthermore, increased national and international investment in 
colorectal screening and detection programmes will lead to improved life 
expectancy for working-aged colorectal cancer patients who will subsequently 
require support when resuming work.  
At present, there is very little information concerning employment outcomes for 
those managing colorectal cancer.  Return to work rates and factors predicting 
return to work for those affected by colorectal cancer are presented in Table 
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2.2.  Two early studies by Feldman (1976; 1978) demonstrated that return to 
work rates were 74% and 75% in this group.  Schultz and colleagues (2002) 
found 67% of colon cancer survivors had returned to work five years post 
diagnosis.  In evaluation, this study was cross-sectional and therefore it is 
difficult to suggest factors predicting return to work; instead, it would be more 
worthwhile to recruit and follow patients soon after diagnosis.  Ultimately, such 
an approach would help to identify the barriers that may prevent returning to 
work immediately following diagnosis.  A recent study has contributed to these 
earlier findings; Sanchez and Richardson (2006) report an 89% return to work 
rate for colorectal cancer patients and 64% returned within two months of 
diagnosis.  Hence, a noticeable improvement when compared with the return to 
work rates as reported by Feldman (1976; 1978).  Eighty per cent of those who 
did not return to work attributed it to health or medical reasons (Sanchez & 
Richardson, 2006): this is consistent with Hewitt, Rowland and Yancik (2003) 
who found that multiple co-morbidities increased the likelihood of work 
limitations or disability (various cancer types) when compared with survivors 
without co-morbidity.   
Some of the factors associated with the unlikelihood of returning to work 
included treatment, marital status and work-factors such as poor support from 
an employer (Sanchez, Richardson & Mason, 2004; Sanchez & Richardson, 
2006).  These researchers also report that chemotherapy was the greatest 
predictor of work delay when compared with person and work-related factors.  
However, the cross-sectional nature of this study renders it difficult to ascertain 
if these results are attributable to actual chemotherapy effects (e.g. fatigue) or 
the actual time period of the treatment regime (Sanchez & Richardson, 2006).  
Therefore, the authors suggest prospective studies of colorectal cancer patients 
would be ideal, especially to inform intervention design (Sanchez & Richardson, 
2006).   
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Table  2.2: Summary of colorectal cancer return to work / work studies. 
Author (year) Design Sample (N, n) Summary of Findings 
Choi et al. (2007) Prospective Colorectal cancer (n = 91); stomach cancer  
(n = 97); liver cancer (n = 117) 
46% of colorectal cancer patients lost their job within 3 months of 
diagnosis.  Of these, 31% were later reemployed within 24 
months.   Age, education, income, stage and cancer site (whole 
sample). 
 
Feldman (1976) Cross-sectional Various (N = 92)  (included colon or rectum) 
all white collar workers 
 
74% returned to work. 
Feldman (1978) Cross-sectional Various (N = 107; colon or rectum n = 38) all 
blue collar workers 
75% returned to work.  Participants were concerned about 
frequent toilet use.  Time lost from work was higher than for those 
with other cancer types; 68% reported absence of 9 weeks or 
more. 
Sanchez et al. (2004) Cross-sectional Colorectal cancer (N = 250; employed 80%) 89% of those that were employed at diagnosis returned to work.  
Of these 81% remained employed for five years post-diagnosis.  
However, 34% delayed there return to work for longer than two 
months post diagnosis due to chemotherapy treatment. 
 
Sanchez et al. (2006) Cross-sectional Colorectal cancer (N = 250; employed n = 
143) 
Those in employment were in better health when compared with 
those who were not.  The presence of co-morbidity, support and 
employment status was associated with quality of life outcomes. 
 
Schultz et al. (2002) Cross-sectional Various (N = 4364) 67% of colon cancer survivors returned to work within 5 years of 
diagnosis. 
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A recent prospective study is presented by Choi et al. (2007).  These results 
showed that of the 46% of colorectal cancer patients that stopped working after 
diagnosis, 31% (n = 13) were reemployed within 24 months, compared to 69% 
that were not (n = 29).  Such job loss was more common among older, less 
educated and lower income patients (Choi et al., 2007).  Despite such studies, 
more research is needed that considers this group further, in particular little is 
known about the employment outcomes of colorectal cancer patients in the UK.   
Furthermore, existing findings are based on samples drawn from either the US 
(Sanchez & Richardson, 2006) or Korea (Choi et al., 2007); due to variations in 
working practices it is difficult to apply these findings to the UK.  Consequently, 
it is difficult to ascertain whether colorectal cancer patients in the UK are 
working due to good health (physically and psychologically more able), or 
whether other factors are driving them to work (finances): thus the present 
research would aim to delineate some of these ambiguities. 
It is apparent that people affected by cancer are able to work throughout 
treatment and a larger proportion return to work once treatment has ceased.  
Such research is useful as it provides insight into employment pathways and 
offers some detail about differences according to cancer types, treatment, 
psychosocial factors such as symptoms of fatigue and depression (e.g. fatigue 
found to predict return to work, Spelten et al., 2003) and person-related factors.  
Nonetheless, little is known about how cancer treatment and stoma appliances 
may impact upon the work outcomes of colorectal cancer patients. 
2.4. Cancer and Work Ability 
The focus of research is now moving towards considering the impact of cancer 
and its treatment on work ability for those who continue to work during 
treatment or return to work following treatment (Munir, Yarker & McDermott, 
2009).  A number of self-report measures assess work productivity.  For 
example, in their review of six generic work productivity self-report measures, 
Prasad, Wahlqvist, Shikiar and Shih (2004) suggest that the Work Productivity 
and Activity Impairment (WPAI) scale and the Work Limitations Questionnaire 
(WLQ) have been studied extensively and have appropriate validity and 
reliability.  The WLQ (Lerner et al., 2001) has been used to assess work 
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productivity in studies of depression (Lerner et al., 2004) and more recently in 
brain tumour survivors (Feuerstein et al., 2007).  When compared with a 
comparison group, Feuerstein et al. (2007) found that brain tumour survivors 
reported lower work productivity and more time lost from work.  For the purpose 
of this study work ability is defined as “...how able is a worker to do his or her 
job with respect to the work demands, health and mental resources,” (Ilmarinen, 
Tuomi & Seitsamo, 2005, p. 3).  Whilst some people affected by cancer are able 
to continue working in a similar manner prior to diagnosis, for others, this is not 
always the case. 
Some experience impairments in their ability to work which are attributable to 
their illness and treatment (Taskila et al., 2007); such impairments can lead to 
decrements in work ability (Short, Vasey & Moran 2008a; Short, Vasey & 
BeLue, 2008b; Bouknight et al., 2006; Taskila, et al., 2007) and even an inability 
to work (some do not resume / return to work) (Hewitt et al., 2003).  In a review 
of 12 studies investigating employment and work ability in cancer survivors, 
Taskila and Lindbohm (2007) suggest impairments in work ability range from 
21% and 31 per cent.  Research suggests cancer patients with the highest 
perceptions of work ability are most likely to work during treatment (Taskila et 
al., 2007; de Boer et al., 2008).  However, when compared with those without 
cancer and other chronic conditions, it has been suggested that cancer 
survivors report poorer levels of health (Hewitt et al., 2003; Gudbergsson, 
Fossa, Sanne & Dahl, 2007) and lower work ability (Short et al., 2008b; de Boer 
et al., 2008).   
Table 2.3 summarises 22 studies that have considered the impact of cancer 
upon work ability, work productivity and work adjustments due to cancer and 
reduced work ability.  Compared with a healthy control group, those diagnosed 
with malignant brain tumours (Feuerstein et al., 2007), stomach (Lee et al., 
2008), breast, prostate, and testicular cancers (Maunsell et al., 1999; Bradley et 
al., 2007; Gudbergsson et al., 2007; Gudbergsson, Fossa & Dahl, 2008) 
reported reduced work productivity and work ability: this included both mental 
and physical work ability and adjustments to their work practices.  However, in 
another study, perceived work ability rates in employed cancer survivors          
 45
Chap
 
 
ter 2                                                        Cancer and Employment: Literature review 
46
(n = 595) and disease free controls (n = 757) were similar (Taskila et al., 2007).  
Similarly, in a longitudinal study of prostate cancer patients and healthy controls 
no difference between hours worked was found, thus suggesting that work 
ability may have been similar in both groups (Bradley et al., 2007).  However, 
survivors reported decrements in both physical (26%) and mental work ability 
(19%) due to cancer (Taskila et al., 2007); this finding is supported further in a 
sample of breast and testicular cancer survivors (Gudbergsson et al., 2007).   
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Table  2.3. Summary of Work Ability studies. 
Author (year) Study Design Cancer Type (N, n)  Work Ability
Measure 
Summary of Findings Factors Associated 
with Work Ability 
Amir et al. (2008) Qualitative Various (N = 41)  Fatigue, cognitive limitations and loss of 
confidence impacted work ability negatively.  
Work adjustments such as reduced hours 
helped to manage such decrements in work 
ability. 
 
Fatigue and cognitive 
limitations. 
Bradley et al. 
(2007) 
Longitudinal  Breast cancer (n = 496); 
Prostate (n = 294); healthy 
controls (n = 300) 
Weekly hours Greatest difference between hours worked 
between breast cancer and controls seen at 
6 months.  Treatment-related impairments 
observed in both cancer groups, however 
more pronounced in breast cancer sample.  
 
Treatment. 
de Boer et al. 
(2008) 
Longitudinal Various (n = 195) Work Ability Index (first 
three items) 
Work ability improved over time from 4.6 (6 
months) to 6.3 (12 months) and 6.7 (18 
months) for all cancers.   Work ability by 
gender improved for both over time but 
more for women.  Current work ability, 
physical work ability and mental work ability 
all correlated with return to work at 18 
months. 
 
Cancer type, treatment 
and return to work. 
Feuerstein et al. 
(2007) 
Cross-sectional  Malignant brain tumour (n = 
95); healthy control group (n 
= 131) 
Work limitations 
questionnaire 
Cancer group reported higher level of work 
limitations than non-cancer group. 
Depressive symptoms, 
fatigue, cognitive 
limitations sleep and 
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Author (year) Study Design Cancer Type (N, n) Work Ability 
Measure 
Summary of Findings Factors Associated 
with Work Ability 
problem solving ability.  
Fobair et al. (1986) Cross-sectional Hodgkin’s disease (N = 403) Number of hours 
worked 
Difficulties at work reported by 42% and 
hours worked highly correlated with less 
depression, younger age and return of 
energy. 
 
Depression, age and 
energy levels. 
Gudbergsson et al. 
(2007) 
Cross-sectional Breast cancer (n = 208); 
testicular or prostate cancer 
(n = 209); healthy controls (n 
= 417) 
Demand control 
support questionnaire, 
weekly hours, changes 
in job tasks (yes/no) 
Survivors who had completed primary 
treatment did not differ in job situation or 
occupational stress when compared with 
controls.  However, females reported more 
job strain.  Mental and physical work 
capacity however, was impacted in 
survivors. 
 
Gender, age, personality 
and anxiety. 
Gudbergsson et al. 
(2008) 
Cross-sectional Breast cancer (n = 219); 
testicular cancer (n = 150); 
prostate cancer (n = 62) 
Work changes 
including employer, 
occupation, work tasks, 
unemployment and 
pension.  Work Ability 
Index 
 
Those who made changes to work had 
poorer work ability and reduced mental and 
physical work ability. 
Work change, age, 
symptoms, co-morbidity, 
support, neuroticism and 
physical and mental 
quality of life. 
Henry et al. (2008) Cross-sectional Various (N = 841) receiving 
chemotherapy or 
radiotherapy 
Missed work days (past 
year) due to treatment 
and treatment-related 
side-effects 
Employed patients missed on average 18 
days (over 12 months) due to treatment side 
effects.  88% reported at least one side-
effect (fatigue most commonly reported)  
Treatment and number of 
side effects. 
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Author (year) Study Design Cancer Type (N, n) Work Ability 
Measure 
Summary of Findings Factors Associated 
with Work Ability 
Kennedy et al. 
(2007) 
Qualitative Various (N = 29)  A third reported they were concerned about 
their reduced work capability and found it 
difficult to concentrate and cope at work.  
Fatigue was difficult to manage at work.  
Employer support and adjustments helped 
gradual resumption of work. 
 
 
Kessler et al. 
(2001) 
Cross-sectional Various chronic conditions (n 
= 2074) including cancer 
Out of past 30 days 
totally unable to work or 
perform normal 
activities because of 
health problems (work-
loss days)  and work-
cut-back days 
 
Cancer group showed greatest impairments 
in work (average 16.4 days lost). 
Fatigue. 
Lee et al. (2008) Cross-sectional Stomach cancer (n = 408); 
healthy controls (n = 994) 
Work-related difficulties 
included reduced hours 
and work-related 
disability (compared to 
pre-diagnosis), fatigue 
and exhaustion 
 
Cancer survivors greater risk of reduced 
hours and lessened work-related ability and 
were more easily fatigued and exhausted 
than controls. 
Fatigue and exhaustion. 
Main et al. (2005) Qualitative  Various (N = 28; working  
n = 27) 
 Due to the impact of pain, fatigue nausea 
participants reduced hours, altered job 
tasks, changed employer to manage 
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Author (year) Study Design Cancer Type (N, n) Work Ability 
Measure 
Summary of Findings Factors Associated 
with Work Ability 
reduced work ability (both mental and 
physical).  
 
Maunsell et al. 
(1999) 
Qualitative  Breast (N = 13)  Apprehensive about returning to work due to 
diminished physical work ability.  Fatigue 
linked to lessened work capacity resulting in 
altered job tasks, hours and even change in 
employer.  Support to manage reduced 
work ability in terms of adjustments from 
employer varied. 
 
 
Mols et al. (2009) Cross-sectional Various (N = 403) Current work situation, 
weekly hours and 
whether changes in 
work situation were 
attributable to cancer 
Some reduced their hours (n = 69) due to 
effects of cancer.  Being older, having more 
than one co-morbidity, chemotherapy and 
disease progression were predictors of work 
changes. 
 
Age, co-morbidity and 
chemotherapy. 
Nieuwenhuijsen et 
al. (2009) 
Longitudinal Various (N = 45) Work Ability Index (one 
item) 
Although those with neuropsychological 
impairment (n = 15) showed lower work 
ability compared with no impairment this 
was not statistically significant. 
 
 
Pryce et al. (2007) Cross-sectional Various (N = 328)  No differences between cancer types.  
Fatigue made it difficult to work during 
treatment and following treatment. 
Fatigue. 
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Author (year) Study Design Cancer Type (N, n) Work Ability 
Measure 
Summary of Findings Factors Associated 
with Work Ability 
Rasmussen & 
Elverdam (2008) 
Ethnographic 
study including 
participant 
observation and 
qualitative 
interviews 
 
Various (N = 23)  Due to physical and psychological side 
effects some participants reduced hours 
following treatment to manage lessened 
mental and physical work ability. 
 
Short et al. (2008a) Cross-sectional Various (n = 504); healthy 
controls (n = 3903) 
Weekly hours Cancer group worked 3-5 hours less each 
week compared with healthy controls. 
 
New cancer diagnosis. 
Short et al. (2008b) Cross-sectional Various (n = 647); chronic 
condition comparison group 
(n = 5988) 
 
Impairments or health 
problems that limited 
their work 
Work disability higher in the cancer group 
compared with chronic condition group. 
 
Steiner et al. (2008)  Various (N = 100) Weekly hours; 
Occupational Role 
Questionnaire 
assessed work 
adjustments 
Of those who remained in employment after 
treatment (n = 92), 42 reduced work hours 
(>4 hours), attributed this to cancer; 12 
altered job duties, 3 changed employer. No 
differences between cancer types. A 
number of physical and psychological 
symptoms were associated with a reduction 
in hours. 
 
 
 
Nausea/vomiting, fatigue, 
depression and anxiety. 
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Author (year) Study Design Cancer Type (N, n) Work Ability 
Measure 
Summary of Findings Factors Associated 
with Work Ability 
Taskila et al. (2007) Cross-sectional Breast, testicular, prostate 
and lymphoma (n = 591); 
healthy controls (n = 757) 
Work Ability Index (one 
item) 
No difference in work ability between cancer 
group and healthy controls.  26% of 
survivors reported physical work ability and 
19% said mental work ability had decreased 
due to cancer.   
 
Chemotherapy and co-
morbidity. 
Yabroff et al. (2004) Cross-sectional Various (n = 1823); healthy 
controls (n = 5469) 
Lost productivity due to 
work limitations 
associated with health 
problems and number 
of work days lost 
 
Compared with healthy controls lost 
productivity was higher in cancer group. 
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More recently, Gudbergsson and colleagues (2008) found that survivors 
(breast, testicular and prostate cancers) who made changes to their work due to 
cancer had poorer work ability and reduced mental and physical work ability 
compared to survivors whose work practices remained unchanged.  Such 
results therefore appear to indicate that survivors with poor work ability required 
work adjustments compared to those with moderate-to-good work ability. 
Although there are only relatively few existing longitudinal studies, these have 
demonstrated improvements in work ability over time in those affected by 
cancer (Maunsell et al., 2004; Bradley et al., 2007; de Boer et al., 2008).  
Research by de Boer et al. (2008), utilised a sample comprised of various 
cancer types and were recruited between four to six months since their first day 
of sick leave, reported increments in perceived work ability (as measured by 
items taken from the Work Ability Index) over time.  Work ability significantly 
improved over time from 4.6 (6 months), to 6.3 (12 months) and 6.7 (18 months) 
(de Boer et al., 2008).  Similarly, a study comparing breast cancer patients and 
healthy controls found the greatest reduction in work hours was observed 6 
months post diagnosis (breast cancer worked on average 7 hours less); 
however, hours worked increased at both 12 and 18 months (Bradley et al., 
2007).  Although the difference was not significant, breast cancer patients on 
average still worked 1.5 hours less than healthy controls at these two latter time 
points (Bradley et al., 2007).   Hence, such research may seem to suggest that 
impairments in perceived work ability may be temporary and this can be 
interpreted as an encouraging finding for people affected by cancer.  However, 
work ability deficits may persist up to 18 months after diagnosis which may 
result in a reduction in hours when compared with those without a history of 
cancer (Bradley et al., 2007).  
2.4.1. Factors Impacting Work Ability 
The literature suggests that levels of work ability are affected by various factors 
with disease recurrence (Short et al., 2005; Short et al., 2008a) and stage of 
cancer having been found to impact upon work ability (Short et al., 2005).  
Cancer type, age, education and type of job have also been reported to impact 
 53
Chapter 2                                                        Cancer and Employment: Literature review 
 
work ability (Taskila-Abrandt et al., 2005; Taskila & Lindbohm, 2007).  These 
findings will be discussed in the ensuing discussion. 
Cancer Type 
Cancer type has been reported to be associated with work ability (Taskila et al., 
2007; de Boer et al., 2008) and employment rates (Taskila-Abrandt et al., 2004; 
2005; Taskila & Lindbohm, 2007).  In terms of cancer type, differences in work 
ability are apparent and diverse; for example, in a cross-sectional study, men 
diagnosed with prostate cancer reported the lowest work ability scores; whereas 
men diagnosed with testicular cancer showed the highest work ability scores 
(Taskila et al., 2007).  However, when compared with testicular cancer, prostate 
cancers are often diagnosed in older men (Cancer Research, 2006a).  
Moreover, testicular cancers are highly treatable (Cancer Research, 2007) and 
this may explain such differences in reported work ability.  Even though de Boer 
et al. (2008) report improvements in work ability longitudinally, differences in 
work ability were also identified according to cancer type.  Firstly, those with 
haematological cancers were reported to have the most impaired work ability 
compared with those with genito-urological and gastrointestinal cancers who 
reported the least impairments in work ability.  Secondly, the greatest 
improvements in work ability over time were reported in women with breast and 
genital cancers (de Boer et al., 2008).  However, Yabroff et al. (2004) found that 
those with gastrointestinal cancers (or lung) reported the most lost productivity 
due to work limitations associated with cancer; this finding is not supported by 
de Boer et al. (2008).  In response, such differences are likely to be due to 
diverse methods used to assess work ability.  Additionally, Yabroff et al’s. study 
(2004) was cross-sectional, whereas de Boer et al. (2008) utilised a longitudinal 
approach and items from the Work Ability Index: hence, these latter findings 
may be considered more reliable.  Closer examination of de Boer and 
colleagues’ (2008) results for the gastrointestinal group (n = 23; which would 
include colorectal cancer) show this group had the second highest mean scores 
in self-assessed work ability across all three time points (5.52, 6 months; 6.95, 
12 months; 7.57, 18 months).  Differences in mental and physical work ability 
have also been reported (Bradley et al., 2007).  These researchers found 
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women with breast cancer reported difficulties in coping with both mentally and 
physically demanding work; whereas men with prostate cancer reported 
impairments in physically demanding work.  Despite these findings, other 
researchers failed to find differences in work ability according to cancer type 
(Steiner et al., 2008).  Although longitudinal study designs are increasingly 
being adopted, research endeavours need to attempt to consider how variables 
other than treatment type and fatigue may account for such differences in 
perceptions of work ability: this thesis aims to consider the role of self-efficacy 
on work ability outcomes.  In addition, there is a lack of data related to the work 
ability of colorectal cancer patients / survivors.  Furthermore, when unpicking 
existing results containing sub-samples of colorectal patients (e.g. de Boer et 
al., 2008), it is difficult as these patients often comprise the gastrointestinal 
group (includes stomach cancer).  Consequently, it is difficult to ascertain the 
precise number of colorectal cancer patients that participated in the study.              
Studies considering employment rates in cancer survivors compared to healthy 
controls are useful as it can be argued they are reflective of work ability.  
Furthermore, in terms of how work ability is best measured there is no 
consensus between existing research.  Therefore, considering employment 
rates of cancer survivors particularly in relation to cancer type could help future 
work ability research design.  In their review, Taskila and Lindbohm (2007) 
report that the probability of employment was lowest in lung cancer; however, 
this low employment rate is probably attributable to a poorer prognosis and 
survival rate associated with this cancer site.  Low employment rates have also 
previously been reported among persons with leukaemia, stomach and cancer 
of the nervous system (Taskila-Abrandt et al., 2004).  There was no significant 
difference in employment rate between those diagnosed with melanoma, non-
melanoma of the skin, Hodgkin’s disease, prostate, kidney, testis or thyroid 
cancers and their age and gender-matched referents (Taskila-Abrandt et al., 
2004).  Table 2.4 summarises more recent Finnish cancer patients’ (n = 46,312 
diagnosed in 1997) employment status according to cancer site (Taskila-
Abrandt et al., 2005); the table shows that higher employment rates (indicative 
of work ability), comparable with age and gender matched controls, were 
associated with cancers diagnosed at younger ages (testicular cancer; 67%) 
 55
Chapter 2                                                        Cancer and Employment: Literature review 
 
compared with cancers associated with increasing age (prostate cancer; 28%).  
When considering colorectal patients, data is limited, however, closer 
examination of Taskila-Abrandt et al’s. (2005) work identifies that employment 
rates were 48% for colon patients and 45% for rectum patients; therefore, lower 
when compared to their matched referents (51% and 48% respectively).   Hewitt 
et al. (2003) found in a sample of 4878, the disability rate for cancer survivors 
was 11% (3% in controls).  Results emerging from such research also indicate 
that work disability rates increase in those with prior cancer history, or with a co-
morbidity / chronic illness (Hewitt et al., 2003; Short et al., 2008b).   
Table  2.4: Employment status of all Finnish Cancer Patients in 1997 (Taskila-Abrandt et 
al., 2005). 
Cancer Site % of cancer 
survivors 
% of referents 
All cancer sites 50 55 
Breast 54 56 
Head & neck 43 51 
Digestive 45 50 
Female genitals 48 52 
Urinary & male 
genitals 
44 48 
Skin 60 56 
Testis 67 67 
Lung 29  46 
Nervous system 43 60 
 
Treatment and Symptoms 
Research suggests that differences in work ability are apparent according to 
type of treatment (Taskila et al., 2007; de Boer et al., 2008; Bradley et al., 2007; 
Mols, Thong, Vreugdenhil & van de Poll-Franse, 2009) and the experience of 
symptoms / side effects such as fatigue (Table 2.3) (Kessler et al., 2001; Henry 
et al., 2008).   
When compared with other treatments, results indicate that chemotherapy 
treatment is most likely to lead to the most significant impairments in work 
ability; such findings are supported regardless of cancer type (Taskila et al., 
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2007).  Similarly, in another sample comprising of various cancer types (N = 
195), de Boer et al. (2008) found that those receiving chemotherapy alone or a 
combination of either chemotherapy plus radiotherapy and / or surgery showed 
the lowest work ability compared with other treatment types.  Recently 
published research also found that chemotherapy was a predictor of work 
changes (reduced hours) (Mols et al., 2009).  However, this study’s cross-
sectional approach makes it difficult to identify how long such work changes 
may last. 
Symptoms and side-effects commonly experienced due to treatment have also 
been found to be associated with work ability.  Symptoms such as depression, 
cognitive limitations, sleep problems, impaired problem solving ability and 
fatigue accounted for 65% of the variance associated with work limitations in a 
study of malignant brain tumour patients (Feuerstein et al., 2007).  Henry et al. 
(2008) found that 88% of their sample (N = 841) reported at least one side-
effect (fatigue most common); furthermore, the more side-effects experienced 
the worse the impact on work absence.  Fatigue is a frequently reported side-
effect in cancer patients undergoing treatment and has also been found to 
impact work ability negatively (Kessler et al., 2001; Feuerstein et al., 2007; 
Henry et al., 2008).  Pryce et al. (2007) reported that symptoms of fatigue made 
it difficult for individuals to work during and following treatment.  Furthermore, 
there are a number of studies that show symptoms of fatigue led to work 
limitations and changes in work productivity (Feuerstein et al., 2007; Pryce et 
al., 2007) and changes to working practices, such as reduced work hours (Amir, 
Neary & Luker, 2008; Bradley et al., 2007; Lee et al., 2008) and increased 
absence (Kessler et al., 2001).  Qualitative studies have provided a useful 
insight into the impact of symptoms and side-effects, particularly in relation to 
when such effects are most pronounced (e.g. during treatment) (Kennedy et al., 
2007; Amir et al., 2008), the persistence of such symptoms (Kennedy et al., 
2007) and how they are managed whilst at work (Rasmussen & Elverdam, 
2008).  Rasmussen and Elverdam (2008) interviewed participants who stated 
that they reduced their hours following treatment to manage lessened mental 
and physical work ability.  Similarly, participants interviewed by Kennedy et al. 
(2007) reported fatigue difficult to manage whilst at work; these problems were 
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manifest between two and six years following the initial diagnosis.  Due to 
differences in study methods and design, it is difficult to ascertain whether such 
impairments, for example, fatigue caused reduced work ability. 
Age, Gender and Education 
A number of person-related variables (e.g. age, gender and education) have 
been identified as factors that influence the work ability of cancer survivors.  In 
terms of age, evidence suggests impairments in work ability and changes to 
work due to cancer could be exacerbated with increasing age (Fobair et al., 
1986; Taskila et al., 2007; Gudbergsson et al., 2008; Mols et al., 2009).  
Subsequently, it is likely that with increasing age it may be difficult for those with 
cancer to continue with or return to work after treatment.  In contrast, other 
research suggests work ability improves over time across various cancers 
regardless of age (de Boer et al., 2008).    
Regarding gender, differences in work ability have been reported.  De Boer et 
al. (2008) found that women had lower work ability at six months when 
compared with males; however, over the course of the study women showed 
the most significant improvement in work ability scores.  However, these results 
could be explained by cancer type as the largest sub-sample in this study was 
women diagnosed with breast cancer (n = 54).  Taskila et al. (2007) showed 
that 20% of men and 28% of women felt that cancer had impaired their physical 
work ability.  The same study found perceived mental work ability impairments 
were experienced by 23% of men and 28% of women.  In another study, it 
emerged that females reported higher cancer-related disabilities than men at 
work (Short et al., 2005).  This study also found gender differences according to 
work outcomes within cancer type.  For both head and neck cancers, females 
were increasingly more likely than males to terminate work.  These researchers 
argued that explanations for such differences are unavailable at present (Short 
et al., 2005).     
In relation to education, Taskila-Abrandt et al. (2004) present results that 
indicate that those with higher education status were more likely to be employed 
after their cancer diagnosis than people with lower education status.  In 
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addition, other research has shown that survivors with higher education levels 
were less likely to retire early or become unemployed than their lower educated 
counterparts (Abrahamsen et al., 1998; Nagarajan et al., 2003).  Further to this, 
in a more recent study, Taskila and colleagues (2007) showed that those with 
higher education status perceived their work ability to be better than those with 
lower education status.  However, such differences could be due to more 
educated persons participating in non-manual work as opposed to those with 
lower education more likely to participate in manual labour jobs.  With regard to 
work ability, physical impairments may lead to more absence or even 
withdrawal from work for those in manual labour jobs (Spelten et al., 2002; Main 
et al., 2005). 
Work-Related Factors, Adjustments and Support 
Factors associated with work have been found to impact work decisions.  
However, little is known about how factors such as type of work, workplace 
adjustments and support may impact work ability (Munir, Yarker et al., 2009).  
For example, research tells us those in manual labour jobs experience 
problems when returning to work (Spelten et al., 2002; Main et al., 2005; 
Maunsell et al., 1999).  Furthermore, Mor (1986) found a higher percentage of 
white-collar workers (78%) than blue collar workers (63%) remained in their jobs 
12 months post diagnosis: this suggests physically demanding employment 
may be more difficult for cancer patients / survivors to maintain or resume.   
With regard to support and workplace adjustments mixed findings are reported.  
Steiner et al. (2008) found that most participants informed co-workers and 
employers about their diagnosis.  Participants reported that colleagues were 
either quite or extremely supportive.  However, when considering the level of 
support received and changes to work, differences in work environment 
between those who reduced their hours and those who did not were not 
identified (Steiner et al., 2008).  Alternatively, Pryce et al. (2007) found that 
workplace adjustments were received by less than half of those who had 
disclosed details of their illness to their employer.  Moreover, those receiving 
support in terms of flexible working and work adjustments were most likely to 
work during treatment.  Based on these findings, it is plausible to suggest that 
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there is a need to include health models and / or social cognitive models (e.g. 
self-efficacy models) in relation to cancer and work studies.  The role of self-
efficacy (i.e. high levels) in organisational settings and subsequent work 
outcomes is plentiful (e.g. Parker, 1994; Jex & Gudanowski, 1992): therefore, 
making use of these proven models could help towards enhancing our 
understanding of the employment outcomes of cancer patients and survivors.   
Other studies report that individuals change their employment because they are 
unable to perform their job role in the way they did prior to having cancer (Main 
et al., 2005; Maunsell et al., 1999).  A qualitative interview study found reasons 
for such job changes were often attributed to a lack of employer 
accommodations (Maunsell et al., 1999; Main et al., 2005).  Studies in women 
diagnosed with breast cancer have reported that they experienced difficulties at 
work upon returning.  These include job loss (Maunsell et al., 1999), reduced 
hours (Maunsell et al., 1999; Main et al., 2005), change in job role (Maunsell et 
al, 1999) and diminished physical capacity (Chirikos, Russell-Jacobs & 
Jacobsen, 2002; Bradley & Bednarek, 2002).  Such problems may be linked to 
the lack of formal policy adopted by employers (Cancer Backup, 2006).  Data 
collected from organisations suggest 73% did not have a formal procedure to 
manage an employee with cancer (Cancer Backup, 2006).  Subsequently, as 
well as impairments in work ability there also appears to be a lack of knowledge 
inherent among employers which needs to be addressed to ensure cancer 
patients / survivors are supported in the workplace.  However, the limited 
understanding of the impact of work-related factors upon work ability makes it 
difficult to draw such inferences at present. 
2.5. Summary 
In conclusion, the majority of the evidence considering how cancer may impact 
upon working life has come from studies from the US, Netherlands or 
Scandinavia.  Few studies have considered cancer patients from the UK.  This 
is concerning as approximately 90,000 of those diagnosed each year 
(approximately 250,000) are of working age (Morrell & Pryce, 2005).  
Furthermore, a substantial amount of existing research has focused purely on 
the experiences of those diagnosed with breast cancer (Maunsell et al, 1999; 
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Drolet et al, 2005; Chirikos et al., 2002; Bushunow et al, 1995; Satariano & 
DeLorenzo, 1996).  However, as outlined in Chapter 1, along with breast 
cancer, colorectal cancer is among one of the top five commonly diagnosed 
cancers.  After breast cancer (largest amount diagnosed of working age), a 
proportion of those diagnosed with colorectal cancer are also likely to be of a 
working age.  The fact that colorectal cancer is associated with increasing age 
may explain why this group has not been considered in great detail.  This 
however adds an interesting dimension to this particular group.  Based upon 
ageing literature, these individuals are likely to be nearing retirement age and 
therefore, these patients could be more at risk of opting for ill-health / early 
retirement (e.g. compared with breast cancer patients).  With the anticipated 
increase in state pension age there is a need to consider such groups as many 
will be able to (either by choice or need) continue with work during treatment or 
return after the completion of treatment (Amir et al., 2007).  However, research 
related to this group is relatively scarce.  Moreover, although research 
demonstrates promising return to work outcomes for this group, little is known 
about the work ability of these individuals.  Additionally, existing research 
focuses on employment pathways (i.e. how many return to work) rather than the 
psychosocial and work factors that may influence return to work intentions, work 
ability and employment decisions made by people affected by colorectal cancer. 
Similarly, the literature related to the physical and psychosocial impacts of 
cancer is vast.  Factors such as fatigue, depression and social support have 
also been found to be related to return to work and work ability outcomes.  
However, although a number of factors impacting upon work outcomes have 
been identified, research naturally evolves searching for new areas to explore 
which could further enhance our understanding of a particular area.  This study 
aimed to add to existing findings by examining the role of factors that have not 
previously been considered in detail.  Earlier discussion highlighted the potential 
usefulness of self-efficacy as a factor that could be related to employment 
outcomes of cancer patients and survivors.  Findings of cancer self-
management studies (e.g. Cunningham et al., 1991; Lev et al., 2001) indicate 
that favourable self-efficacy perceptions are associated with positive quality of 
life outcomes.  Subsequently, studying this construct in relation to the return to 
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work intentions, work ability and employment outcomes of cancer patients is 
worthy of consideration.  This is a matter that this thesis sought to delineate.  
Furthermore, the role of factors such as social support upon self-efficacy beliefs 
was a secondary aim of this study; moreover, the research aimed to explore the 
extent to which work-related advice and guidance is currently being provided to 
patients by health professionals.   
2.6. Research Objectives, Aims and Hypotheses  
While there are a number of studies on cancer and work outcomes, particularly 
breast cancer, little information is available on employment pathways for those 
managing colorectal cancer.  Each year approximately 36,000 people are 
diagnosed with colorectal cancer in the UK (Bowel Cancer UK, 2006) and a 
proportion of these will be of working age.  Research in this area is important for 
the following reasons.  Firstly, colorectal cancer affects older people (90 per 
cent diagnosed are over 55 years, Bowel Cancer UK, 2006) and due to falling 
birth rates and people living longer, Government and policymakers are 
encouraging people to work for longer (Centre for Research in the Older 
Workforce, 2004).  Secondly, as well as undergoing chemotherapy / 
radiotherapy treatment, surgical treatment may result in life changes (e.g. stoma 
appliance), which in turn may impact colorectal cancer patients’ work ability.  
Thirdly, few studies have considered key psychosocial factors that may impact 
upon work ability for colorectal cancer (e.g. self-efficacy, social support and 
treatment).  Although self-efficacy and social support have been considered as 
important factors in patients’ management of their cancer diagnosis and 
treatment, the impact of these two factors on work ability have scarcely been 
considered.  This is somewhat surprising as findings from cancer adjustment 
studies suggest self-efficacy is an important factor (Cunningham et al., 1991) 
and therefore its role should be considered in the return to work and work ability 
of those recovering from cancer. 
This study therefore offers a novel insight into the work ability of newly 
diagnosed colorectal cancer patients.  The research study took approximately 
six months to complete and utilised both quantitative and qualitative methods; 
this helped to gain a holistic and coherent understanding of cancer and work 
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ability a combined quantitative and qualitative approach was chosen.  According 
to some, to understand such experiences “requires a broad range of 
perspectives and skills” (Casebeer & Verhoef, 1997, p. 1).   
Indeed, it is acknowledged that the two paradigms are characteristically 
different, particularly in terms of their associated philosophical assumptions 
(Lincoln & Guba, 1985).  The quantitative paradigm relates to the notion of “an 
objective reality that exists independent of human perception” (Sale, Lohfeld & 
Brazil, 2002, p. 44).  By contrast, the qualitative paradigm is concerned with 
realism, interpretive and constructionist thus focusing on process and meanings 
(Secker, Wimbush, Watson & Milburn 1995; Guba & Lincoln, 1994; Sale et al., 
2002).  Such inherent differences have formed the basis of arguments 
suggesting that using these methods in tandem would be inappropriate (Lincoln 
& Guba, 1985).  However, others refute this argument (Casebeer & Verhoef, 
1997; Steckler et al., 1992; Clarke & Yaros, 1998).  For instance, the argument 
posited by Clarke and Yaros (1988) as cited in Sale et al. (2002) is relevant to 
this thesis, whereby, “combining research methods is useful in some areas of 
research...because the complexities of phenomena requires data from a large 
number of the perspectives” (p. 46).    
In short, this thesis utilised a mixed methodological approach encompassing 
both quantitative and qualitative elements to address the research objectives 
and aims.  Quantitative methods sought to measure the cancer and work 
experience; whereas qualitative methods were used to gain an understanding 
into the nature and meaning of the experience (Sale et al., 2002).  Therefore, 
the resulting research objective and aims were to: 
1. Examine the employment and psychosocial well-being outcomes of 
colorectal cancer patients over a longitudinal period in the UK. 
Firstly, using survey data, this study assessed the employment outcomes of 
colorectal cancer patients over a period of time.  Research discussed earlier 
during this chapter highlighted the importance of variables such as age, 
treatment and psychosocial well-being.  With regard to age, research indicates 
that older patients were less likely to return to work (Bouknight et al., 2006).  
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Lima et al. (1997) found for those aged 50 years or less return to work was 74 
per cent.  However, for those over the age of 50 years return to work was 30 
per cent.  In a sample of various cancer types, Taskila et al. (2007) found older 
age to be associated with lower work ability.  However, other research indicates 
that age does not impact work ability (de Boer et al., 2008) or return to work 
outcomes (Johnsson et al., 2007).  Furthermore, when considering treatment, 
evidence suggests absence was significantly higher in early-stage breast 
cancer patients that underwent chemotherapy or multimodal treatment (Balak et 
al., 2008).  Johnsson et al. (2007) found chemotherapy was significantly 
associated with return to work in breast cancer patients.  Such findings have 
been supported in patients with prostate and breast cancer (Bradley et al., 
2006).  Moreover, de Boer et al. (2008) reports low work ability scores in those 
receiving chemotherapy.  Research investigating the role of cancer diagnosis 
and treatment on work ability is still in its early stages particularly for colorectal 
cancer patients; therefore, this study provides an insight into this group.  The 
hypotheses to be examined in relation to this objective were as follows and the 
results of this study are presented and discussed in Chapter 4: 
Hypothesis i) Levels of fatigue, depression, quality of life and self-efficacy 
(psychosocial well-being) will vary over time; furthermore, when compared with 
individuals receiving chemotherapy or a combination of treatments those 
receiving surgery alone will show the most pronounced improvements. 
Hypothesis ii) Levels of perceived work ability will vary over time; furthermore, 
when compared with individuals receiving chemotherapy or a combination of 
treatments those receiving surgery alone will show the most pronounced 
improvements. 
2. To consider the role of self-efficacy and psychosocial well-being on 
work ability and employment outcomes. 
Studying self-efficacy in relation to cancer patients’ well-being, work ability and 
return to work intentions is important as self-efficacy has been argued to play a 
pivotal role in a variety of health and work-related areas; therefore, indicating it 
may be of importance here.  However, little is known about the mechanisms in 
which self-efficacy may have an effect upon work outcomes of cancer patients 
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that are employed at diagnosis.  On the most basic level self-efficacy could 
operate as a mechanism within the individual that may determine how the 
person perceives their work ability and what their return to work intentions may 
be; alternatively, these relationships may be more complex.  Firstly, a patient’s 
work self-efficacy and cancer-specific self-efficacy may differ.  Whilst patients 
may feel that they are able to confidently self-manage their cancer, they may 
not express the same self-belief in their work ability.  Hence, this highlights the 
need to assess these domains of self-efficacy separately, which to the 
researcher’s knowledge has not been carried out previously.   
Secondly, differing self-efficacy levels may be related to various psychosocial 
and work-related factors.  For instance, a cancer patient who works in a 
physically demanding job may not feel able to perform (poor work ability) in the 
manner prior to the cancer (Spelten et al., 2002).  Thus, the individual could be 
on sick leave for longer or withdraw from work altogether (retire or find 
something new).  Psychosocial and physical well-being such as the experience 
of fatigue, depressive symptoms and altered bowel habits in this group may 
also negatively impact self-efficacy beliefs.  A lack of social support (e.g. from 
employer) may further exacerbate this impact which overall could result in 
poorer self-assessed work ability and employment outcomes.  Considering the 
nature of these variables and their relationships with work ability and 
employment status over time is necessary.  The following set of hypotheses 
was therefore addressed utilising a longitudinal (quantitative) questionnaire for 
which the findings are presented and discussed in Chapter 5:  
Hypothesis iii) Cancer self-efficacy and job self-efficacy may be inherently 
different. 
Hypothesis iv) Levels of self-efficacy and psychosocial well-being will be 
associated with perceived work ability (cross-sectional and longitudinal). 
Hypothesis v) Levels of self-efficacy, psychosocial well-being and work ability 
will be associated with employment status (cross-sectional and longitudinal). 
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In addition to the research objectives outlined previously, a number of research 
aims were derived and addressed using a qualitative approach:  
3. To understand the temporal fluctuations and patterns in cancer 
management, return to work intentions and work ability.  
 
3i)  To understand the temporal nature of self-efficacy beliefs and how such 
beliefs may impact upon self-management and subsequent return to 
work intentions and perceptions of work ability. 
3ii)  To consider the level and nature of social support received and whether 
this may benefit individuals’ self-efficacy beliefs and subsequent self-
management and work outcomes. 
 
As self-efficacy has not been studied in great detail in this research area, this 
study utilised a qualitative diary to explore the temporal nature of this variable 
(research aims 3i and 3ii).  This allowed the researcher to provide a multi-
faceted insight into the possible role of self-efficacy in the experience of cancer 
and how it may impact work ability and return to work intentions over time.  
Research reported in the generic cancer and psychosocial well being literature 
suggests levels of self-efficacy are important in understanding adjustment and 
quality of life (Arora et al., 2002; Lev et al., 2001).  Essentially, an individual’s 
working life could be viewed as a key quality of life outcome; thus, the role self-
efficacy is likely to be multi-faceted and of relevance when considering cancer 
patients’ employment outcomes.  Furthermore, little is known about the extent 
to which self-efficacy beliefs may fluctuate over time, over the cancer pathway 
(e.g. diagnosis and treatment) and how such beliefs may impact work ability 
and return to work intentions within the context of the cancer experience.  
Additionally, Chapter 1 discussed the beneficial value of social support in 
relation to cancer self-management.  Therefore, considering this along with self-
efficacy beliefs was an additional aim.  Chapter 6 therefore presents the 
findings from this study and addresses these aims. 
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4. To explore the nature and extent to which work-related advice is 
provided to colorectal cancer patients by health care professionals. 
 
4i) To understand the nature and type of information currently provided to 
working-aged cancer patients and the impact this may have on patients. 
4ii) To identify factors that may influence the type of information given. 
The nature of the patient and health professional relationship during cancer 
diagnosis and treatment is important.  Health professionals provide information 
to cancer patients on diagnosis, treatment and prognosis.  Although the 
potential effects of different types of treatments are discussed with patients, not 
enough is known about the extent to which disease and treatment(s) effects 
upon work capacity are discussed with working-aged patients (Maunsell et al., 
1999; Verbeek, 2006).  According to some studies, the role of health 
professionals (e.g. doctors) is pivotal in helping patients re-enter the work place 
after a cancer diagnosis (Verbeek, 2006).  In a qualitative study with breast 
cancer patients, Maunsell et al. (1999) reported that these issues were rarely 
discussed.  Moreover, results suggested that these women assumed it would 
be difficult to work during treatment, hence, considered it normal to stop during 
this time (Maunsell et al., 1999).  Research by Verbeek, Sprangers, Kammeijer 
and Sprangers (2003) also found that only half of the cancer survivors in the 
sample had discussed return to work with their physician.  More recently, in an 
interview study, Kennedy et al. (2007) reported that some participants stated 
that work matters were not discussed with their doctor.  Surprisingly, these 
individuals were unsure whether their doctor knew about their work status.  For 
the few that did discuss work matters, it was reported that work decisions were 
ultimately left up to them.  Maunsell et al. (1999) argued that this lack of 
discussion may exacerbate concerns and apprehensions cancer patients and 
survivors may have about resuming work.   
Therefore, research is needed to examine why health professionals may not be 
providing guidance in this area.  Firstly, there are already high demands placed 
upon health professionals, which are indicative in the high levels of stress and 
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burnout observed in these groups (e.g. colorectal surgical consultants) 
(Sharma, Sharp, Walker & Monson, 2008).  Secondly, the proposed short ten 
minute consultation times inevitably lead to the consultation focussing largely on 
disease and treatment factors.  However, Verbeek et al. (2003) suggest that 
with continuity of care, more specific guidance (e.g. work-related) could be 
possible.  Whether this is within the realm of consultants and specialist nurses 
requires further study.  Finally, the present lack of specific guidance may also 
be explained in part by the notion that consultants and specialist nurses are 
unaware of what their role in the return to work process should be (Aitken & 
Cornes, 1990).  Consequently, Chapter 7 explores the type and nature of work-
related guidance currently provided to patients in the UK.  This, along with 
findings from the survey and diary studies may enable common patterns to be 
seen and help to identify subsequent improvements that could be made to this 
aspect of patient care.   
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Chapter 3 
3. Methodology 
3.1. Design 
The study was a longitudinal design where data were collected from participants 
over a six month period.  A combined quantitative and qualitative methodology 
was utilised consisting of survey questionnaires and a qualitative diary that were 
completed by colorectal cancer patients.  This thesis therefore presents data 
based upon three different but interlinked studies: a longitudinal survey; a 
qualitative diary, and an interview study comprised of health professionals.  This 
mixed-method approach has three benefits: different methods or tools are 
suited to different tasks; both are necessary in order to answer complex and 
new questions and combining approaches aims to result in a synergistic effect 
due to the interaction of both approaches (De Vries et al, 1992) and also 
enables feedback between assumptions and data, thereby, enhancing the 
validity of results.  The methodology that is presented within this chapter relates 
to the longitudinal survey study.  Detailed information regarding the diary study 
and the health professionals’ interview study are discussed in their 
corresponding chapters (6 and 7).  For the quantitative survey element, 
participants were assessed at three time points.  Time point one assessment 
provided baseline data and were collected when participants were recruited.  To 
monitor any changes in health, general well-being, work ability and employment 
outcomes, data were collected approximately three (follow-up time 1) and six 
months (follow-up time 2) after baseline.   
3.2. Recruitment and Ethical Approval 
The process of gaining access to colorectal cancer patients and obtaining 
ethical approval took approximately a year.   
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Recruitment
The recruitment process comprised of two approaches where participants were 
recruited from either an NHS (National Health Service) Trust or an online 
support group affiliated to a UK based cancer charity (Macmillan / 
Cancerbackup) that have cancer specialist nurses attached to them.  In terms of 
gaining access to patients through NHS Trusts, the researcher identified and 
approached consultant surgeons (colorectal) and oncologists working within 
hospitals in the Midlands area.  These health professionals were provided with 
information about the study and what it involved. Three consultants, each from 
a different NHS Trust, expressed an interest in collaborating.  Subsequently, the 
researcher was successful in gaining access to patients at three NHS Trusts.   
Ethical Approval 
After receiving support from the three consultants, the researcher obtained 
ethical approval from a local NHS Research Ethics Committee (Nottingham 
REC 2) and the appropriate Research and Development departments affiliated 
to each NHS Trust.  Ethical approval was also obtained from Loughborough 
University’s Advisory Committee (Appendix 2, approval letters).   
3.2.1. Participants  
Participants were recruited from either three acute NHS Trusts (n = 27) across 
the Midlands or an online support group (n = 23).  Fifty colorectal cancer 
patients participated in the longitudinal survey (male; n = 28).  In addition, a 
sub-sample of ten participants (female; n = 7), completed the monthly diary 
study (see Chapter 6, p. 126).  Survey participants were aged between 40 and 
63 years with a mean age of 52.49 years (SD = 5.42).  Those meeting the study 
inclusion criteria were invited to participate by their consultant or cancer nurse, 
who referred them to the researcher, or by responding to the online post 
submitted by the researcher.  The inclusion criteria were: (a) employed at time 
of diagnosis (≥18.5 hours per week); (b) be diagnosed with primary colorectal 
cancer; (c) be able to speak, write and read English, and (d) have a permanent 
address or contact details.  Invitation letters (Appendix 3) and participant 
information sheets (Appendix 4) detailing the research were provided to those 
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expressing an interest.  Those meeting the inclusion criteria and wishing to 
participate were asked to complete an informed consent form (Appendix 5).   
3.3. Power Calculation: Sample Size 
All but two of the hypotheses were to be tested using regression models.  
Calculating power for regression models required prior knowledge from existing 
studies on outcome and predictor variables which is limited in terms of this 
study’s population.  Thus, the researcher used the information that was 
available during the early planning stages (October 2006) in the best way 
possible to estimate power of the models.  The desired sample size was 
calculated based upon a mean return to work rate of 62% that was obtained 
from a review of 14 studies that examined return to work in different cancer 
populations (Spelten et al., 2002).  This was chosen as it was the most 
comprehensive relevant data that was available (at the time) on return to work 
in cancer patients.  All calculations were carried out using Power and Precision 
software (Borenstein, Rothstein & Cohen, 2001).  Hence, for a regression 
model where all significance tests were to be performed at α = 0.05 for two-
tailed tests and beta = 0.80 (power), the researcher required 85 participants to 
detect a 19% increase in return to work related to one standard deviation 
increase in self-efficacy score including a second continuous predictor variable 
of depression1. This model assumed correlation between predictor variables to 
equal r = -0.30 and an odds ratio (OR) of 2.31 for self-efficacy (based on a 1 SD 
change in the self efficacy score) and an OR of 0.50 (based on a 1 SD change 
in depression score) for depression.  This moderate correlation between these 
predictor variables has been reported in persons with asthma (Mancuso, 
Melina, McCulloch & Charlson, 2001). 
 
 
1 Prior self-efficacy (Lam & Fielding, 2007) and depression (Kornblith et al., 2007) 
means/standard deviations were selected from existing research utilising cancer populations. 
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3.4. Measures 
Data collection comprised of three measures: 1) Background Questionnaire 
(Appendix 6); 2) Managing Cancer and Employment Questionnaire (Appendix 
7), and 3) Diary (Appendix 8).  Hence, these included both quantitative and 
qualitative elements.  These are outlined below: 
 
3.4.1. Background Questionnaire 
Demographics 
Information was collected on: participants’ age (date of birth) and ethnicity, 
which was assessed by utilising a Government designed measure (Sustainable 
Development Commission, 2005).  Education was assessed with one item that 
asked participants to disclose the highest qualification that they held.  Three 
items sought to gather information about participants’ occupation (current 
employment status, type of employment [manual / non manual] and tenure).   
Illness 
Six items were developed to gather information regarding the illness (diagnosis) 
and illness severity (stage if known).  Participants were asked to indicate the 
treatment(s) they were receiving and any treatment(s) they had completed 
(surgery, chemotherapy, radiotherapy and / or other).  Prior experiences of 
cancer were noted, along with any additional chronic illnesses. 
3.4.2. Cancer and Employment Questionnaire 
This section describes the measures that were used to assess psychosocial 
and work factors at each time point (baseline, follow-up time 1 and follow-up 
time 2) and are summarised in Table 3.1.  The Managing Cancer and 
Employment Questionnaire (Appendix 7) comprised of three sections: Section A 
was to be completed by all participants; Section B was to be completed by 
those who were working at the time of questionnaire completion, and Section C 
was completed by those who had stopped working, or were on sick leave.  The 
measures contained within each section are described below:   
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Table  3.1: Scales administered at each time point. 
 Baseline  Follow-up Time 1  Follow-up Time 2  
All participants Background Questionnaire (socio-
demographics and disease-specific 
information) 
Beck Depression Inventory 
Fatigue Severity Scale 
Chronic Disease Self-Efficacy Scale  
Functional Assessment of Cancer Therapy 
Scale 
Job Self-Efficacy 
Work Ability Index 
Beck Depression Inventory 
Fatigue Severity Scale 
Chronic Disease Self-Efficacy Scale  
Functional Assessment of Cancer Therapy 
Scale 
Job Self-Efficacy 
Work Ability Index 
 
Beck Depression Inventory 
Fatigue Severity Scale 
Chronic Disease Self-Efficacy Scale  
Functional Assessment of Cancer 
Therapy Scale 
Job Self-Efficacy 
Work Ability Index 
 
Chapter 3                                                        Methodology 
Section A 
Depression 
The Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996) was 
utilised to measure the intensity of depressive symptoms in participants.  This is 
one of the most frequently used depression scales and has demonstrated good 
validity and reliability (Kline, 2000).  In the cancer population, studies using this 
measure have also reported high reliability (Pinquart et al., 2006).  The 
inventory comprises of 21 statements where participants were asked to select 
the one that best described the way they have felt during the past 2 weeks.  
Items assessed depressive symptoms such as hopelessness and irritability, 
cognitions such as guilt and physical symptoms such as fatigue and weight 
loss.  For example, of the following four statements, participants had to choose 
the one statement that they most agreed with: ‘I do not feel sad’, ‘I feel sad’, ‘I 
am sad all the time’, or ‘I am so sad or unhappy that I can’t stand it.’  Items are 
scored on a four-point scale (0 – 3); scores are summed and range from zero to 
sixty-three.  Higher scores denoted more severe depression.  A score >20 is 
usually considered indicative of clinical depression, while a score of <10 is non-
depressed.  Finally a boundary for mild depression is ten.  Internal consistency 
of the scale for each time point was α = 0.86; 0.88; 0.85 respectively. 
Fatigue  
The Fatigue Severity Scale was used to assess fatigue (Krupp et al., 1989).  It 
is a nine item scale developed for measuring fatigue in patients with chronic 
illness.  The scale has been utilised with cancer patients and has demonstrated 
good reliability and validity (Stone, Richards, A’Hern, & Hardy, 2000).  
Agreement with statements such as, ‘fatigue interferes with my physical 
functioning,’ are ranked on a seven-point Likert scale ranging from 1 (strongly 
disagree) to 7 (strongly agree).  The test score is averaged to provide a score 
ranging from 1 - 9.  A score of 5.5 has previously been used as an indicator of 
fatigue (Lichstein, Means, Noe, & Aguillard, 1997).  The scale had an internal 
consistency of α = 0.89 at baseline; α = 0.94 at follow-up time 1 and follow-up 
time 2.   
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Quality of Life 
The Functional Assessment of Cancer Therapy Scale (FACT-G) was utilised to 
assess quality of life (Cella et al., 1993).  The scale comprised of 26 items that 
assessed quality of life in cancer patients undergoing treatment.  The scale has 
been validated utilising 854 cancer patients (Cella et al., 1993).  The scale 
asked participants to rate how true statements such as, ‘I am satisfied with how 
I am coping with my illness’, were on a five-point Likert scale from 0 (not at all 
true) to 4 (very much true).  Responses to the 26 items were combined into four 
quality of life scales: physical well-being (7 items); social/family well-being (6 
items); emotional well-being (6 items); functional well-being (7 items).  A total 
score was calculated to indicate overall quality of life, where a higher score 
indicated more positive quality of life.  The scale had a good internal 
consistency across all three time points, with Cronbach alpha coefficients 
reported of 0.89 (baseline), 0.92 (follow-up time 1) and 0.91 (follow-up time 2). 
Self-Efficacy  
Cancer self-efficacy was assessed utilising 14 items taken from the Chronic 
Disease Self-Efficacy scales (Lorig et al., 1996).  The scale asked participants 
to rate how confident they were in performing certain activities such as, ‘do all 
the things necessary to manage your condition on a regular basis’, on a ten-
point Likert scale ranging from 1 (not at all confident) to 10 (totally confident).  
Four sub-scales were utilised: communicate with physician (3 items); manage 
disease in general (5 items); manage symptoms (5 items), and one item that 
assessed confidence in getting information about the disease.  A total cancer 
self-efficacy score was calculated, where a higher score indicated higher cancer 
self-efficacy.  The scale demonstrated good internal consistency (α = 0.76 
baseline; α = 0.93 follow-up time 1; α = 0.93 follow-up time 2). 
Work Ability 
Work ability was assessed using three items taken from the Work Ability Index 
(Tuomi et al., 1998).  This method has been adopted by previous researchers 
(e.g. de Boer et al., 2008).  For example, participants were presented with the 
following item and were asked to rate their current work ability on a ten-point 
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Likert scale ranging from 0 (cannot work at all) to 10 (work ability at best) 
‘assume that your work ability at its best has a value of 10 points.  How many 
points would you give your current work ability?’  Internal consistency of the 
scale was calculated for each time point; however, these should be treated with 
caution as a small number of items were utilised from the original scale (α = 
0.58; α = 0.59; α = 0.56).  
Job Self-Efficacy 
Job self-efficacy was assessed by modifying a return to work self-efficacy scale 
used in patients with back pain (Shaw & Huang, 2005).  The scale comprised of 
18 items which asked participants to rate how confident they were in performing 
certain activities at work, or if they were at work on a ten-point Likert scale 
ranging from 1 (not at all confident) to 10 (totally confident).  For example, ‘how 
confident are you that you can suggest to your supervisor ways to change your 
work to reduce discomfort?’ A total score was calculated to indicate job self-
efficacy with higher scores indicating higher levels of job self-efficacy.  The 
scale demonstrated respectable internal consistency across all three time points 
(α = 0.90; α = 0.95; α = 0.91). 
Section B 
Disclosure 
Disclosure of illness was measured with two items.  Participants were asked to 
indicate (Yes / No) whether they had disclosed their illness to their line manager 
or employer and colleagues.   
Section C 
Sick-leave and Not working 
Eleven items were included for those who were on sick-leave (when 
questionnaire was completed), or who had withdrawn from the workplace 
altogether.  These items assessed when participants left work, reasons for this 
and whether they intended to return to work in the future.  Items also asked 
whether participants had disclosed their illness to colleagues and managers.  
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3.4.3. Qualitative Data: Diary 
To gather more in-depth and rich information about the role of self-efficacy in 
the management of cancer and work, participants were offered the opportunity 
to complete a diary booklet (Appendix 8).  Of the 50 participants that completed 
the survey data, 10 took part in the diary study.  The diary was designed to 
capture the more subtle, temporal fluctuations in perceptions of self-efficacy and 
the factors (illness self-management) that impacted upon these.  Therefore, it 
served to supplement the data captured by the questionnaires.  Please refer to 
Chapter 6 (pp. 123-179) which discusses this study, its associated methods and 
results in detail.  
3.4.4. Health Professionals’ Interview Study  
The final study recruited a sample of 18 health professionals from a number of 
fields.  These individuals participated in a semi-structured interview to explore 
the extent to which they provided work-related advice and guidance to cancer 
patients.  The aims, methods and results of this study are presented in Chapter 
7 (pp. 180-209). 
3.5. Procedure 
Those meeting the study inclusion criteria were provided with an invitation letter 
(Appendix 3) and participant information sheet (Appendix 4) by their consultant, 
cancer nurse or the researcher (see Figure 3.1).  Consequently, potential 
participants were briefed in writing and / or verbally.  Those wishing to 
participate were required to complete the informed consent form.  Upon 
completion of the consent forms the researcher informed participants that they 
were NOT a clinician or cancer nurse.  Moreover, participants were informed 
that their clinician and cancer nurse would be notified of their participation.  
Participants were advised to contact any of these persons and / or 
Cancerbackup if they felt distressed during any point of the study duration.  The 
researcher explained that all sensitive data would be kept strictly confidential 
and that they would only be identifiable to the researcher by a unique code 
assigned to them at the start of the study.  Participants were made aware (via 
information sheet, consent form and verbally) that they could withdraw from the 
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study at any point without any consequences, particularly in relation to their 
treatment and / or standard of care.  Participants were then provided with the 
study documents. 
3.5.1. Questionnaire Administration 
It is important to mention that participants recruited from the support group were 
given the option to complete the questionnaire by post or online (via Survey 
Monkey).  All participants were administered two questionnaires once they had 
been recruited.  This provided baseline data (time point one).  The first 
questionnaire (Background Questionnaire, Appendix 6) assessed socio-
demographic and illness variables and took no longer than 15 minutes to 
complete.  The second questionnaire (Managing Cancer and Employment, 
Appendix 7) was provided to monitor the effects of colorectal cancer, treatment, 
psychological, social and work factors on ability to work.  This questionnaire 
took approximately 30 minutes to complete.  The researcher advised 
participants to complete the questionnaires at home.  Each participant was 
provided with a stamped addressed envelope to return completed 
questionnaires to the researcher.   
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Recruitment letter/ 
Information Sheet 
Information Sheet 
Consent form 
Background Questionnaire 
Colorectal Cancer Patients 
Diary (Optional) 
Managing Cancer & 
Employment Questionnaire 
Managing Cancer & 
Employment Questionnaire 
 
Recruitment 
Process (varied at each 
NHS Trust and support 
group) 
Briefing Session 
Assessment 1 
(Baseline) 
Assessments 2&3 
(3 & 6 months after  
assessment 1) 
1. Principal Investigator visits 
clinic-patients referred 
2. Support group contact 
researcher.
 
Figure  3.1: Diagram of Protocol 
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The Managing Cancer and Employment Questionnaires were sent to 
participants at time points two (follow-up time 1; approximately 3 months after 
baseline) and three (follow-up time 2; six months after baseline).  This enabled 
the researcher to monitor any changes in health and work ability and to map 
employment behaviours in participants.  It enabled more accurate information to 
be collected on when participants decided to take sick leave, returned to work 
and / or exit employment and what psychosocial and / or work-related factors 
were most likely to influence these decisions.  Participants were asked to 
complete and return the questionnaires in a stamped-addressed envelope 
within a week of when they were received.  The researcher retrieved 
questionnaires completed online and printed a paper copy to store in separate 
participant files.   
3.5.2. Ethical Considerations 
All personal data obtained were kept under conditions of strict confidentiality as 
required by the law in the Data Protection Act 1998.  Data were only accessible 
to the researcher and research supervisors.  However, in order to monitor data 
collated at each time point, participants were allocated a unique code that was 
used as an identifier on study measures.  All personal data linking participants 
to a code were maintained on a database that was kept separately from other 
study documentation.  Personal data and research data were kept on a secure 
password-protected university computer that was only accessible to the 
researcher. 
3.6. Data Analysis 
As an initial step, data cleaning procedures were undertaken to ensure that 
there were no errors inherent (e.g. checked frequencies) and that data were 
normally distributed.  An independent-samples t-test was conducted to compare 
baseline age, fatigue, depression, quality of life, self-efficacy and work ability 
scores for NHS participants and support group participants; no significant 
differences between the groups were detected (p > 0.05).  Subsequently, data 
obtained from the survey assessments were analysed using both analysis of 
variance and hierarchical regression models.  Analysis of variance techniques 
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were utilised to consider the stability of psychosocial well-being and work 
variables over the study period.  Furthermore, differences in self-assessed work 
ability were considered according to treatment type.  Finally, both cross-
sectional and longitudinal hierarchical regressions models were tested to 
consider variables related to both work ability and employment status over time.  
Further details regarding data analysis for each study (particularly qualitative 
studies) are provided in their corresponding chapters.  
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Chapter 4 
 
4. The Impact of Colorectal Cancer on Psychosocial         
Well-Being and Work Ability 
4.1. Introduction 
The aim of this chapter is to consider the impact of time and cancer treatment 
type upon measures of psychosocial well-being and work ability.  Numerous 
studies indicate that the physical and psychosocial impacts of cancer and its 
treatment are plentiful.  Evidence suggests many cancer patients experience a 
range of psychosocial outcomes including: fatigue, depression and poorer 
quality of life outcomes as a result of their cancer diagnosis, treatment and 
recovery (Spelten et al., 2003; Short et al., 2005; Pasquini et al., 2006).  
Furthermore, these symptoms are likely to fluctuate over time; for instance, 
fatigue is more pronounced in patients undergoing more than one treatment 
modality or chemotherapy (de Boer et al., 2008; Bradley et al., 2007).  It is 
important to understand the stability of such psychosocial impacts as they are 
likely to have implications on work ability, return to work intentions and 
employment outcomes.  Evidence suggests that the more side effects or 
symptoms experienced can exacerbate detrimental effects on work ability and 
work outcomes (Spelten et al., 2002; Taskila & Lindbohm, 2007).   
Therefore, this chapter examines the impact of colorectal cancer on 
psychosocial well-being and work ability over a six month period.  Participants 
completed three questionnaires during this time, at baseline (diagnosis), follow-
up time 1 (3 months later), and follow-up time 2 (6 months later) that allowed 
changes in psychosocial outcomes to be identified, these included: fatigue, 
depression, quality of life, self-efficacy and work ability.  Furthermore, 
differences according to treatment type were also examined whereby patients 
receiving surgery alone were compared with those receiving chemotherapy; or 
chemotherapy plus surgery; or radiotherapy plus surgery, or chemotherapy plus 
surgery and radiotherapy.  The hypotheses explored were as follows: 
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Hypothesis i) Levels of fatigue, depression, quality of life and self-efficacy 
(psychosocial well-being) will vary over time; furthermore, when compared with 
individuals receiving chemotherapy or a combination of treatments those 
receiving surgery alone will show the most pronounced improvements. 
Hypothesis ii) Levels of perceived work ability will vary over time; furthermore, 
when compared with individuals receiving chemotherapy or a combination of 
treatments those receiving surgery alone will show the most pronounced 
improvements. 
4.2. Statistical Analysis 
The psychosocial and work measures assessed at baseline, follow-up time 1 
and follow-up time 2 were analysed to examine stability over time.  As an initial 
step, a multivariate analysis of variance (MANOVA) with time as the fixed factor 
was conducted where all the dependent variables (measures) were analysed 
together.  This served to control for the Type 1 error rate.  Subsequently, a 
series of 2 x 3 mixed analyses of variance (ANOVA) were performed if the 
multivariate test was significant (p < 0.05). 
Preliminary analyses revealed that there was not a significant effect of age or 
occupation upon the measures of well being and self-assessed work ability; 
therefore, these were not adjusted for in further analyses.  However, differences 
were found according to treatment type where those who received surgery 
alone were compared with those who received chemotherapy; or chemotherapy 
plus surgery; or radiotherapy plus surgery, or chemotherapy plus surgery and 
radiotherapy.  As a result treatment type was entered as a between subjects 
factor in all repeated measures ANOVAs.   
4.3. Results 
Participant Characteristics 
Participant socio-demographics and cancer-related characteristics are 
presented in Table 4.1.  The mean age of participants was 52.49 years         
(SD = 5.42; range 40 – 63 years) and 28 (56%) were male.  The majority of the  
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Table  4.1: Socio-demographic and cancer-related characteristics at baseline. 
 
N = 50 patients                                             
 n   (%) M SD 
Age  52.49 5.42 
Sex (male) 28  (56%)   
     
Job type     
  Manual 14  (28%)   
  Non manual 36  (72%)   
     
Ethnicity     
  White British 45  (90%)   
  White Irish 3  (6%)   
  Mixed White / Black Caribbean 1  (2%)   
  Asian / Asian British Indian 1  (2%)   
     
Education     
  None 6  (12%)   
  GCSE or equivalent 13  (26%)   
  AS Level or equivalent 7  (14%)   
  Degree 13  (26%)   
  Higher degree 11  (22%)   
     
Treatment     
  Surgery 15  (30%)   
  C; or C + S; or R + S, or S + C + R 35  (70%)   
     
Stoma Appliance     
  Yes 14  (28%)   
  No 36  (72%)   
M Mean, SD Standard Deviation, C Chemotherapy, R Radiotherapy, S Surgery, + and. 
 
participants were ‘White British’ (90%).  Fourteen (28%) were employed in 
manual labour jobs.  With regard to treatment, 15 had undergone surgery alone, 
35 were being treated with one of the following treatment combinations; 
chemotherapy; or chemotherapy plus surgery; or radiotherapy plus surgery, or 
chemotherapy plus surgery and radiotherapy.  Fourteen participants had a 
stoma appliance.  When considering employment status over the study 
duration: 38 (76%) were on sick leave at baseline; 39 (79%) were on sick leave 
at follow-up time 1, and 30 (61%) were on sick leave at follow-up time 2.   
Manova Results 
A one-way within subjects MANOVA was performed on six dependent 
variables: fatigue, depression, quality of life, cancer self-efficacy, job self-
efficacy and work ability.  The independent variable was time (baseline, follow-
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up time 1, follow-up time 2).  Total N of 50 was reduced to 49 with a deletion of 
a case missing scores at follow-up times 1 and 2.  Results of evaluation of 
assumptions of normality, linearity, homogeneity of variance-covariance 
matrices and multicollinearity were satisfactory.  There was a statistically 
significant difference between time points on the combined dependent 
variables, F (12, 280) = 2.40, p = 0.006; Wilks’ Lambda = 0.82; partial eta 
squared = 0.09.  Regarding the predictor variables, fatigue, quality of life, 
cancer self-efficacy, job self-efficacy and work ability were significant (p < 0.05). 
4.3.1. The Effect of Time and Treatment upon Psychosocial Well-Being 
Hypothesis i) Levels of fatigue, depression, quality of life and self-efficacy 
(psychosocial well-being) will vary over time; furthermore, when compared with 
individuals receiving chemotherapy or a combination of treatments those 
receiving surgery alone will show the most pronounced improvements. 
As an initial step, hypothesis (i) was tested to consider the longitudinal stability 
of psychosocial well-being of the colorectal cancer sample; furthermore, this 
allowed results to be compared with findings already reported in the general 
cancer literature.  Repeated measures analysis of variance (2 x 3 mixed 
ANOVAs) with treatment type as a between subjects factor was conducted to 
assess the impact of time and treatment type on participants’ scores on 
measures of fatigue, depression, quality of life, cancer self-efficacy and job self-
efficacy, across three time points (baseline; follow-up time 1; follow-up time 2).  
Results are presented in relation to each measure.  To consider significant 
findings post-hoc, the Bonferroni correction was applied to adjust for multiple 
comparisons. 
Fatigue 
A mixed 2 x 3 ANOVA was conducted to assess the impact of treatment type 
upon participants’ fatigue severity, across three time points.  As shown in Table 
4.2, a significant interaction between treatment type and time was not found      
F (1.45, 68.16) = 0.88, p = 0.39, partial eta squared = 0.02.  Although this was 
not significant, Figure 4.1 does however show that when compared with 
baseline, both groups appeared to experience increased symptoms of fatigue at 
 85
Chapter 4 Colorectal Cancer, Psychosocial Well-Being & Work Ability 
follow-up time 1.  Furthermore, there was a significant main effect for time, F 
(1.45, 68.16) = 7.42, p = 0.003, partial eta squared = 0.14, with a significant 
decline in fatigue severity between follow-up time 1 (M = 4.57; SD = 1.32) and 
follow-up time 2  (M = 3.95; SD = 1.37). 
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Figure  4.1: Mean scores over time with fatigue as the dependent variable in a repeated 
measures ANOVA, with ‘treatment type’ as between group factor and ‘time’ as within 
factor. Lines represent standard deviation. 
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Table  4.2: Mean, standard deviation and ANOVA results for repeated measures with 
‘treatment type’ as between groups factor and ‘time’ as within factor. 
 Baseline  T1 T2 
 
Variable 
 
M 
 
SD 
  
M 
 
SD 
 
M 
 
SD 
 
 
Effect 
 
 
F 
 
 
p 
 
 
Effect 
Size 
Fatigue†  
  
4.08 1.09 4.57 1.32 3.95 1.37 Time 7.42 0.003 
 
0.14 
Surgery 
 
3.63 0.91 3.89 1.40 3.20 1.40  Time x 
Treatment 
0.88 0.39 0.02 
Other 4.28 1.11 4.87 1.18 4.28 1.23     
BDI† 10.22 5.79 9.51 5.93 7.73 5.02 Time 3.96 0.02 0.08 
Surgery 8.73 4.69 7.53 5.84 7.60 6.12 Time x 
Treatment 
1.67 0.20 0.03 
Other 10.88 6.16 10.38 5.84 7.79 4.57     
QOL 67.22 11.53 70.18 12.75 76.06 11.33 Time 20.44 0.0005 0.30 
Surgery 66.20 11.43 74.40 14.82 80.67 10.36 Time x 
Treatment 
3.84 0.02 0.07 
Other 67.68 11.71 68.32 11.47 74.03 11.29     
CSE† 6.86 1.75 7.37 1.29 7.85 1.05 Time 14.70 0.0005 0.24 
Surgery 
 
6.84 1.61 7.74 1.15 7.98 1.05 Time x 
Treatment 
1.02 0.36 0.02 
Other 6.87 1.83 7.22 1.32 7.80 1.07     
JSE  6.44 1.98 6.49 1.78 7.49 1.17 Time 10.85 0.0005 0.19 
Surgery 6.26 1.75 6.90 1.83 7.64 1.09 Time x 
Treatment 
1.32 0.27 0.03 
Other 6.51 2.10 6.30 1.75 7.42 1.21     
† Sphericity not assumed; Greenhouse -Geisser reported, M Mean, SD Standard deviation, Other Chemotherapy; or 
chemotherapy plus surgery; or radiotherapy plus surgery, or chemotherapy plus surgery and radiotherapy, 
BDI Beck Depression Inventory, QOL Quality of Life, CSE Cancer Self-Efficacy, JSE Job Self-Efficacy. 
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Depression 
To consider the stability of depressive symptoms over the 6 month data 
collection period, a mixed 2 x 3 ANOVA was carried out that also assessed the 
impact of treatment type.  As shown in Table 4.2, there was no interactive effect 
F (1.77, 83.34) = 1.67, p = 0.20, partial eta squared = 0.03.  In contrast, there 
was a substantial main effect for time, F (1.77, 83.34) = 3.96, p = 0.02, partial 
eta squared = 0.08.  Figure 4.2 appears to show a gradual decline in depressive 
symptoms over time.  However, when multiple comparisons were adjusted for 
by applying a Bonferroni correction, this significant difference between mean 
depression scores at baseline (M = 10.22; SD = 5.79) and follow-up time 2     
(M = 7.73; SD = 5.02) was no longer apparent (p = 0.06). 
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Figure  4.2: Mean (SD) scores over time with depression scores used as the dependent 
variable in a repeated measures ANOVA, with ‘treatment type’ as between group factor 
and ‘time’ as within factor. Lines represent standard deviation. 
Quality of Life 
A repeated measures ANOVA was conducted to assess the impact of treatment 
type on participants’ quality of life scores, across three time points.  As shown in 
Table 4.2 and illustrated in Figure 4.3, a significant interaction between 
treatment type and time was found F (2, 94) = 3.84, p = 0.02, partial eta 
squared = 0.07.  There was a substantial main effect for time, F (2, 94) = 20.44, 
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p = 0.0005, partial eta squared = 0.30, with a significant improvement in quality 
of life outcomes across all time points (p < 0.001).  Figure 4.3 exemplifies 
improvements in quality of life outcomes over time for both treatment groups; 
furthermore, the most favourable quality of life outcomes were observed in 
participants that were treated with surgery alone.    
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Figure  4.3: Mean (SD) scores over time with work quality of life used as the dependent 
variable in a repeated measures ANOVA, with ‘treatment type’ as between group factor 
and ‘time’ as within factor. Lines represent standard deviation. 
Cancer Self-Efficacy 
At each time point, participants were asked to rate how confident they were 
about managing certain aspects of their cancer.  The results presented in Table 
4.2 show that a significant interaction between treatment type and time was not 
found F (1.30, 61.12) = 1.02, p = 0.36, partial eta squared = 0.02.  There was a 
substantial main effect for time, F (1.02, 61.12) = 14.70, p = 0.0005, partial eta 
squared = 0.24, with a significant improvement in cancer self-efficacy levels 
across all time points (p < 0.05).  Figure 4.4 demonstrates that participant’ self-
efficacy beliefs in relation to managing their cancer increased as more time 
elapsed since diagnosis. 
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Figure  4.4: Mean (SD) scores over time with cancer self-efficacy used as the dep
variable in a repeated measures ANOVA, with ‘treatment type’ as between group
and ‘time’ as within factor. Lines represent standard deviation. 
Job Self-Efficacy 
endent 
 factor 
A 2 x 3 mixed ANOVA was conducted to assess the impact of treatment type on 
participants’ levels of job self-efficacy, across three time points.  As shown in 
Ta
f
illustrates th n job self-
fficacy over the six month study period; whereas when compared with baseline 
ment (i.e. other 
-
with a significant improvement in perceptions of job self-
efficacy across all time points (p < 0.001).  
ble 4.2, a significant interaction between treatment type and time was not 
ound F (2, 94) = 1.32, p = 0.27, partial eta squared = 0.03.  Figure 4.5 
at those receiving surgery alone reported improvements i
e
scores, those receiving chemotherapy, or a combination of treat
than surgery alone) appeared to show a decrement in job self-efficacy at follow
up time 1 that subsequently increased at follow-up time 2.  There was a 
substantial main effect for time, F (2, 94) = 10.85, p = 0.0005, partial eta 
squared = 0.19, 
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Figure  4.5: Mean (SD) scores over time with job self-efficacy used as the dependent 
variable in a repeated measures ANOVA, with ‘treatment type’ as between group factor 
tim s  r.  se dard deviatio
 The E t im  
re, 
mbination of 
treatments those receiving surgery alone will show the most pronounced 
improvements. 
A 2 x 3 repeated measures ANOVA was conducted to assess the impact of 
treatment type on participants’ scores of self-assessed work ability, across three 
time points.  As shown in Table 4.3, a significant treatment type and time 
interaction was found F (2, 94) = 5.20, p = 0.007, partial eta squared = 0.10.  
Figure 4.6 illustrates that those receiving surgery alone reported improvements 
in self-assessed work ability over the six month study period.  Those receiving 
chemotherapy; or chemotherapy plus surgery; or radiotherapy plus surgery, or 
chemotherapy plus surgery and radiotherapy showed a decrement in perceived 
work ability at follow-up time 1 that subsequently increased at follow-up time 2.  
There was a significant main effect for time, F (2, 94) = 18.83, p = 0.0005, 
and ‘ e’ a within facto  Lines repre nt stan n. 
 
4.3.2. ffec  of T e and Treatment upon Work Ability
Hypothesis ii) Levels of perceived work ability will vary over time; furthermo
when compared with individuals receiving chemotherapy or a co
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p
res of work ability across three time points with scores as 
ted measures ANOVA, with treatment as a 
 
artial eta squared = 0.27, with increases in work ability between baseline and 
follow-up time 1 and follow-up time 2 (p = 0.0005). 
Table  4.3:  Mean (SD) sco
dependent variable in a repea
between group factor and time as within factor. 
 Baseline  T1 T2    
Variable M SD  M SD M SD Effect F p Effect 
Size 
Work Ability  
  
5.08 2.18 4.98 2.44 6.22 2.03 Time 18.83 0.0005 
 
0.27 
Surgery 5.13 2.26 6.07 2.18 7.00 2.13  Time x 5.20 0.007 0.10
 Treatment 
 
Other 5.06 2.18 4.50 2.42 5.88 1.91     
M Mean, SD Standard Deviation, Other Chemotherapy; or chemotherapy plus surgery;
radiotherapy plus surgery, or chemotherapy plus surgery and radiotherapy. 
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Figure  4.6: Mean (SD) scores over time with work ability used as the dependent variable 
in a repeated measures ANOVA, with ‘treatment type’ as between group factor and ‘time’ 
as within factor. Lines represent standard deviation. 
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4.4. Discussion 
In this sample of colorectal cancer patients, various temporal patterns in self-
assessed work ability and psychosocial well-being were observed.  Most 
importantly, positive temporal changes in perceptions of cancer self-efficacy 
and job self-efficacy were detected.  These variables have scarcely been 
considered in prior studies comprised of cancer patients / survivors.  In addition, 
els 
l 
 
s 
 their 
t 
so 
 this 
ed for 
 
rk 
the study provided a novel insight into colorectal cancer patients’ work ability. 
Results regarding self-efficacy beliefs were promising.  When considering job 
self-efficacy beliefs, an aspect that has not been considered previously, lev
were found to improve over time.  Nonetheless, an interaction between 
treatment type and time did not emerge.  Despite this non significant statistica
finding, inspection of the mean scores for both groups suggests that the pattern
of self-efficacy beliefs were different according to treatment type.  Participant
that received surgery alone showed increments in their ability to perform
job role across time; whereas those whose treatment comprised of 
chemotherapy, or a combinations of treatments (more than one type) exhibited 
a decrease in scores between baseline and follow-up time 1 (6.51; 6.30) tha
subsequently improved at follow-up time 2 (7.42).  This pattern of findings al
emerged when considering work ability mean scores at each time point for
treatment group (5.06; 4.50; 5.88).  This decrement could therefore be 
attributed to the onset of chemotherapy or radiotherapy treatment.  In other 
words, at baseline (post surgery but pre chemotherapy / radiotherapy) this 
group were likely to be unaware of potential treatment effects; therefore, 
perceptions related to performing their job role may not have been negatively 
influenced.  However, at follow-up time 1, treatment would have commenc
most; this may have meant participants had no choice but to be more realistic 
about what their work capabilities were.  This argument regarding treatment 
effects is further strengthened by the findings from the group that received 
surgery alone who displayed improvements in both job self-efficacy and work
ability across time points.  An alternate argument could be posited, whereby 
patients’ treatment regimen may have been a barrier preventing a return to wo
even when patients felt confident about performing their job tasks.  However, 
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work ability scores do not appear to support this suggestion.  Nevertheless
is a matter the qualitative diary study (Cha
, this 
pter 6) hopes to delineate further.  
l 
uite 
ld have 
tments; though this change was not 
found to be significant.  In evaluation, having another time point beyond six 
pletion of treatment may have led to more significant 
been 
 
 
al. 
ct 
d 
lore the 
Participants demonstrated increased confidence in their ability to self-manage 
their cancer over the six month data collection period.  The potential beneficia
value of high self-efficacy upon disease management has been supported in the 
existing chronic illness literature (Clark & Dodge, 1999; Han et al., 2003).  
Examination of the mean values for cancer self-efficacy at each time point 
(6.86; 7.37; 7.85) however suggest that participants already possessed q
reasonable self-efficacy beliefs at baseline.  Based upon this, one cou
expected the improvement in self-efficacy beliefs to be more pronounced at 
subsequent time points.  Although it is difficult to ascertain the precise 
explanation for this, it could be explained by symptoms such as fatigue that 
were found to worsen at follow-up time 1 for participants that were treated with 
chemotherapy, or a combination of trea
months or upon com
improvements in self-efficacy outcomes.  Prior research has however reported 
an association between treatment type and fatigue severity that has also 
found to predict return to work (Spelten et al., 2003) and work ability outcomes 
(Steiner et al., 2008).  The findings are in line with those that have previously 
examined the association between self-efficacy, adjustment and quality of life
outcomes.  For instance, Cunningham et al. (1991) found strong positive
correlations between self-efficacy and quality of life.  Meanwhile, Kreitler et 
(2007) utilised structural equation modelling to find that self-efficacy had a dire
effect upon quality of life outcomes.  However, self-efficacy beliefs also exerte
an indirect influence upon quality of life, via perceived stress.  Therefore, as 
suggested in Chapter 1, self-efficacy is unlikely to operate as a mechanism 
alone.  Moreover, the diary study presented in Chapter 6 aims to exp
association between self-efficacy and social support that has also been argued 
to be fundamental in understanding the mechanism by which self-efficacy 
exerts an influence (Kreitler et al., 2007). 
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When considering the stability of psychosocial well-being and work ability over 
time, these findings indicate that treatment type may be more important than 
cancer type when considering individuals’ employment outcomes.  Furthermore, 
by assessing patients’ / survivors’ self-efficacy beliefs, particularly during the 
early stages of treatment could help towards identifying those who may require 
supportive strategies to enhance these beliefs.  Self-efficacy enhancing 
strategies have been employed in breast cancer patients undergoing 
chemotherapy (Lev et al., 2001).  This intervention led to increments in quality 
of life and decreased symptom distress (Lev et al., 2001).  Moreover, employing 
these interventions at an early stage may subsequently result in better work 
outcomes; for example, higher self-efficacy beliefs and work ability could lead to 
an earlier resumption of employment. 
4.5. Summary 
In summary, this study adds to existing research findings by identifying changes 
in the self-efficacy beliefs and work ability of colorectal cancer patients.  
Additionally, the study successfully corroborates existing research findings that 
have identified that cancer patients / survivors are likely to experience changes 
in their psychosocial well-being over the cancer pathway.  Furthermore, the 
association between treatment type and psychosocial outcomes in this 
colorectal cancer sample seems to be similar to existing research that has 
utilised various cancer types (e.g. Spelten et al., 2002; Tsunoda et al., 2007), 
whereby those receiving more than one treatment modality or chemotherapy 
treatment were most likely to report unfavourable outcomes.  This was found to 
be the case for work ability and quality of life outcomes.  Encouragingly, the 
results indicate that colorectal patients are likely to show significant 
improvements in both their work-related and psychosocial well-being within the 
six months following diagnosis.  The following chapter aimed to take these 
findings a step further to identify whether any of these factors were significantly 
related to work ability and employment status. 
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Chapter 5 
 
5. Predictors of Work Ability and Employment Status: The 
Role of Self-Efficacy 
5.1. Introduction 
The potential impact of cancer and its treatment on working life is substantial 
with approximately 40% of all cancer patients taking time off work during 
treatment and recovery (Short et al., 2005).  In spite of this, little is known about 
the work outcomes of working-aged colorectal cancer patients.   
Studies have identified a number of key factors that impact upon return to work 
and work outcomes for those recovering from cancer.  These are outlined 
effectively in review papers by Spelten et al. (2002) and more recently by 
Taskila and Lindbohm (2007).  From such research, it is apparent that some of 
the more prominent variables associated with return to work and employment 
outcomes appear to be cancer type (those with head, neck, lung, leukaemia 
and stomach cancer less likely to return to work), treatment (more than one 
treatment modality or chemotherapy are less likely to return to work / take 
longer), age (increasing age less likely to return to work) and occupation 
(manual labour less favourable work outcomes) (Spelten et al., 2002; Taskila & 
Lindbohm, 2007). 
Factors predicting work ability are also becoming more apparent (e.g. Taskila & 
Lindbohm, 2007; Bradley et al., 2007; Feuerstein et al., 2007; de Boer et al., 
2008; Munir, Yarker, et al., 2009).  To provide a more coherent account of the 
factors associated with work ability and employment outcomes, studies need to 
consider whether any additional (unacknowledged) factors pertain.  To the 
researcher’s knowledge, the possible role of self-efficacy as a factor predicting 
work ability has previously not been considered in relation to employment 
outcomes of cancer patients or survivors.  Findings from studies suggest self-
efficacy is an important factor that has been found to predict psychosocial 
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adjustment in individuals affected by cancer (Cunningham et al., 1991).  
Subsequently, the aim of this study is to consider the role of self-efficacy (along 
with previously identified factors) in relation to the work ability and employment 
outcomes of working-aged colorectal cancer patients.  It is acknowledged that 
not accounting for disease severity in  the analyses is an inherent weakness as 
it has previously been found to be associated with  return to work (Buckwalter et 
al., 2007) and perceived work ability (Taskila & Lindbohm, 2007); however, this 
information was not available for the entire sample.     
The study utilised the same longitudinal survey where participants (N = 50) 
completed three questionnaires over a six month period: baseline, follow-up 
time 1 and follow-up time 2 (Chapter 3, Methodology, pp. 69-81).  The 
hypotheses to be addressed were:   
Hypothesis iii) Cancer self-efficacy and job self-efficacy may be different. 
 
Hypothesis iv) Levels of self-efficacy and psychosocial well-being will be 
associated with perceived work ability (cross sectional and longitudinal). 
 
Hypothesis v) Levels of self-efficacy, psychosocial well-being and work ability 
will be associated with employment status (cross sectional and longitudinal). 
 
5.2. Statistical Analysis 
All analyses were carried out using SPSS version 16.0 (SPSS, Inc., Chicago, 
IL).  Missing data did not appear to pose a problem as only one participant 
withdrew from the study at follow-up time 1.  The relationships between the key 
variables were investigated separately at each time point using Pearson 
product-moment correlation coefficients.  Separate hierarchical regression and 
logistic regression analyses were conducted for data at each time point to 
investigate variables related to job self-efficacy, work ability and employment 
status at baseline, follow-up time 1 and follow-up time 2.  Following this, 
prospective analyses were conducted where baseline scores for each 
dependent variable were controlled for along with other baseline psychosocial 
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and work-related variables to predict follow-up time 2 outcomes.  This approach 
was adopted as it allowed variables to be entered into the model in a certain 
order on a theoretical basis (Brace, Kemp & Snelgar, 2006).  Due to the study 
sample size, variables controlled for at each time point were selected based 
upon findings of previous research (e.g. Taskila & Lindbohm, 2007; de Boer et 
al., 2008) with the most prominent ones being entered into the models.  
Therefore, age, occupation and treatment type were included as covariates in 
all the work ability and employment status analyses.  Occupation was 
dichotomized (0 = manual; 1 = non manual) and treatment type was dummy-
coded; whereby surgery was compared against all other combinations of 
treatment (0 = surgery; 1 = chemotherapy; or chemotherapy plus surgery; or 
radiotherapy plus surgery, or chemotherapy plus surgery and radiotherapy).  A 
similar approach has been adopted in earlier research (e.g. de Boer et al., 
2008).  Preliminary analyses were conducted to ensure no violation of the 
assumptions of normality (i.e. normal probability plot of the regression 
standardised residual), linearity and homoscedasticity.  Multicollinearity among 
all study variables was examined and found not to be at a level that would be 
problematic (unless mentioned) for the planned analyses.  All variance inflation 
factors (VIF) were below 10 and tolerance statistics were above 0.2 (Field, 
2005; Brace et al., 2006).   An alpha level of p < 0.05 was accepted as 
statistically significant.   
Sample Size and Regression Analysis 
With regard to sample size requirements and regression analysis there are 
various schools of thought.  According to Brace and colleagues (2006), one 
argument is to have at least ten participants per predictor variable.  However, 
Tabachnick and Fidell (2007) suggest an alternative approach whereby the 
number of participants should be determined either by the number of predictors 
multiplied by 8 plus 50, or the number of predictors plus 104 (whichever is 
greater).  Whilst keeping this in mind, a power calculation was also carried out 
before the study commenced suggesting a sample of 85 participants (Chapter 
3, Methodology, p. 71).  As this sample size was not attained (N = 50) post-hoc 
power calculations were computed using internet-based software that used the 
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The relationships among variables was investigated using Pearson product-
moment correlation coefficients at baseline (Table 5.1), follow-up time 1 (Table 
5.2) and follow-up time 2 (Table 5.3).  The correlations at baseline ranged from 
r = 0.01 to r = 0.63, indicating no highly significant problems with 
multicollinearity.  Table 5.1 indicates that there were correlations among the 
main variables and the dependent variables work ability (hypothesis iv) and 
employment status (hypothesis v).  Of the demographic variables, there was a 
significant negative correlation between age and depression (r = -0.30,              
p < 0.05) and age and quality of life (r = -0.28, p < 0.05).  Regarding the 
psychological and work variables assessed at baseline, there was a significant 
positive correlation between fatigue and depression (r = 0.49, p < 0.01) and a 
significant negative correlation between fatigue and quality of life (r = -0.28,      
p < 0.05); depression correlated negatively with quality of life (r = -0.56,             
p < 0.01) and cancer self-efficacy (r = -0.48, p < 0.01); there was a significant 
positive correlation between cancer self-efficacy and quality of life (r = 0.63,      
p < 0.01), and significant positive correlations between work ability and quality 
of life (r = 0.60, p < 0.01) and cancer self-efficacy (r = 0.40, p < 0.01) were 
found.
Baseline Correlations 
5.3.1. Correlation Analyses 
5.3. Results 
effect size (which was calculated), sample size, alpha level, number of 
predictors and the observed R² value for each analysis (Soper, 2009).  These 
calculations are reported accordingly.   
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Table  5.1: Mean, standard deviations and correlations among the study variables (baseline). 
Variables M SD 1 2 3 4 5 6 7 8 9 10
1.  Age 
 
52.49   5.42 
 
- 
         
2. Treatment   
 
 
 0.01 
 
 
- 
        
       
      
     
    
   
  
 
3.  Occupation   
 
 
 0.49 
 
 
 0.03 
 
 
- 
4.  Fatigue 
 
 
4.08   1.09 
 
 
-0.17 
 
 
 0.22 
 
 
-0.06 
 
 
- 
5.  Depression 10.22   5.79 
 
 
-0.30* 
 
 
 0.20 
 
 
-0.02 
 
  
0.49** 
 
 
- 
6.  Quality of Life 67.22 11.53 
 
 
 0.28* 
 
 
 0.06 
 
  
 0.27 
 
 
-0.28* 
 
 
-0.56** 
 
 
- 
7.  Cancer self-efficacy       6.86  1.75 
 
 
 0.27 
 
 
 0.09 
 
 
 0.23 
 
 
-0.10 
 
 
-0.48** 
 
 
0.63** 
 
 
- 
8.  Work Ability 5.08 2.18 
 
 
 0.08 
 
 
-0.01 
 
 
0.54** 
 
 
-0.17 
  
 
-0.22 
 
 
0.60** 
 
 
0.40** 
 
 
- 
 
9. Job self-efficacy  6.44  1.98 
 
 
 0.16 
 
 
 0.16 
 
 
 0.24 
 
 
-0.19 
 
 
-0.27 
 
 
0.62** 
 
 
0.47** 
 
 
0.63** 
 
 
- 
 
10. Employment Status   
 
  
0.07 
 
 
-0.03 
 
 
 0.24 
 
 
 0.24 
 
 
-0.04 
 
 
0.36* 
 
 
0.36** 
 
 
0.45** 
 
 
0.53** 
 
 
- 
*p < 0.05, **p < 0.01 (2-tailed), N = 50. 
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Follow-up time 1 Correlations 
Correlations among study variables at follow-up time 1 ranged between r = 0.01 
and r = 0.82, suggesting a concern regarding the issue of collinearity.  As 
shown in Table 5.2 there was a significant negative correlation between quality 
of life and depression (r = -0.82, p < 0.01).  Consequently, when compared with 
depression, quality of life correlated most highly with job self-efficacy (r = 0.63, 
p < 0.01), work ability (r = 0.62) and employment status (r = 0.56, p < 0.05) (to 
be entered as dependent variables), therefore, depression was omitted from 
subsequent follow-up time 1 regression analyses.  Once again correlations 
were detected between variables.  When considering the correlations between 
the dependent variables, Table 5.2 indicates that there was a negative 
correlation between treatment and work ability (r = -0.29, p < 0.05).  Regarding 
the psychological and work variables assessed at follow-up time 1, fatigue 
correlated significantly with cancer self-efficacy (r = -0.48, p < 0.01), work ability 
(r = -0.53, p < 0.01), job self-efficacy (r = -0.54, n = 49, p < 0.01) and 
employment status (r = -0.43, p < 0.01).  Depression was found to be negatively 
correlated with work ability (r = -0.45, p < 0.01), job self-efficacy (r = -0.59,        
p < 0.01) and employment status (r = -0.44, p < 0.01).  There was a medium 
correlation between cancer self-efficacy and work ability (r = 0.35, p < 0.05) and 
a strong correlation between cancer self-efficacy and job self-efficacy (r = 0.50, 
p < 0.01); however, this still suggests that the two measures are distinct from 
one another.  Finally, positive correlations were found between work ability and 
job self-efficacy (r = 0.68, p < 0.01), work ability and employment status          
(r= 0.69, p < 0.01) and job self-efficacy and employment status (r = 0.49,           
p < 0.01).
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Table  5.2: Mean, standard deviations and correlations among the study variables (follow-up time 1). 
Variables M SD 1 2 3 4 5 6 7 8 9 10
1.  Age 
 
52.49   5.42 
 
- 
         
2. Treatment   
 
 
 0.27 
 
 
- 
        
 
       
      
     
    
   
  
 
3.  Occupation   0.05 
 
 
 
 
-0.02 
 
 
- 
4.  Fatigue 
 
 
4.57   1.32 
 
 
-0.18 
 
 
 0.34* 
 
 
-0.11 
 
 
- 
5.  Depression 9.51   5.93 
 
 
-0.21 
 
 
 0.22 
 
 
-0.01 
 
  
0.65** 
 
 
- 
6.  Quality of Life 70.18 12.75 
 
 
 0.15 
 
 
-0.22 
 
  
 0.22 
 
 
-0.66** 
 
 
 -0.82** 
 
 
- 
7.  Cancer self-efficacy       7.37  1.29 
 
 
 0.16 
 
 
-0.19 
 
 
 0.01 
 
 
-0.48** 
 
 
-0.50** 
 
 
0.62** 
 
 
- 
8.  Work Ability 4.98 2.44 
 
 
 0.03 
 
 
-0.29* 
 
 
0.29* 
 
 
-0.53** 
  
 
-0.45** 
 
 
0.62** 
 
 
0.35* 
 
 
- 
 
9. Job self-efficacy  6.49  1.78 
 
 
 0.12 
 
 
-0.15 
 
 
 0.31* 
 
 
-0.54** 
 
 
-0.59** 
 
 
0.63** 
 
 
0.50** 
 
 
0.68** 
 
 
- 
 
10. Employment Status   
 
  
0.20 
 
 
-0.21 
 
 
 0.32* 
 
 
-0.43** 
 
 
-0.44** 
 
 
0.56** 
 
 
0.26 
 
 
0.69** 
 
 
0.49** 
 
 
- 
*p < 0.05, **p < 0.01 (2-tailed), n = 49. 
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Correlations among the study variables at follow-up time 2 are presented in 
Table 5.3; these ranged between r = 0.01 and r = 0.80.  Once again, there was 
a highly significant, negative correlation between depression and quality of life  
(r = -0.80, p < 0.01).  Therefore, depression was omitted from subsequent 
analyses.  Positive correlations between occupation and work ability (r = 0.29,  
p < 0.05) and occupation and employment status (r = 0.40, p < 0.01) were 
identified.  With regard to the psychological and work variables assessed at 
follow-up time 2, fatigue correlated with a number of measures including 
dependent variables to be used in following regression analyses; work ability    
(r = -0.45, p < 0.01) and employment status (r = -0.53, p < 0.01).  A medium, 
positive correlation was found between quality of life and work ability (r = 0.44,  
p < 0.01); whereas, quality of life strongly correlated with employment status    
(r = 0.62, p < 0.01).  Cancer self-efficacy significantly correlated with work ability 
(r = 0.45, p < 0.01) and employment status (r = 0.32, p < 0.05).  There were 
strong, positive correlations between work ability and employment status          
(r = 0.66, p < 0.01) and between work ability and job self-efficacy (r = 0.62,       
p < 0.01).  Finally, there was a strong, positive correlation between employment 
status and job self-efficacy (r = 0.57, p < 0.01).     
Follow-up Time 2 Correlations 
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Table  5.3: Mean, standard deviations and correlations among the study variables (follow-up time 2). 
Variables M SD 1 2 3 4 5 6 7 8 9 10
1.  Age 
 
52.49   5.42 
-          
2. Treatment   
 
 
-0.02 
 
 
- 
        
       
      
     
    
   
  
 
3.  Occupation   
 
 
 0.05 
 
 
-0.02 
 
 
- 
4.  Fatigue 
 
 
3.95   1.37 
 
 
-0.06 
 
 
 0.36** 
 
 
-0.07 
 
 
- 
5.  Depression 7.73   5.02 
 
 
-0.25 
 
 
 0.02 
 
 
 0.15 
 
  
0.60** 
 
 
- 
6.  Quality of Life 76.06 11.33 
 
 
 0.17 
 
 
-0.27 
 
  
 0.04 
 
 
-0.63** 
 
 
-0.80** 
 
 
- 
7.  Cancer self-efficacy       7.85  1.05 
 
 
 0.03 
 
 
-0.08 
 
 
 0.01 
 
 
-0.42** 
 
 
-0.47** 
 
 
0.58** 
 
 
- 
8.  Work Ability 6.22 2.03 
 
 
-0.12 
 
 
-0.25 
 
 
 0.29* 
 
 
-0.45** 
  
 
-0.22 
 
 
0.44** 
 
 
0.45** 
 
 
- 
 
9. Job self-efficacy  7.49  1.17 
 
 
 0.04 
 
 
-0.09 
 
 
 0.23 
 
 
-0.41** 
 
 
-0.50** 
 
 
0.66** 
 
 
0.64** 
 
 
0.62** 
 
 
- 
 
10. Employment Status   
 
  
0.07 
 
 
-0.38** 
 
 
 0.40** 
 
 
 0.53** 
 
 
-0.39** 
 
 
0.62** 
 
 
0.32* 
 
 
0.66** 
 
 
0.57** 
 
 
- 
*p <0.05, **p <0.01 (2-tailed), n = 49. 
Chapter 5 Predictors of Work Ability & Employment Status 
5.4. Factors Predicting Job Self-Efficacy 
Hypothesis iii) Cancer self-efficacy and job self-efficacy may be inherently 
different. 
Prior to analysing factors related to work ability, it was important to investigate 
the factors related to job self-efficacy.  This helped to ascertain whether the 
domains of cancer self-efficacy and job self-efficacy were inherently different.  
Hierarchical regression was carried out on data at each time point (baseline, 
follow-up time 1 and follow-up time 2) to assess the ability of cancer self-
efficacy, fatigue, depression (baseline only) and quality of life to predict levels of 
job self-efficacy, after controlling for the influence of age and occupation. 
Baseline 
Table 5.4 presents results from the baseline hierarchical regression analysis.  
Age and occupation were entered at Step 1 and explained 20% (Adjusted        
R² = 0.20) F (2, 46) = 7.21, p = 0.002 of the variance in job self-efficacy.  After 
controlling for age and occupation, the four psychosocial measures (cancer self-
efficacy, fatigue, depression and quality of life) explained an additional 25% of 
the variance in job self-efficacy, R² change = 0.25, F change (4, 42) = 5.11,       
p = 0.002.  In the final model, occupation and quality of life were statistically 
significant.  Examination of the individual betas showed that increased quality of 
life (β = 0.56, t = 3.52, p = 0.01) and being employed in a non manual 
occupation (β = 0.31, t = 2.60, p = 0.001) was associated with higher 
perceptions of job self-efficacy at baseline.  The observed power for this 
hierarchical regression analysis was 0.92 with a medium effect size (0.37). 
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Table  5.4: Hierarchical multiple regression analysis of variables associated with job self-
efficacy (dependent variable) at baseline (N = 50). 
Variable B SE B β 
Step 1    
 Constant  1.90 2.53  
 Age  0.05 0.48  0.16 
 Occupation  1.97 0.56  0.45** 
 R²  0.23   
 ∆R²  0.20   
Step 2    
 Constant -0.78 3.03  
 Age  0.04 0.04  0.12 
 Occupation  1.33 0.51  0.31* 
 Cancer self-efficacy -0.04 0.21 -0.03 
 Fatigue -0.07 0.23 -0.04 
 Depression  0.01 0.05  0.03 
 Quality of life  0.09 0.03  0.56** 
 R²  0.49   
 ∆R²  0.42   
∆R² adjusted R², *p < 0.01, **p < 0.001. 
Follow-up Time 1 
Results from the hierarchical regression analysis at follow-up time 1 are 
presented in Table 5.5.  Age and occupation were entered at Step 1 and 
explained 7% (Adjusted R² = 0.07), F (2, 46) = 2.73, p = 0.07 of the variance in 
job self-efficacy.  After controlling for age and occupation, cancer self-efficacy, 
fatigue, depression and quality of life at follow-up time 1 explained an additional 
40% of the variance in job self-efficacy, R² change = 0.40, F change (4, 42)       
= 8.60, p = 0.0005.  In the final model, occupation was the only statistically 
significant predictor of job self-efficacy at follow-up time 1, where being 
employed in a non manual job was associated with increased job self-efficacy 
levels (β = 0.27, t = 2.24, p = 0.03).  The observed power for the addition of the 
independent variables entered at Step 2 to the overall hierarchical model was 
0.99 with an effect size of 0.66. 
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Table  5.5:  Hierarchical multiple regression analysis of variables associated with job self-
efficacy (dependent variable) at follow-up time 1 (n = 49). 
Variable B SE B β 
Step 1    
 Constant  3.69 2.45  
 Age  0.04 0.46  0.11 
 Occupation  1.18 0.55  0.30* 
 R²  0.11   
 ∆R²  0.07   
Step 2    
 Constant  4.89 3.57  
 Age  0.04 0.04  0.18 
 Occupation  1.05 0.47  0.27* 
 Cancer self-efficacy  0.30 0.18  0.21 
 Fatigue -0.19 0.20 -0.15 
 Depression -0.09 0.06 -0.31 
 Quality of life  0.01 0.03  0.10 
 R²  0.51   
 ∆R²  0.44   
∆R² adjusted R², *p < 0.05. 
Follow-up Time 2 
Results from the hierarchical regression analysis at follow-up time 2 are 
presented in Table 5.6.  Age and occupation were entered at Step 1 and 
explained just 1% (Adjusted R² = 0.01), F (2, 46) = 1.26, p = 0.29 of the 
variance in job self-efficacy.  Cancer self-efficacy, fatigue and quality of life 
scores collected at follow-up time 2 explained an additional 54% of the variance 
in job self-efficacy, after controlling for age and occupation, R² change = 0.54,  
F change (3, 43) = 19.24, p = 0.0005.  In the final model, quality of life, cancer 
self-efficacy and occupation were statistically significant.  Examination of the 
individual betas showed that increased quality of life (β = 0.48, t = 3.41,             
p = 0.001) and increased cancer self-efficacy (β = 0.39, t = 3.26, p = 0.002) and 
being employed in a non manual occupation (β = 0.21, t = 2.18, p = 0.04) were 
associated with higher levels of job self-efficacy.  The observed power for the 
addition of the independent variables entered at Step 2 to the overall 
hierarchical model was 1.00 with an observed effect size of 1.41. 
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Table  5.6:  Hierarchical multiple regression analysis of variables associated with job self-
efficacy (dependent variable) at follow-up time 2 (n = 49). 
Variable B SE B β 
Step 1    
 Constant  6.76 1.66  
 Age  0.01 0.03  0.27 
 Occupation  0.58 0.37  0.22 
 R²  0.05   
 ∆R²  0.01   
Step 2    
 Constant  0.27 1.74  
 Age -0.01 0.02 -0.06 
 Occupation  0.55 0.25  0.21* 
 Cancer self-efficacy  0.43 0.13  0.39** 
 Fatigue  0.07 0.11  0.07 
 Quality of life  0.05 0.01  0.48*** 
 R²  0.59   
 ∆R²  0.55   
∆R² adjusted R², *p < 0.05, **p < 0.01, ***p < 0.001. 
In sum, as cancer self-efficacy was only related to job self-efficacy at follow-up 
time 2, these variables were entered as separate predictors in subsequent work 
ability and employment status regression models. 
5.5. Factors Predicting Work Ability  
Hypothesis iv) Levels of self-efficacy and psychosocial well-being will be 
associated with perceived work ability (cross-sectional and longitudinal). 
To test the above mentioned hypothesis, hierarchical regression analyses were 
carried out on data at each time point (baseline, follow-up time 1 and follow-up 
time 2) to assess the ability of job self-efficacy, cancer self-efficacy, fatigue, 
depression (baseline only) and quality of life to predict levels of work ability, 
after controlling for the influence of age, occupation (0 = manual and 1 = non 
manual), and treatment group (0 = surgery alone, 1 = chemotherapy; or 
chemotherapy plus surgery; or radiotherapy plus surgery, or chemotherapy plus 
surgery and radiotherapy).   
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Baseline 
Results from the hierarchical regression analysis at baseline are presented in 
Table 5.7.  Age, occupation and treatment were entered at Step 1 and 
explained 26% (Adjusted R² = 0.26), F (3, 46) = 6.70, p = 0.001 of the variance 
in perceived work ability.  Measures of job self-efficacy, cancer self-efficacy, 
fatigue, depression and quality of life scores collected at baseline were entered 
at Step 2 and explained an additional 27% of the variance in work ability after 
controlling for age, occupation and treatment, R² change = 0.27, F change       
(5, 41) = 5.17, p = 0.001.  In the final model, occupation and quality of life were 
statistically significant.  Examination of the individual betas showed that being 
employed in a non manual job (β = 0.31, t = 2.65, p = 0.0005) and increased 
quality of life (β = 0.42, t = 2.57, p = 0.01) were associated with increased levels 
of work ability.  The observed power for the addition of the independent 
variables entered at Step 2 to the overall hierarchical model was sufficient 
(0.94) with an effect size of 0.45. 
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Table  5.7:  Hierarchical multiple regression analysis of variables associated with work 
ability as the dependent variable at baseline (N= 50). 
Variable B SE B β 
Step 1    
 Constant  2.08 2.66  
 Age  0.02 0.05  0.06 
 Occupation  2.61 0.59  0.55** 
 Treatment -0.12 0.50 -0.03 
 R²  0.30   
 ∆R²  0.26   
Step 2    
 Constant -1.85 3.01  
 Age -0.03 0.04 -0.07 
 Occupation  1.49 0.56  0.31** 
 Treatment -0.45 0.45 -0.11 
 Cancer self-
efficacy 
 0.01 0.17  0.01 
 Job self-efficacy  0.29 0.16  0.27 
 Fatigue -0.04 0.25 -0.02 
 Depression  0.04 0.05  0.10 
 Quality of life  0.08 0.03  0.42* 
 R²  0.57   
 ∆R²  0.49   
∆R² adjusted R², *p < 0.01, **p < 0.0005. 
Follow-up Time 1 
Results from the hierarchical regression analysis at follow-up time 1 are 
presented in Table 5.8.  A substantial bivariate correlation was found between 
measures of depression and quality of life (r = -0.82); therefore, this raised the 
issue of collinearity.  As a result, depression was omitted.  Age, occupation and 
treatment were entered at Step 1 and explained 14% (Adjusted R² = 0.14),       
F (3, 45) = 3.50, p = 0.02 of the variance in perceived work ability.  Measures of 
job self-efficacy, cancer self-efficacy, fatigue and quality of life scores collected 
at follow-up time 1 were entered at Step 2 and explained an additional 45% of 
the variance in work ability after controlling for age, occupation and treatment, 
R² change = 0.45, F change (4, 41) = 13.14, p = 0.0005.  In the final model, job 
self-efficacy and treatment type were statistically significant.  Examination of the 
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individual betas showed that greater levels of job self-efficacy (β = 0.57,             
t = 4.40, p = 0.0005) was associated with better perceived work ability. 
Regarding treatment, those receiving anything other than surgery alone had 
poorer work ability when compared with those who only received surgical 
treatment (β = -0.19, t = -1.94, p = 0.05).  The observed power for the addition 
of the independent variables entered at Step 2 to the overall hierarchical model 
was 0.99 with an effect size of 1.07.  
Table  5.8:  Hierarchical multiple regression analysis of variables associated with work 
ability as the dependent variable at follow-up time 1 (n = 49). 
Variable B SE B β 
Step 1    
 Constant  4.39 3.27  
 Age  0.01 0.06  0.02 
 Occupation  1.63 0.72  0.23* 
 Treatment -1.49 0.62 -0.32* 
 R²  0.19   
 ∆R²  0.14   
Step 2    
 Constant  1.19 3.52  
 Age -0.03 0.04 -0.07 
 Occupation  0.33 0.54  0.06 
 Treatment -0.91 0.47 -0.19* 
 Cancer self-
efficacy 
-0.34 0.24 -0.18 
 Job self-efficacy  0.78 0.18  0.57** 
 Fatigue -0.13 0.25 -0.07 
 Quality of life  0.05 0.03  0.28 
 R²  0.64   
 ∆R²  0.58   
∆R² adjusted R², *p < 0.05, **p < 0.0005. 
Follow-up Time 2 
Results from the hierarchical regression analysis at follow-up time 2 are 
presented in Table 5.9.  A substantial bivariate correlation was found between 
measures of depression and quality of life (r = -0.80); therefore, this raised the 
issue of collinearity.  As a result, depression was omitted.  Age, occupation and 
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treatment were entered at Step 1 and explained 11% (Adjusted R² = 0.11),       
F (3, 45) = 3.45, p = 0.04 of the variance in perceived work ability.  Measures of 
job self-efficacy, cancer self-efficacy, fatigue and quality of life scores collected 
at follow-up time 2 were entered at Step 2 and explained an additional 34% of 
the variance in work ability after controlling for age, occupation and treatment, 
R² change = 0.34, F change (4, 41) = 7.22, p = 0.0005.  In the final model, job 
self-efficacy was the only predictor that reached statistical significance.  
Examination of the individual betas showed that increased levels of job self-
efficacy (β = 0.50, t = 2.92, p = 0.006) was associated with better perceived 
work ability.  The observed power for the addition of the independent variables 
entered at Step 2 to the overall hierarchical model was 0.98 with an effect size 
of 0.56.  
Table  5.9:  Hierarchical multiple regression analysis of variables associated with work 
ability as the dependent variable at follow-up time 2 (n = 49). 
Variable B SE B β 
Step 1    
 Constant  8.57 2.76  
 Age -0.05 0.05 -0.13 
 Occupation  1.32 0.61  0.29 
 Treatment -1.06 0.59 -0.24 
 R²  0.16   
 ∆R²  0.11   
Step 2    
 Constant  3.75 3.41  
 Age -0.05 0.04 -0.14 
 Occupation  0.77 0.52  0.17 
 Cancer self-efficacy  0.15 0.29  0.08 
 Job self-efficacy  0.88 0.30  0.50* 
 Fatigue -0.32 0.22 -0.21 
 Quality of life -0.02 0.03 -0.09 
 R²  0.51   
 ∆R²  0.43   
∆R² adjusted R², *p < 0.01. 
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Prospective Analysis: Predictors of Work Ability 
A prospective hierarchical regression analysis was conducted to examine 
whether baseline psychosocial and work measures predicted work ability scores 
at follow-up time 2 (whilst controlling for age, occupation and treatment).  Table 
5.10 shows the longitudinal hierarchical regression assessing baseline 
predictors of work ability at follow-up time 2.  Baseline age, occupation and 
treatment were entered at Step 1 and explained 11% (Adjusted R² = 0.11),       
F (3, 45) = 2.96, p = 0.04 of the variation work ability scores at follow-up time 2.   
Table  5.10: Longitudinal Hierarchical Regression analysis for work ability at follow-up 
time 2 (n = 49). 
Variable B SE B β 
Step 1    
 Constant  8.57 2.76  
 Age -0.05 0.05 -0.13 
 Occupation  1.32 0.61  0.30* 
 Treatment -1.06 0.59 -0.24 
 R²  0.16   
 ∆R²  0.11   
Step 2    
 Constant  6.59 3.04  
 Age -0.07 0.04 -0.18 
 Occupation -0.31 0.61 -0.07 
 Treatment -1.03 0.52 -0.24* 
 Fatigue† -0.22 0.25 -0.12 
 Quality of life†  0.03 0.03  0.15 
 Depression†  0.05 0.06  0.15 
 Cancer self-efficacy†  0.01 0.18  0.01 
 Job self-efficacy† -0.09 0.16 -0.09 
 Work Ability†  0.62 0.16  0.67** 
 R²  0.52   
 ∆R²  0.42   
† Baseline score, ∆R² adjusted R², *p < 0.05, **p < 0.0005. 
Baseline assessments of work ability, fatigue, quality of life, depression, cancer 
self-efficacy and job self-efficacy and depression scores were entered at Step 2 
and explained an additional 36% of the variance in follow-up time 2 work ability 
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scores, R² change = 0.36, F change (6, 39) = 4.98, p = 0.001.  High work ability 
at baseline was associated with (β = 0.67, t = 3.99, p = 0.0005) greater work 
ability at follow-up time 2.  Similarly, treatment type; whereby being treated with 
chemotherapy; or chemotherapy plus surgery; or radiotherapy plus surgery, or 
chemotherapy plus surgery and radiotherapy (β = -0.24, t = -1.99, p = 0.05) 
predicted poorer work ability outcomes at follow-up time 2.   The observed 
power for the addition of the independent variables entered at Step 2 to the 
overall hierarchical model was sufficient (0.93) with an effect size of 0.53. 
5.6. Factors Predicting Employment Status   
Hypothesis v) Levels of self-efficacy, psychosocial well-being and work ability 
will be associated with employment status (cross-sectional and longitudinal). 
To examine the above mentioned hypothesis, hierarchical logistic regression 
models were used to identify explanatory variables significantly associated with 
the dependent variable ‘employment status’ (0 = not working 1 = working) for 
each time point (baseline, follow-up time 1 and follow-up time 2), To minimise 
the number of independent variables in the final model, two steps were 
undertaken.  Firstly, an analysis was conducted to identify the psychosocial 
variables that were significantly related to employment status at each time point.  
Based upon these results, variables that emerged as significant factors were 
then added to the final model that contained the work variables (work ability and 
job self-efficacy).  All models adjusted for age, occupation and treatment (Block 
1). 
Baseline 
At baseline a total of 12 participants described their employment status as 
working.  Table 5.11 shows the results from the final hierarchical logistic 
regression analysis at baseline.  A total of 50 cases were analysed.  Age, 
occupation and treatment group were entered in Block 1 and explained between 
9% and 15% of the variance in employment status.  However, this model was 
not found to be statistically different when compared against a constant-only 
model (X² = 5.22, df = 3, p = 0.16).  The model considering psychosocial 
variables was found to be significant (X² = 14.07, df = 7, p = 0.05); however, 
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none of the psychosocial variables (fatigue, depression, quality of life or cancer 
self-efficacy) were statistically related to employment status at baseline.  
Therefore, none of these were included in the final model.  Explanatory 
variables included in Block 2 of the final model included baseline scores of job 
self-efficacy and work ability.  The final model presented in Table 5.11 led to a 
significant outcome (X² = 21.80, df = 5, p = 0.001).  The model accounted for 
between 35% and 53% of the variance in employment status, with 92% of the 
not working participants accurately predicted.  Overall the model accurately 
classified 84% of the cases.  Only job self-efficacy reliably predicted 
employment status (OR = 2.20, 95% CI: 1.17 – 4.13); this indicated that at 
baseline, participants who had lower job self-efficacy were over 2 times more 
likely not to be working than those who had higher levels of job self-efficacy. 
Table  5.11:  Hierarchical Logistic Regression variables related to employment status at 
baseline (N = 50).  
95% C.I. for OR Variable B SE B OR 
Lower Upper 
Block 1      
 Constant -0.07 3.56    
 Age -0.01 0.07 0.99 0.87 1.13 
 Occupation -1.81 1.11 0.35 0.06 1.94 
 Treatment -1.04 0.87 0.16 0.02 1.45 
 Cox & Snell R²  0.09     
 Nagelkerke R²  0.15     
Block 2      
 Constant -3.42 4.46    
 Age -0.11 0.09 0.89 0.75 1.07 
 Occupation -0.42 1.61 0.66 0.03 15.55 
 Treatment -1.26 1.11 0.28 0.03 2.51 
 JSE  0.79 0.32 2.20* 1.17 4.13 
 WA  0.45 0.29 1.56 0.88 2.78 
 Cox & Snell R²  0.35     
 Nagelkerke R²  0.53     
JSE Job self-efficacy, WA Work ability, OR odds ratio, CI confidence interval, *p < 0.001. 
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Follow-up Time 1 
At follow-up time 1 there were only 9 participants who described their 
employment status as working; therefore, this number was deemed to be 
insufficient to carry out analysis for this time point. 
Follow-up time 2 
Table 5.12 shows the results from the hierarchical logistic regression analysis 
assessing variables related to employment status at follow-up time 2.  A total of 
49 cases were analysed.  Nineteen participants were working at this time point.  
Age, occupation and treatment group were entered in Block 1 (variables 
controlled for) and explained between 32% and 44% of the variance in 
employment status at follow-up time 2.  This model was found to be statistically 
different when compared against a constant-only model (X² = 19.17, df = 3,       
p = 0.0005).  When assessing psychosocial variables (fatigue, quality of life and 
cancer self-efficacy) a significant model emerged (X² = 25.88, df = 6,                 
p = 0.0005) where only quality of life was significant; therefore, quality of life 
was included in the final model.  The final model which is shown in Table 5.12 
was found to be significant (X² = 45.60, df = 6, p = 0.0005).  The model 
accounted for between 61% and 82% of the variance in employment status, 
with 93% of the not working participants accurately predicted.  Overall, the 
model accurately classified 92% of the cases.  Work ability (OR = 3.05, 95%  
CI: 1.00 – 12.80) and occupation (OR = 0.03, 95% CI: 0.00 – 0.86) were 
statistically associated with employment status.  
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Table  5.12: Hierarchical Logistic Regression variables related to employment status at 
follow-up time 2 (n = 49). 
95% C.I. for OR Variable B SE B OR 
Lower Upper 
Block 1      
 Constant -4.52 3.96    
 Age  0.08 0.07 1.08 0.94 1.25 
 Occupation -3.33 1.26 0.03** 0.00 0.43 
 Treatment  2.21 0.89 9.09** 1.59 51.91 
 Cox & Snell R²  0.32     
 Nagelkerke R²  0.44     
Block 2      
 Constant -25.55 10.82    
 Age  0.07  0.13 1.08 0.83 1.40 
 Occupation -3.37  1.64 0.03* 0.00 0.86 
 Treatment  1.10  1.41 3.00 0.19 47.58 
 QOL  0.28  0.15 1.32 0.99 1.77 
 JSE -1.05  1.08 0.35 0.04 2.93 
 WA  1.28  0.65 3.05* 1.00 12.80 
 Cox & Snell R²  0.61     
 Nagelkerke R²  0.82     
QOL Quality of life, JSE Job self-efficacy, WA Work ability, OR odds ratio, CI confidence 
interval, *p < 0.05, **p < 0.01. 
Prospective Analysis: Predictors of Employment Status 
A longitudinal hierarchical logistic regression analysis was conducted to 
investigate baseline predictors of employment status at follow-up time two.  
Similar to the cross sectional approach, an analysis was conducted to identify 
the psychosocial variables that were significantly related to employment status 
at each time point.  Based upon these results, variables that emerged as 
significant factors were then added to the final model that included contained 
the work variables (work ability and job self-efficacy). 
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Hierarchical logistic regression results for prospective predictors of employment 
status are reported in Table 5.13.  A total of 49 cases were analysed.  Baseline 
age, occupation and treatment group were entered in Block 1 (variables 
controlled for) and explained between 32% and 44% of the variance in 
employment status at follow-up time 2.  This model was found to be statistically 
different when compared against a constant-only model (X² = 19.17, df = 3,       
p = 0.0005).  Analysis that considered whether any of the baseline psychosocial 
variables predicted follow-up employment status led to a significant model        
(X² = 25.88, df = 6, p = 0.001); however, apart from occupation none of the 
psychosocial variables emerged as statistically significant predictors: therefore, 
these were not included in the final model.  As shown in Table 5.13, the final 
model that comprised of baseline employment status, work ability and job self-
efficacy and controlled for age occupation and treatment led to a significant 
outcome (X² = 23.36, df = 6, p = 0.001).  The model accounted for between 
38% and 51% of the variance in employment status, with 86% of the not 
working participants accurately predicted.  The final model accurately classified 
80% of cases.  Receiving chemotherapy; or chemotherapy plus surgery; or 
radiotherapy plus surgery, or chemotherapy plus surgery and radiotherapy   
(OR = 9.91, 95% CI: 1.57 – 62.50) was associated with a greater likelihood of 
not working at follow-up time 2.  
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Table  5.13: Longitudinal Hierarchical Logistic Regression variables related to follow-up 
time 2 employment status (n = 49). 
    95% C.I. for OR Variable B SE B OR 
Lower Upper 
Block 1      
 Constant -4.52 3.96    
 Age  0.08 0.07 1.08 0.94 1.25 
 Occupation -3.33 1.26 0.03* 0.00 0.43 
 Treatment  2.21 0.89 9.09* 1.59 51.91 
 Cox & Snell R²  0.32     
 Nagelkerke R²  0.44 
 
 
    
Block 2      
 Constant -5.59 4.10    
 Age  0.06 0.08 1.06 0.91 1.23 
 Occupation -2.27 1.37 0.10 0.01 1.50 
 Treatment  2.29 0.94 9.91* 1.57 62.50 
 ES† -0.27 1.12 0.76 0.08 6.79 
 JSE† -0.06 0.29 0.94 0.53 1.67 
 WA†  0.47 0.26 1.60 0.95 2.68 
 Cox &  Snell R²  0.38     
 Nagelkerke R²  0.51     
† Baseline, ES Employment status, JSE Job self-efficacy, WA Work ability, OR odds ratio, CI 
confidence interval, *p < 0.01. 
 
5.7. Discussion 
The aim of the study was to examine cross sectional and prospective predictors 
of work ability and employment status in individuals diagnosed with colorectal 
cancer.  The study adds knowledge to existing cancer and work literature by 
identifying previously unexplored variables as being associated with 
employment outcomes.  Furthermore, the findings from the study indicate that 
predictors and variables related to work ability and employment status are likely 
to alter over time.  Moreover, to the researcher’s knowledge, this was the first 
study to consider the role of self-efficacy, namely, job self-efficacy upon these 
outcomes in a systematic manner.  Variables related to work ability outcomes 
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cross-sectionally included occupation and quality of life (baseline), treatment 
type and job self-efficacy (follow-up time 1) and job self-efficacy (follow-up time 
2).  Meanwhile, variables related to employment status comprised job self-
efficacy (baseline) and occupation and work ability (follow-up time 2).  Along 
with self-assessed work ability at baseline, receiving chemotherapy, or a 
combination of treatments (i.e. not surgery alone) were the strongest predictors 
of follow-up work ability independent of age and occupation.  Finally, treatment 
type was also identified as the strongest predictor of employment status 
approximately six months after diagnosis. 
The finding that job self-efficacy was related to work ability and employment 
status indicates that it is a variable that is worthy of consideration in future 
research endeavours.  Prior researchers have only assessed self-efficacy in 
relation to cancer self-management and adjustment studies (Cunningham et al., 
1991).  Researchers investigating return to work and work ability have failed to 
consider the variable altogether (to the researcher’s knowledge), be it cancer-
related or work-related self-efficacy.  As demonstrated by this study, and 
supported by Bandura (1997), self-efficacy is likely to be domain-specific; thus 
perhaps the reason why job self-efficacy alone was related to work ability and 
employment status.  Initial analyses of variables related to job self-efficacy did 
identify that cancer self-efficacy was related to job self-efficacy at follow-up time 
2.  This may due to the way participants had had time to adjust to their cancer 
and treatment (indicated by quality of life) which led to higher perceptions of 
cancer self-efficacy that resulted in better job self-efficacy beliefs.  More 
favourable perceptions of job self-efficacy were related to higher self-assessed 
work ability outcomes at follow-up time 1 and time 2.  At baseline however 
quality of life and being employed in a non manual occupation were related to 
better work ability outcomes.  In a sample of breast, testicular and prostate 
cancer patients Gudbergsson et al. (2008) also reported that quality of life was 
associated with work ability.  Within the context of the current study, this could 
be explained by the fact that the majority of participants had received surgery 
when baseline questionnaires were completed (but prior to chemotherapy or 
radiotherapy); and therefore, it could be argued that quality of life rather than job 
self-efficacy was more likely to be related to work ability as most patients were 
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recovering following surgery.  In other words, when assessing their work ability, 
patients may have been judging functional capabilities as a result of surgery 
over and above perceptions of job self-efficacy.  In spite of such findings, job 
self-efficacy was not a significant predictor of work ability in the prospective 
model.  Instead, treatment and work ability at baseline emerged as significant 
predictors of work ability at follow-up time 2.  On the face of it, this is in line with 
previous research, yet, inherent differences in measures used to assess work 
ability render it difficult to compare these findings with existing research (Munir, 
Yarker, et al., 2009).   
In contrast to previous research findings, fatigue was not related to job self-
efficacy, work ability or employment outcomes (e.g. Pryce et al., 2007; Kessler 
et al., 2001; Lee et al., 2008; Steiner et al., 2008).  An explanation for this may 
be due to the shorter study duration (six months).  However, previous studies 
that have adopted a cross-sectional design are compromised due to inherent 
limitations to infer causality and inability to address confounding factors at 
baseline: to draw such conclusions is therefore difficult.  Following this sample 
beyond treatment would enable fatigue to be investigated as a predictor of work 
outcomes in the long term.  Such findings have been reported in quantitative 
studies (e.g. Spelten et al., 2003; Steiner et al., 2008; Lee et al., 2008) and 
suggested by qualitative studies that have interviewed patients a number of 
years following diagnosis (Maunsell et al., 1999; Main et al., 2005; Kennedy et 
al., 2007; Amir et al., 2008).  Furthermore, this is a matter that may be 
addressed by the diary study presented in the following chapter.  
The findings do however suggest that treatment modality may be a more 
adequate predictor of work ability and employment status in the six months 
following diagnosis.  In a sample of colorectal cancer patients, Sanchez et al. 
(2004) also showed that chemotherapy treatment delayed return to work by two 
months.  The prospective nature of this study adds to this cross sectional 
finding and demonstrates that treatment predicted work ability and employment 
status longitudinally.  Such finding are consistent with de Boer et al. (2008) who 
also found those receiving chemotherapy or chemotherapy plus radiotherapy 
and / or surgery exhibited poorer work ability outcomes.  Similarly, the results 
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from the prospective model of employment outcomes also showed that 
treatment predicted whether an individual was working at follow-up time 2.  
These findings are in line with prospective return to work studies comprising of 
breast cancer patients (Balak et al., 2008) and head and neck cancer patients 
(Buckwalter et al., 2007); however, until now little was known about colorectal 
cancer patients.  Nevertheless, when assessing work ability, these results 
support the argument posed by prior researchers; that treatment type or 
receiving multiple treatment modalities may be more important than cancer type 
(Bradley et al., 2007; Taskila et al., 2007; de Boer et al., 2008).   
Summary 
In sum, the findings from this study highlight the added value of measuring self-
efficacy beliefs in future research considering the impact of cancer on work 
ability and employment outcomes.  Although job self-efficacy did not 
significantly predict longitudinal work ability and employment outcomes, the 
finding that it was important cross-sectionally suggests it warrants further 
investigation.  Moreover, following patients beyond the current study time frame 
(i.e. after completion of treatment) may provide further insight into how this 
variable may impact upon these work outcomes.  
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Chapter 6 
 
6. Exploring Temporal Patterns in Cancer Management, 
Return to Work Intentions and Work Ability: A Diary Study 
6.1. Introduction 
The overall objective of this thesis was to consider the work ability, return to 
work intentions and employment outcomes of colorectal cancer patients in the 
UK.  Chapter 4 provided results from the quantitative questionnaires which 
sought to monitor changes in patients’ self-efficacy, psychosocial well-being and 
employment outcomes over the six month study period.  Furthermore, the 
results suggested that there were variations in psychosocial and work 
outcomes; as a result, it could be argued that this may result in varying return to 
work intentions over time.  Similarly, findings presented in Chapter 5 suggest 
that self-efficacy plays a key role, particularly when attempting to understand 
colorectal patients’ perceived work ability and actual employment status.  
Moreover, the finding that self-efficacy was only related to work ability and 
employment status at particular time points further indicates that levels of self-
efficacy and the role of such beliefs are likely to alter temporally.  Skaalvich and 
Bong (2003) support this notion further; these researchers argue that 
experimental findings indicate that self-efficacy perceptions respond to changes 
in the experience.  In evaluation, however, it has been suggested that more 
systematic research is needed to assess the stability of self-efficacy (Skaalvich 
& Bong, 2003).  Nonetheless, according to Bandura (1997), self-efficacy beliefs 
are context-specific and for this reason they should not be viewed as a stable 
personality construct.  This has been demonstrated in a group of students; 
Pajares and Graham (1999) found that students’ self-efficacy levels in relation 
to their math ability changed significantly over a six month period.  Such 
findings infer that perceptions of self-efficacy are likely to change over time, 
particularly when changes occur in a given experience (e.g. during a cancer 
pathway).  Subsequently, this was a matter that warranted further investigation 
in these colorectal cancer patients.  It is unlikely that a colorectal cancer 
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patients experience will not be without its challenges.  Furthermore, it can be 
argued that self-efficacy beliefs will be challenged at certain time points.  For 
example, at diagnosis an individual may feel overwhelmed by what he / she is 
faced with; yet, once the individual has adjusted to the diagnosis, self-efficacy 
levels may improve.  However, following this, changes in self-efficacy may 
ensue due the treatment(s) and subsequent side-effects an individual may be 
required to manage.  As a result, it can be suggested that return to work 
intentions and perceptions of work ability may also alter as a result of temporal 
changes in self-efficacy beliefs.   
It was therefore necessary to understand the more complex psychological 
phenomena underpinning patients’ experiences and thoughts about managing 
cancer, its associated treatment and employment intentions.  Consequently, in 
addition to the questionnaire study, a smaller sub-sample of participants 
completed a monthly diary that coincided with the six month quantitative data 
collection period.  The diaries aimed to capture the more subtle and temporal 
fluctuations in perceptions of self-efficacy and the factors (e.g. self-management 
of treatment and symptoms and support) that impacted upon these self-beliefs.  
In other words, the diaries sought to explore what (if anything) participants may 
have been doing to self-manage their cancer and work, and more importantly, 
to understand how their self-efficacy beliefs may shape these behaviours and 
return to work intentions / outcomes.  Adopting this design allowed for a more 
comprehensive understanding of the area, which is likely to better inform future 
intervention design in employment and healthcare that would help employees / 
patients affected by cancer to better manage their work and illness.     
The main objective of the diary study was to understand the temporal 
fluctuations and patterns in cancer self-management, return to work intentions 
and work ability.  In particular, the aims were: 
1.  To understand the temporal nature of self-efficacy beliefs and how such 
beliefs may impact upon self-management and subsequent return to 
work intentions and perceptions of work ability. 
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2.  To consider the level and nature of social support received and whether 
this may benefit individuals’ self-efficacy beliefs and subsequent self-
management and work outcomes. 
6.2. Methods 
A diary booklet was designed to capture temporal variations in perceptions of 
self-efficacy in relation to the management of cancer and work, including return 
to work intentions.  According to Pope and Mays (1995), advances in medicine 
and healthcare have given rise to research questions requiring new methods of 
study.  Consequently, diary methods are a useful tool that can be used over 
time to capture in-depth data on psychological processes relating to ongoing 
experiences (Bolger, Davis & Rafaeli, 2003).  Both quantitative and qualitative 
diary methods have been used in a wide variety of settings, including healthcare 
(Ong & Jinks, 2006) and organisational settings (Harris, Daniels & Briner, 
2003).  For example, Ong and Jinks (2006) used a qualitative diary (one week) 
to describe older people’s everyday experiences of living with knee pain and 
disability.  In a similar manner to the current study, these researchers used 
diaries as part of a mixed-methods design which helped clinicians’ holistic 
understanding of how this phenomenon may impact patients’ quality of life.   In 
this study, this method provided the opportunity to collect meaningful data in a 
non-intrusive manner.  Additionally, it served to supplement the data captured 
by the questionnaires by providing a rich insight into the nature of the cancer 
experience and its impact upon work ability and return to work intentions and 
employment outcomes.     
6.2.1. Participants 
A purposive sampling technique was utilised to recruit ten participants.  These 
participants were those who had completed the survey.  At the time of 
recruitment for the survey, all participants were asked if they would like to 
complete a diary booklet.  Ten participants agreed to take part in the diary 
study.  Thus, the inclusion criteria were the same as mentioned earlier in 
Chapter 3 (pp. 70-71).  As this study was qualitative and therefore concerned 
with understanding individual patient experiences rather than obtaining 
statistical representation this sample size was adequate (Mays & Pope, 1995).   
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The diary study’s aims and objectives were outlined in the participant 
information sheet (Appendix 4).  The information sheet explained that 
participation in the diary study was optional.  The informed consent form asked 
individuals to indicate whether they wished to complete the diary study.   
Participant Characteristics 
Table 6.1 summarises the demographic profiles of the colorectal cancer 
patients that completed the diary study.  The mean age of the participants was 
50.50 years (SD = 5.10, range 44 – 58 years) and seven were women (70%).  
At baseline, two (20%) had undergone surgical treatment alone, seven (70%) 
had received surgery and were expecting to receive chemotherapy or 
radiotherapy and one participant was expecting to receive chemotherapy alone.  
All ten participants were in employment at diagnosis (full-time = 8), of which six 
were on sick leave at baseline.  In total, 43 out of a possible 60 (72%) diaries 
were completed (Table 6.1).  More than half of all participants (n = 6) completed 
all six diary booklets.  Of the remaining four participants, one completed three; 
another completed two and the remaining two completed baseline diary 
booklets alone.  The 44-year-old bank clerk who completed two diaries 
withdrew from the diary study as she felt that the cancer had been dealt with 
after being given the ‘all clear’ after surgery; the 47-year-old senior manager 
and 51-year-old car rental assistant failed to complete or return subsequent 
diary booklets posted after baseline. 
6.2.2. Materials 
The diary booklet was paper-based and was completed by participants on a 
monthly basis over six months (Appendix 8).  Three colorectal consultants and 
two colorectal nurse specialists provided advice and guidance about the content 
and design of the diary booklet.  Prior to submitting the final set of documents to 
the research ethics committee, the diary booklet was piloted by two individuals 
(data not reported here) previously diagnosed with colorectal cancer to assess 
its content and feasibility.  As many participants would be undergoing treatment, 
it was important to design the diary so it did not take up an excessive amount of 
their time to complete.
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Table  6.1: Demographic profiles of participants (n = 10). 
Work Status
 
Participant     Age Gender Treatment Employment
         
(Baseline)  (T1)  (T2)  (T3)  (T4)  (T5) 
1           56 Male S & C Teacher W SL SL SL SL SL
2 48 Female S & C Charity Fundraiser SL SL SL SL SL SL 
3 58 Female S & C Teacher SL SL W W W W 
4 45 Male S & C Teacher SL SL W * * * 
5         
        
         
44 Female S Bank Clerk W SL * * * *
6 51 Female S Car Rental Assistant SL * * * * *
7 52 Female S & C Retail Assistant SL SL SL SL SL SL 
8 47 Male S, C & R Senior Manager SL * * * * * 
9 57 Female C Nurse W SL SL SL SL SL
10 47 Female S & C Policy Advisor W W W W W W 
 
S, Surgery; C, Chemotherapy; R, Radiotherapy; W, Working; SL, Sick Leave; *did not complete the diary. 
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1) Section A was completed by all participants.  First, participants were asked to 
write about the three most important events they had experienced over the past 
four weeks.  This provided an indication of where the participant was in terms of 
their cancer journey.  Second, as a measure of perceived self-efficacy 
participants were asked to describe how confident they felt about managing 
their illness, and to also rate their confidence level on a ten-point Likert scale (1 
= not at all confident to 10 = totally confident).  This item was taken from a 
commonly used chronic disease self-efficacy scale (Lorig et al., 1996).  Finally, 
participants were asked to describe the activities they had carried out to 
manage their illness.  This provided an outcome measure.  
2) Section B was completed by participants that were in employment at the time 
when the diary booklet was completed.  First, participants were asked to rate 
how confident they were in managing their work on a ten-point Likert scale (1 = 
not at all confident to 10 = totally confident).  To gain  insight into what, if 
anything, individuals were actively doing in order to manage their work, and how 
confident they were in doing so, participants were also asked to describe how 
confident they had felt about managing their work. 
It was decided that a monthly diary would be sufficient.  Other studies have 
utilised diaries that are completed over a 1-2 week period (Ong & Jinks, 2006); 
however, this would not have been appropriate for the current study.  A monthly 
approach was better suited to the overall aim of this diary study; that is, to 
capture temporal fluctuations in perceptions of self-efficacy.  The study period 
allowed rich data to be collected relating to different points of the cancer 
pathway, including diagnosis and how the treatment experience may change 
over time.  The completion of diaries coincided appropriately with the 
questionnaire data collection time points.  Figure 6.1 illustrates how diary 
completion coincided with questionnaire completion.  The diary booklet largely 
comprised of prompts that sought to capture qualitative data.  The diary booklet 
was comprised of three sections:  
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Baseline 
 
(0 – 3 months post 
diagnosis) 
 
Time 1 
 
Time 3 
 
(3 – 6 months post 
diagnosis) 
 
Time 6 
 
(6 – 9 months post 
diagnosis) 
Background 
Questionnaire 
 
Managing Cancer 
& Employment 
Questionnaire 
(Assessment 1) 
Diary 
 
Managing Cancer 
& Employment 
Questionnaire 
(Assessment 2) 
 
Diary 
 
 
Diary 
Managing Cancer 
& Employment 
Questionnaire 
(Assessment 3) 
 
 
 
 
 
Time 2 
 
 
Diary 
 
Time 4 
 
Time 5 
 
 
Diary 
 
 
Diary 
Figure  6.1: Diary study procedure within context of questionnaire study. 
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3) Section C was completed by participants who had stopped working, or were 
on sick-leave.  To gain  insight into perceptions about work, specifically, in 
relation to the possibility of returning to work, participants were asked about 
their return to work intentions.  Finally, participants had the opportunity to write 
any further thoughts that they felt were relevant.   
6.2.3. Procedure 
The diary booklet (Appendix 8) was included in the questionnaire study pack, 
which was provided to all those expressing an interest in the study.  Those 
wishing to take part in the diary study were asked to complete and return the 
booklet along with other questionnaire documentation.  The first page of the 
diary booklet explained the purpose of the study and instructions for completion.  
To try and maintain a degree of consistency, participants were asked to 
complete the diary in a quiet environment at a similar time each month.  
Subsequent diaries were sent with a letter to participants approximately three 
and a half weeks after the date the prior diary booklet was completed.  The 
enclosed letter requested participants to try and complete the diary on a 
particular date that coincided with the completion date of earlier diaries.  The 
letter also allowed the researcher to maintain contact and build a rapport with 
participants, which may have helped prevent withdrawals over the study period. 
To encourage participation for the entire duration of the study, participants were 
provided with stamped addressed envelopes in which to return completed 
diaries to the researcher.  Upon receipt of each diary the researcher contacted 
the participant to thank them for taking the time to complete it.  Participants 
were offered a copy of their completed diary at the end of the study such that 
they could reflect back over their experiences should they wish.   
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6.2.4. Analysis 
The paper-based diary booklets were transcribed and organised according to 
participant and stored electronically.  The data were analysed utilising a 
thematic analysis approach adopting the six phase process outlined by Braun 
and Clarke (2006).  According to these researchers, thematic analysis provides 
core skills that are transferable to other qualitative methods.  Some researchers 
suggest the coding process of thematic analysis is common to a number of 
qualitative methods (Ryan & Bernard, 2000); however, in spite of this, Braun 
and Clarke (2006) effectively argue, “thematic analysis should be considered a 
method in its own right” (p. 78).  Thematic analysis is a widely used method that 
seeks to identify and analyse themes inherent in the data (Braun & Clarke, 
2006).  Boyatzis (1998) argues that thematic analysis goes further and can 
provide various insights into a particular research area.  The usefulness of 
thematic analysis in the analysis of diary studies has been supported and 
demonstrated in the literature (Symon, 2004; Gordon, Prohaska, Gallant & 
Siminoff, 2007).  Gordon et al. (2007) employed thematic analysis techniques to 
analyse qualitative aspects of a prospective diary that explored 
immunosupression adherence among kidney transplant recipients.  Due to the 
various thematic approaches used by researchers it is important to outline the 
specific nature of the approach that is being adopted here. 
Thematic analysis was carried out on all data.  Conducting the analysis in this 
manner allowed emerging themes to be analysed according to each time point, 
thus enabling temporal fluctuations and patterns to be analysed over the six 
month study period.  Therefore, themes only apparent at certain time points 
could be extracted.  First, the analysis process involved the researcher and an 
independent researcher systematically reviewing the diary transcripts 
separately.  Second, initial ideas were noted, which guided preliminary codes.  
These codes were grouped into potential relevant themes and discussed 
between the researchers.  Further analysis clarified the specific nature of each 
theme leading to the development of names for each theme.  Subsequently, 
extracts were taken from the transcripts to exemplify each theme and reflected 
the overall experiences reported by participants.  Consequently, results will be 
presented taking into account all completed diary booklets.  Thus, temporal 
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fluctuations within and between themes will be discussed with an overall 
discussion at the end of the chapter. 
6.3. Results 
Four core themes were identified across time points, these are summarised in 
Table 6.2.  These will be discussed in turn and particular attention will be paid to 
the temporal fluctuations within each theme. 
Self-Efficacy and Cancer Self-Management 
The majority of participants discussed their cancer diagnosis (n = 6), including 
initial investigations (e.g. biopsy and colonoscopy) and the implications of 
disease stage upon their treatment.  Within the sample, the role of self-efficacy 
in the management of cancer treatment, symptoms, fatigue, diet and exercise 
was diverse.  At each time point participants were first asked to indicate on a 
scale ranging from 1 to 10 (1 = not at all confident and 10 = totally confident) 
their perceived self-efficacy in their ability to do all the things necessary to 
manage their condition.  Table 6.3 depicts the mean values and range of 
perceived self-efficacy scores according to each time point.   
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Table  6.2: Themes and sub-themes. 
Key Themes 
 
Sub-Themes 
  
Self-Efficacy and Cancer Self-Management Treatment 
 Symptoms 
 Fatigue 
 Diet 
 Exercise 
 Psychological Well-Being 
Normality and Self-Efficacy 
 
Self-Efficacy and Return to Work Intentions The Impact of Treatment, Symptoms and Self-Management Skills 
 Self-Efficacy, Attitude and Self-Management Skills 
 Self-Efficacy, Self-Management and Work Ability 
 
Self-Efficacy and Self-Management of Work Distraction and Normality 
 Work Adjustments, Self-Management and Work Ability 
  
Self-Efficacy and the Role of Support Family and Friends’ Support 
 Employer Support 
 Health Professionals’ Advice and Support 
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Table  6.3:  Perceived self-efficacy in ability to self-manage cancer according to time 
point. 
 
 
     Self-efficacy in relation to Cancer Management 
Time Point n   Mean  ± SD Range 
Baseline 10  8.10  ± 1.59 6 – 10 
Time 1 8  8.75  ± 1.28 7 – 10 
Time 2 7  8.71  ± 1.38 7 – 10 
Time 3 6  8.83  ± 1.16 7 – 10 
Time 4 6  8.67  ± 1.21 7 – 10 
Time 5 6   8.17  ± 2.40 4 – 10 
At baseline the mean self-efficacy score of 8.10 (SD = 1.59) suggests that 
participants possessed high levels of self-belief in their ability to manage their 
cancer.  Figure 6.2 shows mean scores increased after baseline up until time 3 
and these ranged between 7 and 10.  However, beyond time 3, a decrement in 
self-efficacy was apparent at time 4 and 5.  Nevertheless, the mean scores 
indicate that self-efficacy was relatively high and stable over time. 
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Figure  6.2: Mean (SD) self-efficacy in ability to self-manage cancer according to time 
point. 
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Treatment  
Treatment patterns varied within the sample (Table 6.1).  At baseline, over two 
thirds of participants (n = 8) acknowledged the treatment(s) they had received 
or were expecting to receive.  A few 
cancer and their recovery (n = 3).  Five participants specified that they were 
expecting to receive chemotherapy (either adjuvant or neo adjuvant) treatment.  
riences, diagnosis and treatment seemed 
necessary for individuals to understand the nature and extent of their disease 
and w
cons .  
For i  
raise fficacy in her ability to manage: 
t 
ge my illness and symptoms.  It has been essential for me to 
have full understanding of matters to enable me to get fully prepared in better 
Self-efficacy appeared to be important in understanding how participants were 
 
I think I’m trying to get myself as healthy as I can for chemo, to try and put off any 
side effects, not sure whether this will work. 
discussed their surgery to remove the 
Reflecting on their own expe
ith what they were faced.  By doing so, participants felt they could start to 
ider the implications for them in terms of the management of their cancer
nstance, when one woman found out that her cancer had not spread this
d her perceived self-e
The cancer has not gone into my organs…Very confident because the cancer 
was caught early. 
Participant 5, baseline. 
Another participant noted:  
Once I have been informed / learnt what is required of me, I have been confiden
and able to mana
managing my illness. 
Participant 8, baseline. 
approaching their treatment pathway.  Different patterns were observed, for 
example, a 56-year-old teacher described that he was confident about 
managing his treatment by approaching it in stages.  He had undergone surgery
and had adopted a ‘wait and see attitude’.  In contrast, one participant was 
actively preparing herself for chemotherapy by ensuring that she could be as 
healthy as possible: 
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Participant 7, baseline. 
very after surgery was mentioned by two participants at time 1. Reco  A female 
bank clerk described that the only thing that was preventing her resuming 
normality was the soreness.  A male participant who had previously expressed 
that h th 
the progress made particularly over times 1, 2 and 3.  Furthermore, as a result 
this seemed to enhance his perceived self-efficacy in relation to managing his 
canc
n remarkable and I am pleased with my growing 
independence...I have felt confident and this has grown as my recovery proceeds.  
rgery wound appears to have finally healed after 11 weeks.  This is 
another ‘thing’ out of the way to help my movement forward. 
For those receiving chemotherapy, successive diaries captured data on the 
mana seven participants undergoing 
chemotherapy, only one appeared to have a somewhat consistent experience 
e was approaching his treatment in stages appeared to be pleased wi
er:  
The progress has bee
Little advances each day indicate that my ‘illness’ will be overcome.  
Participant 1, time 1. 
Very good recovery from operation.  Each day / each week has seen a very 
pleasing improvement. 
Participant 1, time 2. 
The su
Participant 1, time 3. 
gement of treatment.  When considering all 
temporally.  Moreover, this 58-year-old female teacher’s entire cancer 
experience was somewhat set apart from the rest of the sample.  When 
discussing her chemotherapy treatment this participant experienced few 
problems: 
I seem to still be doing well with everything.  The chemo is going well. 
Participant 3, time 1. 
I seem to be tolerating chemo very well indeed. 
Participant 3, time 2. 
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However, for the remaining six participants chemotherapy treatment 
experiences fluctuated over time.  Once treatment commenced these 
participants initially found it difficult to manage.  For instance, in his third diary, a 
56-year-old male felt his treatment dictated the activities that he could carry out.  
However, over time and after numerous treatment sessions, four of these 
partic
(inclu or example, a 52-year-old retail assistant initially felt 
essed that he 
felt very unconfident prior to starting treatment.  However, modified treatment at 
time 
now that they have reduced the dose (it was too much). 
Participant 4, time 2. 
 
n 
 in 
ly impacted her perceived self-efficacy: 
ween doses is so short which means that I seem to spend my life at 
..treatment is every other week - not much time to recover. 
ir 
ow to 
ipants noted how they eventually became familiar with their treatment 
ding side effects).  F
treatment had started well at time 1; however, at times 2 and 3 chemotherapy 
had become more difficult and therefore harder to manage.  Despite early 
challenges, at time 5 this participant stated that she was more confident in her 
ability to manage treatment.  Similarly, a 45-year-old teacher expr
2 led to improvements in self-efficacy beliefs: 
Much more confident 
Alternatively, a 48-year-old charity fundraiser described how she experienced
extreme highs and lows throughout her treatment.  Furthermore, the manner i
which treatment was administered resulted in problems managing it, which
turn may have negative
Time in bet
the hospital.
Participant 2, time 4. 
Such results indicate that participants needed time to familiarise / adjust to the
chemotherapy treatment.  This seemed a necessary process to learn h
manage their treatment.  As a result, the nature of this experience may have 
influenced participants’ self-efficacy beliefs in their ability to manage their 
cancer and treatment. 
 Symptoms 
When reflecting on their ability to manage their illness, at baseline, four 
participants described that they had not experienced any problems.  One of 
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these individuals felt fortunate that no symptoms / side effects had presented 
themselves.  Furthermore, another participant found it strange that no 
symptoms had surfaced, thus suggesting that they may have anticipated s
side effects.  Disease stage seemed important as one part
ome 
icipant (44-year-old 
bank clerk) expressed confidence in her ability to manage her condition as the 
canc
proactively engaging in forward planning behaviours to ensure that they were 
able to ward off and manage potential problems / symptoms, notably fatigue.  
 
nd his 
as aware of what the 
consequences of not performing this behaviour would be: 
gh sleep to keep up my strength.  If I don’t do this I look 
and feel unwell. 
er daily. 
Participant 3, baseline. 
In co
appe
posit
with abdom
her ability to manage her condition due to symptoms were exacerbated on work 
er was caught at an early stage.  Other participants (n = 3) were 
For example, a few participants acknowledged the need to rest and that this 
was something within their control and therefore indicative of high self-efficacy
levels.  For a 56-year-old teacher, this was a task that he had to perform a
self-belief in his ability to do so was evident as he w
I make sure I have enou
Participant 1, baseline.  
Similarly, a 58-year-old teacher described how she was able to continue with 
tasks around the home; however, she had to pace herself throughout the day 
ensuring that she rested frequently.  Engaging in such self-management 
behaviours seemed to produce positive outcomes: 
I’ve noticed that I’m getting strong
ntrast, those possessing lower self-efficacy levels (n = 3) at baseline 
ared to report more symptom burden compared with those with more 
ive self-efficacy beliefs.  A 57-year-old nurse was experiencing problems 
al’s feelings of low self-efficacy in inal and back pain.  This individu
days.  Interestingly, a male teacher illustrated how perceived self-efficacy varied 
according to the type of situation:   
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I have had problems with needing to visit the loo and the worry associated with 
timing of eating, not being able to find a loo (in time).  A new experience making 
one feel set apart / or part of a different set, confidence in managing this was not 
high…Problems with walking and moving.  I expect to improve to normality so this 
has been managed reasonably well and I felt reasonably confident. 
Participant 4, baseline. 
For the majority of participants, the presentation of symptoms altered over tim
leading to changes in self-efficacy levels.  When attempting to understand
experiences and temporal fluctuations in self-efficacy and symptom- 
management the nature and type of treatment was of key importance.  For 
example, the participant (44-year-old female bank clerk) that received surgery 
alone reported minimal symptoms at time 1.  Moreover, the information th
participant would be receiving surgery alone seemed to boost her self-efficacy 
beliefs to manage these symptoms knowing once they had passed her cancer 
would be overcome.  In contrast, those receiving chem
e, 
 these 
at this 
otherapy (n = 8) 
displayed different patterns over time.  For example, a 47-year-old policy 
advis
Similarly, as treatment progressed 
diarrhoea, which for one woman was most prominent soon after a session of 
 
 to 
 
Hair has started to thin, so this is another thing to deal with but I guess I prepared 
it. 
At baseline and prior to chemotherapy, it was apparent that some participants 
were f 
treatment.  However, for two participants, both of whom were teachers, these 
antic re not experienced.  Consequently, over the study 
or reported that she was finding her treatment harder as it progressed.  
two other participants were managing 
chemotherapy (58-year-old teacher, time 2).  Such side effects did not appear 
to faze this participant especially in relation to her perceived ability to manage
her treatment and symptoms.  Two other participants had problems with 
constipation at time 4.  Iron tablets were being taken by a 48-year-old woman
help alleviate the problem.  At time 3, a 52-year-old retail assistant appeared to
respond well to her hair thinning as it was expected: 
myself for this anyway so it isn’t really a major shock to me just dealing with 
Participant 7, time 3. 
 expecting certain symptoms / side effects to arise as a consequence o
ipated symptoms we
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dura
arise such as tingling and nausea were managed confidently as indicated by 
posit cross all time points: 
sed gloves and bed socks 
to prevent tingling. 
In contrast, symptoms experienced by two other participants led to temporally 
variable self-efficacy beliefs in relation to their cancer management (especially 
ime 3) and improvements the week 
proce rse 
initia r confidence to manage her disease had increased 
since baseline.  However, side effects such as nose bleeds and painful fingers 
at time 2 resulted in reduced confidence in treatment: 
g nose and painful fingers so thinking if side effects get worse it will 
At time 5, this participant’s self-efficacy levels seemed to be at her lowest due to 
the o
Not so confident as now getting a lot of pain...Spending longer in bed. 
 
tion these participants also reported fewer symptoms, symptoms that did 
ive self-efficacy levels a
I seem to still be doing well with everything.  I do not seem to have any bad 
symptoms – the chemo is going well, I am eating well and sleeping well. 
Participant 3, time 1. 
I have been very lucky, I think because I am not getting any sickness or side 
effects. 
Participant 3, time 3. 
My symptoms have continued to be minimal and I’ve u
Participant 3, time 5.       
treatment).  A charity fundraiser seemed to show lowest self-efficacy levels 
shortly after a chemotherapy session (t
eding treatment (time 5).  Alternatively, at time 1 a 57-year-old nu
lly described how he
Had bleedin
be difficult to cope generally this affects confidence with treatment. 
Participant 9, time 2. 
nset of pain: 
Participant 9, time 5. 
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Fatig
The most commonly reported symptom
fatigue (n = 6).  The onset of fatigue for these participants was evident at either 
time 
Still get very tired. 
me ‘inconveniences.’ 
e 
 
f 
 
ed self-
ed appropriate.  For 
instance, a 52-year-old part-time retail assistant acknowledged that her self-
effica
to the
realise that rest was important prior to each chemotherapy session.  Indeed, it 
ue 
 associated with chemotherapy was 
1 or time 2: 
Participant 10, time 2. 
Fatigue was perceived differently by participants:   
Chemo treatment started on 9th June.  It has been a ‘kind’ regime with few side 
effects of any real consequence (some tiredness), just so
Participant 1, time 3. 
During recovery from chemo have found it difficult to focus and very lethargic. 
Participant 2, time 2. 
For the female participant above who described chemotherapy related fatigue 
as problematic, it was clear that once these symptoms had diminished her self-
efficacy beliefs in managing her cancer improved: 
However, when over the lethargy had bursts of energy and felt extremely positiv
and confident.  Did lots of de-cluttering – very cathartic. 
Participant 2, time 2. 
Other results suggest that symptoms of fatigue though initially problematic were
better managed as time progressed.  At time 4, a 48-year-old female 
acknowledged the need to rest; however, she found it frustrating as it was out o
character for her to ‘sit around’.  Three participants were confident that they had
learned when symptoms of fatigue would be most pronounced proceeding a 
chemotherapy session.  Therefore, in response, they successfully engag
management behaviours such as taking rest when deem
cy levels to manage her symptoms decreased between times 1 and 2 due 
 onset of fatigue.  However, by time 3 this participant was beginning to 
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was 
henc .  Alternatively, a 58-year-old 
teacher appeared to be aware of treatment-related fatigue and how to manage 
it as early as time 2.  Furthermore, 
high self-efficacy levels were evident early on and were consistent, thus 
enabled these behaviours to be maintained throughout: 
ore 
rest up on 
I have continued to have confidence about managing my condition!...they 
ant 3, time 5. 
Similarly, at time 5 a 56-year-old male described how a routine was firmly in 
place that allowed him to respond to
consequence of his treatment.  Therefore, results suggest that such behaviours 
and positiv fficacy beliefs to manage symptoms 
as treatment progressed: 
nt 7, time 3. 
Furth
refer
progressed.  A 56-year-old teacher showed that he was bearing in mind this 
cumulative effect and acknowledged that he was prepared and confident in his 
reported that fatigue was most prominent a few days after treatment; 
e, a routine was well in place to manage this
when compared with other participants, her 
On about the Friday of the 1st week of treatment I tend to feel at my worst – m
tired and needing to go to the loo more than normal.  However, I just 
this day – watch rubbish on the television and sleep.  By Saturday / Sunday I feel 
better and by the 2nd week I’m back to normal. 
Participant 3, time 2.  
(oncologist) are very pleased with my progress.   
Particip
 any symptoms that arose as a 
e outcomes strengthened self-e
Very confident – as the weeks progress so does the ‘experience’ and how to deal 
with it. 
Participant 1, time 4. 
I’ve figured out what is best for me with my treatment. I really need to rest up 
before it. A few days after is when the tiredness kicks in, so I make sure I take it 
easy. 
Participa
er analysis of diaries over the study period found that a few participants 
red to experiencing the cumulative effect of treatment (notably fatigue) as it 
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ability to manage any changes as and when they may occur.  This was also the 
case for the 58-year-old teacher who had previously acknowledged that she fe
lucky where treatment was concerned and showed high self-efficacy levels 
throughout: 
lt 
I’ve had a great month and although I’ve been on my last lot of chemo with the 
cumulative effect of it all and do feel a little more tired at the end of the week that 
 how 
 to 
r 
reatment.  At baseline, three 
participants altered their diet by reducing their food intake and consuming 
smaller portions.  Two others expressed 
and balanc ul to drink plenty of water and 
avoid foods that were not recommended.  A 52-year-old retail assistant 
.  
I’ve had chemo. 
Participant 3, time 4. 
On the other hand, after five chemotherapy sessions one woman described
she was feeling ‘yuk’ for longer and that symptoms were also taking longer
wear off (time 4).  As a result, this participant was left feeling as though she was 
‘existing’ rather than living, which as a result seemed to negatively impact he
self-efficacy beliefs.   
Diet 
In an attempt to manage their disease, the majority of participants (n = 8) had 
been monitoring their diet.  This is something colorectal cancer patients are 
advised to do after surgery and during other t
that their diet had always been healthy 
ed; however, they had been mindf
described how at times she found it a challenge to adhere to a diet plentiful of 
fruit and vegetables.  For this woman, performing this management behaviour 
was part of a wider goal to prepare her for oncoming chemotherapy treatment
Alternatively, a female bank clerk stated that although she had not made any 
dietary changes, she had been eating more: 
Have not done anything different except eat more.  I don’t know if that is due to 
nerves or the illness. 
Participant 5, baseline. 
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It was increasingly apparent that over the study period maintaining a good di
was of
et 
 importance to all participants that completed more than one diary (n = 8).  
This was the case regardless of treatment type.  For instance, at time 1 a 44-
year-
of wh
rema ly started chemotherapy treatment diet was 
monitored throughout.  Early behaviours, such as eating a balanced diet set out 
at ba
who 
enab  relative 
ease
 
 
ar-
licy advisor described how she was finding it difficult to manage her diet 
around her stoma appliance (unable to eat fruit and vegetables).  Similarly, a 
57-ye l 
confident about maintaining her weight and iron levels as she was not eating or 
enjoying her food.  Alternatively, at time 2, a 48-year-old appeared to be doing 
well 
concerned about possible weight gain as she had been prescribed steroids.  
Diary entries at time 4 and time 5 suggest that high self-efficacy levels enabled 
this participant to monitor and adjust her diet as new challenges arose over 
old female who received surgery alone stated that she was being mindful 
at she consumed and was slowly re-introducing food into her diet.  For the 
ining eight who subsequent
seline were maintained by three participants.  Two of these were teachers 
seemed to have a healthy diet in place prior to the cancer.  Therefore, this 
led the necessary changes to be made where appropriate with
: 
I eat three regular meals a day.  I try to eat small but healthy portions and I try to
eat my main meal in the middle of the day as I think this is best for my condition in
terms of digestion and so on. 
Participant 3, time 1. 
I’ve managed my diet laid down in diary 5 and I feel I’m eating healthily but being 
careful about eating anything too spicy.  My monthly meal with the girls described 
in diary 4 has been fine and I have enjoyed these as special treats. 
Participant 3, time 5. 
Temporal changes in self-management of diet were evident as a response to 
changing symptoms.  Despite such monitoring behaviours, results suggest that 
self-efficacy beliefs in managing diet varied.  For example, at time 1, a 47-ye
old po
ar-old nurse who had to pulverise her food reported that she did not fee
at managing to eat smaller meals.  Further to this, this participant was 
time: 
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Had to watch diet – include more fibre and fruit because of taking iron tablets 
which cause constipation. 
Participant 2, time 4. 
Because of my weight increase – due to steroids I have been very careful with 
diet. 
Participant 2, time 5. 
Exercise 
my 
Being able to exercise was important to five participants.  At baseline, three 
partic s they 
could.  Therefore, suggesting it was important to them and still within their 
capability.  A 56-year-old teacher stated that regular exercise helped him to 
Participant 4, baseline. 
By tim heir 
activities as they were no longer able 
example, the 45-year-old teacher was participating in more sedentary activities 
e to 
re concerned I am building up my strength as I recover.  
Short strolls are turning into longer ones, albeit in the garden. 
Two other female participants revealed effort
(time 5).  In particular, chemotherapy treatment and side effects may have 
ipants mentioned that they had attempted to exercise as much a
keep in shape and ‘feel’ fit.  A female nurse awaiting chemotherapy treatment 
exercised at a lower intensity which enabled her to continue with her main 
leisure activity.  After surgery, a 45-year-old male teacher seemed to perform 
beyond his own perceived self-efficacy beliefs: 
Enjoying a challenging walk and completing it within a time above all 
expectations. 
e 1, due to treatment effects, these two male participants had to alter t
to exercise in the same manner.  For 
that ‘suited the brain rather than the body’ such as painting and writing.  
Alternatively, the 56-year-old teacher continued to make the effort to exercis
build up his strength, in turn this may have boosted this individual’s self-efficacy 
beliefs, hence reinforced this behaviour: 
As far as activities a
Participant 1, time 1. 
s to exercise in their final diaries 
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preve 8-
year-  do more in terms of 
exerc ment in response to weight gain associated with 
y 
Overall, both treatment and the associated side effects did seem to impact 
study duration.  However, for participants whose 
r-
.  
 
 
.  
he future.  Consequently, self-efficacy beliefs 
may have been negatively impacted.  The most prominent temporal fluctuations 
in psychological well-being were apparent for the female charity fundraiser.  At 
time points 2 and 3, this woman reported feelings of extreme highs and lows.  
nted one of these participants from taking part in exercise earlier.  This 4
old charity fundraiser appeared to be attempting to
ise and diet manage
medication (steroids): 
Because of my weight increase due to steroids I have been very careful with m
diet.  I’m also trying to do more exercise but only gentle exercise – walking, 
wearing a pedometer and endeavouring to achieve 10,000 steps a day.  Some 
days I achieve 12,000 and others only 6,000 or 8,000. 
Participant 2, time 5. 
ability to exercise over the 
routine comprised of exercise prior to cancer it was apparent that they were 
confident in their ability to judge and subsequently amend their activities where 
necessary.  In addition, other participants (n = 2) were confidently able to 
engage in activities as a response to problems associated with their cancer 
treatment. 
Psychological Well-Being 
A few participants attempted to adopt a positive outlook at baseline.  A 48-yea
old charity fundraiser stated that after overcoming the initial shock of diagnosis 
she was trying to remain positive.  This was also the case for a female nurse
Alternatively, despite feeling positive a 56-year-old teacher mentioned that he
had to amend tasks to reduce emotional pressure.  Subsequent diaries suggest 
temporal fluctuations in psychological well-being that appeared to be associated
with the onset and experience of chemotherapy treatment.  Four participants 
exhibited changes in their psychological outlook.  For instance, a 57-year-old 
nurse found her ability to cope challenged by the onset of side effects at time 2
Therefore, initial attempts to remain positive seemed threatened by fears of 
more side effects surfacing in t
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Furth
once  
cumu se impact on well-being, hence 
perceived self-efficacy levels: 
Participant 2, time 4.       
Enco e and 
was r-old 
male teacher seemed to be veering towards the opposing end of the spectrum: 
chievements etc. 
In contrast, the psychological well-being of a 56-year-old male teacher and a 
58-ye
the p well-being 
favourably.  Therefore, this positive outlook may have led to enhanced self-
efficacy beliefs: 
I am still feeling very positive as I’m feeling good and having good experiences as 
er analysis of time 3 data indicated that psychological well-being improved 
 she was over her session of chemotherapy.  Time 4 results suggest the
lative effect of treatment led to an adver
The last few weeks I have felt more despondent and tearful.  Not really sure why.  
It seems like I am existing rather than living and my life is on ‘hold.’  Also side 
effects are taking much longer to wear off. 
uragingly, at time 5 this participant revealed that she felt more positiv
generally coping well.  Meanwhile, compared with baseline, a 45-yea
A retrospective look at my life’s achievements – failures – experiences, 
desperately wanting to spend time with family…I was already in a bad ‘life 
position’ and felt pretty unhappy about my life position, a
Participant 4, time 1. 
I do have a strange feeling of having the ‘sword of Damacles’ hanging over my 
head though – something maybe I should get counselling for – the opposite of 
what one might expect – not indestructible (although I do feel I have 9 lives!) but 
that I will die in a car crash.  I hope it is not prophetic. 
Participant 4, time 2. 
ar-old female teacher seemed to be more consistent.  Moreover, at time 1 
resence of support appeared to impact psychological 
I’ve mentioned already.  I think that all of this really helps. 
Participant 3, time 1. 
The enormous support from family and friends has been uplifting. 
Participant 1, time 1.  
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Such results indicate that psychological well-being may impact self-efficacy.  
r 
ct that 
they had resumed activities such as attending a friend’s wedding or going on 
holid  
night ny years.  The same 
lady, a teacher, had been abroad to visit family, this seemed possible due to her 
 
e 
 her 
Broadly speaking, those with a better psychological outlook appeared to have 
higher levels of self-efficacy.  Hence, in turn this may lead to better self-
management behaviours thus outcomes. 
Normality and Self-Efficacy 
In terms of cancer management, efforts to resume normality were important fo
some.  In particular, those with higher perceived self-efficacy beliefs in their 
ability to self-manage their disease appeared to find this easier when compared 
with those with lower perceived self-efficacy levels.  At baseline, five 
participants discussed normal activities that they had taken part in.  This 
resumption of normality served different purposes.  For one participant, a 56-
year-old male teacher, focusing on other things such as work and family were 
helpful distractions from the disease.  Others placed importance on the fa
ay.  A 58-year-old female stated she had been able to go on a regular girls’
 out, which she has done on a monthly basis for ma
perceived high self-efficacy beliefs in her ability to manage whilst away: 
I managed to go to see my son, daughter-in-law and new baby granddaughter in
Berlin at the end of August…I felt very well while there. 
Participant 3, baseline. 
Efforts to continue as normal appeared to fluctuate temporally for all but on
participant.  When discussing the most important events to occur during each 
diary entry, this 58-year-old teacher consistently reported that she had 
participated in various ‘normal’ activities, such as, visiting family abroad 
(baseline), theatre trips and having a new kitchen fitted (time 2), weekends 
away and Christmas shopping (times 3 and 4).  Besides, this participant’s 
perceived self-efficacy beliefs were invariable across diary entries (rated as 10), 
thus suggesting that being able to maintain a degree of normality in the face of 
cancer may have reinforced self-efficacy beliefs in her ability to manage
cancer.  Similarly, a 45-year-old male teacher who had just started 
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chemotherapy mentioned his efforts to regain normality at time 1, soon after 
surgery.  Other participants (n = 4) exhibited varying patterns.  It was noted 
during the first three diary ent
that 
ries two females (a charity fundraiser and a retail 
assistant) who had both undergone surgery and started chemotherapy 
appe
times
activ ised for one participant due to factors 
associated with the disease: 
ur holiday in the sun to Portugal 
Self-
Intentions to return to work were expressed by participants who were all on sick 
leave at some point over the study duration.  Some were more vehement in 
fluctuations in self-management of treatment and symptoms that led to changes 
 side 
refore, it 
erstand 
 
ared to be more focused on rest and recovery.  Indeed, it was not until 
 3 and 4 when more normal activities were resumed.  Even though normal 
ity was resumed it was comprom
We were all disappointed at having to cancel o
but it was definitely the right decision since I had to go to the local hospital whilst 
away because I was losing blood. 
Participant 2, time 4. 
Efficacy and Return to Work Intentions 
their desire to return to work than others: 
Although currently I am on ‘sick leave’ from work, I think it is worth reiterating that 
I wish to return to work... 
Participant 8, baseline. 
However, the strength of these intentions varied within the sample due to 
in self-efficacy.  Furthermore, symptoms (particularly chemotherapy
effects) appeared to lead to decrements in perceived work ability.   The
was apparent that certain factors were important when attempting to und
return to work intentions. 
The Impact of Treatment, Symptoms and Self-Management Skills 
Self-efficacy and return to work intentions seemed to be influenced by 
treatment, the experience of symptoms such as fatigue and overall self-
management skills.  At baseline, even though three participants wanted to
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return to work, they could not plan when this would be possible as they 
either expecting to receive chemotherapy or unaware of any further treatment 
they may receive.  A 48-year-old charity fund
were 
raiser wanted to return to work but 
did not know when this would be possible.  In addition, at baseline, she was 
focus
Furth
subs ent 
took n to work intent: 
py 
red to 
 
 
ths leave was necessary after major 
abdominal surgery.  Hence, treatment as a barrier preventing return to work 
was  
of thi ills 
enab
plans for her examination classes: 
ed on recuperating after the operation, which she found frustrating.  
ermore, she was awaiting an outpatient’s appointment to discuss 
equent treatment that may be necessary.  For some, focusing on treatm
precedence over retur
Would definitely want to go back to work at some point, but at the moment I can’t 
really plan when this might be possible.  At the moment I need to deal with the 
chemo and see how I go with that before I figure out what to do about work. 
Participant 7, baseline. 
Therefore, subsequent diaries identified that time taken to begin chemothera
was a factor that seemed to impact return to work intentions.  Four participants 
(females; n = 3), started chemotherapy at follow up time 1.  In contrast, a 52-
year-old nurse started her treatment by time 2 and a 56-year-old teacher by 
time 3.  Consequently, treatment (both surgery and chemotherapy) appea
be a barrier to return to work.  This is supported further by the experiences 
reported by a 58-year-old teacher.  In spite of consistently expressing a desire 
to return to work and exhibiting high self-efficacy beliefs throughout the study,
this participant’s return to work was delayed.  This was due to her employer’s
policy stating that at least three mon
also evident in those whose self-management skills were positive.  In spite
s, this participant’s high self-efficacy beliefs and self-management sk
led her to negotiate work to do from home, such as marking and lesson 
I feel that although I’m on sick leave at present due to having had the operation 
and not being able to return until 3 months has passed...However, I have 
prepared schemes of work, lesson plans and marked and set coursework for all 
of my exam classes  
Participant 3, time 1. 
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Further results after baseline suggest that treatment and the associated 
symptoms seemingly continued to exert an influence upon return to work 
intentions.  A 45-year-old male teacher described that he could not consider 
returning to work until his treatment was relatively stable.  At time 2, a reduced 
dose resulted in a degree of stability which in turn enabled this participant to 
eventually return to work.  However, for others, the unpredictable nature of 
treatment and symptoms led to changes in return to work intent.  For example, 
a nurse who had started chemotherapy at time 2 had no intentions to return to 
work due to not knowing how she would feel on a day-to-day basis. The onset 
of mo is 
partic e 4; and 
by tim
Had some very difficult days with sore mouth...difficult to talk or swallow...sore 
rn to 
work...Chemotherapy side effects...would not feel safe to practice. 
 
ills 
t 
 of a barrier.  However, although return to work intentions 
were evident and further strengthened once treatment was not viewed as a 
barrier
consider returning to work upon completion of chemotherapy treatment (beyond 
re troublesome symptoms such as sore fingers and fatigue also led to th
ipant admitting that she had no intentions to go back to work at tim
e 5 she had decided that she would not return to work: 
feet and blisters, difficult walking some days...No intentions to retu
Participant 9, time 4. 
 
No, don’t feel safe to practice.  Accepted for ill-health retirement. 
Participant 9, time 5. 
Two female participants, one a charity fundraiser and the other a retail 
assistant, were only in a position to plan possible return to work at times 3 and
4.  This appeared to be due to improved self-efficacy in self-management sk
that appeared to ensue as a result of adjusting to their chemotherapy treatmen
and the associated symptoms.  Thus, as time passed, treatment and symptoms 
were becoming less
 (to a lesser degree); these women felt that realistically they could only 
study time frame): 
Yes hoping to return after chemo sessions completed– probably after Xmas.   
Participant 2, time 3. 
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Simil  
state  on future diagnosis and treatment.  
Furthermore, even though this participant expressed intentions to return to work 
throughout time points 1 to 5, he acknow
be out of his control: 
ic and I might find that circumstances dictate a delayed 
return to work or, indeed early retirement. 
eturning to work.  However, this will depend on my chemo 
  I am not ready to ‘finish’ / retire although I am in a position 
to do so. 
By time 5, despite the submission that this participant would be returning to 
work
on he
treat ns 
such
abilit ising albeit to a new job type: 
ay 
Consequently, even though some participants intended to return to work and 
tment, symptoms and 
arly, a 56-year-old male teacher who had withdrawn from work at time 1
d that returning to work was dependent
ledged that ultimately the matter may 
I am also being realist
Participant 1, time 1.  
I am thinking about r
and further operation.
Participant 1, time 2. 
I have to make a major decision as alluded to earlier.  I may not be able to return, 
because of chemo, until Jan 09.  I have been asked to consider early retirement 
based on ill-health. 
Participant 1, time 4. 
 for a short period of two weeks, he intended to apply for early retirement 
alth grounds due to an impending operation and further chemotherapy 
ment.  Despite this, he stated that he intended to consider other optio
 as voluntary work in the future, suggesting that self-efficacy beliefs in 
y to work were still prom
I intend to apply for early retirement on health grounds...At my age 56 I feel it m
be the right time to reflect on my work/life balance to return to an exhausting job 
after so much treatment may be too much to handle.  Instead I think other 
‘alternatives’ will prove more attractive: voluntary work, training to become a 
magistrate for example. 
Participant 1, time 5. 
had positive return to work self-efficacy beliefs, trea
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overall self-management skills served as barriers preventing a return
workplace.  Moreover, results suggest such barriers may have been most 
prominent early on during treatment when symptoms seemed more 
problematic. 
Self-Efficacy, Attitude and Self-Management Skills 
Attitudes towards work coupled with perceived self-efficacy and self-
management were also important when considering return to work intentions.   
Being able to work served as a marker of normality for all.  One 44-year-o
male wanted to return to work, thus, normality as soon as it was practicably 
possible.  However, as outlined in earlier results the impact of treatment and 
self-management of symptoms seemed superior to actual return to work 
intentio
 to the 
ld 
ns.  Similarly, a male teacher (45 years) wanted to re-immerse himself in 
his work as it provided an atmosphere and degree of discipline.  Further to this, 
a few
effectively (
necessary for stimulation and self-preservation.  Since having to take time to 
f 
 I 
participant who felt a return to work was the outcome she was striving for as it 
woul
a hectic life seemed to be the favoured 
perform well.  Additionally, this charity fundraiser’s high self-efficacy beliefs and 
return to work intentions appeared to be clouded by her treatment, in particular, 
 
 participants saw work as something that enabled them to function 
n = 5).  For example, a charity fundraiser expressed that work was 
recover a part-time retail assistant appeared to show a greater appreciation o
work: 
We all moan about work, but when it comes to sitting about at home I know
couldn’t put up with it for long!  Your brain starts to feel a bit fuzzy! 
Participant 7, baseline. 
Attitudes towards work were discussed in further diaries, particularly for one 
d help her and her family move forward from the cancer.  Moreover, having 
environment for this participant to 
she was finding the need to rest whilst undergoing chemotherapy problematic:
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I’m aiming for a return to work after Christmas – I need to get back into the world
of work.  I hate not being able to lead my normal hectic life.  Juggling is an art I’v
managed to master. 
Participant 2, time 5. 
With time it seemed that although work was an important aspect of their lives 
some participants (n = 4) were considering the implications of their cancer 
more realistic manner.  These participants (three females) appeared to 
shift in attitude by acknowledging the need to recognise the best way to 
manage and balance their health, well-being and work.  Similarly, at time 3, a 
56-year-old male teacher found the prospect of not teaching again ‘unsettli
after he had been asked to consider ill-health / early retirement.  However, this 
participant’s final diary suggests that this was something he had come to acc
but did not see this as the end of his working life.  Instead, he showed that h
felt he was more than capable (i.e. high 
 
e 
in a 
show a 
ng’ 
ept 
e 
self-efficacy beliefs) of turning his 
attention and skills to something new.  This change of direction and re-
ul 
 
 
ld 
ave 
evaluation of work was also apparent for a 45-year-old male teacher.  This 
participant stated that he was attempting to build a new sense of purpose via 
charity work he was participating in at time 2.  Such work was found to be 
rewarding as it felt as though he was doing something that was more purposef
and effective.  Hence, suggesting that in light of a cancer diagnosis and the 
experience of treatment the meaning of work and its importance may have
changed for some.  
Self-Efficacy and Self-Management of Work  
Section B of the diary was completed by participants who were working when 
the diary was completed.  In total, six participants completed this section as 
they were working at some point during the study.  At baseline, a 56-year-old 
male teacher, a 44-year-old female bank clerk, a 57-year-old female nurse and
a 47-year-old policy advisor continued to work after being diagnosed with 
colorectal cancer.  However, at time 1 all but one of these participants 
(participant 10) had to leave work due to the commencement of chemotherapy 
treatment.  Subsequent time points showed that three participants (58-year-o
female teacher and 45-year-old male teacher) two of whom were on sick le
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at baseline had managed to return to work at time 2.  First, participants 
asked to rate on a scale ranging from 1 to 10 (1 = not at all confident and 10 = 
totally confident) their perceived self-efficacy to do all the things necessary to 
manage their work.  Table 6.4 depicts mean perceived job self-efficacy value
according to time point.  Mean values at baseline (8.50; SD = 1.91) and time 1 
(9.00) show a small increment in perceived job se
were 
s 
lf-efficacy (Figure 6.3).  When 
compared with baseline, all time points suggest high perceptions of job self-
however, only one participant was working at time 1.  Despite only two 
participants (58 ar-old emale teac n ar-old po isor) working 
a  3, 4 an , mea  v
efficacy.  Of all participants working at e o rated th lf-efficacy 
h ith the ximu  score of ten c , one wom lt less able to 
 her wo  rating her self-effi s
Table  6.4:  Perceived self-efficacy in ability to self-manage work according to time point. 
      Work Self-Efficacy 
efficacy.  The only decrement was observed between time points 1 and 2, 
-ye  f her a d 47-ye licy adv
t times d 5 n alues suggest an improvement in perceived job self-
 bas line, tw eir se
ighly, w ma m .  In ontrast an fe
manage rk, cacy a  six. 
Time Point n   Mean  ± SD Range 
Baseline 4  8.50  ± 1.91 6 - 10 
Time 1 1                      9.00  9 
Time 2 3  8.66  ± 0.58 8 - 9 
Time 3 2  9.00  ± 0.00 9 
Time 4 2  9.50  ± 0.71 9 - 10 
Time 5 2   10.00  ± 0.00 10 
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Figure  6.3: Mean (SD) job self-efficacy according to time point. 
Different patterns of return to work and changes were seen amongst the six 
partic ly 
one p y duration 
(participant 10).  Results suggest that these individuals continued / returned to 
work because it served as a distraction and marker of normality.  In addition, 
described how being able to work made her
norm
from
expre have been 
because work was previously a distraction from the cancer, hence, the absence 
of this distraction may have forced her to acknowledge and confront the cancer 
her further described 
that being able to work may have enhanced his coping skills: 
ipants who were working at some point over the course of the study.  On
articipant managed to work throughout the entire stud
work adjustments that were offered and implemented by employers also 
appeared to facilitate work outcomes; in particular, for two participants who 
returned to work whilst undergoing chemotherapy treatment.    
Distraction and Normality 
All six participants viewed work as a welcome distraction from their cancer.  
Moreover, it served as a marker of normality.  A 44-year-old bank clerk 
 feel as though she was leading a 
al life.  However, in the same baseline diary this participant’s transition 
 working to taking sick leave due to surgery became apparent.  She 
ssed that her last day at work was emotional.  This may 
that she was faced with.  Another 56-year-old male teac
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It has given my week(s) structure and a clear purpose and I think it has helped
me cope with the spectre of cancer that lurks in the mind. 
Participant 1, baseline. 
Similarly, an appreciation for work was evident for the two participants who 
returned to work at time two.  The 45-year-old teacher was pleased that things 
were returning to normal.  Meanwhile, the high-self-efficacy beliefs of a 58-year-
old teacher seemed to reinforce her desire to return to work.  Furthermore, 
effective self-management skills (e.g. treatment management) that appeared to 
be associated with fewer symptoms seemed to lead to enhanced self-efficacy, 
thus, a drive to resume normality as early as possible: 
 
 to be managing the symptoms well…I returned to partial 
 it.  Pupils and staff are totally 
g to normal. 
er lunch break and more 
sitting.  Such changes were implemented to address symptoms of fatigue.  
How
work
throu
year-old teacher described how his phased return to work comprising of fewer 
hours enabled him to manage his work commitments and recovery (i.e. rest 
periods) in a satisfactory manner, which in turn appeared to help him 
ed tasks e.g. marking, preparation and 
administration without being under too much pressure both physically and 
, baseline. 
I seem to be tolerating the chemo very well indeed…I listen to my body and rest 
when I need to.  I seem
work on 10/11/08 and I’m thoroughly enjoying
supportive and I’m feeling that things are returnin
Participant 3, time 2. 
Work Adjustments, Self-Management and Work Ability 
At baseline, three of the four participants that were working described work 
adjustments had been made, for example, a long
ever, the most prominent adjustment made related to the number of hours 
ed (i.e. reduced hours).  A 47-year-old policy advisor who worked 
ghout described how she worked fewer hours each day.  Meanwhile, a 56-
psychosocially: 
It has allowed me to carry out work relat
emotionally.    
Participant 1
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In spite of this, this participant had to withdraw from the workplace at time 1 as 
chemotherapy treatment and symptoms such as fatigue became a barrier that 
preve s barrier 
was present even though this participant consistently showed high self-efficacy 
g 
me 3. 
The 
work
year-
Still get very tired…Working slightly less hours than normal and doing some work 
ork at 
me 
was only able to do half a day supply teaching each 
week as it was all he could manage.  Moreover, it appeared that problems with 
fatigue arising during the afternoon may hav
work more hours: 
lf ‘power napping’ a new phenomena.  Tiredness comes on 
fast in the pm – but half an hour’s nap sorts it out well. 
Participant 4, time 2. 
nted him from being able to continue with work.  Furthermore, thi
beliefs in relation to his self-management skills:  
Careful monitoring of diet to make sure it meets my needs – balanced and givin
me the energy levels to cope with chemo...Treatment tends to dictate my 
activities but I am trying to keep myself occupied to avoid boredom and dwelling 
on my ‘situation.’ 
Participant 1, ti
introduction of work adjustments suggests that decrements in perceived 
 ability were inherent within the sample.  This was even the case for the 47-
old female who worked throughout: 
from home. 
Participant 10, time 2. 
However, by time 5 this participant’s work ability appeared to have improved: 
No problems at all – back to full strength…No adjustments necessary. 
Participant 10, time 5. 
A 45-year-old teacher who was on sick leave at baseline returned to w
time 2.  This was because this participant felt that his treatment had beco
more stable.  However, he 
e prevented him from being able to 
Returned to half a day a week of supply teaching although wearing – not as tiring 
as before.  I find myse
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Similarly, for a 57-year-old nurse, work adjustments appeared to be in pla
combat decrements in perceived work ability.  This participant exhibited lower 
perceived self-efficacy beliefs about managing her work when compared with 
her pre-cancer work ability.  In particular, the woman explained that she had to 
finish work early to manage symptoms of fati
ce to 
gue that surfaced during the 
afternoon, hence these symptoms negatively impacted work ability at baseline.  
Time ue to 
a red
mana
participant leaving work:   
o fix definite days as chemotherapy at short notice...Tired. 
The two participants (both teachers) that
described how they had reduced their hours.  One of these provided details of 
her partial return to work that had been implemented because of her positive 
able to carry 
ties.   
Participant 3, time 3. 
 2 results for this participant suggest that decrements in self-efficacy d
uction in perceived self-management skills (i.e. poorer symptom 
gement) resulted in reduced work ability that eventually led to this 
Tired by afternoon so finishing 1 ½ hours earlier than usual. 
Participant 9, baseline. 
No (intentions to return to work).  My work consists of seeing patients with 
appointments.  Unable t
Participant 9, time 2. 
 returned to work at time 2 also 
self-efficacy beliefs in managing her work and her cancer.  Being 
out work tasks from home was also helpful: 
Going back to work part-time.  I’ve returned to school for my exam classes. 
(oncologist’s name) said that he’d be guided by me and as I’ve felt well enough 
I’ve embarked on a partial return to work...I prepare work at home and my 
marking here also. 
Participant 3, time 2. 
I am only going in for my exam classes so if I have an 8.45 hour lesson  
followed by an 11.25 hour lesson, I come home in between (only 1.7 
miles away).  My second in department has taken on some of my Head of  
Department du
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I continue to work 13 out of the 20 lessons I would be doing when working full-
time and this is going very well. 
Participant 3, time 4. 
Self- ent and Perceptions of Work Ability  
Perceptions of work ability were discussed by all participants at some point 
l 
s with tasks able to concentrate on work which 
d hours.  More relaxing lunch break.  More 
 
eemed 
Efficacy, Self-Managem
during the study.  The subject was touched upon by participants who were able 
to work at some point over the study duration.  In contrast, for those who were 
on sick leave, work ability was discussed as a barrier preventing return to work 
even in the presence of high return to work intent.  Those who were working at 
baseline (n = 4) felt unable to perform in the same manner prior to colorectal 
cancer.  In response to diminished work ability, three of these individuals 
reduced their hours to deal with symptoms of fatigue or to avoid undue physica
pressure.  For one of these participants, decrements in physical work ability led 
to diminished self-efficacy levels whilst at work, however, mental work ability 
was not impaired: 
Not so confident as before (at work).  Tired by afternoon so finishing 1 ½ hours 
roblemearlier than usual.  No p
keeps my mind off illness... Reduce
sitting.   
Participant 9, baseline.  
For those not working (n = 6), differences in work ability were evident at 
baseline.  For example, a 51-year-old female rental car assistant who was 
awaiting another operation (stoma appliance reversal) was considering 
returning to work on a part-time basis, as she felt that her current work ability 
was impaired when compared with her prior capabilities.  However, being able
to do so was contingent upon whether her employer would allow it.  Three 
others anticipated that treatment effects may impact work ability, even though 
they expressed a desire to return to work.  Alternatively, others (n = 3) s
to exhibit high levels of self-efficacy in their work ability; one participant had 
managed to continue with some work whilst officially on sick leave: 
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I feel well and am eager to return to work...I’ve prepared lesson plans for my 
ristmas. 
Participant 3, baseline. 
Further diaries showed that changes in perceived work ability seemed to be 
large , a 44-year-old bank 
clerk was unable to sit for long periods of time.  This therefore prevented her 
d.  
Participant 9, time 2. 
Two participants, both teac
at tim
work
teach
symptoms of fatigue.  This participant admitted that in time he was confident 
that he would be able to increase his hours if required.  Hence, suggesting that 
he felt that his work ability would improve over time as he made a full recovery.  
d 
exam classes until Ch
ly associated with treatment effects.  Due to surgery
from returning to work as her job involved her sitting for long periods of time.  
However, this participant was aware that this was a temporary issue.  Six of the 
seven participants that completed more than one diary showed differences in 
perceived work ability over time.  These changes appeared to be associated 
with chemotherapy treatment.  For example, at baseline a nurse who was 
awaiting chemotherapy treatment was able to work.   However, at 1 she was on 
sick leave as she felt unable to perform her job as her treatment led to 
unpredictable symptoms that in turn led to decrements in her perceived work 
ability.  At time 2, symptoms worsened and the cancellation of treatment 
impacted this participant’s work ability further.  As a result, she showed lower 
levels of self-efficacy in her ability to return to work: 
Some days feel well and think I could go to work.   
Participant 9, time 1. 
My work consists of seeing patients with appointments.  Unable to fix definite 
days as chemotherapy at short notice.  Difficult to concentrate.  Sore fingers 
unable to handle certain items or write properly.  Tire
hers, had managed to embark upon a return to work 
e 2.  However, the nature of their return suggested that their perceived 
 ability differed.  A 45-year-old male had returned to half a day of supply 
ing as this was deemed manageable in relation to his treatment and 
Another 58-year-old teacher also believed that once treatment was complete
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she would make a full recovery, thus in turn her work ability would gradually 
improve and be comparable with pre-cancer levels.  This teacher had returne
to work partially (13 / 20 classes only) whilst undergoing treatment, hence 
indicating that treatment impacted work ability.  It was apparent from succes
diaries that this participant was gradually increasing her workload in response to
perceived work ability increm
d 
sive 
 
ents that resulted from her effective self-
management skills.  Consequently, results infer that high self-efficacy beliefs 
k and cancer strengthened over time, 
 
ple it appears that self-efficacy beliefs in ability to 
manage treatment effects may have impacted perceptions of work ability, hence 
se who experienced more symptoms and / or 
 as the 
Self-
The ial support received was described by all participants at 
baseline.  Of the seven participants who completed more than one diary, the 
majority (n = 6) consistently mentioned support received which was particularly 
displayed in relation to managing her wor
which may have led to such positive work outcomes: 
I have continued to have confidence about managing my condition! My symptoms
have continued to be minimal and I’ve used gloves and bed socks to prevent 
tingling.  I’ve managed my diet laid down in diary 5 and I feel I’m eating healthily 
but being careful about eating anything too spicy...I continue to work for 13 out of 
the 20 lessons I would be doing when working full-time and this is going very very 
well! 
Participant 3, time 5. 
Therefore, within the sam
return to work intentions.  Tho
seemed unsure about how to manage them in the context of their work were 
unsure about when they could return to work.  Alternatively, those such
two teachers who did return to work showed that they were in a position to 
confidently manage their symptoms, thus had better perceived work ability and 
therefore returned to work.   
Efficacy and the Role of Support 
nature of soc
important when attempting to understand participants’ self-efficacy beliefs.  
Moreover, such support was provided by various sources, including family and 
friends, health professionals and employers.  Reflecting on these social support 
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networks suggested that they were immensely valued by most of the sample.  
Furthermore, the results suggest the role of support appears to be important in 
relation to self-efficacy beliefs and intentions to return to work and perhaps even 
perce
Fam
The rticipants described how they had drawn upon support 
from their network of family and friends at baseline.  In particular, one 
 
led 
management during chemotherapy at time 3 as this 
was when her energy levels were lowest.  This was also the case for a 48-year-
old female charity fundraiser who found 
o cope well.  I have a wonderful family and fantastic 
friends who have been so supportive. 
For t
enhance s
teacher found her friends accompanying her to chemotherapy sessions and 
other appointments helpful, even though she felt able to attend them alone (time 
3).  Similarly, the 56-year-old male teacher described how such support helped 
him to feel confident.  Additionally, the presence of a positive support network 
ived work ability.   
ily and Friends’ Support 
majority (n = 5) of pa
participant described the relief he and his wife felt after informing close family 
and friends of his cancer.  The potential benefit of such support upon perceived
self-efficacy in relation to self-management was also apparent: 
Their support has been invaluable and made us feel very positive as to what the 
future holds. 
Participant 1, baseline. 
Such support was sustained and evident in subsequent diary entries.  Four 
participants touched upon how support from family and friends had enab
them to feel positive.  A part-time retail assistant felt that support from family 
members helped her self-
chemotherapy challenging at time 5: 
Night before chemo I feel very low and question whether I should proceed with 
the course because I know the pattern by Friday I will feel Yuck!  Generally I’m 
very positive and able t
Participant 2, time 5. 
wo participants, both teachers, such positive support networks appeared to 
elf-efficacy beliefs favourably.  For example, the 58-year-old female 
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appe
self-e
supp ive impact of 
chemotherapy treatment and symptoms by enhancing self-efficacy beliefs and 
ood 
me more important to five participants 
as treatment progressed: 
My routine has been in place from the start and I’ve stuck to it pretty well. Family 
 Their support has really helped.  
Participant 7, time 3. 
elf-
y 
Emp
The 
participants
ared to be associated with more favourable return to work intentions and 
fficacy beliefs.  More importantly, for these two teachers the presence of 
ort from various sources may have buffered the negat
self-management skills:  
Very confident (managing cancer) with help of family, medical staff and friends. 
Participant 1, time 3. 
The role of support in relation to the management and maintenance of a g
diet and help with household tasks beca
At home, my husband retired at Christmas so he keeps many of the household 
tasks done by hovering through, tidying up...as well as doing most of the cooking 
which he really enjoys.  This just leaves me with washing, drying and ironing 
clothes...We’re a good team and I really enjoy keeping my house the way I want it 
and he really helps. 
Participant 3, time 3. 
have had to help a bit more especially week of chemo because that is when my 
energy levels are worst.
Therefore, the role of support from family and friends appeared to enhance s
efficacy beliefs over time.  Results indicate that those with a supportive 
environment such as help with household chores and diet were confident in 
their cancer self-management skills.  As a result, these participants, especiall
the two teachers (58-year-old female and 56-year-old male) consistently 
expressed intentions to return to work. 
loyer Support 
level of support received from their employer was touched upon by seven 
 at baseline.  Those receiving positive levels of support commented 
 164
Chapter 6 Diary Study 
 
upon the reactions of colleagues.  For instance, one participant wanted to show 
thanks and respect to those at work for being very decent in their reaction.  As a 
 
itment. 
as due to a supportive employer who made 
work adjustments such as reduced hours or a phased return to work, which 
enab ick leave 
(at b  had been able to liaise with school to prepare and 
mark work for her exam classes.  In this case it seemed that this individual’s 
 
The role of employer support also seemed important when attempting to 
unde
old s k 
state
Conv rticipant who worked full-time prior to diagnosis was 
contemplating returning to work on a part-time basis but was unsure whether 
her employer would be supportive: 
 
hen 
employers maintained contact whilst they were on sick leave.  For instance, a 
response to this, one of the reasons for him wanting to return to work as a
teacher was due to an obligation he felt to honour his contract commitment: 
I am on sick leave and would like to return: to honour my contract comm
Participant 4, baseline. 
Three others acknowledged that it w
led them to continue to work.  Alternatively, a female teacher on s
aseline) stated that she
high perceived self-efficacy enabled her to continue with such tasks and may 
have been noticed and thus facilitated by her employer: 
I’ve continued to set work and mark all of my examination classes’ work.  I’m in
regular contact with my second in department and she checks things out with me 
on a regular basis...My head is more than prepared to bring in a phased return to 
work until all of my treatment is finished. 
Participant 3, time 2. 
rstand two participants’ return to work intentions.  For example, a 47-year-
enior manager who was awaiting further treatment hoping to return to wor
d that he felt he would be fully supported in this by his employer.  
ersely, another pa
I may go back to work on a part-time basis if allowed, by my employer. 
Participant 6, baseline. 
Support from employers and colleagues was received throughout the study by
five participants.  At the most basic level these participants felt supported w
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58-year-old teacher on sick leave at time 1 mentioned that being in constant 
contact with her colleagues and head teacher made her feel well supported.  A 
charity fundraiser who was keen to get back to work disclosed that her 
employer allowed her to do what she could (from home) although officially on 
sick leave.  Such support may have benefited her sense of self-worth and self-
estee
ave – doctor’s notes submitted, but I have negotiated with 
my manager what I can do if and when I feel well enough.  This makes me feel 
d 
 
tly, 
se to this their employers suggested possible work adjustments that 
could be introduced to aid their return to work process.  Such advice was 
provi
emba t 
poss  
unde : 
turn to a partial return to work in late November, for exam classes 
 hope to return full-time in February after chemo. 
Participant 3, time 1.   
as 
ay 
 
k 
m: 
Officially I am on sick le
useful and still in touch with the ‘real world.’  This agreement is very flexible an
regularly reviewed. 
Participant 2, time 2.   
Three female participants’ experiences showed how the nature of employer 
support changed according to the stage of treatment (and overall cancer 
journey).  As treatment progressed, it was apparent that these individuals were
beginning to consider when they could possibly return to work.  Consequen
in respon
ded as early as time 1 for a 58-year-old teacher, who subsequently had 
rked upon a phased return to work at time 2.  Even though this participan
essed high return to work self-efficacy beliefs, it seemed that having to
rgo chemotherapy treatment resulted in a partial return in the first instance
I have to re
while still on chemo.  I
The importance of support upon self-efficacy in relation to ability to return to 
work was apparent for a retail assistant who had received surgery and w
undergoing chemotherapy.  At time 2 this participant envisioned that she m
encounter problems returning to her role that involved being on her feet and on
the shop floor throughout her shift.  Therefore, suggesting this participant’s 
levels of perceived self-efficacy in her ability to perform her job had decreased.  
In contrast, at time 3 increased levels of employer support in the form of wor
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adjustments seemed to lead to improvement in return to work self-efficacy 
beliefs: 
My manager has been in touch and said that I can work in the office for a bit if I 
want. This would be great because I know I would find going back on the sh
floor too much. So this is an option in a couple of months or so. I’ve always 
worked part-time anyway so this would work out well for me too. My co-workers
have also been in touch which has been nice as it keeps me in the loop o
going on. 
Participant 7, time 3. 
op 
 
f what is 
In sum, employer support revolved around work adjustments.  Work 
 to the employee’s high return to 
ose 
 
etter position to plan a 
potential return).  Differences between employers / organisations were apparent 
thoug
teach y 
as early as time 1.  In contrast, others who wished to return but were concerned 
about their work ability did not seem to be aware that their employer was 
g 
adjustments were introduced as a response
work self-efficacy beliefs and perceived work ability for some.  This was 
particularly apparent for one participant who was confident in her ability to 
return to work whilst undergoing chemotherapy treatment.  Similarly, for th
on sick leave some employers began to suggest work adjustments including a
temporary amendment to a job role and flexible working towards the latter time 
points of the study (i.e. when participants were in a b
h.  For instance, the two participants that returned to work were both 
ers whose employer appeared to draw upon and follow organisation polic
required to offer reasonable adjustments, such as a female participant who was 
concerned about managing her stoma whilst at work.  A finding that indicates 
that some employers may lack the necessary knowledge regarding the 
management and support that should be provided to employees affected by 
cancer.   
Health Professionals’ Advice and Support 
The support provided by health professionals predominantly related to cancer-
specific information as opposed to work-related support, such as following a 
particular diet, taking time to rest and recover (at baseline) and regardin
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treatment.  Such advice seemed to help some participants to understand th
nature of their disease and therefore enhanced their self-efficacy which enable
them to feel confident about managing their cancer: 
e 
d 
Once I have been informed / learnt what is required of me, I have been confident 
dvice 
Alternatively, when considering the role of support in relation to work matters 
 
t she had 
 a 
rapy 
Results after baseline showed that another two participants received / sought 
work-related advice.  At time 4, a part-time retail assist
chemotherapy was contemplating a return to work; however, she stated that 
she would not return unless it was approved by her oncologist.  Alternatively, a 
44-ye  her 
gene ht weeks.  As a result, 
and able to manage my illness and symptoms...Followed guidance and a
given by medical team. 
Participant 8, baseline. 
baseline results show only one participant had received work-related guidance
from their health professional; this participant, a teacher, described tha
been warned of the risk of infection associated with her impending 
chemotherapy treatment.  Consequently, she stated that she would take the 
advice of her consultant prior to returning to work regardless of her own 
perceived work ability.  Subsequent support received from her oncologist 
coupled with her own perceived self-efficacy beliefs in her work ability enabled 
her to resume work at time 2.  Moreover, diaries indicate that there had been
temporal change in the nature of this participant’s relationship with the 
oncologist, in that, compared with baseline she was in control of her work 
decisions.  Therefore, results suggest that this participant’s high levels of self-
efficacy in relation to return to work coupled with her minimal chemothe
effects may have enabled this change to occur: 
I asked Dr (oncologist name) if I could return to school sometime in late 
November while still on chemo to deal with exam classes.  He said he was ok 
with this and would be guided by me. 
Participant 3, time 1. 
ant undergoing 
ar-old bank clerk who had received surgery alone disclosed that
ral practitioner had ‘signed her off’ for a period of eig
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this may have led to this participant assuming that an earlier return would not be 
possible.  Therefore, even though the majority of participants exhibited high 
self-efficacy beliefs in relation to r
importance on the guidance rece
their care.  Consequently, 
self-b   It was apparent that these 
indiv opardise their cancer management or recovery.  
For instance, one woman was waiting for an appointment which would provide 
ot do 
ave 
able to return to work) – awaiting outpatients 
appointment to discuss options and follow up treatment. 
 thinks that I should be wary about returning before 1/2/09 
(last date of chemo) due to the risk of infection.  I am hoping that, if all goes well, I 
 
hough as I do not want to do 
.  
-
ts 
eturn to work intentions, a few placed greater 
ived from health professionals associated with 
this advice / opinion appeared to override their own 
eliefs in their ability to return to work.
iduals did not wish to je
her with the opportunity to discuss her options, whereas a 58-year-old teacher 
stated that although she felt well and eager to return to work she would n
so until her consultants said she could, particularly as her immune system may 
be weakened as a result of chemotherapy:   
When my sick note expires / well being is better (return to work intent).  H
been signed off for 8 weeks. 
Participant 5, time 1. 
Not known as yet (when 
Participant 2, baseline. 
The cancer specialist,
might be able to go back to my exam classes before that and return fully after my
doctor’s advice on this, tlast chemo – I will take 
anything to stop my complete recovery. 
Participant 3, baseline. 
These results suggest that understanding participants’ relationships with their 
health professionals is essential.  This relationship may have influenced 
participants’ perceived self-efficacy, work ability and return to work intentions
Moreover, for some participants such support may have led to a degree of over
reliance upon health professionals.  This is further supported by the findings 
that for a few participants, high return to work self-efficacy beliefs were 
overridden by health professionals’ opinions.  In other words, these participan
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may 
healt
tter and quite eager to go back. I need to get the ok from my 
lf-
e 
ult 
All in 
anised’ manner i.e. limiting visits has 
kept up my spirits.  I visited work to see colleagues and pupils – this was an 
efully has helped. 
have been waiting to receive the go ahead to return to work from their 
h professionals: 
I do have every intention to go back to work. However at the moment the 
oncologist has advised me not to at least until later on into my treatment.   
Participant 7, time 1. 
I’m feeling much be
oncologist first though as recovery comes first. 
Participant 7, time 4. 
Overall, when attempting to understand the role of support in relation to se
efficacy beliefs, results suggest that the amount and sources of support may b
important.  For example, four participants, including two teachers, a retail 
assistant and a nurse all received positive levels of support from family and 
friends, employers (including co-workers), and health professionals as a res
appeared to exhibit the most favourable self-efficacy beliefs in relation to the 
management of their cancer and work outcomes.  Therefore, for these 
participants the presence of support from a wide network of individuals may 
have led to better perceived self-efficacy beliefs:  
Diet has been fine – we eat healthy anyway and my wife has been superb.  
all very confident about ‘managing’ and feeling very positive about my current 
situation...Seeing friends/family in an ‘org
uplifting experience.  Not becoming bored, by filling time us
Participant 1, time 2. 
6.4. Discussion 
The purpose of this study was to explore whether self-efficacy beliefs impacted 
self-management of cancer and return to work intentions over time.  More 
importantly, the six month study period enabled temporal fluctuations and 
factors such as support, treatment and work ability that impacted upon these 
beliefs to be identified.  As far as the researcher is aware the role of self-
efficacy has not previously been considered in existing cancer and work-related 
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studies.  The results from this study indicate that it is a factor that wa
consideration when investigating work outcomes of those affected by cancer.  
When attempting to understand how these colorectal cancer patients were 
managing their cancer and return to work the results indicate that the role of 
perceived self-efficacy beliefs was diverse.  Therefore, the role of self-efficacy 
and factors impacting upon these beliefs (e.g. support) is somewhat complex.  
Consequently, based upon the study results, this section aims to map t
impact of cancer self-management self-efficacy upon self-efficacy in relation to
work including return to work intentions.   
rrants 
he 
 
ent the 
e 
 
f the seven participants that completed two diaries or 
more, one worked throughout the entire study duration and two had 
pletion of their third diary.  This is in line 
 
 
e, even 
ts 
k self-
The Relationship between Cancer and Work Self-Efficacy 
Results suggest that self-efficacy beliefs were important in understanding work 
outcomes and return to work intentions.  Indeed, like cancer managem
role of such beliefs was multi-faceted and influenced by various factors.  At th
start of the study four participants were working.  However, at time 1 all but one
of the participants was on sick leave to recover from surgery and / or manage 
chemotherapy treatment.  Such findings are consistent with both qualitative 
(Morrell & Pryce, 2005; Kennedy et al., 2007) and quantitative research 
(Bradley et al., 2005; Bradley et al., 2006; Pryce et al., 2007; Amir et al., 2007; 
Short et al., 2005).  O
successfully returned to work upon com
with Bradley and colleagues’ (2006) suggestion that cancer patients take at 
least one month off from work following diagnosis and treatment.  However, this
was not the case for the remainder of the study sample.  In evaluation, this may
be due to different cancer types being utilised in their study.  Furthermor
though the majority of participants were treated with both surgery and 
chemotherapy, which is not dissimilar to other cancer types, treatment effec
and altered bowel habits / symptoms are likely to differ.   
For those that were working at some point during the study (n = 6), mean work 
self-efficacy scores decreased slightly between time 1 (9.00) and time 2 (8.66), 
although still indicative of high levels, this may have been due to the 
commencement of chemotherapy treatment.  In spite of this, mean wor
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efficacy values increased and stabilised between times 2, 3, 4 and 5 (8.66 vs. 
9.00 vs. 9.50 vs. 10.00).  Therefore, although these colorectal cancer patients 
may encounter initial problems at work, perhaps some more so than others, 
with time research suggests cancer patients’ performance is comparable if not 
better than those without a history of the disease as suggested by Bradley and 
Bednarek (2002).    
e 
 
 a 
 
is 
 
t 
ce 
Similarly, increased symptom burden such as sore fingers, diarrhoea and 
nausea coupled with fatigue resulted in poorer self-efficacy in ability to resume 
work.  Additionally, those reporting more symptoms appeared to have a more 
negative psychological outlook.  Hence, these participants exhibited the most 
temporal fluctuations in both cancer and work-related self-efficacy beliefs.  
Therefore, in support of research suggesting that a more profound detriment is 
seen in those reporting more symptoms (Short et al., 2005; Bouknight et al., 
2006; Taskila et al., 2007).  Moreover, these findings indicate that some of 
Return to Work Intentions and Barriers 
Intentions to return to work were expressed by all that were not working at som
point during the study regardless of age and gender.  Participants expressed a
desire to return to work as it served as a marker of normality that gave them
sense of purpose.  This notion of being able to work in order to resume 
normality is well documented in the literature (e.g. Kennedy et al., 2007).  
However, results infer that several factors seemed to impact return to work 
intentions and self-efficacy.  Treatment (chemotherapy, fatigue and other 
symptoms) and decrements in perceived work ability were identified as the most
prominent factors.  Fatigue was the most commonly reported symptom, which 
corroborated by previous research (Spelten et al., 2003).  Self-efficacy beliefs in
relation to managing such symptoms differed between participants.  Some 
participants were confident in their ability to manage these symptoms 
successfully whilst maintaining work compared with others.  Alternatively, such 
differences may have arisen because fatigue was perceived differently or, tha
some participants experienced more pronounced levels than others (Lawren
et al., 2004).  The former suggestion may perhaps be supported by lower self-
efficacy levels seen in those who perceived fatigue as most troublesome.   
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these factors appeared to serve as barriers to return to work.  Figure 6.4 
illustrates a model based upon some of the study findings.  The premise is that 
at the most basic level self-efficacy beliefs may have impacted return to work 
intentions.  Therefore, as self-efficacy increased, return to work intentions also 
appeared to improve.  However, the impact of self-efficacy is unlikely to be so 
simplistic. Instead, high levels of self-efficacy and return to work intentions may 
have been overridden by barriers such as treatment and self-management skills 
that appeared to be associated with how symptoms impacted the individual.  
For some, chemotherapy treatment appeared to lead to symptoms such as 
fatigue which were difficult to self-manage.  Hence, these were return to work 
barriers even though the intention to return and high self-efficacy beliefs were 
expressed. 
 
 
even those who wished to return to work felt unable to fulfil the role.  
Return to work 
intentions 
Self-efficacy 
 
Impact of symptoms 
 
Barriers & 
Facilitators 
 
Self-management 
skills 
 
Work ability 
 
Treatment 
cy 
 
Low self-effica
Figure  6.4: Return to work barriers. 
 
Similarly, the impact of symptoms influenced perceived work ability.  The more
negative symptom impact the worse perceived work ability was.  Therefore, 
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Alternatively, for others, low perceived self-efficacy beliefs themselves serve
as a barrier.  For example, those with unpredictable symptoms were less 
confident in their ability to self-manage, thus return to work. 
Return to Work Intentions and Work Ability 
More importantly a degree of disparity between return to work intent and 
perceived work ability was evident early on.  The level of disparity was fu
exacerbated in those undergoing chemotherapy treatment some point after 
baseline.  Even though participants wished to return to work and some even
managed to work, it was widely acknowledged that perceived work ability 
dissimilar to pre-cancer levels.  Furthermore, treatment, particularly receiving 
d 
rther 
 
was 
more than one treatment modality, led to a greater decline in perceived work 
 
ld be 
 
, 12 
 
al. 
 
 of 
ability and less likelihood of resuming work.  Such decrements in perceived 
work ability (Short et al., 2005; Gudbergsson et al., 2006; Kennedy et al., 2007) 
and the impact of treatment upon this have been well documented in prior 
research (de Boer et al., 2008; Amir et al., 2007).  However, some of these 
studies followed patients who were at least one year post diagnosis (ranged
between 1 – 10 years) (Gudbergsson et al., 2006; Kennedy et al., 2007).  
Therefore, the current study is useful in that it offers an insight into how 
perceptions of work ability may be impacted soon after diagnosis and during 
treatment (i.e. early stages).  However, it is acknowledged that it wou
beneficial to further follow-up these results (qualitatively) to consider how
perceived work ability compares with existing quantitative research findings.   
In addition, it is worthwhile to discuss the findings reported by de Boer et al. 
(2008), who followed patients from 6 months after their first day of sick leave
months and 18 months after their first day of sick leave.  This is perhaps the
most relevant in terms of the current study’s time frame.  Unlike de Boer et 
(2008) who reported an improvement in work ability over time, this study’s 
results suggest that negative impacts upon work ability were apparent once 
chemotherapy had commenced (i.e. first and second sessions) and appeared to
improve only after participants had adjusted to their treatment.  The richness
the data enables one to further argue that soon after chemotherapy 
commenced, self-efficacy beliefs were also negatively impacted due to 
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symptoms that had surfaced.  In spite of this, return to work intentions remained
positive on the whole.  Within the context of de Boer et al. (2008) this finding is 
incredibly useful.  In other words, existing research indicates that work ability is 
likely to improve over time.  Coupled with this, by exploring work ability and 
perceived self-efficacy soon after diagnosis this research suggests that the 
likelihood of decrements in both could occur soon after chemotherapy has 
commenced.  Therefore, this may be the most worthwhile time point to offer 
some form of intervention, particularly for those undergoing chemotherapy.  
This is further supported by the finding that perceived work ability appeared to 
improve soon after participants receiving chemotherapy l
 
earned how to self-
manage treatment effects.  Hence, over time self-efficacy beliefs improved 
isparity between return to work intentions and 
s 
ed 
l 
eline 
of 
ith 
 
ed.  As 
leading to a lessened degree of d
perceived work ability.  Additional factors may have also played a role such as 
the participant’s personality.  For example, those who managed to work during 
treatment may have always possessed a positive work ethic.  Thus, even if thi
disparity between perceived work ability and work intentions was apparent it 
may have been to a lesser degree.  Alternatively, the type of job may have been 
important.  For instance, it is quite likely that an individual with a manual job 
requiring physical effort will have lower levels of work ability when compar
with an individual in an office based role.  However, both may still have high 
return to work intent, but the former would find it difficult to resume their manua
role.  Consequently, it is important to unpick this further. 
Social Support and Self-Efficacy 
Support from employers was deemed important to most participants at bas
and the presence of support appeared to enhance self-efficacy.  The majority 
participants received support throughout the six month study period.  As w
previous findings, it was found that both emotional and practical support was 
received from employers and colleagues (Kennedy et al., 2007) and it appeared
to be beneficial (Sapp et al., 2003; Michael et al., 2002; Jackson et al., 2007).  
Participants felt this support kept them in touch with the ‘real world’, thus 
subsequent return to work intentions appeared to be positively reinforc
treatment progressed the support was of a more practical nature.  Employers 
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made work adjustments for employees such as working fewer hours
facilitated a phased return to work, something that has previously been rep
(Maunsell et al., 1999).  In contrast, regarding the role of health professionals 
the findings are insightful.  Less than a third of participants received work-
related advice / guidance.  Most received support regarding their cancer and
treatment management alone.  Alternatively, very little or no support was 
received in relation to work matters. Previous studies also report that cancer 
patients rarely discussed work issues with their health professionals (Maunsell 
et al., 1999; Main et al., 2005; Kennedy et al., 2007).  Moreover, those who di
receive such advice sought it themselves.  It may be the case that some healt
professionals such as oncologists believe cancer patients undergoing 
chemotherapy treatment will be unable to continue to work during treatment.  
Therefore, patients may also assume that they are unable to work.  
Alternatively, it has been suggested that experiences differ from patient to 
patient; therefore, it would be difficult to offer such advice (Mock, 1998).  This is
a matter that will be investigated further in the following chapter.  Base
the overall findings regarding self-efficacy in relation to the cancer itself and 
work Figure 6.5 shows the most favourable outcome as indicated by the res
obtained in this study.  In short, those who possessed 
 or 
orted 
 
d 
h 
 
d upon 
ults 
the highest self- efficacy 
levels in relation to their cancer and work experienced fewest symptoms, hence 
 more promising psychological outlook compared with those with lower self-
efficacy levels.  Self-efficacy beliefs were further enhanced by having a wide 
cial support network comprising of family and friend, employers and health 
professionals.  Therefore, the more support an individual had the greater the 
pact on self-efficacy beliefs.  As a result, this led to the increased likelihood of 
returning to work as indicated by return to work intent and better perceived work 
bility over the study period.  However, in comparison those with less support, 
in particular, fewer sources of support (e.g. only family and not health 
y have encountered problems with self-
anagement, thus, more negative self-efficacy beliefs and less favourable 
return to work intentions. 
 
a
so
im
a
professionals and / or employer) ma
m
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ed within three months.  In line, with 
so reported a difference according to 
treatment type, whereby less favourable quality of life outcomes were seen in 
 impact 
ity 
d 
n 
 
Support from various 
sources 
 
Family and friends 
Employer 
Health professionals 
 
 
 
 
 
 
Figure  6.5: Summary of relationship between cancer self-efficacy and work self-efficacy
and factors impacting upon these. 
Self-Efficacy and Quality of Life 
The findings contribute to existing quality of life research, in particular to studies 
comprising of those affected by colorectal cancer (Karadjova, Shiskov & Petrov, 
2007; Tsunoda et al., 2007).  For example, Tsunoda et al. (2007) assessed 
quality of life each month after surgery for a year.  Quality of life outcomes 
decreased in five domains in the month after surgery when compared with pre-
operative scores.  However, scores improv
the current study these researchers al
those receiving chemotherapy treatments compared with a non chemotherapy 
group.  Furthermore, the findings from this diary study make it feasible to 
suggest the possible role of self-efficacy within this area.  Self-efficacy may 
have a direct impact upon quality of life outcomes, however, it may also
how symptoms and treatment are perceived which in turn could impact qual
of life / psychosocial adjustment / work outcomes.  Kreitler, Peleg and Ehrenfel
(2007) support this further as they reported a direct impact of self-efficacy upo
 
 
High return to work self-
efficacy 
 
 
Treatment type(s) 
 
Fewer symptoms 
 
Positive psychological 
well-being 
Return to work 
 
Higher return to work 
High cancer self-
management self-
efficacy 
 intentions   
Better perceived 
work ability 
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quality of life and an indirect impact (i.e. self-efficacy impacted perceived
thus quality of life).   
Limitations 
There are some limitations of the diary study.  In the first instance, a de
response bias may have been inherent.  Those possessing positive self-ef
beliefs may have opted into the study due to these beliefs.  However, if this was 
the case it 
 stress, 
gree of 
ficacy 
could be argued that participants would have shared similar 
experiences.  Additionally, the results highlight that experiences cannot be 
lely upon self-efficacy beliefs.  Instead, the findings have 
work 
r, 
py) 
a was 
 
ing 
cts) 
alth professionals may 
also be crucial, particularly, in relation to understanding how participants 
understood based so
identified the complex nature of how self-efficacy beliefs, thus return to 
intentions / employment outcomes may be impacted by factors such as 
symptoms, treatment, level of support and perceived work ability.  Moreove
the findings suggest that for some even when high self-efficacy and return to 
work intentions are present, barriers to work (e.g. fatigue and chemothera
can take precedence over these beliefs.  It was unfortunate that some 
participants failed to complete more than one diary (n = 2).  However, the 
overall response rate (72%) was still promising and the richness of the dat
insightful. 
6.5. Summary 
Overall, findings from this study suggest that the role of self-efficacy in 
understanding the management of colorectal cancer, work ability and return to
work intentions is important.  Furthermore, as indicated by the results, the 
nature of this impact is likely to involve additional factors.  Therefore, support
the notion that self-efficacy is unlikely to operate alone as a mechanism 
governing human behaviour (Bandura, 1997).  In the first instance, it seemed 
that the more treatment effects experienced led to reduced self-efficacy and 
prevented most from returning to work because of diminished work ability 
during.  However, this was not applicable to the entire sample as some 
possessed high self-efficacy beliefs to manage treatment (including its effe
and resume work.  Instead, external factors such as he
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perceived their work ability.  For instance, some participants may have been 
under the impression that they were unable to work during treatment due to a 
lack of work-related advice / guidance received from their associated health 
rk 
intent and work ability.  The majority of participants expressed a desire to return 
to work; however, decrements in perceived work ability seemed to prevent a 
ay have been useful to introduce temporary work 
adjustments for those wishing to work.  However, a lack of knowledge on the 
professionals.  This is further supported by the disparity between return to wo
return.  At this point, it m
part of the participants to request reasonable adjustments that they were 
entitled to from employers may have been apparent.   
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Chapter 7 
 
7. Exploring the Role of Health Professionals: An Interview 
Study 
7.1. Introduction 
When attempting to understand cancer patients’ perceived work ability and 
return to work intentions it is important to consider the role of health 
professionals associated with their care.  These health professionals are likely 
to include consultant surgeons, specialist nurses, oncologists and general 
practitioners.  In addition, working-aged patients may also be referred to an 
appropriate occupational health professional associated with their employer
however, 
; 
this facility is not always available.  Chapters 4, 5 and 6 sought to 
provide an understanding of the work ability, return to work intentions and 
 
 
to 
n relation to their perceived work ability and employment 
outcomes.  The results from the diary study presented in Chapter 6 identified 
the
efficac
finding of the diary study was the variation in work-related advice and guidance 
pro  role 
of health professionals, with a view that this, together with findings of Chapters 
etter inform future interventions to support cancer patients.   
el of 
h 
 recent 
ere 
employment outcomes of a sample of colorectal cancer patients in the UK.  
Chapter 4 identified that variations in psychosocial well-being and work ability
were apparent, these could lead to changes in return to work intentions;
furthermore, differences in these outcomes were detected according 
treatment type.  Meanwhile, Chapter 5 identified the role of patients’ self-
efficacy beliefs i
 more complex nature of self-efficacy, whereby fluctuations in levels of self-
y indicate that it is unlikely to be a stable construct.  Moreover, a key 
vided to colorectal patients.  Therefore, this chapter aims to explore the
4 to 6 may help to b
There is a limited amount of prior research that has considered the lev
information provided by health professionals to patients. However, researc
suggests this is an area that is in need of improvement.  For instance, a
study with occupational health physicians found that these individuals felt th
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was a lack of knowledge and information regarding work and cancer (Am
Wynn, Whitaker & Luker, 2009).  Studies with patients and survivors 
themselves also suggest that few received work-related guidance from health 
professionals such as their doctor (Verbeek, et al., 2003; Maunsell et al., 1999
Main et al., 2005; Kennedy et al., 2007).  Therefore, this is an area that 
warrants further investigation as this information (or lack of) may have far-
reaching implications for patients, for example, their return to work intentions / 
outcomes.  More importantly, understanding the current practices of healt
professionals may help towards understanding patients’ perceptions a
perceived work ability.  Furthermore, exploring this may help to identify ways in
which information (e.g. nature and level of guidance) could be improved in the 
future.  These improvements could not only help working-aged cancer patients 
but also health professionals who may currently lack the appropriate know
to provide such advice / guidance in a confident manner (Aitken & Cornes, 
1990).    
ir, 
; 
h 
bout their 
 
ledge 
fessionals from a number of fields (consultant surgeons, 
lth) 
s. 
views were conducted to explore the above stated aims. 
Prior research studies with cancer patients have reported that health 
rofessionals did not discuss work issues or that they provided little work-
related advice (Maunsell et al., 1999; Kennedy et al., 2007).  However, 
xplanations for such findings are unknown at present.  Despite this, these 
As a result, health pro
specialist nurses, oncologists, general practitioners and occupational hea
participated in a semi-structured interview.  The overall objective of the 
interview study was to explore the nature and extent to which health 
professionals provide work-related guidance to colorectal cancer.  In particular, 
the aims were: 
1. To understand the nature and type of information currently provided to 
working-aged cancer patients and the impact this may have on patient
2. To identify factors that may influence the type of information given. 
7.2. Methods 
Semi-structured inter
p
e
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powerful nature of semi-structured 
ms 
quality assessment as it enables 
“unpacking of the complex issues inherent to quality improvement,” (p. 148).  
is, this study may identify issues / barriers related 
 
objectives were outlined in the health professionals’ participant information 
sheet (Appendix 9). 
 
 
studies demonstrate the flexible and 
interviews that as a method help to identify new areas of research (Britten, 
1995).  Earlier interview studies involving health professionals have provided an 
insight into consultants’ views of patients (Britten, 1991).  Similarly, gathering 
data from various viewpoints is a beneficial way to ensure practice is informed 
by a credible research evidence base (Green & Britten, 1998).  Hence, it see
the most appropriate method to adopt here.  Furthermore, according to Pope, 
van Royen and Baker (2002), semi-structured interviews (and qualitative 
methods) are useful when exploring 
Within the context of this thes
to current practice of health professionals when providing work-related guidance
that were previously unknown (Pope et al., 2002).  In addition, identifying 
improvements to current practice could help towards informing the way work-
related advice and guidance is provided to working-aged cancer patients. 
7.2.1. Participants 
A sample of 18 health professionals comprising of consultant surgeons, 
specialist nurses, oncologists, general practitioners, occupational health 
physicians and occupational health advisors participated in this study.  
Recruitment varied according to the health professional’s field.  The consultant 
surgeons, specialist nurses and oncologists were invited to participate from the 
NHS Trusts where patients were recruited for the questionnaire and diary 
studies.  The general practitioners and occupational health professionals were 
recruited via wider research networks.  The sampling strategy was therefore 
determined by the purpose of the research (Morse & Field, 1995) as opposed to 
attaining statistically representative data (Mays & Pope, 1995; Pope et al., 
2002), which is common in qualitative research.  The interview study aims and 
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Participant Characteristics 
Table 7.1 summarises the demographic profiles of the health professionals that 
participated in the interview study.  The mean age of the participants was 45.87 
years (SD . nd re mple 
comprise f
physicians (11%), three colorectal specialist nurses (17%), two oncologists 
(11%), two general practitioners (11%), two occupational health advisors (11%) 
and two specialist registrars (11%); one in oncology and the other in 
occupational medicine.   
7.2.2. Interview Schedule 
The semi-structured interview schedule (Appendix 10) was designed to identify 
the exten w rom a work-
related ad  ary 
that the in i
different f . er to 
diverge and pursue areas of interest as they arose (Mays & Pope, 1995; Britten 
1995).  Initially, the interview schedule was drafted by the researcher based 
upon qualitative findings and findings from the quantitative questionnaire and 
qualitative diary studies.  The draft interview schedule was reviewed by the 
re rche supervisors and tw als
oc atio h g a 
semi-structured interview proforma, the interviews sought to identify the 
following: the extent and nature of work-related guidance provided by eac
health professional; factors that impact upon this; the usefulness of this 
information, and whether any improvements could be made in the future.  The 
researcher therefore attempted to adopt strategies to ensure rigorous qualitative 
research was carried out as outlined in Mays and Pope (1995). 
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1 mog
p *  mpl
Table  7.
Partici
: De
ant
raphic profiles of participants (n = 18). 
Age (years) Gender E oyment Tenure 
1 56 Male Consultant Surgeon 13 years 
2 
3 
4 
43 Male 
49 Male 
42 Male 
57 Male 
34 Female 
47 Female 
53 Female 
9 55 Male 
41 Female 
40 Female 
55 Male 
35 Male 
- Male 
40 Male 
57 Female 
- Female 
40 Female 
Consultant
Consultant
Consultant
5 Consultant
6 Specialist 
7 Specialist 
8 Specialist 
Oncologist
10 Oncologist  
11 Specialist 
12 Occupation
13 Occupation
14 Specialist 
15 General Pr
16 General Pr
17 Occupation
18 Occupation
 Surgeon 7 years 
 Surgeon 12 years 
 Surgeon 4 years 
 Surgeon 20 years 
Nurse 3 years 
Nurse 6 years 
Nurse 9 years 
 - 
 7 years
Registrar (Oncology) 3 years 
al Health Physician - 
al Health Physician 6 years 
Registrar (Occupational Medicine) 4 years 
actitioner 11 years 
actitioner 20 years 
al Health Advisor 11 years 
al Health Nurse / Advisor  2 years 
* Participant number, individual interviews 1 - 18 
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7.2.3. Procedure 
terviews was analysed using thematic 
analysis (see Chapter 6, pp. 131-132).  The analysis process involved the 
e were apparent 
according to the health professional’s field.  Therefore, results will also be 
presented taking this into account.   
7.3. Results 
Four core themes were identified, which are summarised in Table 7.2.  These 
will be discussed in turn. 
Participants were invited to take part in a face-to-face interview.  All interviews 
were conducted at the participant’s place of work and arranged at a convenient 
time for them.  Participants were provided with a participant information sheet 
(Appendix 9) that outlined the aims of the research and what the study involved.  
Prior to completing the informed consent from (Appendix 11), those wishing to 
participate were given the opportunity to ask questions regarding the interview 
and / or study.  Demographic information including age, gender, occupation and 
tenure was collected from each participant.  After eighteen interviews with at 
least two health professionals from each field, the researcher felt that data failed 
to generate anything new and had reached saturation (Mason, 1996).  
Therefore, no further health professionals were invited to participate.  Interviews 
lasted between 15 and 40 minutes, were digitally recorded and transcribed 
verbatim.  
7.2.4.  Analysis 
The transcript data generated from the in
researcher and an independent researcher systematically reviewing the 
interview transcripts separately.  Initial ideas were noted, which guided 
preliminary codes.  These codes were grouped into potential relevant themes 
and discussed between the researchers.  Further analysis clarified the specific 
nature of each theme leading to the development of names for each theme.  
Following agreement of the themes identified, extracts were taken from the 
transcripts to exemplify each theme and reflected the overall accounts reported 
by participants.  During the analysis process it was also noted that differences 
and similarities regarding work-related advice and guidanc
Chapter 7 Health Professionals’ Interview Study 
The Nature of Current Practice 
Participants described the type and level of work-related guidance they had 
previously given to patients that were in employment at diagnosis.  The level of 
patient contact varied according to the health professionals’ field and 
differences within groups were also evident.  For example, up to four patients 
diagnosed with cancer were referred to the occupational health professionals 
each month.  One general practitioner stated that he saw between two and 
three cancer patients each week; whilst a female general practitioner saw just 
as many in a month.  The amount of time spent discussing work matters varied.  
As expected nsultant surge onsulta ncologists and specialist 
nurses had the most frequent pat ntac refore, these individuals were 
likely to have the greatest opportunity to address work matters.  For instance, 
one consultant surgeon mentioned that he met with each patient up to 20 times.  
The s ialis s  o n re given a contact number and 
were  to  h  w .  Subsequently, the matter of 
how t ana rk a e during the cancer pathway 
with a ver, the initiation and timing 
of the discussion varied. 
Initiating the Discussion about Work 
Participants discussed work with employed patients at different time points.  
According to the specialist nurses, for patients receiving surgery, the first 
outpatient appointment proceeding discharge was a good opportunity to discuss 
the management of .  This s argued to be an appropriate time to 
address the matter because by this time consultants (surgeons and oncologists) 
knew whether further treatment would be required.  Therefore, patients have 
been given information post surgery but prior to any other 
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Table  7.2: Themes and sub-themes. 
Key Themes 
 
Sub-themes 
  
The Nature of Current Practice 
 
Factors Impacting the Provision of 
 
 
Barriers to Providing Work-Related Support 
 
 
 
The Need for a Multifaceted Approa
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treatment (e.g. chemotherapy).  In spite of this, a few participants, in particu
the consultant surgeons and oncologists stum
lar 
bled upon this topic more than 
once.  For example, one consultant oncologist stated that he brought up the 
topic
 quite early so probably once they’ve 
a week or two after they’ve been told and 
ents. 
mebody refers, and sometimes I’ll be referred at an early 
stage, and sometimes I’ll be referred when somebody’s about to come back to 
How a 
discussion about work with their patients:   
 
ient about resuming work.  It doesn’t 
Participant 4, Consultant Surgeon. 
 
fter 
t 
’s mind at an early stage.  Participants revealed that 
patients approached them with common questions such as whether or not they 
hould work during treatment, length of time to take off work (e.g. after 
chemotherapy or surgery) and the risk of infection associated with 
 on several occasions: 
Patients often want to know about work
come to terms with their diagnosis, 
before starting their treatm
Participant 9, Consultant Oncologist. 
Alternatively, the occupational health participants met with patients after they 
had been referred by their employer or manager.  This was most likely to be 
when the patient was considering a return to work: 
It’s the point at which so
work; that’s probably more common. 
Participant 17, Occupational Health Advisor. 
ever, four participants, all consultant surgeons, stated that they rarely had 
It’s not part of normal practice.  Patient asks time to resumption to normal activity,
I don’t remember specifically talking to a pat
really cross our minds.  
Further to this, an occupational health physician (participant 14) mentioned that 
he asked his patients if they had spoken about work with their specialist, they
often said that they had not. Subsequently, the majority of the consultants 
pointed out that patients often initiated the conversation themselves soon a
diagnosis.  Therefore, this suggests that this may have been an importan
matter on the patient
s
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chemotherapy.  A consultant oncologist also said that some patients were 
advice 
 lifting and driving, 
however, this was not specific to work.  All but one participant (occupational 
health advisor) felt that some form of
helpf
At the moment we don’t have any written information to give patients, so may be 
help; 
giving 
Participant 17, Occupational Health Advisor. 
Fact
Whe
took 
and p
enga
profe
 
relaying questions asked by their employer: 
They will often bring to me questions that the employer has already asked, 
practicalities if their job involves fairly heavy lifting, or strenuous work. 
Participant 10, Consultant Oncologist. 
How Information is Delivered 
All participants said that work-related guidance was informally given to patients 
in a verbal manner.  A consultant surgeon attributed this to the fact that 
often needed to be tailored to suit each patient individually.  Written guidance 
was minimal and provided advice on tasks involving heavy
 written work-related guidance would be 
ul to give to patients: 
if there is that information for each specific cancer we should be able to 
there might be some available at the moment, but I must say that I’m not 
any away. 
Participant 16, General Practitioner. 
I give verbal advice...I think people like access to written literature...can be really 
helpful because it’s all there in logical form. 
ors Impacting the Provision of Work-Related Guidance 
n providing work-related guidance it was clear that health professionals 
into account a number of factors including the nature of patients’ diagnoses 
rognoses, treatments and symptoms and the type of work they were 
ged in at diagnosis.  This appeared to be irrespective of the health 
ssional’s field. 
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Diagnosis and Prognosis 
The importance and purpose of diagnosis and prognosis information in the 
provision of work-related guidance differed between participants.  For health 
professionals, such as the consultant surgeons, oncologists and specialist 
nurses, the primary purpose of diagnosis information was to help decide upon 
the treatment to be administered to ensure the best possible prognosis for the 
patient.  The implications of prognosis upon work ability appeared to be a 
secondary matter.  A female specialist registrar (oncology) seemed to presume 
ikely to lead to the patient withdrawing from 
that 
olve 
tient’s work ability.  Furthermore, this 
information helped to guide the management of an employee with cancer.  
Howev
and f en accessed on every occasion: 
te to the specialist...so at some point we will have 
the specialist’s report, which will give us a diagnosis and possibly an indication of 
 
r that, yes they are probably going to have ongoing problems and 
go in terms of a negative prognosis. 
Participant 14, Specialist Registrar (Occupational Health). 
that a poor prognosis was l
employment almost immediately; hence, the amount of work-related advice 
would be offered for such a case was likely to be limited: 
Sometimes we see poor prognostic cancer...so in the short term it may affect 
everything, so they may decide to go off work at an early stage and so we inv
the Macmillan team rather than us going through it. 
Participant 11, Specialist Registrar (Oncology). 
Alternatively, a male specialist registrar training in occupational health 
described how this information from oncology helped to understand the 
potential impact of the cancer on a pa
er, it was apparent that efforts to obtain this information were necessary 
or this reason it may not have be
What I normally do is I obviously try and establish the facts of their illness.  We’re 
a little limited in that because as Occupational Health we’re not part of the 
medical loop, we’re agents of the employer.  So we don’t have their medical 
records to look at...I do often wri
prognosis...the focus of my role would be to look at functional capabilities and to
see how the cancer is affecting them both in their home life and also at work...we 
make it clea
that’s probably as far as I would 
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When discussing an employee’s ability to work with the individual’s emplo
manager, one occupational health physician stated that the diagnosis itself was
a barrier that had to be overcome.  This participant described how managers 
quite often did not understand that cancer is increasingly being viewed a
treatable illness.  Consequently, this indicates that employers may also requ
more tailored information about cancer and how to manage an employee with 
cancer.   
Treatment and Symptoms 
The entire sample specified that the nature of a patient’s treatment was an 
important factor taken into account when discussing matters related to work.  
For those undergoing surgery, three consultant surgeons and the three 
colorectal nurse specialists stated that patients were advised that a period 
least six weeks leave from work was necessary to aid recovery.  However, 
participants’ perceptions regardi
yer or 
 
s a 
ire 
of at 
ng the amount of time deemed necessary for 
recovery after a surgical procedure for colorectal cancer varied.  Furthermore, 
differ
this sugges
indivi
About six to eight weeks, not to lift anything heavy, so if they’re manual labourers, 
eks. 
 that 
see how you are, to recover from the surgery. 
Participant 8, Specialist Nurse. 
 
owel 
Participant 7, Specialist Nurse. 
ences between participants within the same field were evident.  Hence, 
ts that patients may receive different guidance according to the 
dual responsible for their care: 
for example, we try and tell them not to lift anything heavy for about eight we
Participant 2, Consultant Surgeon. 
I’m taking it from after surgery, so that’ll be the usual post-operative recovery
we tell them, which is that basically the recovery time is six weeks...generally we 
say take the first six weeks and 
We discuss discharge information with them, and we are telling them not to go
back to work until three months after surgery, especially if they have had a b
resection. 
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As w
chem t 
by pa
healt emotherapy posed challenges when 
 
 
l 
he early stages 
of their cancer journey where the discussion regarding work was inevitable as it 
was  
abilit
opinions of other health professionals via the patient (but not directly from 
specialists themselves), which helped to decide the length of time subsequent 
sick notes would be issued for: 
e. 
Participant 15, General Practitioner. 
Once
frequ
found it more difficult to provide work-related advice.  For a female general 
practitioner, specialist nurses were seen to be better placed to discuss when a 
return to work would be possible: 
iew 
However, it emerged that specialist nurses had conflicting opinions: 
ell as surgery, a number of colorectal patients are likely to undergo 
otherapy treatment.  This was another factor that was taken into accoun
rticipants when discussing work matters with patients.  An occupational 
h physician discussed that ch
attempting to keep people at work.  It was apparent that the level of advice
provided to working-aged patients during treatment varied between participants. 
This was because certain health professionals (e.g. oncologists) had more 
contact with patients than others during this time.  For instance, the two genera
practitioners stated that they frequently met with patients during t
their role to issue sick notes.  It was during these consultations that work
y was discussed.  The general practitioners also attempted to gauge the 
When we give them a sick note, so if you were the person we’d be saying how 
are you doing, all the rest of it; has the hospital given you any idea of how long 
this is going to take, how you might feel.  Then I can issue a certificate, 
depending on what I think is a reasonable amount of tim
 treatment was underway the general practitioners saw patients less 
ently.  Moreover, due to differences in treatment and cancer type they 
It’s difficult for us to give a time limit...There’s usually a cancer nurse attached to 
the unit where they have the treatment, so they can go back and they rev
them every so often and check whether they are ready to go back to work. 
Participant 16, General Practitioner. 
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You need to go back to your general practitioner to make sure that you’re fit to 
work because we don’t see them so often...to be quite honest the information
we’re giving is just based on treatment that they’re having at the hospital really. 
Participant 7, Specialist Nurse. 
 
Views about ability to work (where work ability is defined as: the ability to 
marinen et 
ed 
 
nd give them a realistic view about how 
soon they will be able to go back. 
The at they liaised with the patient’s consultant 
surgeon and oncologist when patients raised questions about their work ability 
 
If the patient raises issues about work, say if they are starting chemotherapy, I will     
down 
Alternatively, a female consultant oncologist stated that some patients were told 
le to work during chemotherapy treatment, when in fact 
perform job with respect to demands, health and mental resources, Il
al., 2005) during treatment differed among participants, which in turn impact
the type of work-related advice given to patients.  A consultant surgeon stated 
that they helped patients plan their work around their treatment: 
We help them plan their work around their treatment.  We tell them how much
time they will probably need to off work a
Participant 2, Consultant Surgeon. 
specialist nurses mentioned th
in relation to their chemotherapy treatment.  In particular, oncologists seemed to
be in the best position to offer such advice, perhaps due to their knowledge 
about treatment types and the associated side-effects: 
discuss that with their consultants.  Our oncologist is very good, he will sit 
and discuss that bit further with them and discuss how it’s going to impact on their 
work. 
Participant 8, Specialist Nurse. 
that they would be unab
there was no real reason why they could not continue to work. Another 
oncologist mentioned that the type of chemotherapy treatment was important 
when advising a possible return to work.  Additionally, a ‘see how you go’ 
approach was often advised: 
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I usually just say if I were you I would take time off during treatment...If it’s very 
aggressive chemotherapy which might leave them open to infection, I would 
advise not returning to work.  If it’s very gentle, easy chemotherapy I’d say, if you 
want to go back to work and you find treatment easy then go back to work. 
It was acknowledged by most that e of symptoms 
expe ms were 
likely to impact work ability and the type of advice given about resuming work.  
nt.  
her nurse felt that decisions about when to return to work 
were ultimately best left up to the patient: 
e 
pecialist Nurse.  
Results suggest that the participants felt that patients who experienced fewest 
e 
ause any 
they can’t attend because they are receiving treatment. 
Natu
Parti rstanding the type of work a patient was 
engaged in prior to diagnosis was important when providing guidance on how to 
manage work.  All participants said that being employed in a manual job was
associated with being less likely to c
consultant surgeon stated that due to diminished physical work ability patients 
Participant 9, Consultant Oncologist. 
the type and natur
rienced by patients was variable.  Nevertheless, such sympto
For example, a specialist nurse pointed out that symptoms such as fatigue, 
constipation or diarrhoea would make it difficult to work during treatme
Furthermore, anot
It depends on the symptoms really and I think the patient himself is the best judg
on whether they are able to work or go off sick. 
Participant 7, S
symptoms were in a better position to either continue with work or return to 
work.  Therefore, in such cases, the health professionals were perhaps mor
likely to offer more specific work-related guidance to these individuals:   
Chemotherapy brings about its own challenges for trying to keep them in 
work...Occasionally the chemotherapy that people receive tends not to c
side effects and they are able to stay at work through it, apart from the days that 
Participant 13, Occupational Health Physician. 
re of Employment 
cipants spoke about how unde
 
ontinue with work.  For example, a 
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were advised to temporarily amend their tasks where possible. Likewise, 
patients taking part in work requiring physical effort such as lifting and handling
were often advised to take more time 
 
off work than those in non manual jobs: 
t 
In co
was 
indiv
T consultant...so one can have a 
conversation and I have my own imaginings about what being an IT consultant 
hey do every day or what their job 
re self-employed were more eager to return to work when 
mployed.  As a result, work matters 
lves: 
that 
n’t 
It also depends on the type of work they do.  If it is a heavy manual job you don’
expect them to return quickly, you need to continuously assess them, what they 
can perform, and advise appropriately. 
Participant 16, General Practitioner. 
ntrast, one consultant surgeon felt that the type of guidance he provided 
limited as he was not always sure about the precise nature of an 
idual’s work: 
They’ll usually say I work in a factory, I’m an I
means.  But I don’t actually know exactly what t
demands are. 
Participant 5, Consultant Surgeon. 
Differences in the extent to which work matters were discussed with patients 
were also dependent upon whether the individual was self-employed.  The 
consultant surgeons, specialist nurses and oncologists all pointed out that 
patients who we
compared with those that were not self-e
were discussed quite early and seemed to be more extensive with self-
employed patients, usually because the patient had raised the topic themse
The self-employed people will probably be wanting to get back before those 
have got sick pay and things.  They tend to recover quicker because they have
got any choice really. 
Participant 6, Specialist Nurse. 
Self-employed people have a completely different approach from somebody who 
has employment benefits. 
Participant 2, Consultant Surgeon. 
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Type of work was also likely to impact whether the individual would be able to
work during treatment, manage a colostomy and the type of adjustmen
 
ts that 
could be offered by the employer: 
 four for chemotherapy...the manager 
nce.  If they’re packing something in a factory or 
on a production line some managers will say, I can’t tolerate that. 
f bending and lifting, manual handling, so 
depending where the colostomy is sited and how well their colostomy fares, it 
s, 
When attempting to provide work-related guidance to patients, participants 
spok
clear advic
evidenc
perceptions and their attitudes also served as barriers when trying to discuss 
ed.  
ment law and matters related to finances 
after a cancer diagnosis made it difficult to answer patients’ questions.  One 
onsultant surgeon felt that knowing more about patients’ social circumstances, 
nature of their occupation and their relationship with their employer would make 
 favourable difference when offering guidance.  Therefore, most participants 
If someone is going to be off one week in
has to be able to allow their abse
Participant 14, Specialist Registrar (Occupational Medicine). 
In warehousing there is an awful lot o
might not be a suitable environment...in warehousing there aren’t any light dutie
the only adjustment you can make are hours. 
Participant 18, Occupational Health Advisor. 
Barriers to Providing Work-Related Support 
e of a number of barriers that prevented them from being able to give as 
e as they perhaps wished.  A lack of knowledge and an insufficient 
e base were commonly referred to as barriers.  Further to this, patients’ 
work matters.  
Lack of Knowledge 
The majority of the health professionals felt that their knowledge about the 
impact of cancer on work ability and employment outcomes was rather limit
Consequently, this made it challenging when advising patients about work 
decisions.  All of the consultant oncologists and specialist nurses stated that 
their lack of knowledge about employ
c
a
 196
Chapter 7 Health Professionals’ Interview Study 
revea
their 
he past. 
formation as I can, within my limitations.  I will not be 
 
to 
hesitant about that...with some people the 
operation doesn’t go well, or the chemotherapy doesn’t go well. 
For t
prob
often wanted precise details of what an employee diagnosed with cancer could 
do an turn to work.  However, one occupational 
health physician stated that not knowing all the facts about the individual’s 
led that the guidance they have provided to date was largely based on 
prior experiences with patients that were employed at diagnosis: 
We haven’t got that much information to give patients, we’re just going from what 
we’ve advised other patients in t
Participant 8, Specialist Nurse. 
I tend to give as much in
commenting about something I don’t know a lot about. 
Participant 15, General Practitioner. 
Regardless of their field, participants appeared most confident when guiding
patients about tasks they should avoid; namely heavy lifting and physically 
demanding work.  However, providing such clear advice was not always 
possible when considering treatment such as chemotherapy.  This was due 
differences in treatment effects and outcomes: 
We’re a little bit uncertain as to what the treatment will be or what the outcome 
will be; so we’re sometimes a bit 
Participant 12, Occupational Health Physician.     
he occupational health professionals, this lack of knowledge was 
lematic when liaising with the patient’s employer.  In particular, employers 
d when they would be likely to re
cancer and treatment made it difficult to answer such questions.  In contrast, an 
occupational health advisor argued that it was important to understand matters 
from the viewpoint of the employer: 
 
 
 197
Chapter 7 Health Professionals’ Interview Study 
I probably ask a lot of employers, and I think health services do...we’re saying i
going to be months before somebody is back up to full speed...it’s an awfully 
difficult thing
t’s 
 for an employer to manage, and I don’t think we take account of 
re entitled to have their job back...and I 
think that’s not always realistic. 
Insuf
Health professionals’ lack of knowledge as a barrier to providing guidance could 
be attributed to a limited evidence base.  Most participants felt that there was an 
unsu
advic  
that a
get b  that 
such varied practice was often likely to lead to different patient outcomes as a 
resul re.  Consequently, this was likely to 
 
yond our 
ple off 
 
out it. 
Participant 1, Consultant Surgeon. 
The  type and nature of advice to 
provi st.  For example, four participants stated 
that information about how a stoma appliance may impact work ability was 
 
that...an employee tends to feel that they’
Participant 18, Occupational Health Advisor. 
ficient Evidence Base 
itable evidence base within their profession to draw upon when giving 
e or discussing matters related to work.  A consultant surgeon disclosed
lthough little evidence was available about when cancer patients should 
ack to work, there was very wide practice.  He went on to suggest
t of the individual involved in their ca
result in conflicting opinions and may even impact relationships between health
professionals from different fields: 
Even if I said you’ll be back at work in a month, there are other things be
control, like occupational health, like their general practitioners who will override 
that...So whatever we think doesn’t make a difference...I think keeping peo
work is very bad for their brains, I really do.  I get so irritated when people do, and
there’s nothing I can do ab
availability of resources to refer to about the
de was deemed inadequate by mo
scarce.  As a result, these participants may have been unsure about the 
usefulness and appropriateness of their guidance: 
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There is not much guidance, either from the Department of Health, as to what 
should be the advice.  There is very little info, especially for cancer patients with a 
stoma. 
Participant 2, Consultant Surgeon.   
There’s a fairly weak-ended space for much of the advice we give in my 
 non-
t 
generally have my spiel after my experience of 
looking after patients...It might be my complete lack of knowledge...I don’t really 
Som es of resources that they made 
use of when providing work-related guidance.  For instance, a female specialist 
d quality of life data related to 
 
 
each 
 
profession unfortunately and that’s something highlighted by Carol Black.  The 
evidence base for the return to work with the diagnosis of cancer is virtually
existent. 
Participant 12, Occupational Health Physician. 
I’m not given any real guidance; there are no guidelines to me to say, this is wha
you should or shouldn’t say.  I 
have a handle on how many patients do get back to into the workplace 
successfully. 
Participant 10, Consultant Oncologist. 
e participants did however provide exampl
registrar (oncology) said that she utilise
treatments that was based upon research conducted within her NHS Trust.  In
an effort to answer patients’ questions a general practitioner and several 
participants from the field of occupational health described attempts to access
information on the internet:   
I’m quite good with the internet...I read and update my knowledge, so I know 
and every cancer, at least in a superficial way. 
Participant 15, General Practitioner. 
Moreover, a specialist registrar training in occupational medicine suggested that 
an insufficient evidence base and lack of knowledge was reflected by patients 
who appeared to have a number of unanswered questions: 
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What emerges is that a lot of people seem to feel that they’ve not got adequate 
information from their hospital appointment, and sometimes their GP, and they’ve
still got unanswered questions...the evidence base in much of occupational health
is pretty limited to the very basics. 
Participant 14, Specia
 
 
list Registrar (Occupational Medicine). 
In contrast, two other occupational health professionals felt there was a suitable 
and s
indiv
deali t 
exist
transferable to cancer patients:  
I think it’s not necessarily identifying cancer.  If you have a policy and a procedure 
everybody, for all conditions, then you will meet the needs of the 
people who’ve got a diagnosis of cancer...The only slight difference might be the 
.  
ts 
hat patients 
rognosis.  This led 
to problems when trying to assess work ability and potential outcomes.  A 
gene s 
made
participants
prior to providing work-related guidance: 
 
ufficient evidence base for them to draw upon to confidently advise 
iduals about how to manage their cancer, treatment and work.  When 
ng with cancer in the workplace, an occupational health advisor felt tha
ing policies and procedures for managing employees with ill-health were 
that works for 
psychological issues. 
Participant 18, Occupational Health Advisor. 
Patients’ Perceptions and Attitudes 
Seven participants, with at least one from each field, expressed that patients 
themselves were sometimes a barrier when discussing how to manage work
Unsurprisingly, participants stated that work was the last thing some patien
wished to discuss.  On the other hand, one specialist nurse stated t
that used denial as a coping strategy did not wish to discuss the cancer let 
alone their employment.  In line with this, an occupational health physician 
spoke about patients who did not want to know about their p
ral practitioner and a consultant surgeon thought that various perception
 it difficult to offer generic advice to patients.  Subsequently, some 
 highlighted the importance of identifying the needs of the patient 
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People are so different, some people see having cancer as a challenge that they 
d 
 sometimes feel that they, because they’ve got a diagnosis of cancer they 
can’t go back to work.  A lot of patients feel the diagnosis of cancer is an end of 
you want to, you 
 be a period of time when you won’t be able to 
work. 
 
 work.  This was common early on in the 
cancer pathway and reflected by the results that some patients initiated a 
discu
(occu
number of unanswered questions.  In spite of such time constraints participants 
appe rk-related guidance: 
 which 
t. 
 
must overcome and have quite a strong work ethic...Other people shrivel up an
think, I can never do anything ever again...you’ve got the cancer to manage, but 
you’ve also got the person to manage.  I think you would need some sort of face-
to-face assessment.  
Participant 15, General Practitioner. 
Patients
life diagnosis for them and you have to take them back from there and say, 
actually no, we are aiming to cure you of this problem...should 
can carry on working but there’ll
Participant 3, Consultant Surgeon. 
Time Constraints 
Apart from the occupational health professionals, the remaining health 
professionals felt that work matters were not discussed at length or at all 
because of the limited consultation times that they had with patients.  
Furthermore, participants felt that patients were already bombarded with a 
wealth of information about their diagnosis, surgery and treatment that it was
difficult to have a discussion about
ssion about work themselves.  Similarly, a specialist registrar 
pational health physician) disclosed that patients came to him with a 
ared more than willing to offer wo
I certainly would be happy to be taught something about work for patients on 
chemotherapy and to provide some advice; but probably the clinic that I do
is really busy and very focused on treatment, might not be the best use of our 
time. 
Participant 9, Consultant Oncologis
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The Need for a Multifaceted Approach 
Participants provided an insight into the way work-related guidance could be 
improved in the future.  It was acknowledged that a level of consistency was 
required at a national level.  It was rare for participants to identify a sole 
indivi
Three participants did however suggest 
pivot
We are the link, we’re the key workers for the patients and if they have queries or 
In sp approach 
would be the most effective strategy to adopt.  Subsequently, such an approach 
would involve a number of health professionals.  The degree of involvement 
be 
t could 
and 
 other participants mentioned that guidance could be 
offered according to where patients were in the cancer pathway and by the 
sional:   
, and 
ld be dangerous.  We all need to know about it and discuss it with 
patients at any given interaction. 
Participant 4, Consultant Surgeon. 
dual who could be responsible for offering such guidance and advice.  
that specialist nurses could have a 
al role: 
questions, they’re the first ones to give us a call at the centre. 
Participant 8, Specialist Nurse. 
ite of this, participants argued that a multi-disciplinary or holistic 
however would vary.  Two general practitioners suggested that it would 
appropriate if they initiated the first discussion about work with patients.  I
be argued this is inevitable as general practitioners assess fitness for work 
issue sick notes.  Eleven
appropriate health profes
It’s probably a multidisciplinary approach…I think we need a certain amount of 
information and advice…We are not all of us, trained as occupational health 
physicians. 
Participant 2, Consultant Surgeon. 
It’s definitely something that surgeons should involve themselves with...but we’re 
all part of the bigger team...there should be ‘the information’ that’s available
it should come to the patient from different sources...Compartmentalising 
information cou
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Four
perso  
overc
ave a separate place to go and 
ebody much more knowledgeable about it.  It 
doesn’t have to be in the hospital; we could always, if it existed, refer them to 
 because we have more than 
enough to contend with at the moment, we don’t have time; but it’s actually true, 
As a result, participants recognised that providing guidance on several 
e.  Developing a two-stage approach 
comprising of verbal and written material was presented as an idea by the 
suggested by most, more vehemently by the consultant surgeons, 
oncologists and specialist nurses, that providing guidance in two stages would 
be us f 
this p
eight e could firstly be 
given on after diagnosis.  Following this, it was 
argued that further guidance could be tailored over time according to the 
patie d return 
to work intentions: 
 participants also suggested that it would be useful to have an independent 
n allocated with this role to which patients be referred.  This solution would
ome the time constraints and the health professionals’ lack of knowledge: 
It might be much better for the patient and us to h
talk about that sort of thing with som
somebody who knew about that. 
Participant 9, Consultant Oncologist. 
We need somebody to be able to signpost to,
we won’t have time to do that with them...need someone who would be able to 
actually go through all this talk with them, that would be a good idea. 
Participant 7, Specialist Nurse. 
occasions would be most worthwhil
majority of participants. 
A Two-Stage Approach  
It was 
eful.  Although participants found it difficult to suggest the precise timing o
rocess the health professionals did share similar ideas.  For example, 
 participants suggested that generic work-related guidanc
 to patients at an early stage, so
nt’s treatment plan, treatment effects, his / her work, prognosis an
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I think because of the variability of the procedures we’re doing with bowel cancer 
and the variable outcomes, it has to be fairly independent or bespoke advice 
give them because everybody’s slightly different.  But there’s a standard
you 
 amount 
of information you can give people.  For example, if they’re within working age, 
 work. 
n and 
Role of the Patient and Employer  
With d 
on th
and a  employer at an 
early stage to discuss adjustments that coul
ork or 
Firm believer in a phased return...And again, if they are going to go on 
y absolutely must make sure that their employer knows. 
s 
you would expect them to go to work eventually. 
Participant 3, Consultant Surgeon. 
I think they need guidance right at the beginning so they’ve got realistic 
expectations as to how long they’re going to be off; then again, when they’re 
getting towards the end of their episode, to discuss return to
Participant 17, Occupational Health Advisor. 
I think verbally, but also back up with written support, written information as 
well...like I said before, they feel they are getting too much...it doesn’t have to be 
a huge leaflet, just pointers probably, just so that they know what they ca
can’t do. 
Participant 8, Specialist Nurse. 
in this potential multi-faceted approach, three participants also commente
e role of the patient and employer.  For example, two consultant surgeons 
n oncologist suggested that patients should contact their
d be made to facilitate their return to 
work: 
Talk to your employer and see what they think about a staged return to w
whether you would expect them to have you back...As a principle, you should be 
able to get back to work, but just talk to them about it 
Participant 1 Consultant Surgeon. 
chemotherapy, the
Participant 10, Consultant Oncologist. 
Similarly, for an optimal outcome, four participants highlighted that the patient’
employer needed to be involved in the process.  For example, a consultant 
surgeon suggested that with a patient’s permission, health professionals could 
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discuss the patient’s capabilities with his / her employer.  Another participant fe
that the psychological impact of cancer often failed to be acknowledged b
employers and therefore could lead to problems in their management: 
Both of those two (cancer and coronary artery disease) have a huge 
psychological effect...The arrangement is that if the NHS cures your cancer the
expect you to go back to work.  But when you look at an individual case, 
somebody may be in their 50s...they’re psychologically just not well enough to 
back to work.  They won’t get that pension often because it’s deemed that they’re 
physically fit enough to go back. 
Participant 14, Specialist Registrar (Occupational Medicine). 
lt 
y 
y 
go 
However, this may simply be due to employers’ lack of knowledge about the 
out 
age 
 
impact of cancer on work ability.  Five participants, from various fields, 
suggested that developing some form of guidance to educate employers ab
the impact of cancer, and in particular treatment effects (including stoma 
advice) could also aid the return to work process: 
There’s a lot of organisations where it’s just the manager, and in some ways if 
there was a generic leaflet or something like that, that will probably be helpful to 
them as well, because I don’t know where they go for advice. 
Participant 12, Occupational Health Physician. 
These results have identified ways in which work-related guidance could be 
improved.  Furthermore, it seems that the most promising approach is likely to 
comprise of a multi-disciplinary effort that involves the patient and their 
respective employer.  Such an approach appears as though it would produce 
more favourable outcomes, such as a quicker return to work and high rates of 
work resumption. 
7.4. Discussion 
When attempting to understand how individuals affected by cancer man
their employment, little is known about the role that health professionals may 
have in work outcomes. Therefore, the primary aim of this research study was 
to investigate the level and type of work-related guidance health professionals
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provide to patients.  By identifying current practices and the factors impa
upon these, researchers can work towards designing and implementing 
appropriate interventions 
cting 
to provide work-related guidance to support working-
aged patients.  Although the health professionals that participated in the study 
lth 
 
sed 
the management of their work with health professionals.  In addition, those who 
ir 
 
 
 
rovided to patients.  This is somewhat concerning as these 
participants appeared to have the most contact with patients.  This is further 
 
cess 
were drawn from different fields, it was likely that they would all meet a cancer 
patient at some point during their pathway (not including occupational hea
professional).  Furthermore, this approach allowed the researcher to study the 
provision of work-related support during follow-up care.  This is in line with a
suggestion presented in prior research, where Verbeek and colleagues (2003) 
argued that with the continuity of care, more specific guidance (e.g. work-
related) could be possible.   
The findings indicated that health professionals did attempt to provide work-
related guidance to patients where possible.  However, in other qualitative 
studies cancer patients and survivors reported that they received little or no 
work-related guidance from their treating health professional (Maunsell et al. 
1999; Kennedy et al., 2007).  Findings from the diary study reported in the 
previous chapter also identified that only a small number of patients discus
did discuss the management of work often initiated the conversation 
themselves.  These results provide an insight into the possible reasons for such 
findings that to the researcher’s knowledge have not previously been presented 
in detail.  It was apparent that all of the participating health professionals felt 
that they lacked the necessary knowledge to provide the most appropriate 
advice; a finding that is supported in a study with occupational physicians (Am
et al., 2009).  Moreover, they were unaware of what was deemed to be the most
suitable approach.  Other results infer that an insufficient evidence base for 
health professionals to draw upon is also part of the problem.  Even consultant
surgeons, oncologists and specialist nurses mentioned that the absence of
guidelines made it difficult to ascertain the level and type of guidance that 
should be p
supported by Aitken and Cornes (1990), who argued that consultants and
specialist nurses are unaware of what their role in the return to work pro
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should be.  Therefore, unsurprisingly it was common to find that health 
professionals were being guided by past experiences with patients who we
employed at diagnosis.   
Encouragingly, when considering the current practices of health professio
degree of consistency was apparent.  This was irrespective of the health 
professionals’ field.  When providing work-related support, participants usuall
took into account the patient’s treatment, symptoms, prognosis and type of 
work.  However, time constraints made it hard to take into account wider issu
such as the patient’s precise job demands, relationship with their employer or 
social circumstances.  Similarly, time constraints and pressures prevented 
some health professionals from being able to give patients the full support they 
wanted to provide.  Research already indicates that stress and burnout is 
concern in colorectal consultant surgeons (Sharma et al., 2008).  Consequent
when considering prior research (Maunsell et al., 1999; Kennedy et al., 2007
and the findings from the diary study, it is unlikely that health professionals we
unwilling to discuss matters related to work.  Instead, certain barriers may h
prevented them from being able to give the guidance they wanted to give. 
Arguably, such an inconsistent approach is likely to result in varied practice.  It
was apparent that the participating health professionals had opposing vie
matters such as the length of time needed to recover from surgery and wh
patients should work during chemotherapy treatment.  More concerning wa
that differences wer
re 
nals a 
y 
es, 
a 
ly, 
) 
re 
ave 
 
ws on 
ether 
s 
e evident between participants from the same field.  As a 
result, differences in patients’ work outcomes could also be explained by the 
rting beliefs and practices of the patients’ health professional.  Therefore, suppo
the notion that the role of health professionals is pivotal in helping patients re-
enter the workplace after a cancer diagnosis (Verbeek, 2006).  Subsequently, 
having a consistent approach, perhaps in the form of guidelines may help 
towards ensuring that the most appropriate guidance is being provided to all 
patients.   
The interviews yielded insightful suggestions about the possible design, 
structure and implementation of future intervention endeavours.  It was 
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encouraging to find that the majority of participants felt that some form o
intervention was required to ensure patients were provided with the most 
appropriate work-related guidance.  The most effective strategy w
f 
as suggested 
to be one that involved various health professionals.  This would include the 
consultant surgeons and / or consultant oncologist, 
s 
nly 
n the 
bout returning to work).  
However, it could be argued that such a multi-disciplinary approach would 
 
spite 
recruit two general practitioners.  It is 
acknowledged that it was most difficult to recruit individuals from this group.  
urthermore, these participants were interviewed last, and it was felt that 
othing new was emerging from the interview data (Mason, 1996).  Hence, two 
general practitioners were deemed to be sufficient.  Moreover, this is the first 
y that has included all of the different health professionals that are likely to 
general practitioner, 
specialist nurses and where possible an occupational health professional.  
Additionally, incorporating the patient and their employer in the process wa
deemed to be important.  Therefore, suggesting that a concerted effort was 
necessary for the best possible outcome.  It also emerged that having a two-
stage process would perhaps be the best way forward.  Participants commo
stated that this could comprise of generic work-related guidance at the outset 
(e.g. soon after diagnosis), followed by tailored or bespoke advice based o
patient’s individual needs (e.g. treatment, side effects and type of work).  
Similarly, a mixture of verbal and written information would help to overcome 
time constraints and enable patients to refer to the guidance when it suited 
them (e.g. written guidance when they are thinking a
require one individual to have a more centred role.  Some participants did 
suggest that an individual needed to be assigned this role to ensure that the
best service was offered.  Alternatively, some felt that specialist nurses would 
be in a good position to provide the bulk of the guidance.  However, the 
specialist nurses themselves disclosed that time constraints and a lack of 
knowledge already prevented them from being able to deal with questions 
posed by patients. 
Although the findings appear to be of immense value, the research is not 
without its limitations.  Firstly, the sample is relatively small.  However, in 
of this, the richness of the data generated from the interviews is reflected in the 
findings.  The researcher only managed to 
F
n
stud
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be involved in the care of working patients.  Therefore, by 
considering their current practices, barriers to better practice and the apparent 
gaps researchers can inform future intervention development.    
7.5. Summary 
ble.  Equally, it is possible to argue that 
      
-aged cancer 
The results from this study indicate that health professionals do attempt to 
provide guidance to working-aged patients.  However, the nature of such 
guidance is likely to vary due to experience, knowledge and time constraints.  
Nevertheless, the results that emerged indicate that health professionals draw 
upon certain factors to inform the type of guidance they give patients.  For 
example, the nature of their treatment seemed to be important.  Even though 
participants mentioned that they did their best to guide patients about the 
management of their work, they highlighted a number of barriers.  Indeed, the 
most common barriers to providing more appropriate guidance was associated 
with a lack of knowledge held by the health professionals and an insufficient 
evidence base for these individuals to draw upon.   
The findings suggest that there is a gap in the provision of work-related advice 
and guidance for individuals affected by cancer.  Furthermore, the findings 
presented and discussed here and in Chapter 6, indicate that such guidance is 
a valuable aspect of patient care that currently falls short.  Moreover, it could be 
argued that it would be unrealistic to expect any one health professional to be 
responsible for providing this guidance.  However, it can be suggested that a 
two-stage process comprising of generic guidance that is later tailored to meet 
each patient’s needs seems most suita
both health professionals and employers require some form of guidelines about 
their role in this arena.  Ultimately, this would help towards ensuring that 
patients and employees are given consistent advice and support, which in turn 
could help attain better work outcomes.     
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8. Discussion 
This thesis sought to investigate the role of self-efficacy beliefs upon work 
ability, return to work intentions and employment outcomes in a sample of 
colorectal cancer patients.  When attempting to understand colorectal cancer 
tant.  
 self-
’ self-
n 
Similarly, the beneficial value of positive social support networks upon self-
 qualitative 
patients’ self-assessed work ability, return to work intentions and employment 
outcomes, the results suggest that perceived self-efficacy beliefs are impor
Moreover, by utilising a mixed-method approach it was apparent that the role of 
perceived self-efficacy beliefs was diverse and somewhat complex.  Results 
from the questionnaire study indicated longitudinal improvements in both
efficacy domains (ability to manage cancer and job self-efficacy).  However, the 
qualitative findings suggest that temporal fluctuations in participants
efficacy beliefs were apparent.  Findings suggest that whilst most expressed a
intention to return to work and possessed high levels of job self-efficacy, these 
beliefs seemed to be overridden by barriers that included treatment type and 
side effects (e.g. fatigue) that appeared to result in diminished work ability.  
efficacy beliefs and subsequent work outcomes emerged from the
data.  The most favourable outcomes appeared to be associated with the 
presence of a social support network that comprised of family, friends, 
employers and health professionals.   
The role and nature of work-related support provided by health professionals 
was a secondary aspect of interest to this thesis.  Interviews carried out with 
health professionals revealed that the absence of work-related guidance was 
largely associated with these individuals feeling unsure about what their role 
should be.  Consequently, this emerged as an aspect of patient care that could 
be improved. 
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In short, the findings indicate that the factors related to work ability, return 
work intentions and employment status varied over time; whereby certain 
variables took precedence over others at particular time points.  In addition, it is 
crucial to point out that self-efficacy is unlikely to operate as a stand-alone 
factor: i
to 
ndeed, the researcher argues that it may be a construct that is 
considered alongside other psychosocial factors which would inevitably help 
 
tions and work ability, and finally there is a 
need to address the role of health professionals in providing patients with work-
: 
 over the 
 
 
towards gaining a more comprehensive account of the factors related to the 
work outcomes of individuals affected by cancer.   
Overall, the studies presented in this thesis allow the researcher to draw four 
main conclusions.  Firstly, employment (work ability, job self-efficacy) and 
psychosocial (cancer self-efficacy, quality of life) well-being outcomes changed
over time and some differences were apparent according to treatment type; 
secondly, factors related to and predicting work ability and employment 
outcomes varied over time; thirdly, temporal fluctuations in self-efficacy and the 
role of support were important in understanding individuals’ cancer 
management, return to work inten
related support as findings suggest that these individuals may have benefited 
from such support.  Each of the study objectives are discussed in detail below
Employment and Psychosocial Well-Being Outcomes over Time 
Findings from the questionnaire study showed that employment rates
six month study duration varied in this sample of colorectal cancer patients.  At 
baseline 24% continued to work after diagnosis; however, at follow-up time 1 
this reduced to 21%; encouragingly, at follow-up time 2, 39% of participants 
were working.  Feldman (1976) found that 68% of colon cancer patients 
reported an absence of nine weeks or more; in comparison, these results 
suggest higher absence rates with 79% reporting an absence of at least 12 
weeks.  By follow-up time 2, 61% reported an absence of at least 24 weeks.  
The reduction in employment rates between baseline and follow-up time 1 could
be attributed to the onset of either chemotherapy or radiotherapy treatment.  
This finding is in line with prior research that has utilised a colorectal cancer 
sample (Sanchez et al., 2004).  Sanchez and colleagues (2004) reported that
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chemotherapy treatment resulted in a delay in the resumption of work.  In 
evaluation, earlier studies comprising colorectal cancer patients and survivors 
have predominantly utilised a cross sectional approach.  This prospective study 
 
f 
 to a 
e 
 
 
 
 after 
 colorectal cancer patients’ self-efficacy beliefs in their ability to self-
manage their cancer and perform their job role are likely to improve 
acy 
lf-assessed work ability may prevent participants from resuming work.  
 
he 
sults 
therefore adds knowledge to the extant literature concerned with this cancer 
type.   
In comparison to the return to work rates reported in the general cancer and
employment literature, the employment rates from this study are slightly lower.  
However, these colorectal participants were recruited from the point o
diagnosis (post surgery but pre-chemotherapy / radiotherapy) as opposed
number of years later (Spelten et al., 2002).  Similarly, prior return to work rates 
are based upon samples comprised of different cancer types and varying ag
groups (Spelten et al., 2002; Taskila & Lindbohm, 2007; Balak et al., 2008).  
However, no differences according to age were apparent in this sample.  
Furthermore, it is reported that approximately 40% of cancer patients take time
off work for treatment and recovery (Short et al., 2005), which is the more 
pertinent matter of interest here. 
These results could partly be explained by changes in participants’ self-efficacy,
work ability and psychosocial well-being over time.  More importantly, results
from the longitudinal questionnaire indicate that approximately six months
diagnosis
(irrespective of treatment type).  However, in spite of such positive self-effic
levels, se
Decrements in work ability were found between baseline and follow-up time 1;
however, between follow-up time 1 and follow-up time 2 these improved.  T
mean work ability value reported at six months by de Boer et al. (2008) was 4.6; 
considerably lower than the value of 6.22 that was found in this sample.  When 
compared with the mean value of 5.52 reported in the gastrointestinal cancer 
patients, this difference is not as marked.  However, this sub-sample utilised in 
de Boer et al’s. (2008) study was quite small (n = 23).  Nevertheless, the re
obtained from this sample infer that the most detrimental impact upon work 
ability is likely to be observed in patients undergoing either chemotherapy or 
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more than one treatment modality.  This argument is in line with prior research 
(Bradley et al., 2007; de Boer et al., 2008).   
Overall, the apparent disparity between self-efficacy beliefs and work ability 
(diary study findings) suggest that whilst some patients wished to work
were unable to do so because their ability to perform their job role was 
compromised (i.e. low work ability).  These findings therefore imply that for 
those colorectal cancer patients who possess high levels of job self-efficacy b
diminished work ability, it may be worthwhile to offer temporary work 
adjustments (especially during treatment).  Although, the practicalities of 
employers being able to do this, needs to be addressed.  The value of provid
workplace adjustments and support has been demonstrated by Pryce et al. 
(2007); these researchers found those receiving such support were m
to continue with work during treatment.  However, it was also reported that less 
than half of those that disclosed details about their cancer received workplace 
adjustments.  Similarly, Steiner et al. (2008) did not find a difference betw
the level of workplace support received and workplace adjustments.  These 
finding
, they 
ut 
ing 
ost likely 
een 
s suggest that there may be a need to educate employers about the 
impact of cancer and its treatment along with the benefits of offering workplace 
acts 
, 
 
 
act 
 
05; 
adjustments.  Such efforts could help towards improving work outcomes for 
both the individual affected by cancer and the organisation to which they 
belong.  
Factors Related to Work Ability and Employment Status: The Role of Self-
Efficacy 
As outlined in Chapters 1 and 2, there are a number of psychosocial imp
and physical effects commonly experienced in individuals diagnosed with 
cancer (e.g. fatigue, poor quality of life, depressive symptoms).  For this reason
these have been studied in relation to return to work and employment outcomes
extensively (Feuerstein et al., 2007; Amir et al., 2008; Henry et al., 2008; Munir
et al., 2009).  More recently, researchers have started to investigate the imp
of these factors on perceptions of work ability.  Unsurprisingly, the factors 
related to work ability are similar to those previously identified as being related
to return to work (e.g. Spelten et al., 2002; Gruber et al., 2003; Main et al. 20
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Lee et al., 2008).  As a result, the questionnaire study considered whether the 
impact of self-efficacy beliefs upon these outcomes could add to existing 
knowledge.  It is acknowledged that the findings indicate that predictors a
variables related to work ability and employment status are likely to alter over 
time; therefore, highlighting the importance of re
nd 
searchers adopting a 
longitudinal methodological approach.  Factors related to perceived work ability 
p 
 not 
rk 
 
 after 
 
ss 
ding 
most 
 
cing 
 a 
decline in symptom distress and improved quality of life outcomes.  Such a 
outcomes cross-sectionally included type of occupation and quality of life at 
baseline, treatment type at follow-up time 1 and job self-efficacy at follow-u
time 1 and 2.  In contrast, factors related to employment status (i.e. working,
working) were job self-efficacy at baseline and occupation and perceived wo
ability at follow-up time 2.  Along with self-assessed work ability at baseline,
receiving chemotherapy alone or a combination of treatments (i.e. other than 
surgery alone) were the strongest predictors of follow-up work ability 
(independent of age and occupation).  Finally, treatment type was also identified 
as the strongest predictor of employment status approximately six months
diagnosis; therefore, receiving chemotherapy alone or a combination of
treatments had the significant impact on colorectal patients not going back to 
work. 
Although job self-efficacy was not found to be significant in the longitudinal 
models assessing predictors of work ability and employment status, the cro
sectional findings suggest otherwise.  When considered along with the fin
that treatment type predicted follow-up work ability and employment status 
appropriately, implications for future interventions can be posited.  Treatment 
type has been proven to be associated with work ability (e.g. Bradley et al., 
2007; Taskila et al., 2007; Henry et al., 2008; de Boer et al., 2008) and 
employment outcomes (Taskila et al., 2007); therefore, those receiving either 
chemotherapy or more than one treatment modality are likely to experience a 
greater detriment upon their work ability and are less likely to be working when 
compared with those receiving surgery alone.  These results suggest that this
detrimental impact may be more pronounced for those possessing low self-
efficacy beliefs.  Indeed, Lev et al. (2001) employed a self-efficacy enhan
intervention in breast cancer patients undergoing chemotherapy that led to
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technique could be used with working-aged cancer patients that could ai
management which in turn could lead to improved work ability and bet
d self-
ter 
employment outcomes.  In terms of practice, informing newly diagnosed 
 
 that the role of self-efficacy in the self-
management of cancer and return to work intentions appeared to be more 
k 
 
ough 
 
al., 
2008).  Follow-up diary data indicated that increased symptom burden resulted 
working-aged patients about the potential impacts of treatment on work ability
could be useful, prior to the start of treatment.   
Temporal Fluctuations and Patterns in Cancer Management, Return to Work 
Intentions and Work Ability: The Role of Self-Efficacy and Social Support  
Results from the diary study showed
complex than the findings suggested by the questionnaire study.  From the 
early diaries, self-efficacy levels appeared to affect participants’ return to wor
intentions, whereby high self-efficacy beliefs seemed to be associated with a 
greater desire to return to work.  However, at some point during the study, all of
the participants expressed an intention to return to work; findings beyond 
baseline suggested that this relationship was unlikely to be simplistic.  
Therefore, several factors seemed to impact return to work intentions and self-
efficacy.  Treatment (chemotherapy, fatigue and other symptoms) and 
decrements in perceived work ability were identified as the most prominent 
factors.  Furthermore, the findings that treatment type and diminished work 
ability were commonly referred to as problematic factors corroborated the 
results obtained from the longitudinal questionnaire study.  However, the 
questionnaire analyses did not identify fatigue as a factor related to (cross 
sectional), or, a predictor (longitudinal) of work ability or employment status.  An 
explanation for this could be because the measure utilised to assess fatigue 
(Fatigue Severity Scale; Krupp et al., 1989) was not sensitive / specific en
for this patient group.  Nevertheless, this finding is in line with previous research
(Spelten et al., 2002; Spelten et al., 2003; Kennedy et al., 2007; Steiner et 
in poorer self-efficacy in ability to resume work.  These participants exhibited 
the most temporal fluctuations in both cancer and work-related self-efficacy 
beliefs (self-assessment of self-efficacy varied from high-to-low).  These 
findings therefore lend support to previous findings that a more profound 
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detriment is seen in those reporting more symptoms (Short et al., 2005; 
Bouknight et al., 2006; Taskila et al., 2007; Feuerstein et al., 2007).   
These qualitative findings add to existing knowledge, particularly quantitative 
study results by showing that those not returning to work are not necessarily 
choosing this option because they do not wish to work; instead, barriers such as 
ses 
have 
her 
ance 
iends, 
dy et al., 2007; Sapp et al., 2003; Michael et al., 2002; 
Jackson et al., 2007).  Alternatively, in relation to work-related guidance, very 
text 
th 
 
d from 
sed 
y 
ork ability.   
ed 
their treatment may be stopping them from returning.  This further emphasi
the importance of offering temporary work adjustments to patients who 
strong intentions to return to work.   
When attempting to understand how self-efficacy levels were related to return to 
work intentions and perceptions of work ability, social support adds anot
dimension to the overall picture.  The presence of support appeared to enh
participants’ self-efficacy beliefs.  The most favourable outcomes were seen in 
those who received support from a wide network comprised of family, fr
employers and health professionals.  The majority received support from their 
employers and the support was reported as beneficial; a finding that is in line 
with others (Kenne
little, or no support was received from health professionals.  Within the con
of this study, those not having a discussion regarding work-related matters wi
their health professional may have assumed that they would not be able to
work.  In the diaries, it was clear that most patients would have benefite
such support.  Previous studies also report that cancer patients rarely discus
work issues with their health professionals (Maunsell et al., 1999; Main et al., 
2005; Kennedy et al., 2007).  These findings highlight the importance of 
considering the role of health professionals as it may be significant, particularl
in relation to understanding how participants perceived their w
The Need for Work-Related Advice: The Role of Health Professionals 
The diary study showed that few participants received work-related guidance 
from a health professional associated with their care.  This, along with the 
findings from the questionnaire study that treatment type may impact perceiv
work ability and subsequent employment outcomes (i.e. chemotherapy or a 
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combination of treatments less likely to be working) suggests that these patie
may have benefited from some work-related guidance.  For instance, it may 
have helped those with high self-efficacy and high return to work intentions
diminished work ability to discuss the possibility of temporary work adjustments
during treatment with their employer.   
Even though the diary study found that few patients received work-related 
support, the interview study suggests that health professionals are not 
necessarily reluctant about offering such guidance.  In fact, the health 
professionals’ interview study identified common patterns amongst the 
participants.  Most participants stated that they had a conversation with patie
about how to manage their work most appropriately, particularly during 
treatment; however, this seemed to be a matter that was discussed rather 
fleetingly.  This finding may be interpreted as encouraging as it indicates at the
very least that the type of information provided at present is somewhat 
consistent across different health fields (e.g. oncologist to occupational health 
physician); however, this emerged as an as
nts 
 but 
 
nts 
 
pect of patient care that was in need 
of improvement.   
were 
ences in 
health professionals’ views resulted in varied guidance; for example, the length 
urgery or whether a patient should 
. 
o 
When meeting with a new working-aged cancer patient, the majority 
drawing on past experiences to guide their practice and to inform the type of 
work-related guidance that they would provide.  Irrespective of the health 
professional’s field, participants usually took into account the patient’s 
treatment, symptoms, prognosis and type of work.  However, differ
of time deemed necessary to recover from s
work during treatment was diverse.  More importantly, such differences were 
evident between health professionals within the same field.   
Prior research has reported that patients and survivors received little or no 
work-related guidance from their treating health professional (Maunsell et al
1999; Kennedy et al., 2007).  In contrast, the findings generated from the 
interview study do indicate that health professionals try to offer work-related 
support and guidance, albeit limited.  The findings are invaluable and add t
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existing knowledge by offering explanations regarding the nature of current 
practice (or lack of) and potential improvements.  The majority of the 
professionals felt that their lack of knowledge coupled with an insufficient 
evidence base resulted in them being unaware of what was deemed to be th
most suitable approach.  Similarly, the absence of guidelines made it difficult to
ascertain the level and type of guidance that should be provided to patients.
This lack of clarity is concerning, particularly when some researchers have 
argued that with the continuity of care more specific guidance (e.g. work-
related) could be possible (Verbeek et al., 2006).  Moreover, when considering
these findings along with those obtained from the questionnaire and diar
studies, it is apparent that those receiving more than one treatment type or 
chemotherapy (diary study) are more likely to experience diminished work 
ability.  Furthermore, those possessing low self-efficacy beliefs, lack of supp
and increased symptom burden appear to be most at risk of experienc
most profound impact upon work ability and return to work outcomes.  
Therefore, it 
health 
e 
 
  
 
y 
ort 
ing the 
is plausible to suggest that there is a need to address the type of 
support provided by health professionals.   
 
mportance of adopting a prospective design are 
reflected by the findings presented within this thesis; whereby the factors 
Most importantly, the interviews yielded insightful suggestions about the 
possible design, structure and implementation of future intervention 
endeavours; hence, suggesting areas for future research especially in terms of 
possible pilot interventions.  It was encouraging to find that the majority of 
participants felt that some form of intervention was required to ensure patients 
were provided with the most appropriate work-related guidance.   
8.1. Methodological Considerations 
In the review of existing literature, several limitations were identified.  Previous 
research has utilised various cancer types or has largely considered women 
affected by breast cancer.  Similarly, many studies have adopted a cross-
sectional design which renders it difficult to map factors predicting employment
outcomes over time.  The i
related to work ability and employment status were found to vary over the six 
month period.  In addition, only a small number of findings are based on a 
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sample of cancer patients or survivors from the UK and little is known about 
those diagnosed with colorectal cancer.  Further to this, a degree of 
inconsistency regarding the assessment of work ability was inherent (T
al., 2007).  Whilst this study has its strengths in that it attempted to address 
these prior limitations, it is not without its own weaknesses.  Participants were 
recruited via NHS Trusts or a support group.  Not all cancer patients utilise 
support groups, thus it is difficult to ascertain the extent to which these results
are reflective of all colorectal cancer patients.  Similarly, it was not possible to 
compare the demographic and cancer-related information of those who we
successfully recruited from the NHS Trusts and those who chose not to 
participate.  It is also acknowledged that those choosing to participate may ha
already possessed high levels of self-efficacy, hence, leading to the proble
self-selection bias.  However, the diary study found self-efficacy fluctuated 
temporally, even in those who exhibited high levels at baseline; more 
pronounced changes were apparent in individuals undergoing chemotherap
treatment.   
When considering the study sample further, it is noted that the absence of a 
disease-free, working-age comparison group renders it difficult to determine 
whether changes in self-efficacy, work ability and employment status were 
exclusively attributable to cancer and its treatment.  In addition, the absence of 
a control group makes it difficult to ascertain whether scores assessed by th
questionnaire regressed toward the mean (Shaughnessy & Zechmeister, 1990)
Noneth
askila et 
 
re 
ve 
m of 
y 
e 
.  
eless, recruiting patients was a challenge for the researcher as 
resources were limited.  It could be argued that the most useful approach to 
y would be to develop 
ta to 
o 
improve sample size, overall research design and reliabilit
a nationwide multi-disciplinary team.  This concerted effort would allow da
be collected from a greater number of NHS Trusts; furthermore, this would als
be the most appropriate route for implementing future interventions.  Inevitably, 
this would facilitate a greater understanding into how cancer patients manage 
their treatment and work.  
Overall, the scales utilised to measure the various dimensions of psychosocial 
well-being (fatigue, depression, quality of life, cancer self-efficacy) and work-
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related factors (work ability and job self-efficacy) were robust and validated; 
however, certain scales may have lacked a degree of specificity when applied 
to the colorectal cancer sample.  For example, some of the items that 
comprised the Beck Depression Inventory (Beck et al., 1996) may have been a 
 
 the 
 
 
ary burden on participants; therefore, an effort was made to keep 
scales (i.e. length) minimal: this may have helped to maintain participation (one 
useful 
cy 
ng 
d, it is 
ent 
o 
 of 
s 
side effect of chemotherapy treatment (e.g. items related to tiredness and lack
of energy) rather than a depressive symptom per se.  Similarly, in hindsight,
measure used to assess fatigue (Fatigue Severity Scale; Krupp et al., 1989) 
may have been too generic in nature.  In addition, correlations between some of 
these measures indicate that a level of common variance may have been 
inherent; for example, the quality of life (FACT-G; Cellar et al., 1993) and 
depression (BDI; Beck, 1972) measures were significantly correlated at both
follow-up time 1 and time 2 (r = -0.82; r = -0.80), thus, raising the issue of 
duplication. However, such measures have previously been adopted in studies
utilising cancer samples.  Furthermore, it was important not to place an 
unnecess
participant withdrawal) over the study duration.  The measure used to assess 
job self-efficacy was a modified version of a return to work self-efficacy scale 
designed for those with back pain (Shaw & Huang, 2005).  Even though this 
measure was found to be related to work ability and employment status cross-
sectionally, it was not significant in the prospective models.  It would be 
to follow-up these patients post-treatment to see whether this would alter.  
Alternatively, it may be worthwhile to design a cancer specific job self-effica
scale. 
8.2. Implications of Findings and Future Directions 
Undoubtedly, the implications of these findings suggest that self-efficacy 
warrants further investigation in this area of research.  Indeed, it is not bei
proposed that self-efficacy be considered alone in future research; instea
a factor that needs to be studied alongside pre-existing ones such as treatm
type and fatigue that have previously been found to impact work ability, return t
work and employment outcomes.  Furthermore, there is a need to consider self-
efficacy beliefs in other cancer groups as these findings may not be reflective
the general cancer population.  Additionally, this would enable any difference
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to be mapped.  Alternatively, these results do implicate the role of treatmen
perhaps being of more importance than cancer type itself.  However, this is a
matter that needs to be addressed in future research endeavours.   
Self-efficacy beliefs are argued to be amenable to change (Lev et al., 2001).  
Interventions incorporating self-efficacy enhancing techniques could prove 
beneficial especially for patients whose treatment is multi-faceted or those who
experience a greater degree of symptom burden.  This is because these results 
indicate that these individuals are likely to encounter the most detrimental 
impact in terms of their work ability.  Consequently, researchers need to find
way to minimise this impact.  The findings showed that self-efficacy beliefs 
improved over time; therefore, it could be argued that offering some form 
guidance would be most beneficial at an early stage.  Further to this, the di
study results imply that the presence of support could also enhance self-ef
beliefs.   
Based upon the diary study results, it seemed appropriate to recommend t
support in the form of advice or guidance could be provided in a rather gene
form at the outset.  Tailored support could then be provided based upon the 
specific needs of the individual, such as their perceived self-efficacy (to ma
cancer and return to work), work ability and type of job once treatment, 
t as 
 
 
 a 
of 
ary 
ficacy 
hat 
ric 
nage 
particularly chemotherapy has commenced.  However, it has been suggested 
is difficult to carry out (Mock, 1998).  This is further 
iagnosis.  
Future research could therefore involve carrying out two studies with health 
professionals that would help to identify aspects to be included in any given 
that doctors may find th
supported by the findings that emerged from the health professionals’ interview 
study.  These participants indicated that the most effective strategy would be 
one that involved various health professionals as opposed to a particular 
individual being allotted the role.  Subsequently, the most useful approach is 
likely to include the general practitioner, consultant surgeons, consultant 
oncologist, specialist nurses and where possible an occupational health 
professional.  However, prior to the implementation of an intervention, it is 
necessary to formulate guidance for health professionals to ensure consistent 
work-related support is provided to those that are in employment at d
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guidance.  Firstly, a questionnaire could be designed and completed by a 
variety of health professionals that are most likely to be involved in a cancer 
patient’s care (consultant surgeons, oncologists, specialist nurses, general 
practitioners, occupational health professionals).  Secondly, for more in-depth 
data a sub-sample could participate in a semi-structured interview.  To furthe
ensure that the correct guidance is provided to health professionals, cancer 
patients and survivors could be interviewed to explore the most useful type of 
support (i.e. information) that could be provided.  Additionally, incorporatin
patient and their employer in the overall management of work and cancer was 
deemed to be important.  From patients’ point of view, having a discussion 
regarding work ability during and after cancer treatment could facilitate better 
management of their work.  Similarly, the diary study highlighted that the 
involvement of the employer is also important.  It was apparent within this 
sample that participants wished to return to work.  However, reduced self-
efficacy in ability to perform their job and treatment was preventing a return.  In 
response, employers (especially those without a return to work policy) could be 
educated and trained on how to manage an employee with cancer and to 
facilitate work adjustments where possible.  Future research could involve 
interviewing employers to identify where gaps in knowledge may lie.  This could 
then lead to a brief leaflet or tool being developed that details how certain 
treatments may impact employees and how a return to work could be manag
8.3. Conclusion 
The data collected from this study provides an account of how colorectal cancer 
patients manage their disease and work from the point of diagnosis and durin
treatment.  The role of self-efficacy, to the researcher’s knowledge, has not 
previously been considered in this area.  Despite the sample being relatively 
small, the longitudinal nature of the overall study and the results obtained 
indicate the richness of the data collected.  Furthermore, adopting a mixed-
methodological a
r 
g the 
ed.         
g 
pproach allowed for a more comprehensive understanding of 
the temporal changes and patterns in self-efficacy, work ability, return to work 
intentions and employment outcomes to be identified in this group.   
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In sum, the findings provide invaluable knowledge about how colorectal canc
patients’ self-efficacy beliefs impact work ability, return to work intentions and 
employment status.  Furthermore, the findings from the study indicate tha
predictors and variables related to work ability and employment status are likely 
to alter over time.  Over a six month period, cancer self-efficacy and job self-
efficacy were found to improve over time.  Closer examination of changes in job
self-efficacy according to treatment group suggested that compared with th
receiving surgery alone, those receiving chemotherapy or more than one 
treatment type showed a decline in scores between baseline and follow-up tim
one.  However, this group difference was not statistically significant.  Despite 
this, it should not go unnoticed as it identifies a possible point at which patients 
could be offered support (e.g. guidance about treatment effects in relation to 
work outcomes).  This is further supported by the work ability findings, where
a significant time x treatment type ef
er 
t 
 
ose 
e 
by, 
fect was found.  Furthermore, treatment 
type was also identified as a predictor of follow-up work ability and employment 
status; those receiving chemotherapy alone or a combination of more than one 
treatment type were most likely to report worse work ability and were less likely 
to be working at follow-up.  The diary study findings yielded results that were 
further insightful.  In particular, it was apparent that most participants displayed 
high self-efficacy levels in relation to managing their work and expressed an 
intention to return to work; however, barriers were apparent: notably cancer 
treatment and treatment effects often led to diminished work ability which 
seemed to prevent patients resuming work.  Based upon these findings, it is 
plausible to suggest that it would be useful to provide colorectal cancer patients 
and perhaps cancer patients in general with information about the impact of 
cancer and its treatment on work ability.  Whilst, the diary study identified that 
only a few participants received verbal work-related guidance or information 
from their treating health professional, the health professionals’ interview study 
suggested that the majority felt this was an aspect of patient care that needed to 
be addressed.   
Moreover, the results in their entirety suggest that patients, who undergo more 
than one treatment modality, report the most symptom burden and have poor 
social support networks are most at risk of reporting worse work ability and work 
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outcomes.  Furthermore, this unfavourable impact is likely to be even more 
ronounced in those possessing low levels of self-efficacy.  Consequently, it is 
 
r, prior to developing any form of intervention for patients, researchers 
need to address the lack of knowledge found to be inherent among health 
 employment outcomes 
f 
tion is 
provided to working-aged patients.  
p
important to work towards ensuring that these individuals especially are 
provided with information and guidance (e.g. from a health professional) so that
they are aware of the potential impacts of cancer and its associated treatments.  
Howeve
professionals.  Developing some form of guidance for health professionals 
regarding the impacts of cancer upon work ability and
would essentially ensure that patients are provided with a consistent level o
work-related guidance.  Therefore there is much scope to develop interventions 
for the patients themselves and guidance for healthcare professionals and the 
employment sector to ensure that the necessary support and informa
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Appe
 
The TNM Staging System
ndices 
 
 
Tumour size (T) is staged as follows:  
 
 tained within the inner lining of the bowel wall. 
• 
• 
• at are 
 
Subse
 
• -3 lymph nodes contain cancer cells. 
• N2 – 4 or more lymph nodes contain cancer cells, which are more than 
3cm away from the primary tumour (Cancer Research UK, 2002). 
 
The degree of metastasis (M) is staged in two ways: 
 
• M0 – The cancer has not spread to any other part of the body. 
• M1 – The cancer has spread to other parts of the body. 
 
Therefore, once the cancer has been categorised according to the above it is 
assigned one of the following stages: 
 
• Stage 0 – The cancer cells are confined to the lining of the bowel. 
• Stage 1 – Cancer cells are present in the inner lining of the bowel, or 
have grown into the muscle layer of the bowel.  However, cancer cells 
are not present in the lymph nodes (T1, N0, M0 or T2, N0, M0). 
• Stage 2 is divided into: 
• T1 – The tumour is con
T2 – The tumour has grown into the muscle layers of the bowel wall. 
T3 – The tumour has grown through the membrane covering the outside 
of the bowel. 
T4 – The tumour has expanded into other parts of the body th
located nearby to the bowel. 
quently, lymph node (N) involvement is categorised as follows: 
• N0 – No lymph nodes contain cancer cells. 
N1 – 1
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Stage 2a – The cancer has passed through the outer membrane of the 
bowel.  However, the lymph nodes do not contain cancer cells (T3, N0, 
M0). 
Stage 2b – The cancer has passed through the membrane covering the 
bowel wall into surrounding tissues / organs nearby.  There is no lymph 
node involvement or metastasis (T4, N0, M0). 
• Stage 3 is divided into: 
Stage 3a – The cancer cells are contained within the inner layer of the 
bowel, or have grown into the muscle layer.  In addition, between 1 and 3 
lymph nodes nearby contain cancer cells (T1, N1, M0 or T2, N1, M0). 
Stage 3b – The cancer has passed through the bowel wall, or 
surrounding tissues / organs.  In addition, between 1 and 3 lymph nodes 
nearby contain cancer cells (T3, N1, M0 or T4, N1, M0).   
Stage 3c – The cancer can be of any size, spread to 4 or more lymph 
nodes.  However, there is no metastasis (anyT, N2, M0).  
• Stage 4 – The cancer has spread to other parts of the body (anyT, anyN, 
M1).  
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Participant Invitation Letter 
 
adam, 
earch student undertaking 
naging Cancer and Employment at Loughborough University.  
ospital, and has also been approved by the Research Ethics Committee. 
 at e management of cancer, and the effect this has on a person’s 
ork.   
ipating in this research project does n cal treatment, but it 
ill give you the opportunity to discuss how you manage your illness and work (if 
ate in th at 
our treatment in a  
tion collected during the course of th  confidential. 
ils are given in the attached information sheet.  If you are interested in 
king part, or would like some more information contact Miss Bains directly (Tel: 
ains@lboro.ac.uk
ithfully 
 
Dear Patient / Sir / M
 
We would like to let you know about a research study that is being undertaken in our 
Colorectal Department by Miss Manpreet Bains, who is a res
a PhD in Ma
 
The proposal has been approved by the Research and Development office at this 
H
 
Miss Bains would greatly appreciate any help you are able to offer with this study, 
which aims to look th
ability to w   
 
Partic ot form part of your clini
w
employed).  Choosing not to particip is study, or withdrawing from the study 
any stage, will not affect y ny way.  If you do decide to take part all
informa e study will be kept strictly
 
Further deta
ta
01509 228152 E-mail: M.B ). 
 
Yours fa
 
 
Consultant Surgeon 
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Research Participant Information Sheet 
 
Managing Cancer and Employment 
 
• Approximately 40% of all cancer patients take time off work during 
treatment and recovery. 
• Return to work rates in cancer patients range from 30-93% 
• Why do some people choose to stop working whilst others continue? 
• How confident do you feel about managing your illness and your work? 
 
We are running a study to look at the management of cancer, and the effect this has on 
ability to work.  We are interested in hearing from people who work full or part-time or 
are on sick leave. 
 
You are being invited to take part in a research study.  Before you decide it is important 
for you to understand why it is being carried out and exactly what is involved.  Please 
take your time to read through the following information carefully.  If anything is unclear 
please do not hesitate to get in touch with us for more information. 
 
1.  What is the purpose of the study? 
The purpose of the study is to investigate cancer patients’ experiences in managing 
cancer.  Evidence suggests this age group is more likely to take time of sick, and less 
likely to return to work.  Past research tells us for some cancer patients returning or 
continuing with work is straightforward, however, for others it can be challenging.  We 
want to know whether you are currently employed (full or part-time) or on sick leave, 
and how cancer may have impacted your working life.  We also want to know how 
confident you are feeling about managing your symptoms and illness.   
 
2.  Why have I been chosen? 
We would like to gain an insight into whether cancer patients continue to work, take 
sick-leave, leave work, or retire after diagnosis.  This will help us to better understand 
the needs of this group.  We are interested in your views on your health, your work and 
work environment (if you are working) and your feelings towards managing your health 
and work effectively.  We have chosen to include people who meet the following 
criteria: 
 
1. Be in employment at the time of diagnosis (including those currently on sick-
leave) (≥18.5 hours per week). 
2. Diagnosed with colorectal cancer. 
3. Provide written informed consent. 
4. Have a permanent address or contact details. 
 
3.  Do I have to take part? 
Whether or not you decide to take part is entirely up to you.  If you do decide to take 
part, you may keep this information sheet and you will be asked to read and complete a 
consent form.  If you decide to take part you have the right to withdraw from the study 
at any time without giving us a reason.  Choosing not to participate in this study, or 
withdrawing from the study at any stage, will not affect your treatment/standard of care 
in any way.       
 
4.  What do I have to do? 
• If you would like to participate you will be asked to complete a consent form.   
• After this you will be asked to complete a questionnaire.   
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• The questionnaire will ask you about your health and whether or not you are 
working.  The questionnaire will ask you about any concerns you may have 
about your health and your work (if you are working).   
• To monitor any changes in your health and work, this same questionnaire will 
be sent to you again three months later, and if appropriate six months later.   
• You will also have the opportunity to complete a monthly diary, which is 
optional.  This will ask you about your feelings of confidence in managing your 
symptoms, diet, activities, cancer and work (if you are working).   
• We will provide you with stamped-addressed envelopes to return all study 
materials to us.   
 
5.  What are the possible disadvantages and risks of taking part? 
The areas covered in the questionnaire and diary booklet are not designed to cause 
you any distress.  However, we acknowledge that some people may view them as 
being sensitive.  We would like to reassure you that the necessary measures will be put 
in place to deal with this should it occur.  Your clinician and nurse will be briefed if you 
take part.  In addition, if you feel distressed at any point you can contact Cancerbackup 
(0808 800 1234), or your Patient Advice and Liaison Service (PALS).  It may be one of 
your concerns that your confidentially might be at risk if you do discuss personal 
experiences. We would like to reassure you that taking part will be completely 
confidential.  We would like to reassure you that you can withdraw from the study at 
any point without providing us with a reason.  Your welfare and well-being is of key 
importance, and we would retain this thought throughout the study period.  
 
6.  What are the possible benefits of taking part? 
Participating in this research project will give you the opportunity to discuss how you 
manage your illness and work (if employed).  By gathering information on your 
thoughts and experiences we aim to be in a position to design interventions to help 
people like you better manage cancer and employment.  With this information we can 
work with organisations and healthcare professionals to ensure that the necessary 
support and information is given to working-aged patients.  With your help we hope to 
highlight the barriers that may be preventing some individuals from continuing with/or 
returning to work.   
 
7.  What happens when the research study stops? 
The principal investigator (Manpreet Bains) will write up the results of the study and 
discuss the implications of the findings with staff in the Human Sciences Department  
at Loughborough University.  A summary of the findings and the associated guidance 
will be provided to both you and your NHS Trust. 
 
8.  Will my taking part in this study be kept confidential? 
We aim to ensure anonymity of participants at all times. All information that is collected 
about you during the course of the study will be kept strictly confidential.  Any 
quotations utilised from your comments and findings will be presented anonymously.  
All consent forms will be separated from the responses on receipt of the questionnaire 
by the research team. The study will comply with the Data Protection Act of 1998.  
 
9.  What will happen to the results of the research study? 
The results will be held on a personal computer until the project is complete.  The 
principal investigator (Manpreet Bains), Dr Fehmidah Munir (chief investigator and 
project supervisor) and Dr Joanna Yarker (co-supervisor) are the only people that will 
have access to the results.  If the study is successful and put forward for publication, 
we will ensure that the presentation of any results will not identify any individual’s 
details. 
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10.  Who is organising and funding the research? 
The research is being organised by Miss Manpreet Bains and Dr Fehmidah Munir at 
Loughborough University, and Dr Joanna Yarker at Goldsmiths College, London.  
 
11.   Who has reviewed the study? 
This study has been reviewed and given a favourable ethical opinion for conduct by an 
NHS Research Ethics Committee and Loughborough University’s Ethical Advisory 
Committee. 
 
12. What if something goes wrong? 
If you are harmed by taking part in this research project, there are no special 
compensation arrangements.  If you are harmed due to someone’s negligence, then 
you may have grounds for a legal action but you may have to pay for it and should 
consult a solicitor specialising in clinical negligence.  Regardless of this, if you wish to 
complain about any aspect of the way you have been approached or treated during the 
course of this study, the normal National Health Service complaints mechanisms may 
be available to you.  The Patient Advice and Liaison Service at are available to help if 
you have any concerns, or require advice: (Birmingham – (0121) 424 1212; Nottingham 
- (0115) 9249924 ext 64924) 
 
13.  Contact for further information 
If you require more information, or wish to take part in this study please contact: 
 
 
 
Miss Manpreet Bains, Principal Investigator. 
PhD Research Student.  BSc (Hons).  MSc. Health Psychology. 
 
Department of Human Sciences 
Loughborough University 
Loughborough 
Leicestershire 
LE11 3TU 
 
Email: M.Bains@lboro.ac.uk 
Tel: 01509 228152 
 
Thank you for taking the time to read this information sheet. 
 
 If you have any queries please contact: 
Manpreet Bains (Principal Investigator) Tel: 01509 228152   
E-mail: M.Bains@lboro.ac.uk or Dr Fehmidah Munir (Chief Investigator) Tel : 01509 228228 
E-mail : F.Munir@lboro.ac.uk
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If you have any queries please contact: 
Manpreet Bains (Principal Investigator) Tel: 01509 228152   
E-mail: M.Bains@lboro.ac.uk or Dr Fehmidah Munir (Chief Investigator) Tel : 01509 228228 E-mail : 
F.Munir@lboro.ac.uk 
 
 
RESEARCH PARTICIPANT CONSENT FORM 
 
MANAGING CANCER AND EMPLOYMENT 
 
      (Please circle) 
 
1.  Have you read the participant information sheet (version 2, 12/12/2007)?  
        
       YES/NO 
 
2.  Have you had the chance to discuss this study and ask questions about it? YES/NO 
 
3.  Have you had the satisfactory answers to all your questions?   YES/NO 
 
4.  Have you been given enough information about the study?   YES/NO 
 
5.  Who has explained the study to you?.................................................................YES/NO 
 
6.  Do you understand that you are under no obligation to take part in the study? YES/NO 
 
7.  Do you understand that you are free to withdraw from the study?   
• At any time? 
• Without having to give a reason? 
• Without affecting your future medical care?     YES/NO 
 
8. Do you understand that all information that you provide will be treated as  
      STRICTLY CONFIDENTIAL?      YES/NO 
 
9.  Do you understand that any material used in project reports and academic YES/NO 
     papers will be used anonymously and will not identify you in any way?    
 
10.  Do you give permission for the researcher to contact a colorectal nurse if  YES/NO 
       they become concerned for your well being?    
 
11.  I understand that sections of any of my research records may be looked YES/NO 
      at by responsible individuals from regulatory authorities or from the NHS Trust 
      where it is relevant to my taking part in research.  I give permission for these 
      individuals to have access to my records. 
 
12.  Have you had enough time to come to a decision?    YES/NO 
 
13.  Do you agree to take part in this study?     YES/NO 
 
• Would you like to participate in the diary element of the study? 
YES    NO 
Participant Name:    Date:   
Address:     E-mail:   
 
Participant Signature:    
Investigator Signature:      
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Today’s date:  
 
Part 1: About you 
 
The following questions are confidential; answers will not be used to identify individuals.  This 
information is very useful as it will help us look for patterns among cancer patients.  Please tick 
or write the answer that best applies to you in the space provided. 
 
1. Gender: 
 
    Male     Female     
 
 
2.  Date of Birth: 
   
3.  Ethnicity:  (please choose one section from a) to e) and then tick the box that best  
    applies to you).  
 
a)  White  
 
b)  Mixed 
British 
 
White and Black Caribbean 
Irish 
 
White and Black African 
Any other white background 
 
White and Asian 
c)  Asian or Asian British Any other mixed Background 
 
Indian 
 
d)  Black or Black British 
Pakistani 
 
Caribbean 
Bangladeshi 
 
African 
Any other Asian Background 
 
Any other Black Background 
e)  Chinese or other ethnic group 
 
Chinese 
 
Any other ethnic group 
 
 
4.  Please indicate below your height and weight.  Please circle measurement    
     used.  
 
     Height:  feet/inches   Weight:     Stones/lbs 
   or metres          or kilos 
 
 
 
 
 
 
Managing Cancer and Employment:  Background Questionnaire 
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5.  Education level (please tick the box next to your highest qualification) 
      
None 
 
Degree 
GCSE (or equivalent) 
 
Higher Degree (MSc, MA, PhD) 
AS Level (or equivalent) 
 
 
 
Part 2:  About your work 
 
6.  How would you describe your current employment status? 
Working full-time 
 
On sick leave Incapacity Benefit 
Working part-time 
 
Unemployed Retired 
 
7.  What is/was your occupation? 
 
         
 
8.  How long have you/did you work  
       in this role? 
 
                      
 
 
                       Years                     Months 
 
 
9.  Do you/did you do shift work or 
       regular hours? 
 
10.  What sort of employment contract 
       do you/did you have? 
Shift work 
 
Permanent 
Regular hours Fixed-term 
 
 
11.  Approximately how many people are/were employed by your organisation? 
1-10 employees 
 
50-199 employees 1000+ employees 
11-49 employees 
 
200-1000 employees Not applicable  
Self employed 
 
12.  Salary: (please tick the box that best applies/applied to you) 
Up to £15,000 
 
£21,100 - £25,000 £34,100 - £45,000 
£15,100 - £21,000 
 
£25,100 - £34,000 Above £45,100 
 
Part 3: About your condition 
  
13.  What type of cancer do you have? 
 
14.  When were you diagnosed? 
                      Year                     Month 
 
  
 
15.  What is the severity of your condition (stage and grade)? 
 
                                            Don’t know        
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16.  Please complete the table below about the treatments you are receiving/  
       have already received (please circle all that apply). 
 
Treatment Receiving Frequency Complete 
Surgery 
 
 
 
Yes 
 
No 
 Yes 
 
No 
Chemotherapy 
 
Yes 
 
No 
Daily 
 
Weekly 
 
Monthly 
 
Yes 
 
No 
Radiotherapy 
 
 
 
 
Yes 
 
No 
Daily 
 
Weekly 
 
Monthly 
 
Yes 
 
No 
Other (Please 
specify) 
 
 
 
 Daily 
 
Weekly 
 
Monthly 
 
Yes 
 
No 
 
17.  Have you been diagnosed with 
cancer in the past? 
18.  What type(s) of cancer(s) were   
       you diagnosed with and when? 
Yes 1.                                Date 
 
No        
        ease go to Q38) 
2.                                Date 
 3.                                Date 
 
 
 
19.  What type(s) of treatment(s) did you receive? Please tick the appropriate  
       boxes. 
Surgery               1   
 
Chemotherapy            1           2           3 
 
Radiotherapy      1   
 
Hormone Therapy      1           2           3 
 
 
 
20.  Do you currently have any other  
       chronic or life threatening   
       diseases? 
 
21.  Are you currently receiving any  
       other treatment(s) for any other  
       conditions? 
Yes  (Please specify) 
 
                  
 
 
                               
Yes           (Please specify) 
 
                  
 
 
                                                                          
No        
        
No             
 
 
Thank you for taking the time to complete this questionnaire! 
     
          
          
     
         (Pl
        2           3 
        2           3 
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                                                              Today’s date: 
 
Why is this research important? 
 
We would like to gain an insight into the employment decisions of cancer patients. We 
are interested in your views on your health, your work and your feelings towards 
managing your health and work effectively. 
 
By gathering information on your thoughts and experiences we aim to be in a position 
to design interventions to help people like you better manage cancer and employment.  
With this information we can work with organisations and healthcare professionals to 
ensure that the necessary support and information is given to working-aged patients.   
 
What do I have to do? 
Completion of this confidential questionnaire is entirely voluntary, but we would be 
grateful for your help with this study because your contribution can make a big 
difference.  The questionnaire overleaf should take approximately 30 minutes to 
complete.  There are three sections to this questionnaire: 
 
• Section A is to be completed by all participants 
 
• Section B is to be completed only by those who are currently working 
 
• Section C is to be completed only by those who have stopped working or 
who are on sick leave. 
 
Please be as frank and honest as possible.  Do not dwell too long on any one question 
as it is your initial thoughts and feelings that are most valuable.  Please return your 
completed questionnaire to us in the prepaid envelope provided by (insert date). 
 
What happens after I have returned my questionnaire? 
The questionnaires will come back to the principal investigator (Manpreet Bains) at the 
University.  No one will see your questionnaire.  The questionnaire is anonymous, 
therefore, no individual can be identified. 
 
Any questions? 
Please feel free to contact Manpreet Bains, the principal investigator at the University 
on  (01509) 228 152, or M.Bains@lboro.ac.uk
 
Should the questionnaire raise any health issues which you would like to discuss with 
someone, you should contact your clinician, nurse or Cancerbackup (0808 800 1234). 
 
 
 
 
Thank you for your time and help! 
 
 
 
 
 
 
Managing Cancer and Employment: Questionnaire Assessment 1 
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Section A is to be completed by all participants 
 
1. Below are a series of statements regarding fatigue.  By fatigue we mean a sense of tiredness or lack of energy. 
 
   Please read each statement and circle a number from 1 to 7 that indicates your degree of agreement with each  
   statement where 1 indicates you strongly disagree and 7 indicates you strongly agree.  Please answer these  
   questions as they apply to the past 4 weeks. 
 
                                                                                                       Strongly                      Strongly
                 Disagree           Agree
a) My motivation is lower when I am fatigued 
 
1 2 3 4 5 6 7 
b) Exercise brings on my fatigue 
 
1 2 3 4 5 6 7 
c) I am easily fatigued 
 
1 2 3 4 5 6 7 
d) Fatigue interferes with my physical functioning 
 
1 2 3 4 5 6 7 
e) Fatigue causes frequent problems for me 
 
1 2 3 4 5 6 7 
f) My fatigue prevents sustained physical functioning 
 
1 2 3 4 5 6 7 
g) Fatigue interferes with carrying out certain duties and responsibilitie
 
1     2 3 4 5 6 7 
h) Fatigue is among my three most disabling symptoms 
 
1      2 3 4 5 6 7 
i) Fatigue interferes with my work, family, or social life 
 
1 2 3 4 5 6 7 
 
2. Below is a list of statements that other people with your illness have said are important.   
 
    Please read each statement and circle a number from 0 to 4 that indicates how true each statement has been for   
    you during the past 7 days, where 0 indicates it has been not at all true and 4 indicates it has been very much  
    true. 
  Not at 
all true
true 
A little 
bit 
Some-
what 
Quite 
a bit 
Very  
much
true 
1) I have a lack of energy 
 
0 1 2 3 4 
2) I have nausea 
 
0 1 2 3 4 
3) Because of my physical condition, I have trouble meeting the needs of my
family. 
0 1 2 3 4 
4) I have pain 
 
0 1 2 3 4 
5) I am bothered by side effects of treatment 
 
1 2 3 4 5 
6) I feel ill 
 
0 1 2 3 4 
7) I am forced to spend time in bed 
 
0 1 2 3 4 
8) I feel close to my friends 
 
0 1 2 3 4 
9) I get emotional support from my family 
 
0 1 2 3 4 
10) I get support from my friends 0 1 2 3 4 
11) My family has accepted my illness 0 1 2 3 4 
Managing Cancer and Employment: Section A 
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12) I am satisfied with family communication about my illness 0 1 2 3 4 
13) I feel close to my partner (or the person who is my main support) 0 1 2 3 4 
14) Regardless of your current level of sexual activity, please answer the   
following question.  If you prefer not to answer it, please tick this box and
  go the next section ? 
I am satisfied with my sex life   
 
 
 
 
 
0 
 
 
 
 
 
1 
 
 
 
 
 
2 
 
 
 
 
 
3 
 
 
 
 
 
4 
15) I feel sad 0 1 2 3 4 
16) I am satisfied with how I am coping with my illness 0 1 2 3 4 
17) I am losing hope in the fight against my illness 0 1 2 3 4 
18) I feel nervous 0 1 2 3 4 
19) I worry that my condition will get worse 0 1 2 3 4 
20) I am able to work (include work at home) 0 1 2 3 4 
21) My work (include work at home) is fulfilling 0 1 2 3 4 
22) I am able to enjoy life 0 1 2 3 4 
23) I have accepted my illness 0 1 2 3 4 
24) I am sleeping well 0 1 2 3 4 
25) I am enjoying the things I usually do for fun 0 1 2 3 4 
26) I am content with the quality of my life right now 0 1 2 3 4 
               
 
3. We are interested in knowing how you feel.  Among the group of four statements in each question please 
choose one statement that best describes how you have been feeling during the past 4 weeks. 
 
Please circle the number beside your choice. 
a) 0   I do not feel sad 
1   I feel sad 
2   I am sad all the time 
3   I am so sad or unhappy that I can’t stand it 
b) 0   I feel the same about myself as ever 
1   I have lost confidence in myself 
2   I am disappointed in myself 
3   I dislike myself  
c) 0   I am not particularly discouraged about my  
     future 
1   I feel discouraged about the future than I used to be
2   I do not expect things to work out for me 
3   I feel worse that my future is hopeless and will 
     only get worse 
d) 0   I do not feel I am worthless 
1   I don’t consider myself as worthwhile and useful as  
     I used to be 
2   I feel more worthless as compared to other people 
3   I feel utterly worthless 
e) 0   I do not feel like a failure 
1   I have failed more than I should have 
2   As I look back, all I see is a lot of failures 
3   I feel I am a total failure as a person 
f) 0   I don’t have any thoughts of killing myself 
1   I have thoughts of killing myself, but I would not  
     carry them out 
2   I would like to kill myself 
3   I would kill myself if I had the chance 
g) 0   I get as much pleasure as I ever did from the things h) 0   I don’t cry any more than I used to 
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1   
2   
    
3   
    
i) 0   
1   
    
2   
3   
k) 0   
1   
2   
3   
m) 0   
1   
    
2   
    
3   
o) 0   I don’t criticise or blam
1   I am more critical of m
2   I criticise m
3   I blame m
q) 0   
1   
2   
3   
    
s) 0   
    
1   
2   
3   
u) 0   
1a 
1b
2a 
2b
3a 
3b
 I enjoy 
I don’t enjoy things as much as I used to 
I get very little pleasure from the things I used  
 to enjoy 
I can’t get any pleasure from the things I used  
 to enjoy 
1   I cry more than I used to 
2   I cry over every little thing 
3   I feel like crying, but I can’t 
ngs than  
eople or things
d to do 
ed to do 
uch 
ng 
very long 
y sleeping 
ack to sleep 
I don’t feel particularly guilty 
I feel guilty over many things I have done or 
 should have done 
I feel quite guilty most of the time 
I feel guilty all of the time 
j) 0   I am no more irritable than usual 
1   I am more irritable than usual 
2   I am much more irritable than usual 
3   I am irritable all the time 
I don’t feel I am being punished 
I feel I am being punished 
I expect to be punished 
I feel I am being punished 
l) 0   I have not lost interest in other people or activities 
1   I am less interested in other people or thi
     before 
2   I have lost most of my interest in other p
3   Its hard to get interested in anything 
I make decisions about as well as ever 
I find it more difficult to make decisions than 
 usual 
I have much greater difficulty in making decisions 
 than I used to 
I have trouble in making any decisions 
n) 0   I don’t get more tired than usual 
1   I get tired more easily than I used to 
2   I am too tired to do a lot of the things I use
3   I am too tired to do most of the things I us
    
e myself more than usual 
yself than I used to be 
yself for all of my faults 
yself for everything bad that happens 
p) 0   I have as much energy as ever 
1   I have less energy than I used to have 
2   I don’t have enough energy to do very m
3   I don’t have enough energy to do anythi
I am no more restless or wound up than usual 
I feel more restless or wound up than usual 
I am so restless or agitated it’s hard to stay still 
I am so restless or agitated I have to keep moving  
 or doing something 
r) 0   I can concentrate as well as ever 
1   I can’t concentrate as well as usual 
2   Its hard to keep my mind on anything for 
3   I find I can’t concentrate on anything 
I have not noticed any recent change in my interest
 in sex 
I am less interested in sex than I used to be 
I am much less interested in sex now 
I have lost interest in sex completely 
t) 0   I have not experienced any changes in m
     pattern 
1a I sleep somewhat more than usual 
1b I sleep somewhat less than usual 
2a I sleep a lot more than usual 
I have not experienced any change in my appetite 
My appetite is somewhat less than usual 
 My appetite is somewhat greater than usual 
My appetite is much less than before 
 My appetite is much greater than usual 
I have no appetite at all  
 I crave food all the time 
 2b I sleep a lot less than usual 
3a I sleep most of the day 
3b I wake up 1-2 hours early and can’t get b
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4. We would l
please choo
time. 
 
 How confident are you that you can… 
a) Get in
resou
 
b) Ask y
conce
 
c) Discu
proble
 
d) Work
arise?
 
e) Do all the t
on a reg
 
f) Judge 
should
 
g) Do th
mana
need to
 
h) Redu
conditi
life? 
 
i) Do thi
how mu
 
j) Reduc
k) Keep the fatigue caused by
interfe
 
l) Keep
illness from interfering 
to do? 
 
m) Keep
have from inte
 
n) Control a
so tha
to do? 
 
5. We woul
today.  For each of the foll
can / could 
 
 How confident are you that you can… 
a) Meet 
produc
 
b) Sugge
work t
 
ike to know how confident you are in doing certain activities.  For each of the following questions 
nt 
otally 
nfident
9 10 
9 10 
9 10 
9 10 
9 10 
9 10 
9 10 
work 
ce that you 
otally 
nfident
9 10 
se the number that corresponds to your confidence that you can do the tasks regularly at the prese
Not at all                                                                                           T
Confident                                                                                        co
formation about your cancer from community  
rces? 
1 2 3 4 5 6 7 8 9 10 
our doctor things about your cancer that  
rns you? 
1 2 3 4 5 6 7 8 
ss openly with your doctor any personal  
ms that may be related to your illness? 
1 2 3 4 5 6 7 8 9 10 
 out differences with your doctor when they  
 
1 2 3 4 5 6 7 8 
hings necessary to manage your condition
ular basis? 
1 2 3 4 5 6 7 8 9 10 
when the things in your illness mean you  
 visit your doctor? 
1 2 3 4 5 6 7 8 
e different tasks and activities needed to 
ge your health condition so as to reduce your 
 see a doctor? 
1 2 3 4 5 6 7 8 9 10 
ce the emotional distress caused by your health
on so that it does not affect your everyday  
1 2 3 4 5 6 7 8 
ngs other than just taking medication to reduce
ch your illness affects your everyday life? 
1 2 3 4 5 6 7 8 9 10 
e your physical discomfort or pain? 1 2 3 4 5 6 7 8 
 your illness from  
ring with the things you want to do? 
1 2 3 4 5 6 7 8 9 10 
 the physical discomfort or pain from your 
with the things you want 
1 2 3 4 5 6 7 8 
 any other symptoms or health problems you 
rfering with the things you want to do?
1 2 3 4 5 6 7 8 9 10 
ny symptoms or health problems you have 
t they don’t interfere with the things you want 
1 2 3 4 5 6 7 8 
 
d like to know how confident you are in doing certain activities at work today / if you were at 
owing questions, please circle the number that corresponds to your confiden
do the task at the present time: 
Not at all                                                                                           T
Confident                                                                                        co
your employer’s standards for quality of  
ts or services? 
1 2 3 4 5 6 7 8 9 10 
st to your supervisor ways to change your  
o reduce discomfort? 
1 2 3 4 5 6 7 8 
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c) Fulfil all of your duties and responsibilities? 1 2 3 4 5 6 7 8 9 10 
d) Change
disco
 
e) Expla
your co
 
f) Meet exp
g) Perform mos
h) Get co
cause d
 
i) Keep
j) Modify
k) Work at y
l) Get e
or talk
 
m) Avoid
n) Stop t
your w
 
o) Meet 
p) Reduc
q) Reduc
r) Mana
 
 
6. We are int
a) Are the d
Mental       
Physical        
Both mental and phy
 
b) Assume that 
current 
0 
w c) How do 
to the phy
Very good      
Rather goo
Moderate      
Rather poor    
9 10 
9 10 
9 10 
9 10 
9 10 
9 10 
9 10 
9 10 
9 10 
ve your 
10 
y in relation 
 the type of work activities you do to reduce  
mfort? 
1 2 3 4 5 6 7 8 
in any physical limitations you may have to  
-workers? 
1 2 3 4 5 6 7 8 9 10 
ectations for job performance? 1 2 3 4 5 6 7 8 
t of your daily activities at work? 1 2 3 4 5 6 7 8 9 10 
-workers to help you with activities that might
iscomfort? 
1 2 3 4 5 6 7 8 
 up with the pace at work? 1 2 3 4 5 6 7 8 9 10 
 the way you work to reduce any discomfort? 1 2 3 4 5 6 7 8 
our usual pace 1 2 3 4 5 6 7 8 9 10 
motional support from co-workers (e.g. listening
ing about any problems)? 
1 2 3 4 5 6 7 8 
 activities that are likely to cause discomfort? 1 2 3 4 5 6 7 8 9 10 
hinking about any discomfort so you can get  
ork done? 
1 2 3 4 5 6 7 8 
your production requirements? 1 2 3 4 5 6 7 8 9 10 
e your physical workload? 1 2 3 4 5 6 7 8 
e your mental workload?  1 2 3 4 5 6 7 8 
ge any discomfort effectively while at work? 1 2 3 4 5 6 7 8 
erested in your current work ability: 
emands of your work primarily? 
                        ∀ 
                     ∀ 
sical  ∀ 
your work ability at its best has a value of 10 points.  How many points would you gi
work ability? (0 cannot currently work at all to 10 work ability at best). 
 
1 2 3 4 5 6 7 8 9 
 
you rate your current work ability in relation
sical demands of the job? 
d)  How do you rate your current work abilit
to the mental demands of the job? 
∀ Very good       ∀ 
d   ∀ Rather good    ∀ 
 ∀ Moderate        ∀ 
∀ Rather poor     ∀ 
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Section B is to be completed by those that are currently working 
 
 
1. Have you told your line manager about your cancer? 2. Have you told your colleagues about your cancer?
 
Yes                                 No 
 
Yes                                 No 
 
 
3. With reference to the management of your cancer, have any changes been made to your work (e.g. working 
fewer hours, reduced workload, change in tasks, flexible hours)?  Please describe these briefly below. 
…………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
……………………………………………………………………………………………………………… 
 
 
 
……………………………………………………………………………..................... 
 
   
 
 
 
 
 
Section C is to be completed by those who have stopped working/long-term sick 
1. What best describes your current work status? 
 
2. How long have you been out of the workplace? 
a) On sick leave       
                
 a) Less than 1 week  
b) Unemployed 
 
 b) 1-2 s  
c) Retired 
 
 c) 3-4 weeks  
d) On incapacity benefit 
 
 d) More than a month    Please specify how  
   long  
Very poor       ∀ Very poor        ∀ 
week
Section B (Currently working) 
Section C (Currently not working) 
Thank you for completing Section A 
• If you are currently working please complete Section B only.  
• If you are not currently working (e.g. have stopped working, taken early retirement or are 
on sick leave) please complete Section C only. 
Thank you for completing Section B 
If you have any further thoughts that you feel are important please use the space 
provided at the end of this questionnaire. 
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3. Why did you decide to stop working? 
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
……………………………………………………………………… 
 
4. Did you leave with the intention of returning in the  
    future? 
5. If you decide to return to work in the future will  
    you… 
 
Yes                                 No 
 
Return to the same job         (Go to Q7) 
 
Change job                             (Go to Q6) 
 
N/A                                           (Go to Q7) 
 
6. What would be your reasons for changing job? 
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
…………………………………………………………………………… 
 
7. Have you told your line manager/supervisor about  
    your cancer? 
8. Have you told your colleagues about your cancer?
 
Yes                                 No 
 
Yes                                 No 
 
 
 
 
 
9. Since leaving work have you remained in contact  
    with your line manager/supervisor? 
 
 
10. Since leaving work have you remained in contact 
      with your colleagues? 
 
Yes                                 No 
 
Yes                                 No 
 
 
 
 
……………… ……………………………………………… …………………………
………………………………………………………………………… …………………………
………………………………………………………………………………………………………………
……………… ………………………………………………………………………………
………………………… ………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………… 
………………………………………………………………………………………………………………
……………… ……………………………………………… …………………………
………………………………………………………………………… …………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………… 
……
……
……
……
…………
……
……
…………
………… …… ……
…… ……
Thank you for completing Section C 
If you have any further thoughts that you feel are important please use the space 
provided overleaf. 
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………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………… 
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………… 
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
 
Wish to participate in future research?  
 
If you would like to be contacted to take part in any future research e.g. follow-up and/or 
interviews please complete the details below.  Any personal details will be kept confidential.   
 
 
Your name _______________________________________ Email address______________________ 
 
Contact telephone number (day)_____________________  (evening)__________________________ 
 
Please indicate most convenient time(s) to contact you _____________________________________ 
Thank you for taking time to complete this questionnaire.
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Why is this research important? 
We would like to gain an insight into the employment decisions of colorectal cancer patients. We are interested in your views on your health, 
your work and your feelings towards managing your health and work effectively. 
 
The purpose of this diary is to find out more about your experiences of managing cancer and work (if you are working).  By gathering 
information on your thoughts and experiences we aim to be in a position to design interventions to help people like you better manage cancer 
and employment.  With this information we can work with organisations and healthcare professionals to ensure that the necessary support and 
information is given to older working-aged patients.   
 
What do I have to do? 
Completion of this confidential diary is entirely voluntary, but we would be grateful for your help with this study because your contribution can 
make a big difference.  The diary overleaf should take approximately 15 minutes to complete.  There are three short sections to this diary: 
 
• Section A is to be completed by all participants 
 
• Section B is to be completed only by those who are currently working 
 
• Section C is to be completed only by those who have stopped working or who are on sick leave. 
 
Please be as frank and honest as possible.  Do not dwell too long on any one question as it is your initial thoughts and feelings that are most 
valuable.  Please return your completed questionnaire to us in the prepaid envelope provided, by (insert date). 
 
What happens after I have returned my diary? 
The diary will come back to the principal investigator (Manpreet Bains) at the University.  No one will see your diary entries.  The diary is 
anonymous, therefore, no individual can be identified. 
 
Participant No: 
Date:        Managing Cancer and Employment: Diary Sheet
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Any questions? 
Please feel free to contact Manpreet Bains, the principal investigator at the University on  (01509) 228 152, or M.Bains@lboro.ac.uk
 
Should the diary raise any health issues which you would like to discuss with someone, you should contact your clinician, nurse or 
Cancerbackup (0808 800 1234). 
 
 
Thank you for your time and help! 
 
Section A is to be completed by all participants 
1.  Please describe the 3 most important events that you have experienced  
over  the past 4 weeks. 
 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
 
 
 
 
 
 
2. How confident are you that you can do all the things necessary to manage  
your condition on a regular basis? (Please circle number that applies) 
 
Not at all                                                                                                                         Totally 
Confident       1       2       3       4       5       6       7       8       9       10       Confident 
 
 
3.  During the past 4 weeks please describe how confident you have felt about  
managing your illness (e.g. symptoms, treatment, diet)? 
 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
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                 Section A is to be completed by all participants     Section B is to be completed by those that are currently working 
 
 
 
 
 
                              Appendix 8 
             
  
  283 
 
4. What activities have you carried out to help manage your illness over the past 
4 weeks, for example, in terms of your diet, treatment, symptoms and so on? 
 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
 
 
1.  How confident are you that you can do all the things necessary to manage  
your work on a regular basis? (Please circle number that applies) 
 
Not at all                                                                                                                         Totally 
Confident       1       2       3       4       5       6       7       8       9       10       Confident 
 
 
2. During the past 4 weeks please describe how confident you have felt about  
managing your work  (e.g. tasks, hours)? 
 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
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Section B is to be completed by those that are currently working 
3.  What activities have you carried out to help manage your work over the past 4 
weeks, for example, in terms of your hours, work tasks and so on? 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
 
 
Section B is to be completed by those that are currently working 
4.   If you have any further thoughts that you feel are important please use the 
space provided below. 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
 
 
Section C is to be completed by those who have stopped working/sick leave 
1.  Are you thinking about returning to work?  Please could you explain your  
reasons for this? 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
2.  If you have any further thoughts that you feel are important please use the 
space provided below. 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
……………………………………………………………………………………... 
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Interview Information sheet 
 
Managing Cancer and Employment 
Background 
 
The nature of the patient and health professional relationship during cancer diagnosis 
and treatment is important.  Health professionals provide information to cancer patients 
on diagnosis, treatment and prognosis.  Although the potential effects of treatment are 
discussed with patients, little is known about the extent to which disease and treatment 
effects upon work capacity are discussed with working aged patients (Maunsell et al., 
1999; Verbeek, 2006).  Consequently, there is a need to explore the type and nature of 
work-related guidance / advice currently provided to patients in the UK by health 
professionals (consultant specialists, specialist nurses and occupational health 
physicians / advisors).  This will enable common patterns to be seen and identify 
subsequent improvements.       
 
Research Aim 
 
• To consider the extent to which health professionals provide work-related 
guidance / advice to individuals affected by cancer. 
 
What is involved? 
 
Your involvement 
 
• Participate in short interview lasting approximately 20 minutes.   
 
 
Confidentiality and ethical approval  
 
All information given will be kept strictly confidential and will only be accessible to the 
research team. The project is anonymous.  The identification of participants will not be 
made known. This project has been granted ethical approval by Loughborough 
University Ethical Advisory Committee.  As members of the British Psychological 
Society we are also bound by its Code of Conduct and Ethical Guidelines for research.  
 
Contact for further information (Principal Investigator) 
 
Miss Manpreet Bains BSc, MSc (PhD student) 
Department of Human Sciences,  
Loughborough University,  
Leicestershire, LE11 3TU 
Tel: 01509 223048    
E-mail: M.Bains@lboro.ac.uk 
 
This PhD project forms part of wider research collaboration between Dr Fehmidah 
Munir, Miss Manpreet Bains, Loughborough University and Dr Joanna Yarker, 
Goldsmiths College, University of London.  
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UInterview Schedule 
 
 
Introduction:  
 
We are conducting a series of interviews to explore the extent to which return to work 
information / guidance is provided to individuals affected by cancer.  To gain a broad 
and varied insight, we are conducting interviews with health professionals (oncologists, 
specialist nurses, occupational health) and health and safety managers. 
 
About you 
a) Briefly describe your job role? 
 
b) How much interaction do you have with patients / clients / employees? 
 
c) On average, how many cancer patients do you see each week? 
 
d) How often would you see or have contact with cancer patient / client diagnosed 
with cancer / employee diagnosed with cancer? 
 
e) When would you see patient / client with cancer / employee with cancer? (e.g. 
diagnosed, follow-up, upon RTW, as part of sickness absence procedures, ill-
health early retirement decisions) 
 
Current Practice 
a) In the past, if you have had a patient / client / employee diagnosed with cancer 
and in employment have you discussed, or given any advice on, how cancer 
may affect their ability to work? (If yes, probe) (If no, ask why, is the patient 
referred to anyone else/ directed to alternative information?) 
 
b) What type of work-related information do you give the patient / client / 
employee? (e.g. written, verbal, sign posting to a charity, advice in reports to 
GPS/employers) 
 
c) When do you tend to give this advice? and, when would be the ideal time? 
 
d) Are there any factors that influence the type of information / advice you give? 
(type of work / treatment). 
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e) Are there any common concerns / questions patients / clients / employees have 
raised with you about managing cancer and work? (If so, probe). 
 
f) When giving advice, or discussing work and cancer, are there any barriers to 
you giving as clear/ comprehensive advice as you would like? Is there any other 
clinical/ employment/ other information that would help you provide more 
targeted advice? How might you access this? 
 
g) Do you ever discuss the patient/ employees ability to work/ employment with 
others e.g. consultants, occupational health, line management? If so, what/ how 
do you go about this? If not, do you think this would be valuable to the patient/ 
how would / could it work? 
 
Usefulness of information – potential improvements 
a) Do you think the level of information about managing cancer and work currently 
provided to patients / clients / employees is sufficient?  (Probe – e.g. how could 
it be improved) 
 
b) Whose role do you think it is to provide information / guidance / advice about 
how cancer and its treatment may impact ability to work? 
 
c) When do you think it would be most appropriate to provide this information? 
 
d) What would be the most effective way to deliver information about how cancer 
can impact ability to work, and offer guidance about managing cancer and 
work? 
 
e) Would you recommend any strategies that would help patients / clients / 
employees manage their cancer and work? 
 
f) Do you think there is suitable and sufficient evidence base within your 
profession for you to draw on to enable you to confidently advise 
patient/client/employees on work-related issues? 
 
Do you have anything to add that you feel is of importance and has not 
already been covered? 
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CONSENT FORM 
 
UManaging Cancer and Employment 
 
              (Please Tick) 
 
1.  Do you understand the background to the study?     
                       ∀ 
 
2.  Have you had the chance to discuss this study and ask questions about it?                 ∀ 
 
3.  Have you had the satisfactory answers to all your questions?                    
 
 
4.  Have you been given enough information about the study?                    
 
 
5.  Do you understand that you are under no obligation to take part in the study?            
 
     
6.  Do you understand that you are free to withdraw from the study?   
                    
7. Do you understand that all information that you provide will be treated as  
      STRICTLY  CONFIDENTIAL? 
        
 
8.  Do you understand that any material used in project reports and academic                 
     papers will be used anonymously and will not identify you in any way?   
    
9.  Have you had enough time to come to a decision?                   
 
10.  Do you agree to take part in this study?      
 
Participant Name:    Date:  
Participant Signature:    
Investigator Signature 
